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Abstract 
Introduction: Cardiovascular disease (CVD) is the world’s biggest 
killer. In 2012, 43,946 people in Australia died from preventable 
cardiovascular-related diseases. Among cardiovascular diseases, coronary 
heart disease (CHD) is recognised as the leading cause of death in both men 
and women in Australia. Percutaneous coronary intervention (PCI) is a 
treatment option that patients with severe CHD may undergo as an elective 
or emergency procedure. Over the last 25 years the numbers of PCIs have 
steadily increased, both nationally and internationally. The literature 
identifies length of stay for PCI as anywhere between 1.0 and 3.6 days in 
Australia. This short length of stay has been shown to heighten patient 
anxiety, prevent the detection of both anxiety and depression, while also 
limiting nurse teaching time and patient opportunities for learning. Patients 
who undergo PCI may be discharged home without receiving and 
understanding education about their chronic disease state and self-
management. As a result, patients may develop various health 
misconceptions that may also contribute to a limited understanding of 
cardiac rehabilitation (CR) and its benefits. With the aforementioned issues 
identified, patients’ confidence or self-efficacy (SE) to manage post-PCI 
may be reduced, while anxiety may be enhanced. Thus, a nurse-led clinic 
was trialled with the primary aim to enhance SE and reduce anxiety. 
Secondary aims were to reduce symptoms of depression and to encourage 
effective post-discharge self-management. Areas of self-management 
targeted included complication identification and management, medication 
adherence, and CR attendance. 
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Methods: This study was undertaken as a pilot study in two phases 
utilising an experimental design and Bandura’s self-efficacy (SE) theory as 
the underpinning theoretical framework. Phase One implemented a nurse-
led clinic intervention and was undertaken to determine the feasibility for a 
Phase Three, multicentre study. In Phase Two, the principal investigator (PI) 
interviewed a subset of intervention group participants and healthcare 
professionals about the nurse-led clinic in relation to the educational 
benefits, content, timing, and its potential effect on primary and secondary 
aims. Participants were recruited from two hospital sites, one private and 
one public hospital. After satisfying eligibility criteria, participants gave 
informed consented and baseline data were collected. A total of 188 
participants were screened, with only 33 participants recruited and 
randomised to the study. Well-validated assessment tools were used to 
measure primary and secondary outcomes. Salivary cortisol assays were 
undertaken to measure acute stress in all participants. In Phase One, 
intervention group participants attended a one-on-one, face-to-face, nurse-
led clinic on day 5–7 post-discharge from hospital. Participants received 
tailored education and support while also undergoing a primary health 
assessment, physical examination, and psychological assessment for anxiety 
and depression. The nurse-led clinic assessment took approximately 45 to 
60 minutes to complete. Follow-up measures for all participants were 
assessed at the following time-points: Baseline (Time 1), day 5–7 post-
discharge (Time 2: pre-intervention), 1 month post-discharge (Time 3: post-
intervention), and 3 months post-discharge (Time 4: post-intervention).  
Results: Although it was expected that this intervention would 
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achieve primary and secondary aims, results did not demonstrate strong 
support for the study’s hypotheses. Cardiac Self-Efficacy (CSE) (d=0.60) 
and trait anxiety (d=0.50) evidenced a positive moderately reducing effect 
for intervention group participants, while nil effect was evidenced on CSE 
(d= -0.19) or trait anxiety (d=0.16) on randomisation to the standard care 
group. The primary endpoint at Time 3 (1 month) was chosen as this was 
the best time to gauge an effect of the nurse-led clinic on psychological 
distress, salivary cortisol levels, and post-discharge complications. Small 
enhancements were evidenced in mean ratings for some CSE items and 
included: (a) confidence to lose weight, (b) confidence to change diet, (c) 
confidence in physical activity, (d) confidence to maintain usual work 
activities, and (e) confidence to control breathlessness by taking 
medications. Medication adherence was maintained in both groups while re-
attendance to CR was a challenge. 
Phase Two analytical findings indicated that intervention group 
participants felt supported by the nurse-led clinic and, thus experienced a 
sense of self-awareness and an ability to self-manage (i.e., complications, 
medications) after attending. Healthcare professionals commented on the 
potential benefit to participants in terms of the level of interaction and 
methods of information delivery. Early repetition of PCI education outside a 
busy hospital setting was highlighted as potentially effective in enhancing 
SE, reducing anxiety, and facilitating self-management. Furthermore, as the 
nurse-led clinic was conducted by a registered nurse (RN), the PI considered 
this to be a substantial benefit as participants could ask questions from an 
informed healthcare professional and, therefore, reduce post-discharge 
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anxieties. Suggestions for nurse-led clinic improvements by healthcare 
professionals included greater influence to encourage CR re-attendance, and 
encouraging patient discussion with a doctor (i.e., general practitioner [GP] 
or cardiologist) if contemplating medication cessation. Additionally, 
healthcare professionals also recommended cautioning participants about 
the potentially inaccurate health information available on the internet and 
offer a list of reputable websites.   
Conclusion: This intervention, particularly Phase Two descriptive 
evaluative feedback, has demonstrated preliminary evidence to support a 
Phase Three, multi-centre study investigating the effects of the nurse-led 
clinic on SE and psychological distress in cardiovascular patients. Although 
the Phase One quantitative results did not demonstrate unequivocally the 
utility of the nurse-led clinic, Phase Two feedback from both healthcare 
professionals and intervention group participants provided support for the 
clinic’s potential. This nursing intervention is within the scope of practice of 
an RN and could be carried out by a level 2 clinical nurse (CN) in the 
cardiac catheterisation theatre (CCT), hospital ward and/or outpatient setting 
(i.e., cardiology practice). Overall, the present study has provided some 
initial evidence that nurse-led clinics may be effective in providing post-PCI 
patients with early post-discharge support and education. This study 
provides preliminary evidence that nurse-led clinics undertaken within the 
first week post-PCI may fill a much-needed gap in support and information 
for patients during a potentially vulnerable post-discharge period and is in 
line with a focus on person-centred care. Undertaking a Phase Three, multi-
centre study is thus an important future consideration to establish whether 
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behavioural changes following nurse-led clinic attendance can be 
maintained in the medium to long term. 
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Chapter 1: Introduction 
Chapter 1 outlines the research background, context, purpose, and problem. 
The research aims, questions, and hypotheses for Phase One and Phase Two of the 
study are also presented. An overview of the theoretical framework that guides this 
study is discussed and its application and importance specified. The remaining 
chapters of the thesis are outlined in Section 1.6 
1.1 Background and Context 
The following section provides background and context to justify undertaking 
the present study. The subsections explore and highlight the research gap and issues 
surrounding the post-discharge period after a percutaneous coronary intervention 
(PCI). Furthermore, the problems identified aim to clarify how they may affect SE 
from hospitalisation through to the post-discharge period. The concept of a nurse-led 
clinic will also be introduced in subsection 1.1.6 with the benefits to healthcare and 
managing patients with chronic illness highlighted. Chapter Two explores the 
theoretical framework, the research problem and post-discharge gap in greater depth. 
1.1.1 Cardiovascular Disease (CVD) Statistics, Coronary Heart Disease 
(CHD), and Implications 
The term cardiovascular disease (CVD) describes a group of disorders of the 
heart and blood vessels (World Health Organization [WHO], 2015). This group of 
diseases is responsible for the death of one Australian every 12 minutes and may 
include: coronary heart disease (CHD), cerebrovascular disease, peripheral arterial 
disease, rheumatic heart disease, congenital heart disease, deep vein thrombosis, and 
pulmonary embolism (National Heart Foundation of Australia [NHFA], 2015; WHO, 
2015).  
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Cardiovascular disease is still annually the world’s biggest killer (WHO, 
2015). Between 2011 and 2012, there were 523,805 people hospitalised in Australia 
as a result of CVD, while in 2012 some 43,946 Australians died from preventable 
cardiovascular-related diseases (NHFA, 2015). Of the cardiovascular diseases, CHD 
is responsible for the death of 55 Australians daily and 20,046 in 2012 (NHFA, 
2015). In 2012, approximately 17.5 million deaths occurred worldwide as a result of 
CVD, with one American dying every 40 seconds (Go et al., 2013; WHO, 2015). 
While cardiovascular disease is no longer the biggest killer in the United Kingdom 
(UK), CHD was responsible for 74,000 deaths in 2012 (Townsend, Williams, 
Bhatnagar, Wickrahmsinghe, & Rayner, 2014). Cardiovascular disease is the cause 
of most deaths in Europe, with CHD and stroke identified as the highest precursor 
(Nichols, Townsend, Scarborough, & Rayner, 2013a; Nichols, Townsend, 
Scarborough, & Rayner, 2013b). Furthermore, CVD is accountable for over 4 
million deaths in Europe and the European Union with CHD responsible for 
approximately 1.8 million deaths annually (Nichols et al., 2012; Nichols et al., 
2013a; Nichols, Townsend, Scarborough, & Rayner, 2014). Cardiovascular disease 
is the leading cause of deaths in males and females both nationally and 
internationally (Go et al., 2013; NHFA, 2015; Nichols et al., 2012; Nichols et al., 
2013a, Nichols et al., 2014; Townsend et al., 2014; WHO, 2015).  
It is estimated that, each year, the effects of CVDs are costly to the healthcare 
system both nationally and internationally, with $7.6 billion dollars spent on the 
disease in Australia annually (Go et al., 2013; National Vascular Disease Prevention 
Alliance [NVDPA]/NHFA, 2014; Nichols et al., 2012; Tarride et al., 2009; 
Townsend et al., 2012). With the burden of CVD (a non-communicable disease 
[NCD]), the WHO (2014) highlight the importance of implementing a group of NCD 
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interventions globally. The WHO (2014) aim to achieve nine targets and reduce the 
burden and cost of NCDs by 2025. Tarride et al. (2009) and the NVDPA/NHFA 
(2014) also highlight the increasing financial burden (both direct and indirect) on 
healthcare as a result of growing population obesity rates and increasing life 
expectancy. The burden of CVDs and, in particular, CHD means that health funders 
are favouring prevention programs, therapies, and management systems and 
procedures such as percutaneous coronary interventions (PCIs) that require shorter 
lengths of stay in hospital or are managed outside of the hospital system entirely 
(Blair, Corrigall, Angus, Thompson, & Leslie, 2011; Chin et al., 2011; Laarman & 
Dirksen, 2010; Mavromatis, 2013; Tarride et al., 2009).  
Percutaneous coronary intervention aims to restore blood flow to the 
myocardium in patients with CHD (Australian Institute of Health and Welfare 
[AIHW], 2014). It is not only cost efficient to discharge patients who have 
undergone successful PCIs early, but it is vital for individuals to be in the comfort of 
their own home, and to be mobile (Laarman & Dirksen, 2010). Furthermore, being 
discharged to home minimises the patients’ risk of infection and psychological 
distress (Laarman & Dirksen, 2010). There have been some consequences of this 
rationalisation of healthcare that include longer waiting times for follow-up to access 
GPs, cardiologists, and cardiac rehabilitation (CR) clinics in the outpatient setting 
(British Heart Foundation [BHF], 2010; 2011; Cupples et al., 2010; Dafoe, Arthur, 
Stokes, Morrin, & Beaton, 2006; Lacey, Tozer, & Cacavas, 2010). More concerning 
are the extremely poor and varying compliance and attendance rates to programs like 
CR worldwide. Referral rates to CR are also a problem, with Australia reporting as 
low as 11% and course attendance rates ranging from 10 to 30% (Arena et al., 2012; 
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BHF, 2014; Colbert et al., 2013; Clark, Redfern, & Briffa, 2013; Cupples et al., 
2010; Gallagher et al., 2013; Heartwire, 2011; NHFA, 2014; Varnfield et al., 2011).  
1.1.2 Percutaneous Coronary Intervention (PCI), Post-Discharge Issues 
and Gaps 
Clearly, there are gaps within current practice that emphasise the importance of 
understanding CHD. The intention of this research was to study and test the 
effectiveness of a nurse-led follow-up clinic within 5–7 days post-PCI. The two main 
types of PCIs are with and without coronary stenting (AIHW, 2014). Percutaneous 
coronary intervention without stenting, or coronary angioplasty, involves the 
inflation of a balloon in the affected coronary artery to dilate the artery(ies) and 
remove the plaque (AIHW, 2014). Coronary artery stenting entails the deployment 
of stents, which are identified as “expandable mesh tubes”, to allow for 
revascularisation of the diseased coronary artery(ies) (AIHW, 2014, p. 74).  
1.1.3 Percutaneous Coronary Intervention: Statistics  
Although PCI procedure rates in Australia appear to be stabilising, there has 
been a steady increase in PCIs in the last 25–30 years both nationally and 
internationally (AIHW, 2014; Dehmer et al., 2014; Go et al., 2013; Nichols et al., 
2012; Townsend, Williams, Bhatnagar, Wickramasinghe, & Rayner, 2014). The age-
standardised rates for PCI in Australia between 2000/2001 and 2012/2013 increased 
by approximately 27%, while it remained stable for men and women in 2007/2008 
(AIHW, 2014). The rates for PCI in Australia gradually increase for all groups until 
the ages of 75–84 and then decline for the 85 years and older age group (AIHW, 
2014). Percutaneous coronary intervention rates in European countries and the EU 
vary with Germany displaying the highest rates for PCI, while PCI rates in the US 
have increased (Go et al., 2013; Nichols et al., 2012). Interestingly, in Australia, 
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coronary angiography rates and medical treatment for acute coronary syndrome 
(ACS) is increasing (i.e., antiplatelet, antihypertensive, and lipid-reducing therapies) 
(AIHW, 2012; 2014). With the current trends changing, an intervention to improve 
the post-discharge follow-up care, education, and support of PCI patients was 
deemed necessary. Additionally, with an increase in medical therapies and an ageing 
population, the intervention appeared timely as it can be extended to the 
management of patients with ACS, and diagnostic cardiovascular procedures such as 
coronary angiography (i.e., with CHD diagnosis) outside the hospital setting (AIHW, 
2010; 2012; BHF, 2010; Molina & Heng, 2009; NVDPA/NHFA, 2014; Townsend et 
al., 2014). Moreover, as hospital length of stay for PCI and cardiac events are 
declining, the need to investigate the effects of post-discharge follow-up within the 
first week of discharge in chronic disease patients it appeared that an outpatient, 
tailored post-PCI nurse-led educational intervention with a person-centred approach 
was warranted (AIHW, 2012, 2014; Tuso et al., 2013; Yu, 2014). Furthermore, with 
the cost burden to the healthcare system (for CVDs and in particular, CHD), an 
outpatient, nurse-led clinic may assist in reducing or keeping costs to a minimum by 
preventing or minimising post-discharge readmissions (Blair et al., 2011; Go et al., 
2013; Nichols et al., 2012; NVDPA/NHFA, 2014; Tarride, 2009; Townsend et al., 
2012; WHO, 2014). The following section identifies further issues surrounding 
hospitalisation and the post-discharge period for cardiac patients.  
1.1.4 Psychological Distress, Patient Education, and Timing 
Anxiety disorders affect approximately 20% of the population and are the most 
common psychological disorders in the population (Weiner & Craighead, 2009). 
Symptoms that can be experienced include fear, muscle tension, sleep disruption, 
poor concentration, and avoidance (Weiner & Craighead). Diagnosis of anxiety 
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disorders may include individuals reporting feeling distressed by the symptoms 
suffered or that their lives may have been considerably affected by symptoms 
experienced (Weiner & Craighead). Approximately 70–80% of patients who 
experience an “acute cardiac event” experience anxiety (Moser, 2007, p. 362). An 
international study of 912 post-acute myocardial infarction (AMI) patients identified 
anxiety in participants—46% (Australian), 35% (English), 43% (Japanese), 52% 
(South Korean), and 50% (American) (Moser, 2007, p. 363). While patients 
identified in the present study underwent PCI, patients in Moser’s (2007) study 
experienced a cardiac event, highlighting anxiety experienced by cardiac patients. 
Moreover, the findings of anxiety in such large numbers of patients are important 
and support the need to undertake the present study to provide early post-discharge 
education and support, routinely screen for anxiety, and refer for management if 
required (Moser, 2007, p. 363). 
The link between anxiety, depression, and cardiovascular events is highlighted 
in the literature and was investigated in this study, given the nature of the PCI 
procedure and the declining length of stay for PCI patients (AIHW, 2011; Chin et al., 
2011; Colquhoun et al., 2013; Damen et al., 2011; Davidson et al., 2008; Heart 
Foundation, South Australia Division, 2011; Lane, Carrol, & Lip, 1999; NVDPA, 
2012; Parissis et al., 2011; Riccardi et al., 2012). With the current trends based on 
sound clinical grounds favouring an earlier discharge, some patients may fail to 
receive any pre-discharge education or advice on the management of their condition 
(phase one CR) or even referral to a CR program (AIHW, 2011; Briffa et al., 2009; 
Bunker & Goble, 2003; Clark et al., 2013; Fischer, 2008; Flynn, Cafarelli, Petrakos, 
& Christopherson, 2007). Additionally, with the period between discharge and CR 
commencement being reported as a vulnerable time (particularly the first week post-
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discharge), the present study was warranted (Günal  et al., 2008; Rassaf, Steiner, & 
Kelm, 2013; Trotter, Gallagher & Donoghue, 2011; Tuso et al., 2013; Yan et al., 
2011; Wong, Wu, Chan, & Yu, 2006).  
The ongoing debate concerning best timing for patient education and delivery 
mode (i.e., face-to-face, online, telephone) is well argued and continues within the 
literature, with recommendations for pre-procedural education, ongoing repetition 
into the post-discharge period, and self-education (Asilioglu & Celik, 2004; 
Catherine, 2005; Chair & Thompson, 2005; Davis, Maguire, Haraphongse, & 
Shaumberger, 1994; Di’Amore, Murray, Powers, & Johnson, 2011; Hobbs; 2002; 
Johnson, 2000; Lyons, Fanshawe, & Lip, 2002; Trotter, Gallagher, & Donoghue, 
2011; Tuso et al., 2013). Based on experiences as an RN and an in-depth review of 
the literature, the PI selected a time (day 5–7) and delivery mode (face-to-face) best 
suitable to review (physical and psychological assessment) post-procedural PCI 
patients, and to repeat basic post-PCI patient education (Tuso et al., 2013; Wong et 
al., 2006). Furthermore, the intervention was undertaken to allow for questions to be 
asked as patients would have had time to reflect on their recent hospitalisation and 
procedure. The first week post-discharge was selected, along with a face-to-face 
delivery mode, as it was anticipated that more-effective education could take place, 
and SE may be enhanced. Additionally, with less distraction (unlike during 
hospitalisation), it was hoped that health behaviour change and maintenance could 
occur through enhancing SE, reducing anxiety, and effectively communicating the 
importance of health promotion and prevention (Holloway & Watson, 2002).  
As patient education is imperative, the short length of stay, limited staffing, 
knowledge deficits, limited nurse-teaching time, and patient anxiety during 
hospitalisation all contribute to poor information retention (Holloway & Watson, 
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2002). The importance of early follow-up has been widely discussed within the 
literature, with recommendations for post-discharge telephone follow-up for high-
risk patients within 72 hours post-discharge and a post-discharge visit with a 
“primary care physician” within 1 week post-hospital discharge (Grace et al., 2012; 
Lane et al., 1999; Lauck et al., 2009; Tuso et al., 2013; Wong et al., 2006). 
Moreover, recommendations from a heart failure study by Hernandez et al. (2008) 
revealed that if patients were followed up within 1 week post-discharge the hospital 
readmission rate for those reviewed was 10% versus 31% for those who were not 
followed up by a primary care physician at this time (Tuso et al., 2013, p. 61). Tuso 
et al. (2013) encourage further research investigating the implications of early post-
discharge follow-up (the first week post-discharge by a primary care physician) in 
patients with chronic disease as research in this area is limited, highlighting the 
importance of the present study. Thus, the timing of the nurse-led intervention at 
Time 2 (day 5–7 post-discharge) was investigated utilising a face-to-face mode for 
education based on the aforementioned arguments presented. 
1.1.5 Health Misconceptions and Wait Times 
It is interesting to note that some patients may have altered perceptions of their 
disease state and may both believe and accept that they have been cured of CVD 
(Carroll, 2005; Gaw, 1992; Young & Murray, 2011). The impression that they are 
cured may be as a result of their healthcare professional advising that “We fixed the 
artery”, or “We fixed the culprit narrowing” (Carroll, 2005; Young & Murray, 2011, 
p. 29). Moreover, the short length of stay, coupled with anxiety, a decreased capacity 
to concentrate (in the presence of psychological distress), poor information retention, 
and inadequate pre-discharge education may result in additional health 
misconceptions (Carroll, 2005; Gallagher et al., 2013; Heart Foundation, South 
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Australia Division, 2011; Young & Murray, 2011). The lack of preparedness for 
discharge home and ongoing health management as a result of patients’ 
misconceptions may result in (a) risk factor and behaviour misconceptions, (b) poor 
CR attendance (or not at all), (c) poor medication adherence and compliance, and (d) 
complication identification and management issues (Carroll, 2005; Clark et al., 2013 
Gallagher et al., 2013; Heart Foundation, South Australia Division, 2011; Young & 
Murray, 2011).  
The short amount of time for hospitalisation is discussed well in the literature 
and comes with both positive and negative consequences, which will be presented 
later in this chapter. The average length of stay in Australia after undergoing PCI 
ranges from 1.0 to 3.6 days; while internationally, hospitalisation in the USA ranges 
between 2.7 and 3.6, and between 2.8 and 10.2 days in London, UK (AIHW, 2012; 
Astin, Closs, McLenachan, Hunter, & Priestly, 2009; Astin, Jones, & Thompson, 
2005; Chin et al., 2011; Corones, Coyer, & Theobald, 2009; Cronin, Freeman, Ryan, 
& Drake, 2000; Davis et al., 1994; Department of Human Services [DHS], 2008; 
Kattainen, Merilainen, & Jokela, 2004; National Institute For Health Research 
[NHS], 2008; Thomson Reuters, 2013; Tooth & McKenna, 1995; Wong et al., 2006; 
Yan et al., 2011). Cosman, Arthur, and Natarajan (2011) highlight the short 
hospitalisation for coronary artery catheterisation and uncomplicated PCI to be 
anywhere between 6 to 24 hours, reinforcing the diminishing length of stay. 
Importantly, coupled with a coronary event, patients who undergo PCI may also 
experience anxiety and depression (AIHW, 2011; Lane et al., 1999). Anxiety and 
depression are well-reported in the literature, with the presentation of symptoms 
often occurring in the post-discharge period due to the short hospitalisation (AIHW, 
2011; Astin et al., 2009; Astin et al., 2005; Colquhoun et al., 2013; Corones et al., 
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2009; Chin et al., 2011; Cronin et al., 2000; Davis et al., 1994; Kattainen et al., 2004; 
Lane et al., 1999; Tooth & McKenna, 1995; Wong et al., 2006; Yan et al., 2011).  
Currently, a significant gap of between 7 and 64 days exists between the period 
in which patients are discharged from hospital post-PCI, reviewed by their GP or 
cardiologist, and attend a CR program (BHF, 2014; Cupples et al., 2010; Dafoe et 
al., 2006; Grace et al., 2012; Heart Foundation, Western Australia, 2012; Lacey et 
al., 2010; Pack et al., 2013; Shakib, Philpott, & Clark, 2009). The presence of 
anxiety and depression during this period is highlighted and may preclude the 
understanding of information delivered during hospitalisation, thus warranting the 
trial of the present study in the early post-discharge period (Kattainen et al., 2004; 
Kristofferzon, Lofmark, & Carlsson, 2007; Lauck, Johnson, & Ratner, 2009). 
Furthermore, the short hospitalisation for PCI precludes effective nurse–patient 
teaching, therefore limiting time for effective health education, promotion and 
prevention (Holloway & Watson, 2002; Young & Murray, 2011).  
Effectively delivering tailored health-specific education can increase SE and 
enable behaviour change; however, given the short length of stay for PCI patients, 
facilitating enhancements in SE and encouraging behaviour change and correcting 
health misconceptions may not be possible (Holloway & Watson, 2002). As a result 
of the short length of stay and consequences, the literature highlights a poorer 
understanding of patient experience, their underlying CVD, risk factor modification, 
medication knowledge, and adherence (The Heart Foundation, South Australia 
Division, 2011; Young & Murray, 2011). Young and Murray (2011) highlight the 
post-discharge period as a challenge in that, during a short admission, patients are 
essentially forced to comprehend and absorb the information disclosed to them and 
are expected to be able to effectively manage themselves post-discharge. 
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Additionally, the associated health misconceptions post-PCI have been widely 
reported in the literature, with patients believing they are cured of their CHD and do 
not need to make lifestyle adjustments (i.e., diet and exercise), or attend a secondary 
prevention program (Astin et al., 2009; Gaw, 1992; Young & Murray, 2011).  
There is a large under-referral and under-attendance rate to secondary 
prevention programs, along with issues surrounding the post-discharge period and 
the patient’s needs during this time (Bethell, Evans, Turner, & Lewin, 2006; Briffa et 
al., 2009; Cupples et al., 2010; Corones et al., 2009; Dolansky et al., 2010). 
Moreover, complication identification and management and medication adherence 
also present with issues during the post-discharge period (Bethell et al., 2006; Briffa 
et al., 2009; Cupples et al., 2010; Corones et al., 2009; Dolansky et al., 2010; Yan et 
al., 2011). The table displayed in Appendix A presents various publications 
highlighting the presence of anxiety among patients who have experienced a 
coronary event, along with potential post-discharge complications. Furthermore, this 
table highlights a post-discharge period gap between the day of discharge from 
hospital, cardiologist review, and commencement of CR, thus supporting the need 
for this study. Subsection 1.1.6 introduces the concept of a nurse-led clinic, the 
benefits to patients with chronic illness and healthcare. Chapter 2 discusses nurse-led 
clinics in greater depth.  
1.1.6 Nurse-led Clinics  
Schadewaldt and Schultz (2011) identify a nurse-led clinic as a service for 
patients that is solely directed by specialist nurses. In addition to managing the 
clinics, the clinic nurses also engage in patient monitoring and support (Schadewaldt 
& Schultz). Nurse-led clinics exist for patients with chronic disease in areas such as 
respiratory, vascular, obesity, diabetes, cancer, palliation, chronic kidney disease 
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(CKD), hypertension, and CHD identified in the literature. These clinics focus 
primarily on patient education and health promotion (Chummun, 2011; Hatfield et 
al., 2008; The Joanna Briggs Institute [JBI], 2010; Schadewaldt & Schultz, 2011). 
There are various types of nursing care in chronic disease management (CDM), with 
Forbes and While (2009, p. 122) identifying the following types of nursing 
involvement:  
Nurse-led care: “the nurse identifies the needs and then organises a care 
 package or refers to others; independent nursing practice”. 
Nurse-led and nurse-delivered care: “the nurse identifies the needs and 
 manages the problem herself; independent nursing practice”. 
Nurse-delivered care: “the nurse provides care under the direction of others, a 
 more advanced nurse or a doctor; dependent nursing practice”. 
Nurse-led clinics have been identified as successful in meeting short-, 
medium- and some long-term goals, with further research suggested to investigate 
the maintenance of long-term patient outcomes in nurse-led clinics (Hatfield et al., 
2008; JBI, 2010; Schadewaldt & Schultz, 2011). Chummun (2011) highlights 
success in hypertension management with nurse-led clinics receiving recognition for 
exceptional team support, achieving medication compliance, and diminishing patient 
complications; while Hatfield et al. (2008) highlight the benefits in risk reduction in 
nurse-led vascular clinics that use patient care-paths and encourage effective self-
management.  
While not curative, nurse-led clinics may provide a better quality of life (QOL) 
for patients with chronic disease as they may be more closely monitored in the 
community, thus preventing the worsening of their condition (Hatchett, 2005). 
Furthermore, while nurse-led clinics may encourage effective self-management and 
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prevent patient deterioration, they may also offer a therapeutic nurse–patient 
relationship (Hatchett, 2005; Hatfield et al., 2008). Continuity of care and patient 
centeredness may contribute to this relationship in that patients should be treated as 
people, as opposed to their illness (Hutchison et al., 2011). Conversely, while 
continuity of care presents as beneficial, in order for patients to be satisfied with the 
relationship they needed to have trust in the healthcare professional (Mahomed, St. 
John, & Patterson, 2012).  
Nurse-led clinics for patients with CHD are widely discussed in the literature 
with the benefits highlighted (JBI, 2010; Schadewaldt & Schultz, 2011; Thompson, 
Quinn, & Stewart, 2002). Thompson et al. (2002) identify that, if undertaken early, 
nursing interventions aimed at psychological wellbeing and education may result in a 
reduction in psychological distress, enhanced patient knowledge and satisfaction 
reported at 6-months post-hospitalisation (Thompson et al., 2002). Furthermore, 
nurse-led clinics are reported to reduce cardiac risk factors in both healthy patients, 
patients with diagnosed CHD, and those with cardiovascular risk factors (JBI, 2010).  
As a result of modern medicine, people are living longer, including those with 
chronic illness, with a rise in chronic diseases observed (Barlow, Wright, Sheasby, 
Turner, & Hainsworth, 2002; Forbes & While, 2008; Thorne, 2008). While acute 
illnesses place a demand on the healthcare system, so too does chronic illness 
(Barlow et al., 2002). With this increased demand placed on the healthcare system 
and medical staff, there is a need for nurse-led clinics (Hatchett, 2005; Hutchison et 
al., 2011; Queensland Health, 2013). Additionally, as the cost to manage chronic 
diseases is high, developing and instituting cost-effective and clinically effective 
measures to support patients with chronic disease is essential (Forbes & While, 
2008). Furthermore, while nurses are currently providing supportive roles (i.e., 
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primary and secondary prevention) in supporting patients with chronic illness, it is 
timely and important to undertake the present study in the form of a nurse-led clinic 
(i.e., nurse-led care), with a person-centred approach (Forbes & While, 2008; WHO, 
2007; Yu et al., 2014).  
1.2 Theoretical Framework: The Self-Efficacy Theory  
1.2.1 Self-Efficacy Theory (SE), Self-Management, and Cardiovascular 
Disease 
Bandura’s (1977) SE theory, which developed from the social cognitive theory 
(SCT) was used as the theoretical framework to guide this study. Bandura’s (1977) 
SE theory is based on the premise that a person’s beliefs about their individual 
abilities, “mastery and vicarious experiences” can forecast performance outcomes 
(Bandura, 1995; Callaghan, 2003). Bandura highlights how mastery and vicarious 
experiences can lead to a strong SE (Bandura, 1995, p. 3). SE influences a person’s 
feelings, thoughts, behaviours, and motivation (Zulkosky, 2009). Zulkosky (2009, p. 
94) identifies an association between low perceived SE and “stress, anxiety and 
helplessness” and highlights how individuals with lower SE experience poor 
motivation, low self-esteem, and are pessimistic, particularly concerning personal 
achievements and growth (Zulkosky, 2009). Conversely, those with higher SE 
perform at a high level, are motivated, and will persist in order to accomplish 
challenges (Zulkosky, 2009). Bandura (1989, p. 1175) identifies SE beliefs as 
essential in that they influence “motivation, affect and action”. Thus, a person with a 
higher perceived SE will have greater confidence, ambition, and dedication to 
achieve their goals (i.e., both short- and long-term) (Zulkosky, 2009).  
The concept of SE was important to this study as the primary aim was to 
enhance patients’ SE and reduce anxiety. It was anticipated that, by undertaking the 
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nurse-led clinic within the first week post-discharge, participants’ perceived SE 
would improve. The PI anticipated that as participants developed the confidence and 
motivation to manage aspects of their post-discharge health and behaviours that SE 
would be enhanced and anxiety (i.e., trait anxiety) reduced. As highlighted earlier, a 
person with high perceived SE is more motivated and has the confidence and 
persistence to accomplish personal tasks and achieve growth (Zulkosky, 2009).  
Anxiety, in relation to SE as identified by Schuster (1990, p. 11), is due to 
“coping inefficacy”. In stressful situations, where inefficacy is experienced, anxiety 
is heightened (Bandura, 1988). In the present study, it was hoped that by enhancing 
participants’ SE, any anxiety experienced in the post-discharge period could be 
reduced. The PI also anticipated that in reducing anxiety, and enhancing SE as 
primary aims, that secondary aims facilitating post-PCI effective self-management 
would be initiated and/or improved. Butki, Rudolph, and Jacobsen (2001, p. 1129) 
identify how Bandura’s theory proposes a relationship between high perceived SE, 
reduced anxiety, and “biological response” to stress, which is why anxiety reduction 
was identified as a primary aim. In the present study, Spielberger’s trait anxiety 
construct was measured.  
Dehdari, Heidarnia, Ramezankhani, Sadeghian and Ghofranipour (2008) 
highlight the impact of anxiety after a coronary event, particularly on health 
outcomes, symptoms, and QOL. Dehdari et al. (2008) recognise the negative 
psychological effects of anxiety post-cardiac event and identify SE as essential 
health determinant in this group of patients (Dehdari et al., 2008). As patients who 
undergo PCI endure a short hospitalisation, the authors identify limited time 
available for psychological interventions and to prepare patients for discharge 
(Dehdari et al., 2008). Dehdari et al. (2008) reinforce the relationship between SE 
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and anxiety in PCI patients, highlighting that a patient with higher uncertainty has 
lower “perceived control” (pertaining to SE), high anxiety and depression levels, and 
poorer coping (Dehdari et al., 2008). It was anticipated that undertaking a nurse-led 
clinic, providing education and support for PCI patients in the first week post-
discharge, could enhance SE, reduce anxiety, while also achieving the secondary aim 
to reduce symptoms of depression. It was also hoped that by highlighting areas of 
self-management and behaviour change that short-term goals could be identified, set, 
further explored and maintained long-term through attendance at a CR program (i.e., 
medication adherence, CR attendance, complication identification and management).    
The SE theory is based on the premise that an individual’s beliefs (or efficacy 
beliefs) and confidence in their abilities to master a task can predict the outcome and 
enhance SE (Bandura, 1977). The SE theory has been widely used in health 
educational interventions to encourage or measure behaviour change and to facilitate 
effective self-management (Bandura 1995; Holloway & Watson, 2002; Sarkar, Ali, 
& Whooley, 2007). Self-efficacy is often of interest in sufferers of chronic disease, 
particularly patients with CVD and, more specifically, those with CHD as it 
illustrates how behaviour, personal factors, and the environment all interact in 
chronic illness (Frei, Svarin, Steurer-Stey, & Puhan, 2009; Kang, Yang, & Kim, 
2010; Rasheed et al., 2012; Sarkar et al., 2007; Sullivan, LaCroix, Russo, & Katon, 
1998). Sarkar et al. (2007) highlight the extensiveness of the SE theory and how the 
construct of SE may be applied in areas other than psychology, with successful 
application in health behaviour change and chronic disease.  
Cardiac rehabilitation (CR) programs often adopt the SE theory to gauge the 
outcomes of CR on SE in patients with CVD (Sarkar et al., 2007). Frei et al. (2009) 
highlight how SE assessment in patients suffering chronic diseases is essential as it 
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aids patient education. Furthermore, Frei et al. (2009) identify that by measuring SE, 
its levels (i.e., low levels in patients) can be identified and the CR program can then 
be tailored to the patient with the view to enhance SE. The authors also identify the 
importance of SE measurement over time so that the effect of the educational 
intervention can be gauged (Frei et al., 2009, p. 2). Lastly, measuring SE can also 
allow for comparison and contrast between patients and potentially anticipate various 
health-related outcomes and events (Frei et al., 2009).  
Corbin and Strauss (1988, p. 30) identify that after a person receives a 
diagnosis of a chronic illness there may be a time of “diagnostic limbo” for patients 
and they may continue to seek answers. Corbin and Strauss (1988) highlight that 
during this period of uncertainty patients explore and seek information about their 
diagnosis. Furthermore, although after receiving a diagnosis, there may still be 
uncertainty about the physiological implications and treatment options, often leading 
patients to read about and/or identify with others who have experienced a similar 
diagnosis and experience (Corbin & Strauss, 1988). This period of post-diagnosis 
has been identified as traumatic due to its uncertainty; however, it is also a time of 
learning, questioning, and maintaining control (Corbin & Strauss, 1988). Thus, as 
highlighted above, it was important to undertake the nurse-led clinic in the early 
post-discharge period so that support and education offered could help participants 
with understanding their diagnosis and offer information to enhance their SE and 
reduce post-discharge anxiety. Moreover, in educating participants, it was hoped that 
they may be empowered and learn the importance of effective self-management of 
their chronic disease. 
Self-efficacy and its importance in CVD is also highlighted in the literature in 
terms of its effects on clinical outcomes and on self-management (Katch & Mead, 
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2010; Sarkar et al., 2007). It has been identified that the better educated a patient is 
about their disease, the more efficiently and effectively they manage their health and 
risk factors (Katch & Mead, 2010). The literature identifies the term ‘self-
management’ in terms of a person’s “ability to manage symptoms, treatment 
protocols, physical and psychosocial consequences and lifestyle changes inherent to 
living with a chronic condition” (Katch & Mead, 2010, p. 34). The literature 
highlights how people make health-behaviour decisions on a daily basis and label 
this as “unavoidable” (Katch & Mead, 2010, p. 34). What is most important when 
making these choices is being able to make quality health behavioural choices, also 
known as “effective self-management”, as this enhances an individual’s health 
(Katch & Mead, 2010, p. 34). Studies have been undertaken in the area of chronic 
disease that reveal the positive outcomes of effective self-management (Barlow et 
al., 2002; Bodenheimer, Lorig, Holman, & Grumbach, 2002; Katch & Mead, 2010; 
Sarkar et al., 2007). Corbin and Strauss (1988) reveal three constituents to effective 
self-management as: illness management; maintenance, adoption or change 
behaviours; and emotional management (current or future emotional changes). 
Kang et al. (2010) highlight the importance of learning positive health 
behaviours in those with coronary artery disease (CAD) in that it may preclude 
future coronary events while also maintaining good health. Importantly, Kang et al. 
(2010) further identify how CAD sufferers are passive in their learning and often fail 
to comprehend the significance of effective self-management and how it may 
prevent symptom and event recurrence. The authors, therefore, recommend nursing 
interventions that encourage and address positive health maintenance practices in 
those with CAD (Kang et al., 2010). Moreover, Kang et al. (2010) identify how a 
positive or high SE predicts health behaviour change and maintenance in CAD 
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sufferers, therefore reinforcing the importance of undertaking the study. It was, 
therefore, identified as important that SE in CHD and, more specifically, PCI 
patients was measured over time. Section 1.3 identifies the purpose of the study and 
presents the study’s aims, research questions and hypotheses.   
1.3 Purpose 
The study was undertaken in two phases as a pilot study to determine the 
feasibility for a Phase Three, multicentre study. Phase One was undertaken as a 
randomised controlled clinical trial (RCT), while in Phase Two the PI undertook 
interviews with healthcare professionals and intervention group participants to 
analytically explore their views and attain feedback of the potential effectiveness of 
the nurse-led clinic.  
1.3.1 Phases One and Two  
The primary aim of Phase One of the study was to investigate the effectiveness 
of a nurse-led educational intervention in the early post-discharge period on 
participant SE and anxiety after undergoing a PCI procedure. As identified, the 
present study was guided by Bandura’s (1977) SE theory, which is based on the 
premise that a person’s beliefs of their individual abilities, mastery, and vicarious 
experiences can forecast performance outcomes (Bandura, 1995; Callaghan, 2003). 
The present study undertook a second phase to analytically evaluate the 
effectiveness of the nurse-led clinic from the perspectives of participants who were 
randomised to the intervention, as well as healthcare professionals. Secondary aims 
were also investigated as a range of issues surrounding the post-discharge period 
emerged from the literature as highlighted earlier in this chapter. Post-discharge 
period concerns and issues identified included: post-discharge depression, low 
cardiac rehabilitation referral and attendance rates, poor medication adherence, and 
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post-discharge complication identification and management.  
After undertaking an extensive literature review, the PI identified secondary 
aims and key factors that would ultimately affect a patient’s SE and post-discharge 
psychological health and wellbeing. Furthermore, it was essential that secondary 
aims were explored as PCI patients’ ability to effectively self-manage post-discharge 
and beyond was highlighted as important. Therefore, to gauge the effectiveness of 
the intervention on primary and secondary aims, and to achieve greater depth and 
richness in data, the study, the study was undertaken in two phases with the 
problems, aims, questions, and hypotheses guided by the SE theory (Bandura, 1977).   
1.3.2 Phase One: Research Aims, Questions and Hypotheses 
Phase One investigated the effect of the nurse-led clinic on primary and 
secondary aims. Research aims, questions, and hypotheses for Phase One are 
identified below.  
Primary Aim  
 Evaluate if a post-discharge, nurse-led clinic providing education and 
support can increase SE and reduce anxiety in post-PCI patients.  
Secondary Aims  
 Evaluate if a post-discharge nurse-led clinic, providing education and 
support can reduce depressive symptoms in intervention group 
participants.  
 Evaluate if a post-discharge, nurse-led clinic, providing education and 
support can encourage effective patient self-management (i.e., 
complication identification and management, medication adherence, 
and CR attendance)? 
With the primary and secondary aims identified above, the primary and 
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secondary research questions are as follows: 
Primary Research Question 
Can the post-discharge, nurse-led clinic providing education and 
support increase SE and reduce anxiety in post-PCI patients as 
measured by the Cardiac Self-Efficacy Scale (CSE) (see Appendix  B) 
and STAI-Y2 Form, respectively (see Appendix C)?  
Secondary Research Questions  
 Can the post-discharge, nurse-led clinic providing education and 
support within the first 5–7 days post-discharge reduce depressive 
symptoms as measured by the Cardiac Depression Scale (CDS) (see 
Appendix D)?; 
 Can the post-discharge, nurse-led clinic, providing education and 
support within the first 5–7 days post-discharge encourage effective 
self-management (i.e., complication identification and management, 
medication adherence, and CR attendance)? 
Primary Aim: Null Hypothesis 
H°: Attending the post-discharge, nurse-led clinic providing education 
and support within the first 5–7 days post-PCI will not improve SE and 
reduce anxiety in intervention group participants.  
Secondary Aims: Null Hypotheses 
H°: Attending the post-discharge, nurse-led clinic providing education 
and support within the first 5–7 days post-PCI will not reduce 
depressive symptoms in intervention group participants.  
H°: Attending the post-discharge, nurse-led clinic providing education 
and support within the first 5–7 days post-PCI will not lead to effective 
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self-management in intervention group participants (i.e., complication 
identification and management, medication adherence, and CR 
attendance).   
1.3.3 Phase Two: Descriptive–Evaluative  
Phase Two aimed to evaluate the effectiveness of the nurse-led, educational 
intervention in greater detail. Participant interviews involved reapproaching 
intervention group participants, as well as healthcare professionals, seeking detailed 
feedback to gauge the effect of the intervention. Greater depth of information was 
sought from participants who attended the clinic, as well as healthcare professionals, 
regarding their thoughts on the clinic (i.e., education, support), enhancing SE (post-
discharge confidence), anxiety reduction, and overall potential impact of the nurse-
led clinic. Data analysis in Phase Two was descriptive-evaluative and utilised an 
abductive approach to ensure greater understanding and breakdown of the data and 
personal interpretation (Alvesson & Karreman, 2011; Brinkmann, 2014). Charmaz’s 
(2006) techniques to code, analytically evaluate data and determine relationships 
between Phase One and Two were utilised to analyse data in the present study and 
will be explored further in Chapter 3.   
1.4 Significance, Scope and Definitions 
As highlighted above, the gap in research identified for patients who 
experience a cardiac event and/or PCI is multifactorial and surrounds hospitalisation 
for PCI and the early post-discharge period. Moreover, without appropriate hospital 
and post-discharge support, patients may experience low SE and psychological 
distress. With the primary aim to enhance SE and reduce anxiety, it was hoped that 
the following self-management problems, issues, and/or concerns could be addressed 
as they may affect, or be affected by, a lower SE. The research problems are, 
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therefore, as follows: 
 importance of SE (particularly enhancing SE in cardiac patients); 
 cardiovascular events and post-PCI anxiety;  
 cardiovascular events and post-PCI depression; 
 deficits in nurse health promotion and prevention (during 
hospitalisation); 
 post-PCI self-management; 
 poor referral, attendance, and compliance rates to a CR program post-
PCI;   
 poor medication knowledge, adherence and compliance; and 
 risk period post-PCI (i.e., puncture-site management, medications, 
chest pain). 
As identified earlier, low SE can impact on all individuals, particularly during 
hospitalisation, in the post-discharge period and recovery. Participants who may 
have low efficacy beliefs and do not feel they have the ability to achieve mastery in 
tasks such as changing and maintaining health behaviours (i.e., reducing modifiable 
risk factors), and undertaking post-PCI cares and self-management will not achieve 
success in these areas. Moreover, patients with low efficacy beliefs will experience 
low self-confidence or low SE, reduced motivation, negativity and thus, 
psychological distress. Having a high or low SE may not only influence the post-
discharge period, but post-discharge experiences, emotional wellbeing, health 
behaviours, maintenance, and practices—thus SE theory was chosen as the 
framework to guide the present study.  
This study highlights the importance of enhancing SE in post-PCI patients 
given the aforementioned problems discussed. Furthermore, the present study 
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identifies the benefits of enhanced SE in the post-discharge period, the effect of 
enhanced SE on participants’ emotional wellbeing, and how increased SE offers 
patients the confidence to resume their pre-discharge roles. This study also reinforces 
the benefits of high SE and its impact on patients’ health behaviour choices and 
change, maintenance practices, and overall self-management. Aiming to enhance SE 
for all patients admitted and hospitalised for elective coronary angiography, elective 
PCI or primary PCI (PPCI) can and should begin on admission and continue into the 
post-discharge period. Furthermore, earlier post-discharge follow-up, as highlighted 
in the present study, is essential. Section 1.5 identifies a list of the study’s terms with 
definitions provided.  
1.5 Definition of Key Terms 
The following definitions are used to describe the meanings of keywords used 
in the present study. Definitions are as follows:  
 Acute coronary syndromes (ACS): “An umbrella term for heart 
attacks and unstable angina”. (National Heart Foundation of Australia, 
2010, p. 1) 
 Acute myocardial infarction (AMI): “the early critical state of 
myocardial necrosis caused by blockage of a coronary artery”. 
(Anderson, Anderson, & Glanze, 1998, p. 31) 
 Anxiety: “anticipation of impending danger and dread accompanied by 
restlessness, tension, tachycardia, and breathing difficulty not 
associated with an apparent stimulus”. (Anderson et al., 1998, p. 110) 
 Anxiety state: “a mental or emotional; reaction characterised by 
apprehension, uncertainty, and irrational fear. Anxiety states may be 
accompanied by physiologic changes such as sweating, tremors, rapid 
heartbeat, dilated pupils, and dry mouth”. (Anderson et al., 1998, p. 
110) 
25 
 Atherosclerosis: “a common arterial disorder characterised by 
yellowish plaques of cholesterol, lipids, and cellular debris in the inner 
layers of the walls of large and medium-sized arteries”. (Anderson et 
al., 1998, p. 142) 
 Chronic diseases: “conditions that last one year or more and require 
ongoing medical attention or limit activities of daily living or both” 
(Centers for Disease Control and Prevention, 2015).   
 Coronary artery disease (CAD): See coronary heart disease (CHD) as 
term is used interchangeably. 
 Coronary heart disease (CHD): “the collective term for diseases that 
occur when the walls of the coronary arteries become narrowed by a 
gradual build-up of fatty material called atheroma. The two main forms 
of CHD are heart attack (also known as myocardial infarction) and 
angina”. (Townsend et al., 2012, p. 11)  
 Coronary revascularisation: “The group name for the set of surgical 
procedures to improve blood flow to the heart muscle. These include 
coronary artery bypass graft surgery (‘CABG’, ‘bypass surgery’ or 
‘open heart surgery’) and percutaneous transluminal coronary 
intervention (coronary angioplasty)”. (NHFA, 2010, p. 1) 
 Depression: “Major depression is sometimes called major depressive 
disorder, clinical depression, unipolar depression or simply depression. 
It involves low mood and/or loss of interest and pleasure in usual 
activities, as well as other symptoms. The symptoms are experienced 
most days and last for at least two weeks. Symptoms of depression 
interfere with all areas of a person's life, including work and social 
relationships. Depression can be described as mild, moderate or severe; 
melancholic or psychotic”. (“Types of depression”, Beyondblue, 2015) 
26 
 Nurse-led clinic: “A clinic where the nurse has his or her own patient 
caseload. This involves an increase in the autonomy of the nursing role, 
with the ability to admit and discharge patients from the clinic, or to 
refer on to other more appropriate healthcare colleagues. This power to 
refer to others is often highly variable between clinics, but can include 
referrals to professionals allied to medicine, such as dieticians, 
physiotherapists, chiropodists and social work teams, through to 
medical teams or consultants. An educative role – explaining the illness 
to the patient and carers. This includes the significance of symptoms, 
differentiating between those of concern that require further treatment 
or adjustment of medication and those that may be from alternative 
causes. The issues of health education and promotion fall into this 
category. Psychological support – this does not appear in all of the 
literature focussing on nurse-led clinics, but listening to the patient’s 
concerns, fears and perceived improvements in health is clearly an 
important role. Monitoring the patient’s condition – this is an area 
which has developed rapidly in recent years. This involves the skills of 
history taking and physical assessment, considering the significance of 
assessment and ordering further investigations. This will also involve 
referring on to more appropriate colleagues or initiating treatments. The 
emergence of Patient Group Directions (PGDs) and nurse prescribing 
has meant that manipulating medications is an increasing role of the 
nurse-led clinic”. (Hatchett, 2003, p. 2) 
 Patient education: “Patient education is a process of assisting people 
to learn health-related behaviours so that they can incorporate those 
behaviours into everyday life. As stated previously, the purpose of 
patient education is to help clients to achieve the goal of optimal health 
and independence in self-care. It involves establishing a relationship 
between the teacher and learner so that the information needs 
(cognitive, affective, and psychomotor) of a client can be met through 
the process of education”. (Bastable, 2005, p. 11) 
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 Patient-centred communication: “invites and encourages the patient 
to participate and negotiate in decision-making regarding their own 
care”. (Langewitz, Eich, Kiss, & Wössmer, 1998, p. 269)  
 Primary prevention: “Primary prevention describes reducing the risk of 
a heart event or heart disease among people who do not have heart 
disease” (National Heart Foundation of Australia [NHFA], 2013, p. 1).  
 Psychological traits: “trait anxiety, life change events, and emotion 
suppression”. (Nakatani et al., 2013, p. 50)  
 Self-efficacy theory: see Section 1.2. 
 Self-management: “The individual’s ability to manage the symptoms, 
treatment, physical and psychosocial consequences and lifestyle 
changes inherent in living with a chronic condition. Efficacious self-
management encompasses the ability to monitor one’s condition and to 
effect the cognitive, behavioural and emotional responses necessary to 
maintain a satisfactory quality of life”. (Barlow, 2001, p. 545) 
 Trait anxiety: “Individual differences in the likelihood that a person 
would experience state anxiety in a stressful situation”. (Caci, Baylé, 
Dossios, Robert, & Boyer, 2003, p. 394) 
 Unstable angina: “is due to the detachment of a stable clot or plaque 
from the wall of the coronary artery. This may cause spasm of the 
coronary artery, which results in myocardial ischaemia, at least 
temporarily”. (Mittal, 2006, p. 169)  
1.6 Thesis Outline 
This chapter has provided an overview of the thesis and presented the 
background, research problems, followed by the research aims and hypotheses. The 
chapter presented the underpinning theoretical framework, while detailing the two 
phases in which the study was undertaken. Chapter 2 will discuss and justify the 
reasons for undertaking this study, as supported by the literature. Furthermore, 
Chapter 2 will present various arguments from major cardiovascular nursing and 
medical research areas supporting the study while also identifying the importance of 
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nurse-led clinics and presenting the differences between the present study and other 
nurse-led clinics trialled for cardiovascular patients. Chapter 3 will discuss the 
methodology and research design addressing participants, instruments utilised, 
procedure, analysis, ethics, and ethical limitations. Chapter 4 will present the study’s 
results, while Chapter 5 will present a Phase 3, multi-centre study based on Phase 
One and Two findings for future consideration. Chapter 6 will discuss the results in 
greater depth and detail. Lastly, Chapter 7 will discuss the study’s key findings, 
while reporting on its various strengths, limitations, difficulties; it also offers 
recommendations for future research, nursing practice and policy. The final chapter 
will discuss the literature with respect to the theoretical framework and the area of 
investigation. The following chapter will highlight the problems and research gap, 
justify the importance of nurse-led clinics with a person-centred approach for cardiac 
patients and chronic disease. 
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Chapter 2: Literature Review 
This chapter begins with a background on coronary heart disease (CHD) and 
reviews the literature with respect to the theoretical framework and both primary and 
secondary aims. This literature review is divided into seven sections and critically 
reviews the background surrounding CHD and its management, trends, and 
treatment, and highlights the importance of the first week post-discharge. 
Furthermore, this chapter discusses nurse-led clinics and how this pilot study differs 
from other post-operative, nurse-led cardiovascular interventions for patients with 
CHD or who have undergone a percutaneous coronary intervention (PCI) procedure. 
Lastly, Chapter 2 provides evidence to validate completing the present study. 
2.1 Coronary Heart Disease (CHD), Acute Coronary Syndromes 
(ACS) and Treatment  
Coronary heart disease, also referred to as ischaemic heart disease (IHD) or 
used interchangeably with coronary artery disease (CAD), is a disease that is 
characterised by a decreased supply of blood to the heart due to blockages within the 
artery wall (American Heart Association [AHA], 2015; Stanner, 2005) (see 
Appendix E). These blockages are often referred to as lesions or plaques and can 
either rupture, causing a clot within the artery and therefore inhibiting blood flow to 
the heart, or solely decrease blood flow to the heart leading to the patient 
experiencing chest pain and/or exertional breathlessness (Stanner, 2005). The result 
of a complete arterial occlusion is a heart attack or myocardial infarction (MI) 
(Stanner, 2005).  
Acute coronary syndrome is the term used to describe the signs and symptoms 
of myocardial ischaemia and may include any of the following: “unstable angina; 
non-ST-segment elevation myocardial infarction; and ST-segment elevation 
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myocardial infarction” (Overbaugh, 2009, p. 42). These diagnoses can determine the 
gravity of the patient’s condition and determine the direction of care required 
(Overbaugh, 2009).  
2.1.1 Guidelines for the Management of Coronary Heart Disease (CHD) 
and Acute Coronary Syndromes (ACS) 
In Europe, the United States of America (USA), United Kingdom (UK), 
Australia, and New Zealand, evidence-based guidelines direct the management of 
patients who present with ACS (Achar, Kundu, & Norcross, 2005; Amsterdam et al., 
2014; Aroney, Aylward, Kelly, Chew, & Clune, 2006; Aroney et al., 2008; Chew et 
al., 2011; Dracup et al., 2009; O’Gara et al., 2013; Scottish Intercollegiate 
Guidelines Network [SIGN], 2013; Steg et al., 2012). For example, the management 
guidelines for acute chest pain in Australia and New Zealand identify the phases 
from the initial identification of chest pain to the type of intervention patients may 
undergo based on diagnosis (Aroney et al., 2006). Furthermore, these guidelines are 
in place to provide optimal patient care to establish and manage the diagnosis and 
prognosis of ACS (Aroney et al., 2006). 
In Australia and New Zealand the definition and management of ACS has 
changed over the years. The terminology to describe ACS was based on a 
presentation diagnosis; however, terminology has shifted towards a “working 
diagnosis”, with the introduction of “NSTEACS” or “non-ST-segment-elevation 
acute coronary syndrome” (Aroney et al., 2006, p. S10). Aroney et al. (2006, p. S10) 
advise how this working diagnosis provides practitioners with an appropriate 
management pathway as they reach a final diagnosis.   
An ST-segment elevation myocardial infarction is defined as:  
Presentation with clinical symptoms consistent with an acute coronary 
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syndrome with ECG features including any of: Persistent ST-segment 
elevation > 1mm in two contiguous limb leads; ST-segment elevation of > 
2mm in two contiguous chest leads; or new left bundle branch block (LBBB) 
pattern. (Aroney et al., 2006, p. S13) 
Patients with a ST-segment-elevation myocardial infarction (STEMI) may be 
managed as per the ACS guidelines (Aroney et al., 2006; Aroney et al., 2008; Chew 
et al., 2011). Grades of recommendation should be followed when managing an ACS 
patient (Chew et al., 2011). These grades reflect evidence supporting the practice and 
are rated from “grade A” through to “grade D” (see Appendix F, Table F1) (Chew et 
al.). Grades of recommendation are based on data from high-quality randomised 
controlled clinical trial data (i.e., grade A), through to panel judged, non-evidence-
based recommendations (i.e., grade D). Management of patients with NSTEACS is 
determined by a patient’s level of risk. The levels consist of low, intermediate, and 
high-risk NSTEACS. The pathway guiding clinician treatment is dependent on the 
patients risk level with management recommendations, as evidenced in Appendix G, 
Table G1. 
Further to the aforementioned recommendations, the CSANZ and NHFA also 
provide management pathways consisting of long-term recommendations for 
medications, lifestyle modifications, CR, and chest pain management (Aroney et al., 
2006). Therefore, as these recommendations for management are in place, the need 
for the present study was warranted as it aimed to: (a) enhance participant SE and 
reduce anxiety as its primary aim, (b) reduce symptoms of depression, (c) encourage 
post-discharge effective self-management by reiterating post-PCI education, and (d) 
provide nurse-led support as secondary aims. 
Coronary artery revascularisation (i.e., PCI) and current trends towards its use 
as a treatment option for CHD internationally has become an increasingly popular 
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and more prevalent procedure due to its lower risk and quicker recovery (AIHW, 
2010; British Heart Foundation [BHF], 2011; Lloyd-Jones et al., 2010; Mavromatis, 
2013; Scarborough, Wickramasinghe, Bhatnagar, & Rayner, 2011; Townsend et al., 
2012; Townsend et al., 2014; Wijns et al., 2010). For patients who are suitable 
candidates, PCI as opposed to coronary artery bypass surgery (CABG) offers less 
risk, immediate symptom relief, and a faster return to activities of daily living 
(ADLs) and work (Leeper, 2004; Lyons et al., 2002; White & Frasure-Smith, 1995).  
Prior to PCI, a diagnostic coronary angiogram is performed to determine the 
degree of coronary artery stenosis (Mathur, 2002). This procedure involves the 
insertion of a coronary artery catheter through into the leg (femoral artery) or arm 
(radial or brachial artery) (Bates, 2008) (see Appendix H). Under X-ray guidance, 
together with the use of a contrast medium, the degree of coronary artery stenosis 
can be gauged (AIHW, 2010; Bates, 2008; Mathur, 2002; Wijns et al., 2010). If there 
is an appropriate candidate and revascularisation via PCI is to proceed (as opposed to 
CABG surgery), a balloon catheter is placed into the coronary artery or arteries 
where the blockage or blockages are present and is inflated, thereby compressing the 
plaque (Mathur, 2002; O’Grady, 2007). Additional measures such as stenting, 
artherectomy, and ablation can be incorporated to allow for better patient outcomes 
(Mathur; O’Grady). Percutaneous coronary intervention can be performed either 
electively or as a primary procedure, with the average time spent hospitalised post-
PCI having decreased over time (AIHW, 2012; Higgins, Theobald, & Peters, 2009; 
Lauck et al., 2009; Leeper, 2004; Radcliffe et al., 2009; Rolley, Salamonson, 
Dennison, & Davidson, 2010; Wong et al., 2006; Yan et al., 2011).  
In 2011, the AIHW (2014) reported that, of the group of cardiovascular 
diseases, CHD was the leading cause of death in both men (11,733 deaths) and 
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women (9780 deaths) in Australia. The AIHW highlight that between 2000 and 2001 
and 2007 and 2008 there was a 57% increase in the number of PCIs with an increase 
of 57% and 52% for both males and females, respectively (AIHW, 2015). Coronary 
artery bypass graft surgeries between 2000 and 2001 and 2007 and 2008 have 
reduced by 19%—from 16,696 to 13,612—suggesting PCI as the preferred treatment 
option for CHD during this time (AIHW, 2015). Notably, the reduction in CABG 
surgery has reduced more significantly for women (25% reduction) than men (16% 
reduction) (AIHW, 2015). The USA reports approximately 1 million PCIs per year, 
with approximately 1,313,000 PCI procedures performed as compared to 448,000 
CABG surgeries in 2006 (Khouzam, Soufi, Nakhla, & Naidu, 2014; Lloyd-Jones et 
al., 2010, pp. 202-203; Mavromatis, 2013). While a positive upward trend in PCI 
volume was evidenced, stabilisation in procedure volume is highlighted in the 
literature (AIHW, 2014; 2015; Dehmer et al., 2014; Molina & Heng, 2009; Riley, 
Don, Maynard, Powell, & Dean, 2011) 
In Europe, a widespread variation in statistics concerning the areas of CVD, 
PCI, and CABG surgery exists (Nichols et al., 2012). Rates for PCIs were low in 
Portugal and Romania, while the most PCIs were performed in Germany, followed 
by Austria and the Czech Republic, respectively (Nichols et al., 2012). The highest 
rates for CABG surgery were in Switzerland, Germany, and Estonia, while Finland, 
Slovakia, and Romania reported the lowest procedure rates (Nichols et al., 2012).  
In the United Kingdom (UK) the rate of PCI procedures has increased twofold 
over the last 10 years with 92,445 interventions undertaken annually versus 16,791 
CABG surgeries (Townsend et al., 2014). These figures represent a slight reduction 
in CABG surgeries and a doubling of PCI procedures (Townsend et al., 2014). 
Trends show the number of PCIs are increasing annually, with CABG surgeries 
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remaining either stable or declining (Lauck et al., 2009; Molina & Heng, 2009; 
Townsend et al. 2014). The data have been presented not to suggest superiority of 
PCI over CABG, but rather propose that the combination of factors such as 
improvements in technology and informed decision-making by the patient has led to 
this upward trend (Lauck et al., 2009; Mathur, 2002; Rolley et al., 2010; Wijns et al., 
2010). Furthermore, the attractiveness of lower risk (as opposed to CABG) surgery, 
instant symptom relief, faster recovery, and return to ADLs and work appear to be a 
more attractive alternative to consumers if they have the treatment choice (Lauck et 
al., 2009; Leeper, 2004; Mathur, 2002; Mavromatis, 2013; Widimsky, Fajadet, 
Danchin, & Wijns, 2009; Wijns et al., 2010).  
2.2 Hospitalisation for the PCI Procedure 
Reducing patients’ length of stay is a prevalent topic within the literature, with 
researchers looking to further reduce the hospitalisation time for patients with a 
femoral artery access approach, while investigating and encouraging the use of a 
radial approach if the patient is an appropriate candidate (AIHW, 2011; Blicq et al., 
2010; Dalby et al., 2003; Kaluski et al., 2008; Lauck et al., 2009; Ludman, 2013). It 
is interesting that in the UK, use of the radial approach has increased from 10% in 
2004 to 58% in 2011 (Ludman, 2013, p.5). The AIHW (2014) identify the 
decreasing length of stay in CVD patients, identifying discharge for some on the 
same day. In the years 2007–2008 approximately 46% of patients were discharged 
on the same day of hospital admission (AIHW, 2011, p. 31). The AIHW (2011) 
attribute a variety of factors, such as treatment changes and diagnostics and transfers 
to other facilities, for the larger number of same-day discharges. 
In 2009, Lauck et al. followed 98 PCI patients who underwent their 
revascularisation procedure and were discharged on the same day they were 
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admitted. The authors identified same-day discharge post-PCI as a feasible option; 
however, several issues surfaced as a result of the shortened length of stay. These 
issues included poor post-PCI health-related behaviours, vascular complications, and 
misguided beliefs about their disease management, with half of participants unsure 
of the cause and management of their disease process. Furthermore, approximately 
77% of these patients had no plans on attending a CR program, with 37.8% believing 
they had been cured of CAD (p. 194). This study also highlighted the stress and 
anxiety surrounding PCI, while identifying the shortened length of stay as 
problematic. Given the aforementioned concerns, and as identified by these authors, 
recommendations for additional methods of follow-up for short-stay patients, 
including telephone and internet are suggested so that this groups’ learning and 
educational requirements are met. Mavromatis (2013) highlights the shift towards 
same-day discharge in the US and identifies how hospitals may, at some point in the 
near future, be required to undertake PCI as a day procedure because the number of 
hospital beds may not meet the demands of a growing population. While the 
shortened length of stay and movement towards same-day discharge for PCI patients 
is imminent, the first week post-PCI appears to be problematic and the post-
discharge issues are highlighted in the next section.  
2.2.1 The First Week Post-PCI 
The first week post-PCI is important for both psychological and physical 
reasons. Among cardiac patients, psychological distress may either present, continue, 
or subside after approximately one week (Lane et al., 1999). Psychological distress 
in the post-discharge period highlights a concern and the importance of the present 
study is supported by the aim to reduce psychological symptoms that cardiac patients 
may experience. Additionally, the first week following PCI is important for the 
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patient as this is the time that they are at risk of post-PCI-related complications 
(Rassaf et al., 2013; Trotter et al., 2011; Wong et al., 2006).  
As identified in Chapter 1, Tuso et al. (2013) reviewed hospital initiatives with 
the aim to reduce readmissions in PCI patients. The authors reported one-third of 
readmissions occurring within the first week, highlighting the first 7 days to be a 
particularly vulnerable period for patients with psychosocial issues and low 
treatment success highlighted (2013). In Tuso et al.’s study, initiatives to prevent 
readmission of high-risk patients were established and included educative measures 
(2013). Furthermore, to reduce 30-day readmission it was noted that primary 
physician follow-up within the first week post-discharge needed to be initiated that 
was tailored, patient-centred, had a strong focus on disease prevention, and 
addressed social issues (2013). Timeliness was also highlighted as important, with 
recommendations to trial with chronic disease patients (Tuso et al., 2013).  
Wong et al. (2006, p. 582) identify that patients’ “immediate post-discharge 
care” should surround the identification of complications, which may be due to any 
of the following: access site, contrast dye, medications, and/or stent(s) (i.e., 
thrombosis formation). Curtis et al. (2009) also reinforce post-discharge 
complications and subsequent readmission to hospital post-PCI to include the 
vascular access site, bleeding, contrast-induced nephropathy, patient co-morbidities 
and cardiovascular disease-related complications. Grace et al. (2012) highlight the 
importance of the post-discharge period after an acute cardiac event and reinforce 
how patients and their families can suffer emotionally as a result. The authors stress 
the importance of “timely access” to a CR program to enhance patients’ health and 
wellbeing post-discharge, with recommendations for a reduction in wait times post-
PCI (Grace et al., 2012, p. 1). Thus, as patients may suffer emotional distress as a 
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result of the procedure and post-discharge isolation, the psychological distress 
experienced by cardiac patients is reviewed in Section 2.3.  
2.3 Psychological Distress, Cardiac Events and Coronary Heart 
Disease (CHD)  
Lane et al. (1999) highlight how anxiety and depression symptoms present 
instantaneously after an MI. The AIHW (2011) and Colquhoun et al. (2013) 
recognise the strong link between depression and cardiovascular events and highlight 
the importance of post-discharge patient follow-up and screening. As anxiety and 
depression may co-morbidly exist, the present study measured the effect of the 
nurse-led clinic on both anxiety and depression (NHFA, 2007; Tully, Baker & 
Knight, 2008). Janszky, Ahnve, Lundberg, and Hemmingsson (2010) undertook a 
longitudinal study involving 49,321 male participants between the ages of 18 and 20 
years formally diagnosed with anxiety disorder (ICD-8 Classification). The authors 
found a stronger prognostic relationship between coronary heart events and early-
onset anxiety over depression, with a doubling of coronary events noted in 
participants with diagnosed anxiety (Janszky et al., 2010). 
A study of the effects of anxiety versus depression on vascular function was 
undertaken with 89 patients with CVD and 54 healthy participants (Stillman, Moser, 
Fiedorowicz, Robinson, & Haynes, 2013). The study identified significant effects of 
anxiety on vascular dysfunction (depression was controlled for). Although Stillman 
et al. (2013) highlighted a strong correlation between anxiety and depression (r = 
.682, p = <.001) with respect to vascular function, overall, anxiety was reported to 
worsen atherosclerosis and vascular functioning independently of medications, 
depression, and CVD risk factors. Of note, body mass index (BMI) did not appear to 
affect atherosclerosis or vascular function (Stillman et al., 2013). The authors 
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concluded that anxiety should be studied further, and noted that anxiety is often not 
factored in when identifying cardiovascular risk, thus, highlighting the importance of 
undertaking the present study (Stillman et al., 2013). Moreover, the authors highlight 
the degree to which anxiety contributes to CVD, identifying strong associations with 
sudden cardiac death and atherosclerotic events (Stillman et al., 2013). Further 
research investigating the exact processes concerning the relationship between 
anxiety and CVD are warranted and discussed in the literature. Stillman et al. (2013, 
p. 1) recommend behavioural interventions and pharmacotherapy aimed at: “1. 
anxiety; 2. lifestyle; 3. risk-factors; and/or 4. sympathetic nervous system”.  
Narita et al. (2007) highlight an increased risk (2–5 times greater) of 
developing CVD in those with anxiety and depression. Narita et al. (2007) 
investigated the effects of anxiety and depression on CVD highlighting a greater risk 
for CVD in patients with higher trait anxiety. The authors reported more significance 
in endothelial dysfunction and abnormalities in sympathetic activity and recommend 
further research into the pathophysiology of anxiety and its contribution to 
atherosclerosis and CVD (Narita et al.). Thus, given the aforementioned 
recommendations and, as depression is already well-investigated within the 
literature, the PI chose to explore anxiety and the potential effects of nurse-led 
support and education on SE, psychological distress, and self-management in the 
present study. 
Roest, Martens, de Jonge, and Denollet (2010) recognise how anxiety may 
predict future cardiac events, reporting an average of 11 years into the future and 
internationally, with predictions for America, Norway, Russia, Sweden, Japan, and 
the UK highlighted. Janszky et al. (2010) undertook a study of 49,321 Swedish men 
(18–20 years of age) to investigate the long-term effects of anxiety and depression 
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over time. Janszky et al. (2010, p. 35) reported early-onset anxiety to be a predictor 
of CHD and cardiac events in male participants, suggesting “sympathetic 
overactivity and autonomic dysfunction” increases the chance of a coronary event. 
Nabi et al. (2010) reinforce the association between anxiety and CHD, 
identifying that somatic and psychological effects of anxiety contribute greatly to 
CHD development, particularly in women. This highlights the importance of the 
present study as the PI aimed to not only screen participant for anxiety (and refer for 
psychological intervention if required) in the post-discharge period, but to also 
provide an early post-discharge, supportive, and educational intervention to reduce 
post-discharge issues and concerns by enhancing SE and reducing anxiety.  
The AIHW (2011) identify how depression may occur simultaneously with a 
coronary event, while conversely increasing the likelihood of CVD. They advise that 
patients presenting with CVD be assessed for depression; while patients presenting 
with psychological signs of depression be assessed for CVD. There has been a shift 
in focus towards psychological distress (i.e., anxiety and depression) and coronary 
events and post-event mortality within the literature (Davidson et al., 2008; Lane et 
al., 1999; Turner et al., 2010). Lane et al. (1999) identify that the severity of 
psychological disturbances are dependent on the following: (a) the physical event, 
(b) personal characteristics, and (c) psychological adjustment ability. Psychological 
distress may subside after approximately 1 week in some cardiac patients, while 
others endure their symptoms for much longer (Lane et al.). Importantly, 
psychological symptoms may not be detected during hospitalisation due to the focus 
on treating the physical effects of the cardiac event (Lane et al.). Given the 
prevalence of depression in AMI patients is approximately 40–65 %, and there is 
strong evidence of high post-event mortality, the assessment of anxiety and 
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depression in the present study was warranted (Davidson et al., 2008; Sardinha, 
Araujo, Soares-Fiho, & Nardi, 2011). Furthermore, as patients with anxiety and 
depression have poorer adherence to post-discharge rehabilitative programs, 
screening participants in the present study was important given that low or non-
adherers could be identified and referred to their general practitioner (GP) if required 
(Davidson et al., 2008; Sardinha et al., 2011).   
The urgency to undergo coronary artery catheterisation and PCI, along with the 
short length of stay often, precludes effective patient education and can cause the 
patient anxiety (Astin et al., 2005; Astin et al., 2009; Cronin et al., 2000; Davis et al., 
1994; Kattainen et al., 2004; Tooth & McKenna, 1995). The literature identifies 
patient anxieties surrounding PCI as being awake intra-operatively and potential 
post-operative complications (Chair & Thompson, 2005; Corones et al., 2009; 
Harkness, Morrow, Smith, Kiczula, & Arthur, 2003; Kern, 1999; Koo & Brouwer, 
2001). Astin et al. (2009) and Carroll (2005) identify how the speed of treatment 
required for primary PCI is often overwhelming and indicate that patients endure 
diverse emotional reactions as a result of this experience. Carroll (2005, p. 15) 
further highlights that hospital education for patients is “less than optimal” in that 
patients are suffering various levels of psychological distress and their capacity for 
learning and information retention is often diminished. Carroll (2005) also identifies 
how the complexity of information type also contributes to patient and family 
confusion during this time. Furthermore, Jaarsma, Kastermans, Dassen, and 
Philipsen (1995), Kristofferzon et al. (2007), and Roebuck, Furze, and Thompson 
(2001) reinforce the emotionality surrounding patients who undergo cardiac events 
and identify how patients in this group assign high importance to their emotional 
state—this is highlighted in the following literature presented.  
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In 2001, Denollet and Brustaert undertook a non-RCT in 150 CR male 
participants with diagnosed CHD in Belguim. The authors investigated the effects of 
CR on emotional distress and mortality over time, as the literature suggested 
psychological improvements in CR patients may predict patient outcomes. The 
authors reported enhanced emotional states, while also suggesting that the 
improvement in short-term emotional wellbeing as a way to enhance long-term 
prognosis. Denollet and Brustaert recommended further interventions for CHD 
sufferers to reduce emotional distress, therefore highlighting the importance of the 
present study.  
West, Rose, and Brewis (1995) reinforce the presence of emotionality after a 
coronary event and identify how CHD sufferers experience clinical levels of distress 
for up to 12 months while undertaking CR. The authors highlight how emotional 
distress may lead to poor adherence (particularly to the advice of medical 
practitioners), decreased return to work, greater use of the medical system, and 
increased risk of mortality (West et al., 1995, p. 168). There are many contributing 
factors attributed to a poorer recovery and may include personality type and lifestyle 
(West et al. 1995). Good social support, modification of personality-type behaviours, 
and making lifestyle changes greatly influence post-coronary event outcomes such as 
associated mortality and esteem support (West et al., 1995).  
Dehdari et al. (2008) reinforce the effects of anxiety post cardiac event and, in 
particular, highlight the effects on quality of life (QOL), morbidity, mortality, and 
potential rehospitalisation. The authors report a sixfold increase in MI and death in 
patients who are clinically anxious. Importantly, an individual’s social support 
network and SE have been identified as pertinent factors in post-event survival. The 
authors advise that education and emotional support post-PCI are not as widely 
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recognised as with CABG patients. Dehdari et al. (2008) highlight that, as the length 
of stay post-PCI is considerably shorter (as compared to CABG surgery), there is 
limited time for education and psychological intervention. Moreover, with the 
aforementioned issues surrounding the post-PCI period the authors undertook a 
study measuring anxiety, SE and perceived social support in this group of patients. 
The results displayed higher anxiety in PCI participants (as compared to CABG 
participants) and lower perceived social support. They found that SE in PCI 
participants was high (Dehdari et al., 2008). Again, this study reinforces the need for 
an early post-discharge, nurse-led educational intervention for post-PCI patients to 
try to enhance SE and reduce anxiety suffered during this time.  
Holt et al. (2013) investigated the association between anxiety, depression, and 
CVD in 1,578 men and 1,417 women using the Hospital Anxiety and Depression 
Scale (HADS). The results revealed a greater association between CAD and those 
who had anxiety and depression. Furthermore, depression and the risk of CVD was 
found to be twofold higher in those likely to have depression. Anxiety in study 
participants was consistent with findings in other studies, presenting in 
approximately 30% of participants. There is evidence to suggest a synergistic effect 
of anxiety and depression and the risk of increased cardiac mortality, especially in 
those with generalised anxiety disorder and major depression (Phillips et al., 2009). 
Furthermore, depression itself has a “bidirectional” effect with CVD, meaning that 
depression is both the cause and consequence of CVD (Holt et al., 2013). 
Lichtman et al. (2008) highlight how depression is threefold higher in those 
who experience an AMI compared to the general population without CHD. 
Furthermore, of those diagnosed with an MI, approximately 15–20% of these 
patients meet depression criteria, while a larger number of patients present with 
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significant depressive symptoms (Lichtman et al., 2008). Lichtman et al. also 
highlight how the prevalence of depression in PCI, CABG, valve replacement, and 
unstable angina is similar to that found in AMI. Colquhoun et al. (2013, p. 1) 
reinforce this prevalence rate reporting major depression in approximately 15% of 
patients post-AMI or CABG, while those with mild depressive symptoms post 
cardiac event occur in approximately 40%. Colquhoun et al. recommend screening 
patients for depression; however, do caution the diagnosis of depression in this group 
due to the similar symptoms experienced such as tiredness and limited energy. 
Furthermore, diagnoses may also be masked by patients’ response to their illness and 
report denial, avoidance, withdrawal, and anxiety as barriers to depression diagnosis 
(Colquhoun et al., 2013).  
A meta-analysis investigating the relationship between anxiety and CHD was 
undertaken between 1980 and 2009 (Roest, Martens, de Jonge, & Denollet, 2010). A 
strong relationship between anxiety and CHD was found, with patients suffering 
anxiety being 26% more at risk for CHD (Roest et al., 2010). Roest et al., (2010) 
highlight how having anxiety may predict future cardiac events, identifying that 
symptoms of anxiety can predict the onset of CHD approximately 11.2 years later. 
Furthermore, there was a strong association between anxiety and cardiac death, with 
anxiety sufferers 48% more at risk of death as a result of a cardiac event. Also, being 
depressed placed participants at greater risk of CVD by 46% and at 55% increased 
risk of cardiac mortality (Roest et al., 2010). While depression is clearly highlighted 
as a strong risk factor for CVD, as identified, considerable research has been 
undertaken investigating and supporting this relationship. As reported, attention has 
become increasingly focused on anxiety and its effects on the coronary vasculature 
and cardiac events, demonstrating significant effects on vascular dysfunction and 
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cardiac events equal to that of depression (Stillman et al., 2013). While the 
mechanisms of anxiety are not yet identified, a strong relationship exists (Stillman et 
al., 2013). Thus, while anxiety and depression often coexist, in the present study the 
effects of the nurse-led clinic and SE effects on both anxiety and depression were 
investigated.  
The AIHW (2011) also identify the influential nature of depression on other 
CVD risk factors. For example, inactivity in a person with depression can lead to a 
more sedentary lifestyle and the uptake of smoking than among a non-depressed 
person. Poor social support networks and social isolation were recognised as causes 
of CVD in those with depression (AIHW, 2011). Thus, with a greater risk for post-
event mortality and a short hospitalisation, it is essential that the early detection and 
management of psychological distress occurs (Davidson et al., 2008). Moreover, as 
the primary focus on the treatment of cardiovascular events is a high priority, 
psychological distress may not be recognised (AIHW, 2011; Davidson et al., 2008; 
Lane et al., 1999; Turner et al., 2010). It was therefore the intention of this study to 
detect psychological distress early, and refer participants for appropriate and timely 
management. With the link between psychological distress and cardiac events, the PI 
sought to measure stress experienced by participants via salivary cortisol levels. The 
following subsection discusses the measurement of salivary cortisol as a biological 
marker of stress. 
2.3.1 Stress and Salivary Cortisol Measurement 
Cortisol is “a glucocorticoid and is synthesised from cholesterol, secreted by 
the adrenal cortex and released into the blood” (Bozovic, Racic, & Ivkovic, 2013, p. 
375) and is released during the body’s response to stress (Smyth, Hucklebridge, 
Thorn, Evans, & Clow, 2013). Smyth et al. (2013) identify that the release of cortisol 
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is often understood to demonstrate a stress–health relationship. Given that 25% of 
serum cortisol is metabolised by the liver and 75% by the kidneys, salivary cortisol 
measurement has become increasingly popular as opposed to blood or serum cortisol 
(Bozovic et al., 2013). Bozovic et al. (2013) highlight how taking blood or serum 
cortisol may cause the patient further stress resulting in a false-positive result, that 
the test does not measure biologically active cortisol and may be affected by illness 
and medications (Bozovic et al., 2013). In the last decade saliva collection has 
become a significant diagnostic method undertaken in areas of psychology to 
investigate social factors and cortisol release (Smyth et al., 2013; Streckfus & Bigler, 
2002).  
The technique for measuring salivary cortisol is uncomplicated, while cortisol 
has been identified as highly stable (Bozovic et al., 2013). Salivary cortisol samples 
may be left at room temperature for up to 4 weeks unaffected, after which it must be 
stored at -20 degrees Celsius (Bozovic et al., 2013). It is best measured in the 
morning due to the highest readings attained within 30 to 50 minutes of awakening 
(Bozovic et al., 2013).  
Bozovic et al. (2013) also highlight how episodes of acute stress (i.e., physical, 
biological, psychological) have been shown to considerably increase the secretion of 
cortisol with blood levels at their peak within 10 to 30 minutes of exposure to the 
stressor. As highlighted by Bozovic et al. the benefits of using salivary cortisol is in 
its ease of measurement in both the natural or laboratory setting, the fact that it is 
non-invasive and does not stimulate further stress in the participant. Moreover, 
Smyth et al. (2013) highlight the importance of measuring cortisol in that it may 
validate or contribute to patient self-report data attained. Thus, as participants in the 
present study may have encountered acute episodes of stress (i.e., both biological 
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and psychological) during their hospitalisation, after reviewing the literature the PI 
decided to measure salivary cortisol.  
In addition to emotional distress, participants who experience a cardiac event 
or PCI procedure have other needs to be met during hospitalisation including 
education. Section 2.4 will discuss patient education, issues surrounding in-patient 
delivery of information, and timing for best impact. 
2.4 Education, Timing, Repetition and Modes 
2.4.1 Timing of Patient Education for Highest Impact 
Previous research in this area has explored participant information needs and 
best timing for delivery of education (Brezynski et al., 1998; Corones et al., 2009; 
Gaw, 1992; Gulanick et al., 1998; Murphy et al., 1989; Tooth & McKenna, 1995; 
White & Frasure-Smith, 1995). A number of studies recommend that, although 
timing is important, the most effective method of patient education is to individually 
tailor the information to suit each patient’s needs (Corones et al., 2009; Page, 
Jackman, & Snowden, 2008). A large group of studies have also trialled nurse-led 
initiatives that involve pre and/or post-procedural and post-discharge education 
(Brezynski et al., 1998; Catherine, 2005; D’Amore, Murray, Powers, & Johnson, 
2011; Gaw, 1992; Gould, 2009; Gulanick et al., 1998; Johnson, Inder, Nagle, & 
Wiggers, 2001; Murphy et al., 1989; Scherrer-Bannerman et al., 2000; Tooth & 
McKenna, 1995; White & Frasure-Smith, 1995). These studies have assessed the use 
of a variety of information delivery methods, including telephone and internet 
communication, take-home lists of informative websites, and pocket-sized 
information cards (Brezynski et al., 1998; Catherine, 2005; D’Amore et al., 2011; 
Gaw, 1992; Gould, 2009; Gulanick et al., 1998; Murphy et al., 1989; Scherrer-
Bannerman et al., 2000; Tooth & McKenna, 1995; White & Frasure-Smith, 1995). 
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While timing for education and specific interventions have been trialled in other 
studies, the present study aimed to meet post-discharge period needs at a more 
comprehensive level through tailored face-to-face education, physical examination, 
and the measurement of anxiety, depression and management (if required), along 
with referral to CR. 
Recommendations for teaching include the procedure and comprise the 
following content areas: intravenous therapy, bed-rest post-procedurally, nutrition, 
medications, post-discharge complications management, and activity levels (Corones 
et al., 2009; Kern, 1999). The requirement for immediate and ongoing education is 
essential among this group of patients as they perceive themselves to be cured of 
CAD post-PCI, although this is clearly not the case (Astin et al., 2009; Gaw, 1992; 
Sampson, O’Cathain, & Goodacre, 2009).  
In addition to the benefit of education in general to gain greater knowledge and 
skills, is it essential to educate patients as this may also result in the reduction of 
anxiety (Palmer, 2007). As identified, a number of studies argue the preferred timing 
for patient education; however, what is of most importance is the focus of an 
individualised education program to enhance SE and reduce patient anxiety (Palmer, 
2007). Palmer (2007) undertook a preoperative nurse-led educational intervention for 
plastic surgery patients to evaluate if they experienced less anxiety, greater post-
operative confidence and knowledge. After undertaking the intervention, participants 
in this group reported less anxiety, as measured pre and post-intervention using the 
State-Trait Anxiety Inventory (STAI) when compared to standard-care group 
participants. As the study by Palmer (2007) was a preoperative intervention and the 
patients were different to the present study (i.e., plastic surgery patients as opposed 
to PCI patients), the question of timing of patient education, as identified above, 
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should be continuous throughout hospitalisation and information individualised 
(Corones et al., 2009; Kern, 1999; Koo & Brouwer, 2001; Page et al., 2008).  
Dracup et al. (2009) held education groups for patients with CAD with the aim 
to reduce hospital admission time. The authors highlighted to patients the 
management of their ACS symptoms should they reoccur. Although results did not 
demonstrate a reduction in time-delay as hypothesised, patients involved in the 
experimental group were shown to be more conscious of their actions in the event of 
chest pain symptoms. These included the self-administration of aspirin and the 
reporting of symptoms to emergency services within the first 6 months of attending 
the ACS clinic as opposed to the responses of those in the control group (Dracup et 
al., 2009). Thus, as patients in Dracup et al.’s study benefited from the education 
providedit was hoped that patients in the present study may benefit in knowledge as 
education is reiterated early in the post-discharge period. 
It is, therefore, for the following reasons that the present study was undertaken: 
 Patients who experience a cardiovascular event may experience 
psychological distress (i.e., anxiety and depression).  
 The presence of anxiety prevents the absorption and retention of vital 
information, and thus, inhibits patient learning. 
 This group of patients may not display symptoms of anxiety and 
depression until days to weeks post-event. 
 Cardiovascular patients are discharged after a short hospitalisation. 
 The short hospitalisation precludes effective nurse-teaching. 
After experiencing a cardiac event and PCI, patients often await CR, 
cardiologist, and/or GP follow-up at approximately 7 to 64 days. (AIHW, 2011; 
BHF, 2009, 2010; Carroll, 2005; Cupples et al., 2010; Dafoe et al., 2006; Goble & 
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Worchester, 1999; Kattainen et al., 2004; Kristofferzon et al., 2007; Lacey et al., 
2010; Lane et al., 1999; Lauck et al., 2009; NHFA, 2010; Wenger, 2008; Young & 
Murray, 2011).  
Thus, it was because of the aforementioned reasons that this nurse-led 
intervention was undertaken within the first 5 to 7 days post-PCI. While the timing 
of patient education is highlighted, issues surrounding referral to and attendance at 
secondary prevention or CR programs will be considered. Section 2.5 discusses 
barriers and initiatives concerning CR programs.  
2.5 Post-Discharge Problems  
2.5.1 Cardiac Rehabilitation: Timing, Barriers, and Initiatives 
Participation in a secondary prevention or CR program is strongly advised in 
the post-discharge period. Cardiac rehabilitation is a secondary preventative service 
available to patients who have experienced a cardiovascular event (Australian 
Cardiovascular Health & Rehabilitation Association [ACRA], 2008). Cardiac 
rehabilitation encourages positive behavioural changes, promotes self-management 
of the disease process with an aim to return the individual to normal ADLs and, thus, 
prevent future cardiac events (ACRA, 2008). In Australia, the commencement of a 
CR program is recommended to begin on admission to hospital and continue with an 
outpatient phase, followed by a maintenance phase (ACRA, 2008; Goble & 
Worchester, 1999). Canyon and Meshgin (2008) highlight the reduction in hospital 
readmissions in patients who attend CR as opposed to those who do not. In their 
study of 308 patients, 110 attended CR and 198 did not (Canyon & Meshgin, 2008, 
p. 576). Of the 198 non-attending, 56 were readmitted to hospital, with only nine 
patients readmitted in the CR intervention group, demonstrating the importance and 
effectiveness of attending CR (Canyon & Meshgin, 2008, p. 576). 
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Outpatient CR programs are ideally recommended to commence within several 
days post-discharge. Courses vary in length from 4 to 12 weeks in Australia, 6 to 12 
weeks in the UK, 2 to 24 weeks in Europe, and 35 days to 6 months in the US (BHF, 
2009, p. 19; Bjarnason-Wehrens et al., 2010, p. 413; Briffa et al., 2009, p. 683; 
Dafoe et al., 2006; NHFA/ACRA, 2004, p. 6; Pack et al., 2013; Thomas et al., 2007, 
p. 1617). The European Society of Cardiology (ESC) advise the commencement of 
the outpatient phase within 7 to 14 days after a primary PCI for STEMI patients and 
after 24 hours for elective PCI patients (Wijns et al., 2010). For patients who have 
extensive damage to the myocardium, it is recommended that they are clinically 
stable prior to commencing CR (Wijns et al., 2010).  
Although recommendations suggest early CR commencement, the literature 
has identified waiting times to commence up to 1 month or more post-PCI (BHF, 
2009; Goble & Worchester, 1999; NHFA, 2010; Wenger, 2008). Goble and 
Worchester (1999) and Worcester, Murphy, Mee, Roberts, and Goble (2004) 
highlight the many barriers to the commencement of a CR program and identify the 
short hospitalisation period, as well as patient anxieties during this time, are 
obstacles to effective in-patient education and referral. Furthermore, the patient’s 
perception that CR is unwarranted may also contribute to their decision not to 
partake in the program (Worcester et al., 2004). Bethell et al. (2006), Briffa et al. 
(2009), Bunker and Goble (2003), and Dolansky et al. (2010) further identify patient 
and CR commencement delays that may include poor funding, the patient’s health 
status, demographic and societal issues, and poor practitioner referral. These issues 
are not only on a national scale but internationally, with reports of worldwide under-
referral and attendance rates to CR programs post-discharge (BHF, 2009; Dafoe et 
al., 2006; Fernandez, Salamonson, Juergens, Griffiths, & Davidson, 2008; NHF, 
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2010; Wenger, 2008).  
Grace et al. (2012) undertook a study of patients, CR programs, and specialists 
regarding CR wait times, while comparing current wait times and perceived reasons 
behind this delay. Participants reported a mean of 65.6 + 88.4 days after hospital 
discharge and commencing a CR course. Approximately 91.5% of patients reported 
this wait time as satisfactory; however, noted that their preferred wait time was 
between 33.1+22.3 days. It was interesting that PCI patients reported a preference 
for a shorter wait time than patients who had been admitted for a CABG, pacemaker, 
or arrhythmia. As identified earlier, hospitalisation for PCI is an anxious time 
coupled with the short time for hospitalisation and limited nurse–patient teaching 
opportunities (Grace et al., 2012). In Grace et al.’s study, specialist and CR teams 
were of the opinion that patients were commencing at favoured wait times, while CR 
teams also believed benchmarked times were being met. The aforementioned issues 
surrounding CR wait times not only reinforce the need for a post-PCI, nurse-led 
clinic—as it aims to enhance SE and reduce anxiety—but its secondary aims to 
reduce symptoms of depression and encourage effective self-management are 
relevant. Thus, as patients await CR program commencement, the nurse-led clinic 
may offer early post-discharge support, reiteration of education, with the aim of 
increasing patients’ confidence or SE by enhancing knowledge and understanding 
the benefits of attending CR.  
Briffa et al. (2009) performed a systematic review of secondary prevention 
programs in the literature with the aim to promote change and allow for the 
enhancement of CR and secondary prevention within Australia. The authors 
identified a set of strategies that may assist in overcoming barriers to commencing a 
CR program. Strategies included communication between the healthcare practitioner 
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and the CR team, an automatic referral system, flexibility in the program, and a 
personalised, culturally sensitive approach (Briffa et al., 2009). Additionally, Bunker 
and Goble (2003) identified the poor suitability of CR to certain societal groups, 
including elderly women, non-English-speaking persons, Indigenous Australians, 
patients of low socioeconomic status and from rural areas. Bunker and Goble (2003) 
recommended similar strategies as highlighted by Briffa et al. (2009) including the 
further investigation and rectification of referral issues, the individualisation of the 
program, and content at an organisational level (Bunker & Goble, 2003).   
As a result of the under-referral and non-attendance of patients at CR, the BHF 
(2009), Bjarnason-Werens et al. (2010), Lloyd-Jones et al. (2010), the NHFA (2010), 
and Wijns et al. (2010) highlighted the importance of, and sought to rectify, this 
problem over time through the composition of new CR guidelines and initiatives. In 
particular, the NHFA (2010, p. 3) in Australia developed a set of nine actions aimed 
at “governments, health system planners, policy makers, health professionals and 
consumers” in a plan to improve the health of all Australians with new and 
previously diagnosed CVD. These actions aim to promote secondary prevention 
programs, enhance program accessibility, and patients’ health (NHFA, 2010). Lastly, 
it is through the implementation of the nine actions that may allow for a decrease in 
the morbidity and mortality rates associated with CVD (NHFA, 2010). Additional 
initiatives to improve CR attendance have also included early post-discharge 
orientation (within 10 days post-discharge). Pack et al. (2013) undertook an RCT of 
150 patients and assessed whether early enrolment appointment would encourage 
attendance to the first CR orientation session. This intervention proved to be 
effective with recommendations to apply this intervention on a national level (Pack 
et al., 2013).  
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This critical review of the literature undertaken for this study has highlighted 
that a gap between the day of discharge, review by a cardiologist, and the 
commencement of a CR program exists. Furthermore, as a large number of under-
referrals and poor attendance to CR has been identified, this study aimed for a 100% 
referral and attendance rate. Further to the issues surrounding the post-discharge 
period are matters concerning medication adherence and compliance. Subsection 
2.5.2 identifies the types and reasons for medication non-compliance. 
2.5.2 Medication Adherence, Compliance, Barriers, and Management in 
PCI and Chronic Disease 
Based on current evidence-based practice, a patient experiencing a cardiac 
event and PCI for the first time will be discharged on an average of six new 
medications (based on A and B grade recommendations and in addition to 
medications prescribed for other co-morbidities) (Aroney et al., 2006). This may 
create various problems surrounding medication adherence and compliance. Brown 
and Bussell (2011) identify the difference between adherence and compliance in that 
adherence refers to the patient being in full understanding and agreement with the 
medications and regime, while compliance suggests a submissiveness and obedience. 
Brown and Bussell (2011) identify 50% of patients with chronic illness are 
non-compliant with their medications and highlight how non-adherence contributes 
significantly to mortality and is costly to the healthcare system. Brown and Bussell 
undertook a literature review of articles relating to CVD, health literacy, medication 
adherence and pharmacotherapy between 1990 and 2010. Brown and Bussell 
highlight long-term medication adherence issues in patients with CVD, especially in 
adherence to hypoglycaemics (lowers blood glucose), anticholesterolaemics 
(reducing cholesterol), and antihypertensives (lowering blood pressure). In the group 
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of CVDs, the authors draw attention to non-adherence in patients who have 
experienced a cardiac event and highlight non-adherence in approximately 50–80% 
of patients prescribed antihypertensive medications. Their literature search 
uncovered several issues surrounding medication adherence and involve the patient, 
the physician, and the healthcare system. Table 2.1 identifies the factors presenting 
as barriers to medication adherence as highlighted by Brown and Bussell (2011).  
Table 2.1. Medication adherence barriers for patients in CVD  
Factors affecting medication adherence and barriers in CVD 
Patient factors Physician factors Healthcare 
system factors 
limited understanding of their illness 
limited participation in their treatment  
poor health literacy 
health misconceptions 
medication misconceptions  
prior medication utilisation 
poor motivation 
cost 
socioeconomic status 
transportation issues 
poor social support networks 
pharmacy wait times 
poor information recall  
failure to identify non-adherence 
prescription of a complicated 
medication regime 
poor communication 
not identifying of medication side 
effects and benefits 
financial burden to patients not 
reflected on 
not attaining appropriate medication 
history 
(i.e., use of alternative medicines) 
system barriers 
poor access to 
care 
medication cost 
co-payments 
limited health 
information 
technology 
access (for 
treating 
doctors) 
limited 
consultation 
time  
Source: Brown & Bussell (2011) 
Patient-related factors: Solutions to medication adherence issues 
While medication adherence is complex, there are approaches to achieving 
enhanced adherence and thus, better patient health and wellbeing (Brown & Bussell, 
2011). The strategies involve consideration of the aforementioned problems and 
providing alternate solutions to encourage patient empowerment and medication 
adherence (Brown & Bussell, 2011). The authors highlight that for patient-related 
factors, education programs engaging in formal patient education may encourage 
medication adherence. For patients who may not have access to a formal educational 
program, offering a variety of information (i.e., books, internet) and community 
55 
resources (i.e., libraries, pharmacists, courses) may encourage medication adherence. 
Further interventions, such as improving patient health literacy is discussed with 
alternative information sources to be offered (i.e., visual and/or audio) to meet the 
needs of the. Moreover, acknowledging the financial burden on patients and 
referring them to programs that offer financial support may also facilitate medication 
adherence. As the issues surrounding medication adherence are complicated, the 
authors highlight a multifaceted approach to management and given its complexity 
(Brown & Bussell, 2011).  
Physician-related factors: Solutions to medication adherence issues 
Brown and Bussell (2011) also highlight the importance of effective 
communication and patient-centredness in enhancing the physician–patient 
relationship and encouraging medication adherence. Involving the patient in their 
care and decision-making may empower the patient and thus, encourage adherence. 
It is also encouraged that physicians be more culturally aware and acknowledge 
cultural beliefs to create a trusting relationship. Furthermore, offering praise (as 
opposed to blaming) is also encouraged in achieving goals and will also lead to 
better medication adherence. By asking the correct questions, physicians may gain 
further insight to patients’ medication regimes and adherence status. Questions 
recommended example include: “Of the medications you listed, which ones are you 
taking” and/or “Have you had to stop any of your medications for any reason?” 
(Brown & Bussell, 2011, p. 310). Lastly, establishing an easier medication regime 
(i.e., once per day frequency) may encourage or improve adherence as the effects of 
daily dosing has been proven to encourage medication adherence (Brown & Bussell, 
2011). 
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Healthcare system related factors: Solutions to medication adherence issues 
As identified above in Table 2.1, Brown and Bussell (2011) highlighted the 
time constraints for physician consultation as barriers to medication adherence. 
Solutions offered to increase consultation time include the training of staff and 
encouraging a “team-based approach” (p. 311) to undertake responsibilities of the 
physician, so that the physician may have more time to discuss issues such as 
medication adherence. Alternatively, other suggestions to assess and address 
medication adherence include consultations with pharmacists, office personnel, 
medication reminder services (i.e., telephone), highlighting available internet 
resources, or case manager referral (Brown & Bussell, 2011).   
The use of electronic systems for prescribing and medical records are also 
offered so that at-risk patients may be identified and flagged for intervention. 
Interventions may include automatic medication reminders to patients to have 
medications dispensed, while physicians may also be reminded if their patient has 
not had their prescriptions filled. Furthermore, the commencement of all long-term 
medications during hospitalisation and the creation of medication lists may also 
prove to be effective in encouraging medication adherence. As these issues of 
medication adherence and solutions are multifaceted, patient medication 
administration and handling issues will be discussed further.  
Rudd, Ramesh, Bryant-Kosling, and Guerrero (1993) investigated the 
medication administration behaviours in cardiology clinic and primary care patients. 
An important finding reinforced by additional research highlights what is described 
as ‘outpatient subgroups’ (Rudd et al., 1993). These groups consist of the following: 
 “near-optimal compliers”: included 50 to 60% of participants; are 
aware of the benefits of medication administration; and believe they 
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are effective in self-administration and adherence and compliance. 
  “partial compliers”: are accepting of treatment concept; have poor 
adherence; and most commonly omit medications. 
  “noncompliers”: have good intentions; and have very poor adherence 
(i.e., medication administration just prior to doctor review). (Rudd et 
al., 1993, p. 665)   
Fernandez, Davidson, Griffiths, Juergens, and Salamonson (2007) identify 
high medication adherence in post-PCI patients; however, they also highlight poor 
medication storage and individual cessation of medications undertaken unnecessarily 
by the patient. Two percent of patients ceased their medications after believing they 
felt better and they were no longer necessary, while 4.5% ceased medications as they 
believed they were feeling worse (Fernandez et al., 2007, p. 57). An additional 5% 
did not take medications as they were going on an outing (Fernandez et al., 2007, p. 
57). Approximately 7.5% of patients were reported to have missed 1 to 3 tablets 
within a period or 1 week, while 2% missed 4 and more medications within 1 week 
(Fernandez et al., 2007, p. 57). Furthermore, 4% were unable to recall if they 
consumed their medications (Fernandez et al., 2007, p.57).  
It is, therefore, imperative that patients are well educated on their medications 
and the importance of adherence and compliance. Post-procedural complications also 
present as a problem in the post-discharge period. Subsection 2.5.3 will discuss post-
procedural complications and hospital readmissions in post-PCI patients.  
2.5.3 Post-procedural Complications and Readmission 
Post-procedural complications and self-management were investigated 
throughout the course of the present study as part of its secondary aims. It was hoped 
that the one-on-one nurse-led support and reinforcement of patient education may 
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facilitate effective self-management by increasing SE. Early post-PCI complications 
may include chest discomfort, bleeding (both puncture site and other), 
pseudoaneurysm, pulmonary emboli, deep vein thrombosis, contrast-induced 
allergies, and renal failure (Bates, 2008; Laarman & Dirksen, 2010; Perret et al., 
2009). Gallagher et al. (2008, pp. 73-74) assessed chest pain in 129 post-PCI patients 
at both 4 and 10 weeks post-PCI. The authors reported 68% of patients experienced 
chest pain up until 10 weeks post-PCI, with CR identified as an important service in 
educating patients on the identification and management of these symptoms during 
this time (Gallagher et al., 2008, p. 76). Patients in a study by Burney, Purden, and 
McVey (2002) identified the need for more information on the post-discharge period, 
recommending information on chest pain and management, return to physical 
activities, management of stress, complication identification, and family education. 
The authors recommend an educational intervention for discharge that not only 
meets patients’ needs but is also conducive to the working environment in a hospital 
setting (Burney et al.). Thus, as post-discharge capabilities and psychological 
distress have been highlighted as an important aspect of patient education, the 
present study measured participant anxiety and depression.  
In a retrospective observational analysis, Gupta et al. (2010, p. E1049) 
highlight the number of readmissions to four hospitals in the USA over a 1-year 
period, 2095 of whom underwent PCI. The authors identify that, of the 2095 
patients, 1070 patients were readmitted. Of the 1070 readmissions, 254 patients 
underwent revascularisation. Importantly, 148 patients returned with angina, 32 
experienced an MI, 61 experienced heart failure, 20 were diagnosed with cardiac 
arrhythmias and 51 with IHD. These results reinforce the importance of the present 
study and the reiteration of symptom identification and management education as a 
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way to reduce hospital readmissions.  
Curtis et al. (2009, p. 904) performed a retrospective analysis of 315,241 
patients who had undergone PCI in the USA. Curtis et al. (2009, p. 906) identified 
that, within 30 days post-PCI, 1 in 7 patients are readmitted to hospital, with 
approximately one-quarter of participants requiring repeat PCI. Other causes for 
readmission within 30 days post-discharge included vascular complications, 
bleeding, and contrast-induced nephropathy, while other patients were required to 
return as their revascularisation procedure was to be undertaken in stages. Lastly, 
other causes for readmission were of cardiovascular origin and co-morbidity related 
(Curtis et al., 2009). 
In the UK and Belgium, Fox et al. (2010, p. 2756) studied a total of 3,721 ACS 
patients over approximately 5 years. In the UK group of patients (n = 2065) 320 
patients experienced an MI within 24 hours and up to 5 years after their first event 
(2010, p. 2759). Furthermore, in the UK, 292 of these patients underwent PCI and 
393 underwent revascularisation procedures taking place within 6 days after the 
index procedure. These results identified the need for early post-discharge period 
follow-up, support, and education, with a focus on short- and long-term post-PCI 
cares and self-management. Referral and attendance to a CR program to reinforce 
post-discharge education and long-term health management was deemed paramount. 
McCaul, Hobbs, Knuiman, Rankin, and Gilfillan (2004, p. 1036) studied 
423,922 Western Australian patients over a 20-year period to determine whether 
there was a decline in repeat revascularisation procedures and/or mortality in patients 
who had previously undergone PCI or CABG. The authors highlight a significantly 
higher risk of repeat revascularisation procedures after undergoing the first PCI 
procedure (as opposed to CABG) (McCaul et al., 2004). Furthermore, from the 
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period 1980–2001, McCaul et al. (2004, p. 1043) identified a change in the 
characteristics of these patient groups, but in particular noting from 1989 to 1990 the 
risk of repeat PCI within one year being greater than 30%, with CABG less than 2%; 
whereas from 2000 to 2001, the risk of repeat revascularisation after 2 years had 
decreased to 12.4% with repeat CABG risk after 2 years declining further.  
The data evidenced above reinforced the importance of the present study. Not 
only did they highlight the groups in the population at risk for repeat 
revascularisation (be it PCI or CABG surgery), but they established the need for an 
early post-PCI intervention providing post-discharge support, while reiterating post-
procedural education and encouraging post-discharge self-management. 
Furthermore, with the repetition of education—and in a one-on-one, face-to-face 
environment—it was hoped that participants could identify and appropriately 
manage any complications, symptoms (i.e., angina) and, thus, effectively self-
manage. With early review of access sites, a 100% referral and initial attendance to 
CR was to be achieved, it was therefore anticipated that, with the early repetition of 
education, participants’ SE would be enhanced, they would experience less anxiety, 
reduced depressive symptoms, and may effectively manage post-discharge and 
beyond with reiteration, support, and long-term follow-up in CR. Another issue 
occurring post-procedurally is that of haematomas and this will be discussed in the 
following subsection.  
2.5.4 Haematoma: Signs, Symptoms, and Assessment 
Haematomas are a common complication after undergoing PCI (Higgins, 
Theobald, & Peters, 2008; O’Grady, 2007; Sherev, Shaw, & Brent, 2005). Banfić et 
al. (2008, p. 386) observed the access sites of 319 patients who underwent coronary 
artery catheterisation by using ultrasound at 24 to 48 hours after the artery was 
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successfully manually sealed. In this group, 232 patients underwent coronary 
angiography and 87 underwent PCI (p. 385). The authors highlighted the most 
common complications being haematoma, pseudoaneurysm, arteriovenous fistula, 
and femoral artery dissection (pp. 386–388). Approximately 5.3% of patients 
experienced a pseudoaneurysm, while 15.1% developed haematomas (p. 386). These 
results, therefore, highlight the need for the present study to identify potential post-
discharge complications early.  
Sherev et al. (2005) in their study of 868 diagnostic cardiac catheterisations 
and 702 PCI cases noted specific vascular-related complications post-procedurally 
(p. 198). From the 1,570 femorally catheterised patients, the authors reported 20 
haematomas, six retroperitoneal haemorrhages, two pseudoaneurysms, and five 
femoral artery dissections (p. 198). Complications were reportedly due to the 
arteriotomy location; however, the authors highlight how additional factors may 
predispose a patient to access site complications (Sherev et al., 2005). They include 
the following:  
 female gender; 
 weight (over and underweight); 
 older age; 
 uncontrolled hypertension; 
 previous catheterisation at the same site; 
 high level of anticoagulation; 
 larger arterial sheaths; 
 renal failure; 
 concomitant venous sheath; 
 prolonged sheath duration. (Sherev et al., 2005, p. 200) 
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The discussion of radial versus femoral approaches, as identified earlier, is 
present in the literature. Patients who are appropriate candidates for a transradial 
approach usually suffer less haemorrhagic complications when undergoing PCI 
(Koutouzis, Matejka, Olivecrona, Grip, & Albertsson, 2010). While haemorrhagic 
complications are reportedly low, post-PCI haemmorhage can still occur; however, 
there is lower risk associated with this procedure (Koutouzis et al., 2010; Rao et al., 
2008; Ziakas et al., 2010). Thus, as access site complications can occur within hours 
post-procedurally and up to 1 year post-discharge, participants were followed up in 
this study as soon as 5–7 days post-discharge (Higgins, Theobald, & Peters, 2008; 
Sherev et al., 2005).  
With vascular complications identified above, Ndrepepa et al. (2010, p. 297) 
highlight how PCI-related haemorrhage most commonly occurs in patients who 
present with a higher “cardiovascular risk profile” or those who have additional co-
morbidities pre-PCI. The authors advise that patients who have an increased risk of 
bleeding at the time of PCI are most likely to die in the first 3 months post-PCI 
(Ndrepepa et al., 2010, p. 297).  
Signs of a haematoma are assessed by observing any swelling to the inguinal 
area, if access was via the femoral artery (O’Grady, 2007). Assessment of the arm or 
wrist are required for brachial or radial approaches (O’Grady, 2007). Tingling and 
numbness to both lower limbs and digits should be assessed as recommended by 
O’Grady (2007). Bruising is common and may also accompany the haematoma and 
spread down the leg or arm. Bruising may begin as a “dark blue to greenish yellow” 
colour (O’Grady, 2007, p. 27). In addition to the complication of bruising, a 
pseudoaneurysm may also be experienced. Subsection 2.5.5 discusses this 
complication and methods to confirm the diagnosis. 
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2.5.5 Pseudoaneurysm 
A pseudoaneurysm is another commonly identified complication associated 
with coronary artery catheterisation and PCI and is often referred to as a “false 
aneurysm” (Banfić et al., 2008; O’Grady, 2007, p. 27). A pseudoaneurysm forms 
when the artery accessed for PCI is not adequately sealed due to an insufficient 
application of pressure (O’Grady, 2007). A haematoma with a surrounding casing 
then forms with a connection maintained to the artery accessed, forming a hardened, 
lumpy, bounding mass that can be heard with a stethoscope placed over the access 
site (O’Grady, 2007). An ultrasound can verify this finding. A pseudoaneurysm may 
resolve naturally; however, should the mass enlarge, the patient may need to undergo 
a non-surgical, ultrasound-guided procedure to repair the aneurysm (O’Grady, 2007). 
As identified earlier, the study by Banfić et al. (2008) highlighted pseudoaneurysm 
as a common complication in PCI patients. Furthermore, the authors reported 5.3% 
of their patients having experienced a pseudoaneurysm between 24 to 48 hours after 
haemostasis had been achieved (Banfić et al., 2008, p. 386). These results, therefore, 
highlighted the importance of undertaking the post-PCI, nurse-led clinic, so that 
possible complications could be detected early. Stethoscope auscultation just above 
the incision site to assess for a bruit should be undertaken and is characterised by “an 
extra whooshing sound” heard over the vessel (O’Grady, 2007, p. 241). Access site 
infections may also occur post-PCI and these post-discharge complications will be 
identified next. 
2.5.6 Post-PCI Access Site Infection: Signs and Symptoms 
Wong et al. (2006) identify how access site wound infections may occur; 
however, they are rare and mostly identified in patients who have a closure device 
present to seal the artery (i.e., Angioseal, Femoseal, Perclose). Wong et al. highlight 
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how wound site infections post-PCI may lead to femoral arterial rupture if not 
treated and highlight the importance of antibiotic treatment for this if an infection 
occurs. Similarly, Merriweather, and Sulzbach-Hoke (2012) reinforce the low rate of 
access site infections in post-PCI patients, highlighting that <0.1% of patients may 
be affected. The authors identify that access site infection causes may include 
extended arterial sheath presence, insertion technique, personal hygiene issues, and 
closure device used (Merriweather & Sulzbach-Hoke, 2012). Prada-Delgado et al. 
(2011) undertook a study of 558 patients and compared the safety and efficacy of 
vascular closure devices (n = 464) versus manual compression (n = 94) in patients 
who experienced a primary PCI (PPCI). While closure devices proved to be safe and 
have a lower risk of a major vascular complication, the authors also identified the 
presence of access site infection in this group. While only a lower risk of infection in 
the closure device group (0.2%), no participants in the manual compression group 
experienced an infection, therefore, demonstrating the increased risk (although low) 
of access site infections (Prada-Delgado et al., 2011).   
Signs of infection in PCI patients should be assessed by taking the patient’s 
body temperature and observing the access site for any redness, palpating the area, 
and feeling for any heat, swelling or site pain (Gould, 2001). Furthermore, 
accompanying an access site infection may be a pus-like and odorous ooze (Gould, 
2001). O’Grady (2007) recommends that patients who are, and continue to be, 
febrile should have pathology tests taken, along with a urine specimen. Importantly, 
contrast dye used in the procedure may also result in an increase in body 
temperature; however, this usually resolves within 24 hours (O’Grady, 2007). Other 
post-discharge concerns include angina (i.e., chest pain) and patient self-
management, these will be reviewed next.  
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2.5.7 Chest Pain: Angina Identification and Management 
Chest pain in the post-discharge period could potentially indicate “stent 
thrombosis or re-stenosis” (Levine et al., 2003, p. 130). Levine et al. (2003, p.130) 
highlight re-stenosis in <10% of patients with bare metal stents and 10–20% of 
patients with drug eluting stents. Furthermore, the authors identify in-stent re-
stenosis occurring within 1 to 8 months post-PCI, with most patients (i.e., 25–85%) 
presenting with exertional angina symptoms (Levine et al., 2003, p. 129). The 
occurrence of stent re-stenosis thus reinforces the study’s primary endpoint of 1 
month (Time 3) post-discharge from hospital (Levine et al., 2003). Additionally, 
with stent thrombosis occurring in approximately 1% of PCI patients, those 
presenting with chest pain within days to weeks post-PCI require hospital 
readmission to undergo investigations (Levine et al., 2003, p. 130). Wong et al. 
(2006, p. 584) identify chest pain in approximately 50% of patients post-PCI. The 
origin of the chest pain can range from the sensation experienced after stent 
implantation to ischaemic chest pain. The authors highlight that re-stenosis usually 
occurs within 3 months post-PCI and stabilises at approximately 12 months (Wong 
et al., 2006). 
Chest pain identification and management reiteration is essential as delay in 
symptom recognition and management is highlighted as a worldwide concern 
(Gallagher et al., 2012). Gallagher et al. undertook a nurse-led, chest pain 
educational intervention of CR patients (n = 137) to test if participants could be 
better educated on symptom recognition and action using the NHFA’s “Chest Pain 
Action Plan” to avoid delay to hospitalisation. The study reported statistically 
significant results in participant reporting heart attack warning signs but no changes 
were observed in the time participants tolerated these symptoms. The study by 
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Gallagher et al. (2012) is important and supports the need for the completion of the 
present study for the following reasons from the literature presented thus far. As CR 
does not commence until approximately 4–8 weeks post-discharge, it is essential that 
patients are educated, are able to recognise their chest pain symptoms, and take 
appropriate recommended actions early. The issues surrounding the post-discharge 
period after undergoing PCI, as identified above, reinforce the need for a post-
discharge, nurse-led clinic. In the following section Bandura’s Self-Efficacy (SE) 
theory is discussed as the chosen theoretical framework and its application to the 
present study, nursing and chronic illness. Section 2.7 later discusses the importance 
and benefits of nurse-led clinics, and person-centred care for cardiac patients and 
chronic disease, while presenting a detailed review of literature to demonstrate the 
present study has not been previously undertaken or replicated.  
2.6 Bandura’s Self-Efficacy (SE) Theory 
2.6.1 Expectancies 
As identified in Chapter 1, Bandura’s (1977, 1995) SE theory was chosen as 
the theoretical framework to guide the study over other psychological constructs as it 
is based on the foundation that an individual’s inherent beliefs and confidence in 
their abilities to master a task can predict the outcome and enhance their SE. In 
developing the nurse-led clinic utilising the SE theory, it was anticipated that by 
offering participants early, face-to-face, nurse-led post-discharge support—coupled 
with the reiteration of post-PCI education—SE may be enhanced and anxiety may be 
reduced. Furthermore, it was hoped that participants could engage in the 
management of their post-discharge health and wellbeing by both believing and 
engaging in potential behaviours that may then lead to positive outcomes or mastery, 
as highlighted by the SE theory.  
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The aim for healthcare professionals is to facilitate independence in the health-
management of their patients (Lenz & Shortridge-Baggett, 2002), and this was one 
overarching aspect of the present study. Therefore, as the study aimed to enhance SE 
and reduce psychological distress, while also encouraging effective self-
management, the present study also aimed to provide participants with the 
knowledge and skills, emotional and clinical support, reassurance and feedback. 
Moreover, ongoing telephone follow-up and assessment throughout the course of the 
study was also provided, given that the aforementioned influences are required to 
achieve behaviour change (Shortridge-Baggett, 2002). Additionally, so that health 
independence and management could be achieved through behaviour change, a 
strong support network in the healthcare team and family was ensured (Shortridge-
Baggett, 2002). Self-efficacy and the SE theory are important considerations and 
widely used in the healthcare arena (i.e., chronic illness and health promotion). In 
achieving behaviour change, the SE theory postulates that individuals can perform 
behaviours by (a) believing in their abilities or confidence to do so, and (b) allowing 
others to comprehend and impact on behaviours, thus leading to change (Shortridge-
Baggett, 2002).  
The SE theory posits two main expectancies that influence behaviour 
modification (a) “efficacy expectations or perceived SE”, and (b) “outcome 
expectations” (see Appendix I) (Bandura, 2004, p. 144; Bandura, 1977, p.193; 
Callaghan, 2003, p. 248). Efficacy expectations refer to an individual’s beliefs in 
their ability to carry out a certain behaviour, while outcome expectations propose 
that participation in certain behaviours will lead to particular outcomes (Callaghan, 
2003). Bandura (1995) highlights how efficacy expectations play a part in stress and 
anxiety control and arousal, respectively, and how people with poor efficacy beliefs 
68 
suffer more distress and poorer functioning as compared to those who have strong 
efficacy beliefs.  
An individual’s efficacy beliefs in combination with two additional 
expectancies—“perceived coping SE” and “thought control efficacy”—may also 
have a positive impact on coping behaviour as they act to decrease stress and anxiety 
by altering environmental perceptions and threats within (Bandura, 1995, pp. 9–10). 
Therefore, when SE beliefs are high, challenges are undertaken with greater 
confidence and control; whereas lower SE beliefs may lead to episodes of anxiety 
and depression (Bandura, 1995). Thus, the nurse-led clinic aimed to provide post-
PCI patients with early post-discharge education and support with the anticipation of 
impacting on each participant’s efficacy expectancies so that their SE could be 
enhanced and anxiety reduced. Furthermore, by educating participants and 
enhancing SE, it was hoped that participants’ ability to effectively manage their 
health would be achieved (or self-management). It was hoped that the intervention 
would encourage participants to either adopt and/or continue with positive health 
behaviours and be able to overcome challenges when faced by them with the 
additional skills offered in the repeated, uninterrupted, face-to-face, nurse-led clinic 
(i.e., post-discharge chest pain management). 
Schwarzer and Fuchs (1995) recognise the impact of poor health behaviours on 
disease and identify stress and poor coping as the cause of this unhealthy behaviour 
adoption. The authors highlight three expectancies that can facilitate health change 
through positive self-belief, namely:  
 Expectancy 1: “Situation-outcome expectancies”: Outcomes are the 
result of the environmental occurrences as opposed to individual acts.  
 Expectancy 2: “Action-outcome expectancies”: Resultant outcomes 
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caused by the individual.   
 Expectancy 3: “Perceived SE”: The individual’s personal conviction in 
their own potential to act accordingly and that it will result in the 
outcome they are aspiring to achieve. (Schwarzer & Fuchs, 1995, p. 
261) 
While the aforementioned efficacies are responsible for facilitating behaviour 
change, the actual adoption of healthy behaviours or discontinuation of harmful 
behaviours is subject to three “cognitions” (Schwarzer & Fuchs, 1995, p. 261). The 
three cognitions are identified below and include examples for the present study:  
 Cognition 1: “The expectancy that one is at risk” (Schwarzer & Fuchs, 
p. 261). For example, some participants in the intervention group may 
have believed that there is a high probability that they may have 
another heart attack being smokers. 
 Cognition 2: “The expectancy that behavioural change will reduce the 
threat” (Schwarzer & Fuchs, 1995, p. 261). Participants in this study 
may have considered that attending a CR program may support them 
in smoking cessation, and the risk of a future heart attack would 
therefore be reduced.  
 Cognition 3: “The expectancy that one is sufficiently capable of 
exercising control over a risky habit” (Schwarzer & Fuchs, 1995, p. 
261). Participants may have then believed that they do have the ability 
to attend CR and engage in smoking cessation and, thus, attend a 
secondary prevention program.  
This process is identified as “functional optimism” (previously defensive 
optimism) and is dependent on both personal coping and positive outcome 
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expectancies (Schwarzer & Fuchs, 1995, p. 262). To both adopt and maintain 
positive health behaviours Schwarzer and Fuchs (1995) highlight that an individual 
must believe that they can carry out the behaviour. Therefore, both efficacy beliefs 
and outcome expectancies are essential when assuming healthy behaviours, 
eliminating poor practices, and maintaining change (Schwarzer & Fuchs, 1995). 
Moreover, and as identified by these authors, individuals firstly have intent (to 
change behaviour), followed by an attempt (to change behaviour). Most importantly, 
however, it is noted that both SE beliefs and outcome expectancies work together to 
achieve behavioural change. Outcome expectancies act to establish intention (to 
change) while SE plays a large role in intent, actioning behaviour change, 
maintenance and overcoming challenges (Schwarzer & Fuchs, 1995). Thus, it is a 
combination of inherent beliefs that patients may be able to cope in the face of risk 
and have the vital skills necessary to overcome stressful circumstances such as those 
faced by post-PCI patients.  
2.6.2 Self-Efficacy (SE) Theory: Achieving Beliefs 
Holloway and Watson (2002) identify how the SE theory has served as a 
framework for many educational interventions, including those promoting and 
facilitating health behaviour change. Holloway and Watson (2002) highlight the four 
main information sources to which SE beliefs may be achieved (see also Appendix 
J), these include:  
 performance attainment/accomplishments or mastery; 
 vicarious experience; 
 verbal persuasion; and 
physiological feedback/emotional arousal. (Bandura, 1995; 2004, p. 
195; Holloway & Watson, 2002, pp. 109–111) 
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Performance attainment is highlighted to be the most “influential source of 
efficacy information” and encompasses performance accomplishment (Holloway & 
Watson, 2002, p. 109). Performance attainment involves participants achieving 
mastery through learning, and it is through achieving mastery that SE is enhanced 
and task competence is achieved. (Holloway & Watson, 2002).  
Holloway and Watson (2002) describe how vicarious experience encompasses 
observational learning and includes learning from events or from others. This 
expectancy can influence SE and mastery if a person observes successful modelling 
of a similar task undertaken. Conversely, if a task observed is failed, the observer’s 
SE may be reduced (Holloway & Watson, 2002). The authors highlight that 
healthcare professionals may and do act to model behaviour change. They advise, 
however, exercising caution and accounting for environmental changes experienced 
by participants attempting behaviour change through observational learning 
(Holloway & Watson, 2002).  
As an efficacy expectancy, verbal persuasion encourages an individual to adopt 
particular behaviours in certain health practices (Holloway & Watson, 2002). It is 
highlighted by these authors that verbal persuasion increases a person’s inherent 
ability and skill to perform a task as it enhances SE. The persuader can have a great 
effect on a person’s SE if they demonstrate proficiency and can convey a sense of 
trust to the patient. However, if the patient does not comprehend the task to be 
undertaken, the outcome of persuasion may not result in increased perceived SE 
(Holloway & Watson, 2002).  
Physiological feedback is the last of the efficacy expectancies and identifies 
how achieving enhanced SE can be affected by a person’s physiological state 
(Holloway & Watson, 2002). The authors highlight that increased physiological 
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states can impair performance in that patients may perceive themselves to be less 
competent. Emotions such as anxiety can also impact on a person’s physiological 
state and may be eliminated by undertaking interventions to eliminate negative 
emotions (Holloway & Watson, 2002).  
The adopted framework (see Appendix K) presents how nurse-led clinic 
participants may make positive health-related changes or engage in effective self-
management after attending the early intervention post-procedurally. It suggests that, 
by participating in the intervention, participants will be able to set goals that will 
lead to behaviour adoption and, lastly, positive health-related outcomes. Importantly, 
and as displayed in Appendix K, some standard-care group participants may also 
follow this path. For example, if standard-care group participants possess high SE or 
efficacy expectations, the routine care received during hospitalisation will naturally 
lead to goal setting, behaviour adoption, and positive health outcomes. Conversely, if 
standard-care group participants do not have high SE due to influencing factors, no 
health behaviour changes will be achieved and, consequently, lead to poor post-PCI 
health outcomes. Adoption of Bandura’s SE theory as the theoretical framework was 
therefore essential for this study as it was anticipated that attending a nurse-led clinic 
may increase participants’ SE, enhance their motivation, and provide them with the 
confidence to effectively manage their post-discharge health, behaviours, and 
emotions. Moreover, in enhancing SE it was hoped that problems, issues, and 
concerns such as accompanying anxiety may be reduced. Lastly, it was hoped that 
risky post-discharge behaviours could be avoided through the adoption of positive 
self-beliefs and, thus, healthy practices and more effective post-discharge self-
management. 
Lau-Walker (2007) highlights the importance of early pre-cardiac 
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rehabilitation intervention in that it may address control, illness beliefs, and 
management of symptoms. Furthermore, Lau-Walker (2007) identifies that an early 
intervention may also enhance the effectiveness of CR in terms of making and 
maintaining lifestyle changes. The author reports how identifying and addressing 
psychological needs is essential in those who experience a cardiac event and how it 
is often is not self-resolving. Lau-Walker (2007, p. 188) does reinforce though, in 
order to address psychological needs, patients “beliefs and expectations” must be 
managed. She also argues how addressing psychological needs may lead to positive 
attitudes (towards health and recuperation) and can be best achieved applying the SE 
theory as it can be individualised. Thus, as a pre-rehabilitation intervention, it was 
essential that the present study be trialled so that SE could be enhanced, 
psychological needs could be met, positive attitudes could be achieved, and 
participants could engage in self-management. 
2.6.3 Self-Efficacy (SE) in the Healthcare Setting 
Holloway and Watson (2002, p. 106) reinforce the strong link between SE and 
“health-related behaviours” in the healthcare setting. They emphasise how the SE 
theory and its constructs combined with health education in the hands of nurses (as 
they are in frequent contact with patients) presents as an “ideal” situation to 
encourage health behaviour change (Holloway & Watson, 2002, p. 106). 
Furthermore, in order for nurses to facilitate behaviour change through health 
prevention, promotion, and to enhance SE, any health intervention must be patient-
specific, the RN should be knowledgeable in the area (Holloway & Watson, 2002). 
The authors highlight how health education in the hospital setting can be ineffective 
in encouraging health behaviour change due to patient allocation workloads, limited 
teaching time, poor staffing, and limited understanding of the concept of health 
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promotion and education. Thus, the aforementioned reasons provided grounds for 
undertaking the present study in the early post-discharge period. Moreover, as 
healthcare organisations are under pressure to “reduce, ration, and delay health 
services to contain health costs”, application of the SE theory in encouraging 
individual long-term health management as the theoretical framework to guide this 
study was appropriate (Bandura, 2004, p. 144). The SE theory and its constructs 
were used to guide this study in order to identify poor health behaviours, educate 
patients, and facilitate health behaviour change over time by enhancing SE and 
reducing anxiety. As recommended by Holloway and Watson (2002), the present 
study was patient-specific as it pertained to PCI patients only, and at the time of 
undertaking the nurse-led clinic the PI had approximately 7 years’ experience as an 
RN in the cardiology field, including secondary prevention and CCT training.   
2.6.4 Effective Self-Management, Self-Efficacy (SE) and Chronic Illness 
With advances in modern medicine, patients with chronic illnesses are 
surviving longer (Thorne, 2008). As the healthcare system struggles to cope with the 
rise in the number of chronically ill patients and costs, a shift in the delivery of care 
for this group of patients has occurred (Thorne, 2008). Thorne (2008) highlights how 
nurse-researchers over many decades have successfully and qualitatively captured 
the experiences and journeys of chronically ill patients, identifying a gap between 
what the healthcare system feels patients need versus what patients believe they 
actually need. Thorne (2008, p. 8) recognises the disparity between the healthcare 
system and the “social reality of illness” and highlights how the mismatch has led to 
a change in the management of chronic illness from an acute-care approach to 
addressing the context of chronic illness.  
While chronic illness has been identified as a burden on society, if optimally 
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treated a patient’s life expectancy and QOL may be enhanced (Farrell, Wicks, & 
Martin, 2004). Furthermore, while many patients are provided with education and 
are aware of the need to engage in modification of lifestyle behaviours to enhance 
overall wellbeing, a majority fail to maintain behavioural changes (Farrell et al., 
2004). Farrell et al. highlight how aiming to enhance a patient’s perceived SE, in 
combination with medical treatment and health education, can enhance a patient’s 
self-confidence or SE to self-manage, particularly in chronic disease (Farrell et al., 
2004). The authors undertook a 6-week quasi-experimental pretest–posttest pilot 
study on a group of 48 rural, low socioeconomic participants to determine if 
participation in a chronic disease self-management intervention enhanced SE, SE 
health, and encouraged self-management. The study demonstrated significant 
enhancements SE to perform self-management of symptoms (p = .1) and SE health 
(p = .001), demonstrating the effectiveness of self-management programs on SE. 
Enhancements were also evidenced in communication with healthcare professionals 
and walking. These findings are important to the present study in that it aimed to 
enhance SE to encourage effective self-management as a secondary aim. Both 
primary and secondary aims will be discussed in greater detail in Chapter 3.  
Bodenheimer et al. (2002, p. 2469) identify how chronic disease sufferers are 
more involved in their health management and engaging in self-management. 
Bodenheimer et al. (2002) discuss how traditional health education complements 
“disease-specific” education coupled with management skills. Self-management is 
described as differing from traditional approaches as it offers problem-solving 
approaches to disease management. Importantly, self-management is not a 
replacement for conventional health education but rather an adjunct that combines 
traditional patient education while teaching and encouraging problem identification, 
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decision-making, management and action where health and illness states may alter 
(Bodenheimer et al., 2002).  
Bodenheimer et al. (2002) highlight the difficulty in generalising findings 
concerning self-management education; however, they do conclude that self-
management education programs are superior in achieving self-management 
compared to conventional education styles directly delivering information to 
patients.  Furthermore, the authors identify that some chronic disease outcomes may 
be enhanced and cost may be reduced as a result of such enhanced outcomes. It was 
therefore important that the present study and nurse-led, educational intervention be 
trialled, as it offered patients both education (verbal and written) and was 
complemented by offering skills and techniques for health decision-making, 
management, action.  
Barlow et al. (2002) reviewed the literature surrounding the effectiveness of 
self-management methods for chronic disease sufferers. Barlow et al. (2002) bring to 
light the ageing population and increased life expectancy in those suffering with 
chronic illness, and highlight the demands placed on the healthcare system for acute 
illness management alone. Methods of self-management delivery may include a 
clinical setting or home and be undertaken by various health professionals, with 
various modes of delivery, including group, one-on-one, and telephone to name a 
few (Barlow et al., 2002). The format of self-management can also vary, with 
booklets and role-play being offered. 
The authors highlight the effectiveness of self-management interventions, 
versus that of standard care for patients, reporting that knowledge, undertaking self-
management tasks, SE, and health status can be enhanced (Barlow et al., 2002). 
Furthermore, the authors recognise potentially equal benefits in attending either a 
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group or an individual education session, with the only issues in one-on-one sessions 
for patients being cost. Finally, it is argued that the self-management approach may 
also be equally as advantageous as “cognitive–behavioural interventions”, which is 
of interest given the present study was undertaken as a nurse-led clinic and utilised 
techniques to encourage effective self-management. The potential effectiveness of 
self-management interventions is important for the present study in that it aimed to 
not only enhance SE and reduce anxiety as a primary aim, but to reduce symptoms of 
depression and encourage effective self-management as secondary aims. 
Thorne (2008) recognises the importance of nurses and how they are in the 
position to better understand patients with chronic illness and how their lives and 
social contexts may affect how they respond and learn about their disease. The 
author highlights how nursing research has and will assist in the alignment of 
chronic illness management with the patient’s experience to enhance patients’ lives 
and wellbeing. With nurses highlighted as essential components of patients’ 
interaction and empowerment (particularly in chronic disease), Section 2.7 will 
discuss the importance of nurse-led clinics and person-centred care in educating and 
empowering patients in the post-discharge period.  
2.7 Nurse-Led Clinics and Community Follow-Up Initiatives for Acute 
Coronary Syndromes (ACS) 
Both in the field and captured in the literature, patients have commented on 
their lack of post-discharge knowledge, capabilities and feelings of isolation, with a 
large prevalence of emotional distress evident (Brezynski et al., 1998; Chair & 
Thompson, 2005; Corones et al., 2009; Davidson et al., 2008; Gulanick et al., 1998; 
Higgins, Dunn, & Theobald, 2000, 2001; Higgins et al., 2005; Kimble & King, 
1998; Murphy, Fishman, & Shaw, 1989; Sardinha et al., 2011; Tooth & McKenna, 
78 
1995; White & Frasure-Smith, 1995). Although CR is available, there appears to be 
a gap between discharge, cardiologist review, and the commencement of a CR 
program where participants appear concerned about their post-discharge capabilities 
(Bronskill, Normand, & McNeil, 2002; Burney et al., 2002; Corones et al., 2009; 
Shoulders-Odom, 2008).  
Nurse-led clinics are widely discussed within the literature, particularly in 
relation to chronic disease management (i.e., CHD, chronic heart failure, 
hypertension, diabetes mellitus, peripheral vascular disease) (Chummum, 2011; 
Clark, Smith, Taylor, & Campbell, 2011; Mason, Freemantle, Gibson, & New, 2005; 
Murray, 1997; Page, Lockwood, & Conroy, 2005; JBI, 2010). While nurse-led 
clinics have, and continue to be, trialled, the concept of a nurse-led, post-discharge 
clinic for patients within or up to 1 week post-PCI does not appear to be present in 
the literature reviewed. The PI undertook a broad search of the literature to ensure 
the present study had not been previously undertaken. A table of cardiology nurse-
led clinics for PCI and CHD patients was prepared to demonstrate the uniqueness of 
the present study (see Appendix L).  
In a randomised clinical trial, Carroll, Rankin, and Cooper (2007, p. 315) 
assessed the effectiveness of a community follow-up of 247 older MI and CABG 
patients by an Advanced Practice Nurse (APN) and peer advisor. Participants in the 
treatment group received a home visit by an APN at 72-hours post-discharge, 
followed by a telephone call at 2, 6, and 10 weeks and a telephone call by an advisor 
every 12 weeks post-discharge (Carroll et al., 2007, pp. 313–-319). Cardiac 
rehabilitation attendance and rehospitalisation was tracked over 12 months. Carroll 
et al. (2007) achieved their aim of increased participation in CR and lower hospital 
readmission rates. The authors attribute the role of the APN and peer advisor in 
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attaining such results.   
Alfakih et al. (2009) set up a follow-up clinic for patients diagnosed with ACS. 
Their main aim was to reduce 6-monthly readmissions to hospital through early 
detection of chest pain and appropriate management. The authors reported 
effectiveness of the intervention with a decrease in readmissions by approximately 
14.3%. The difference between the clinic trialled by Alfakih et al. (2009) and the 
present study are clearly identified in their aims. Alfakih et al.’s (2009) study aimed 
to detect chest pain in the early discharge period and to reduce the number of 
hospital readmissions, while the present study aimed to enhance SE and reduce 
patient anxiety as its primary aim. As secondary aims, the present study aimed to 
reduce depressive symptoms and enhance participant confidence or SE to effectively 
self-manage in the early post-discharge period after undergoing PCI. A consequence 
of achieving primary and secondary aims is reduced hospital readmissions; however, 
while these were not identified as aims in the present study they could be trialled in a 
larger scale project.  
As identified in Chapter 1, the present study aimed to provide support for 
patients between the day of discharge from hospital until specialist follow-up and the 
commencement of CR. It aimed to provide early support and to reiterate patient 
education delivered during hospitalisation and to reinforce the benefits of CR. From 
the literature reviewed, nurse-led clinics include both primary and secondary 
preventative initiatives for patients who have experienced a cardiovascular event, 
surgical or interventional procedure (i.e., PCI), or who have diagnosed CHD as 
opposed to early, first-week interim support for patients who have undergone PCI as 
per the present study. While psychological distress and cardiovascular risk factors 
(i.e., cholesterol, physical activity, smoking, diabetes, hypertension) and 
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management interventions (i.e., medication adherence, self-care, angina 
management) have been investigated by other researchers (as identified in Appendix 
L), no similar study appears to have been undertaken.    
The Queensland Government and Department of Health acknowledge the 
benefits of nurse-led outpatient clinics to both patients and the healthcare system and 
aim to introduce more clinics to the communities so that healthcare may be more 
accessible to all Queenslanders(QLD Health, 2013), this reinforced the undertaking 
of the present study. The JBI (2010) and Hatchett (2005) highlight how nurse-led 
clinics have become much more widely recognised and utilised in the healthcare 
community and benefit patients in many ways, including managing chronic illnesses 
in the community, preventing health deterioration, and reducing specialist follow-up, 
while also providing a therapeutic relationship. The JBI (2010) also highlight the 
health-promotive component of nurse-led clinics and how they benefit both the 
patient and nurse. Hatchett (2005) identifies that, in order to fulfil the role of a nurse-
led cardiology clinic, it must comprise some of the following characteristics: offer 
education, provide psychological support and clarification, monitor the participant, 
undertake physical assessment, undertake investigations and clarification, engage 
with a multidisciplinary team in individualising care-paths, offer medication 
management, and encourage the participant or guardian to engage in self-care. Thus, 
the aforementioned roles were acknowledged in designing the present study and 
adapting the underlying theoretical framework.  
Schadewaldt and Schultz (2011), in a systematic review, sought to determine 
the effectiveness of nurse-led clinics on participants’ short- and long-term health 
outcomes. The authors identified a greater effect on short-term health outcomes with 
regard to nurse-led clinics. Furthermore, they identified more success of the 
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programs with greater nurse–patient support and a better quality of life. The authors 
recommend longer patient support to achieve long-term health goals and earlier 
access as being essential to patient survival. Additionally, Schadewaldt and Schultz 
(2011) advise that nurses should have appropriate clinical qualifications prior to the 
initiation of a nurse-led clinic, while advising the consideration of funding and the 
healthcare system. These recommendations were taken into account in the set-up of 
the present nurse-led clinic.  
2.7.1 Nurse-Led Clinics and Person-Centred Care (PCC) 
In addition to encouraging effective self-management and providing nurse-led 
education and care, healthcare professionals engage more in a person-centred 
approach to healthcare delivery, particularly in respect of patients with specific 
chronic illnesses (Yu, 2014). Yu (2014) suggests that a person-centred approach to 
patient care is pertinent to effectively managing chronic illness and patients with 
multiple co-morbidities. Dudas et al. (2013) highlight the importance of PCC in that 
it identifies patients as people, as opposed to their illness. Patient-centred care 
recognises the illness experience and how patients’ symptoms affect their daily lives. 
Dudas et al. (2013) highlight how PCC may improve hospital length of stay and 
activities of daily living in patients with CHF through the collaboration between the 
healthcare provider and patient throughout their hospital admission. Further to this, a 
care path, based on a patient’s account of their illness, can more effectively manage 
the individual’s specific needs as a result of the illness encountered. Dudas et al. 
(2013) argue that the structure provided by PCCs may facilitate greater patient 
assurance in their illness and management. 
Dudas et al. (2013) undertook a controlled, before-and-after design study of 
248 patients with worsening heart failure to determine if a patient who received a 
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PCC approach in their health and illness management reported lower illness 
uncertainty. Patients in the intervention group reported less uncertainty in their 
illness as opposed to standard-care group participants. Participants in the 
intervention group were reportedly more symptomatic of their heart failure versus 
standard-care group participants. The authors propose the potential effectiveness of 
PCC in empowering and preparing patients in their illness management. 
Additionally, Dudas and colleagues suggest that PCC transpires into everyday 
practice for patients receiving hospital treatment for deterioration with heart failure 
(2013).      
The WHO released a policy framework on PCC and identifies how healthcare 
organisations are engaging in a more holistic approach to patient care and interest in 
understanding the patient to address their needs (WHO, 2007). The WHO highlight 
the importance of a people-centred approach in that people, prior to assuming the 
role of a patient, should be both “informed and empowered” in their health 
protection and promotion (WHO, 2007, p. 5). People-centred healthcare is 
highlighted to uphold values of international law to improve outcomes for both 
individuals, families, the community, healthcare professionals, healthcare 
organisations and systems. The WHO (2007) identify the following measures to 
improve outcomes for all:  
 informing and involving consumers of healthcare of their options and 
decisions;   
 holistic approach by healthcare providers towards consumers; and 
 support within the healthcare environment.  
Further to the aforementioned measures, the WHO (2007) identify strategies to 
achieve holism and compassion in healthcare and thus, person-centred healthcare. 
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The strategies identified are targeted at individuals, families, communities, 
healthcare professionals, organisations and systems to meet the needs of healthcare 
consumers and providers in a positive, compassionate and humanitarian manner 
(WHO, 2007).  
This critical review has identified clear gaps within the literature for patients 
who have experienced a cardiac event and/or undergone PCI. Section 2.8 now 
summarises the findings and implications as a result of this critical review.  
2.8 Summary and Implications 
As identified, a post-discharge gap is apparent from the day of discharge to the 
recommencement of a CR program, and cardiologist follow-up. The literature review 
critically highlighted that the present study is not a secondary prevention program 
but rather aims to provide early post-discharge education, follow-up and support to 
patients awaiting cardiology review and CR program attendance. This chapter 
discussed the literature with respect to theoretical framework and the primary and 
secondary aims. It reviewed, examined, and highlighted the importance of SE to 
patients, particularly those diagnosed with a chronic disease and highlighted how 
education, support, and a high SE can positively impact on post-discharge anxiety. 
As psychological distress, particularly anxiety and depression, are identified in the 
literature and strongly linked to CHD, coronary events, and cardiovascular 
procedures, the post-discharge, nurse-led clinic was warranted. Moreover, with 
heightened anxiety, limited time for nurse-teaching (during hospitalisation), and poor 
information absorption, support of the primary aim to enhance SE and reduce 
anxiety through early reiteration of post-PCI discharge education and nurse-led 
support may be maintained. Furthermore, this chapter reviewed the literature in 
relation to nurse-led clinics in CDM and in particular CHD. Moreover, a summary of 
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CHD literature was presented to demonstrate that the present study has not been 
previously undertaken. This chapter also discussed how high SE may positively 
impact on the post-discharge period and, in particular, patient self-management.  
Thus, with a short hospitalisation, the effect of a high SE on CHD patients, the 
presence of psychological distress (from admission to the post-discharge period), the 
importance of effective self-management, and under-referral and attendance to CR, 
the present study was deemed as necessary. Moreover, not only are ACS patients 
commenced on a mean of six new medications (in addition to possible other 
medications consumed), adherence and compliance appears to be problematic. 
Although there has been a large reduction in post-discharge complications, they may 
still be experienced, thus highlighting the importance of early detection and 
management. Lastly, the importance of nurse-led clinics with a person-centred 
approach for the management of chronic disease was highlighted in the literature and 
supported. With the aforementioned issues surrounding PCI patients and their 
recovery, the study aimed to test the timeliness and effectiveness of a nurse-led clinic 
within 5–7 days post-discharge, post-PCI versus standard care and follow-up using 
Bandura’s SE theory to guide the research. The next chapter discusses the methods 
utilised to undertake the study’s two phases.
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Chapter 3: Research Design 
This chapter details the development of Phases One and Two, while also 
discussing the methodology and design, to achieve the study aims and objectives. 
Study participants, the procedure, instruments, and associated validity and reliability 
are also presented. Timelines for the procedure and data collection in Phases One 
and Two are also described and ethical considerations and limitations are examined. 
Lastly, this chapter presents the data analysis techniques for both study phases. 
3.1 Methodology and Research Design: Phases One and Two 
3.1.1 Study Development: Phase One 
The PI considered it paramount, given the healthcare agenda and demands 
currently placed on the healthcare system, that a nurse-led clinic be undertaken in 
outpatient setting by a cardiology trained RN or Clinical Nurse (CN) (Queensland 
[QLD] Health, 2013). The decision to undertake a face-to-face, nurse-led clinic was 
also determined by the potential to reduce the workload on GPs, cardiologists, and 
emergency departments, while optimising patient outcomes (Queensland Health, 
2013). Furthermore, given the geographical isolation of many patients, the PI 
deemed it important that the study be undertaken as a face-to-face nurse-led clinic 
with a telephone treatment arm that might benefit remote and rural patients and those 
unable to attend a face-to-face clinic. Lastly, with a short hospitalisation, follow-up 
within 4–6 weeks post-discharge, and given the relationship between a cardiac event 
and psychological distress coupled with health-related misconceptions, the PI aimed 
for early post-discharge follow-up and support. Thus, the study’s early design took 
the form of a three-arm, randomised controlled clinical trial with participant follow-
up within the first 72 hours over a 12-month period (see Appendix M). 
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Recommendations from the university panel, however, suggested that given (a) the 
timeline for a PhD, (b) the number of participants required to achieve a well-
powered study, (c) the PI’s intention to undertake such a sizeable study using 
multiple modes of communication without the assistance of a research assistant 
(RA), the telephone intervention arm was removed and study arms reduced to two 
(i.e., face-to-face intervention versus standard care). Additionally, the research team 
and literature recommended the first week for post-discharge follow-up was an ideal 
time to review this group of patients (Günal et al., 2010; Rassaf et al., 2013; Trotter 
et al., 2011; Tuso et al., 2013; Yan et al., 2011; Wong et al., 2006). Thus, the nurse-
led clinic emerged as a clinic to be held within the first 5 to 7 days post-PCI. 
The PI and supervisory team began approaching three hospital sites for 
feedback regarding the potential study, research protocol and real-world application. 
The research team met with various hospital executives and teams on numerous 
occasions and included the following: 
 two Directors of Nursing (DON); 
 one nursing Director of Research; 
 three Cardiology Directors; 
 one Director of Medical Services; 
 one Director of Emergency Medicine; 
 one Nurse Practitioner (NP); 
 three senior CR Clinical Nurses (CNs) 
 a group of senior CNs (provided a detailed study presentation); 
 one research institute; 
 one site contact; 
 two Clinical Nurse Managers (CNMs); and 
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 two outpatient departments (OPD). 
The study protocol and risk management protocols were drafted and multiple 
versions created to ensure the safety of all potential participants and the suitability 
for each study site. Once all executives agreed on the potential study, the PI 
submitted an application for ethical approval at two potential sites and to one 
research institute. The main area of concern raised by the committees were: risk 
management of acute psychological distress, medical emergencies, a request for a 
detailed sample size calculation, and desired effect or units of change of the nurse-
led clinic on the study’s main outcomes. The research institute requested that as their 
patient review system coincided with the present study’s follow-up the PI should 
undertake telephone review at their site and collect data utilising both the research 
institute assessment tool in conjunction with The ‘REALITY CHEC’ Project data 
collection form.  
Prior to the commencement of the nurse-led clinic, the PI conducted hospital 
in-service sessions to brief both nursing and medical staff regarding the study and 
management of potential adverse events on-site. Staff members provided the PI with 
input on management and their potential concerns regarding risk management at the 
sites. After such consultation, the PI negotiated the use of rooms and materials at the 
sites, which also presented as a delay to the commencement of participant 
recruitment. Overall, the total time from the commencement of initial meetings at 
each site, receipt of ethical and research governance approval, gaining clinic access, 
to participant recruitment was approximately 16 months. A contract with the 
university legal team was also drawn up and agreed upon with each site regarding 
study related data and access. One site requested a detailed protocol and assistance 
with a post-discharge, outpatient clinic set-up. In addition to legal team discussion, 
88 
QUT’s Bluebox (i.e., innovation and knowledge transfer company) was updated 
about the study regularly throughout the course of the study and offered assistance 
with the packaging of the intervention. 
Prior to the commencement of the study, the PI prepared participant packages, 
which consisted of the following (see Appendix N): 
 one salivette and prepaid envelope; 
 saliva sample instruction sheet (with images and documentation); 
 educational booklet, ‘My Heart, My life’; 
 three access site diagrams and three prepaid, addressed envelopes (to 
document wound healing and observations); and 
 tape measure (for waist measurements). 
In addition to the preparation of participant packages, the PI created the 
following templates on QUT letterhead: 
 potential risk reporting to the Human Research Ethics Committees 
(HRECs); 
 participation letters to cardiology groups and GPs for their patients’ 
participation (also emailed if this was provided by participant); 
 missed nurse-led clinic follow-up call and rescheduling; 
 lost to follow-up and giving thanks for participation; and 
 thank-you letters for participation. 
In addition, if the PI had concerns regarding a participant, telephone 
communication was followed up with a formal letter. The PI also prearranged car-
parking tickets and vouchers at each site for participants. 
Following Phase One, it was anticipated that a second phase would provide 
detailed feedback on the nurse-led clinic if the PI reapproached intervention group 
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participants and healthcare professionals (i.e., cardiologists and cardiology nurses). 
The PI applied for ethics variation approval for Phase Two, with all committees in 
agreement. 
3.1.2 Research Design 
Research methodology and design: The pilot study 
This study employed an experimental design and was undertaken in two 
phases as a pilot study, which is “a small scale version of the study that goes in 
advance, incorporating all aspects of the procedures of the main study and providing 
guidance for the larger study” (Roberts & Taylor, 2002, p. 259). Phase One, as 
identified above, investigated the effect of a nurse-led, educational intervention at 5–
7 days on anxiety and SE after participants were discharged from hospital and 
focused on the collection of data via quantitative means. Phase One was undertaken 
to determine the safety and efficacy of the nurse-led intervention (see Appendix O). 
Baseline data collection occurred at day of discharge (Time 1) and follow-up 
occurred at day 5–7 (Time 2), 1 month (Time 3), and 3 months (Time 4) post-
hospital discharge. 
Phase Two explored intervention group participants’ and healthcare 
professionals’ opinions of the effectiveness of the nurse-led educational intervention, 
as well as its efficacy and safety. Participants undertook an interview at a date and 
time convenient for them at approximately 6-months post-discharge from hospital 
with analytical findings explored through participants’ narratives. The study’s third 
phase is presented in Chapter 5 and was undertaken to determine the efficacy of the 
intervention on a significantly larger group of participants utilising an electronic 
visual mode of communication to reach a broader population. A pilot study was 
chosen to determine the feasibility for a Phase 3 study and to determine the adequacy 
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of the study design and methodology. 
As identified, the present study was undertaken as a pilot to determine the 
feasibility for a Phase Three, multi-centre study. The purpose of the present study 
was to evaluate the effectiveness of the nurse-led clinic from the perspective of 
participants and healthcare professionals through more formative evaluative means 
(Clarke & Dawson, 1999). Clarke and Dawson (1999, p. 11) highlight that, in 
undertaking formative evaluation, “the aim is to ascertain if any changes are needed 
in order to improve the programme”. Information concerning the process of the 
intervention implementation and operation, strengths and weaknesses, difficulties 
encountered and the opinions and feedback of participants and healthcare 
professionals was thus attained to determine the effectiveness of the study and 
feasibility for a Phase Three, multi-centre study (Polit & Beck, 2010). 
As highlighted by Connelly (2008), the conduct of pilot studies within the 
clinical setting is essential in that they may facilitate the management of any 
unforeseen events and gauge participant recruitment. The PI, in undertaking the pilot 
study, was able to determine the strengths and limitations in the research protocol, 
methods, and tools utilised, while also measuring effect size and therapeutic 
outcomes. Although pilot studies are of smaller sample size, conducting the present 
study has assisted greatly in the planning of a Phase Three, multi-centre study. 
Furthermore, after engaging in post-study critical reflection, areas noted for 
improvement were identified and may offer ideas for planning a nurse-led clinic of 
this nature. Issues encountered in the present study are identified with suggestions 
for enhancements offered. 
Phase One used a randomised controlled clinical trial design to test the 
effectiveness of the nurse-led clinic, while Phase Two utilised a descriptive-
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evaluative technique to analytically explore participants’ and healthcare 
professionals’ feedback related to the nurse-led clinic to inform a Phase Three, 
multi-centre study. The study’s first phase is discussed below in detail. Figure 3.1 
below diagrammatically presents the research plan for Phase One: 
 
Figure 3.1.  Research plan – Phase One of the ‘REALITY CHEC’ Project© 
3.1.4 Study Phases 
Phase One: Randomised controlled clinical trial (RCT): A pilot study 
Phase One involved the delivery of the nurse-led educational intervention in an 
outpatient clinic setting and was strongly guided by Bandura’s Self-Efficacy (SE) 
theory (1977, 2004). The SE theory, as discussed in chapters 1 and 2, identifies how 
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mastery and vicarious experience positively influence beliefs in one’s self and 
abilities and lead to positive behavioural changes, thoughts, and feelings (Bandura, 
1977, 2004). Consequently, motivation and an individual’s SE are strengthened and 
enhanced (Bandura, 1977, 2004). Furthermore, in enhancing one’s SE, it was hoped 
that anxiety would be reduced and participants would be able to effectively engage 
in their health and wellbeing management in the post-discharge period and beyond.  
The key constructs of Bandura’s (1977, 2004) SE theory have been adapted for 
this study and are represented in the theoretical framework (see Appendix K). The 
theoretical framework diagrammatically represents how external influences, the 
individual, socio-structural factors, and outcome expectations can affect goal setting 
and lead to long-term behaviour change or, conversely, no change at all. The main 
aim in Phase One was the delivery of the nurse-led clinic to intervention group 
participants and collection of quantitative data. Furthermore, Phase One aimed to 
determine the overall effect of the intervention on participants’ SE and anxiety levels 
in the post-discharge period versus post-PCI standard care. Some qualitative data 
were collected throughout Phase One of the study. Quantitative data were also 
collected around the secondary aims and included post-discharge depression, CR 
attendance, medication adherence, and post-discharge complications. 
The Phase One pilot study involved the collection of quantitative data and 
comprised a prospective, randomised controlled clinical trial (see Appendix O). 
Houser (2008) and Parahoo (2006, p. 247) highlight how randomised controlled 
designs are the “gold standard” in testing the efficiency of both new and existing 
interventions. Randomisation of participants assumes equality, thus allowing the 
effect of the intervention to be measured (Houser, 2008). Furthermore, by 
randomising participants, the effects of confounding variables may be diminished or 
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removed (Ryan, 2007). Therefore, to achieve accuracy and reliability and controlling 
for bias and variability, participants in this study were randomised (Chow & Liu, 
2004). Chow and Liu also encourage blinding to control for bias and to ensure 
accuracy and reliability of the study. Participants in this study were not blinded as it 
would be easily discernible (by participants) which group was receiving the 
intervention. Chow and Liu also identify how both the investigator and research 
team can introduce bias into the study. It was suggested that a research assistant 
could be employed to undertake blinded follow-up to control for researcher bias and 
to ensure accuracy and reliability of the study’s data and results. Queensland 
University of Technology (QUT) staff members serving on a student review panel 
recommended and encouraged the candidate to undertake this position as part of the 
PhD learning process. Furthermore, as the PhD student allocation did not allow for 
the employment of an RA, the candidate undertook participant recruitment, 
randomisation, data collection, data entry and analysis. 
Although “gold standard”, there are limitations associated with experimental 
designs, particularly within the healthcare setting (Houser, 2008; Parahoo, 2006, p. 
247). These limitations were taken into account in the design of this study and 
included the (a) difficulty and complexity in design; (b) requirement of time, skill, 
and participant accessibility; (c) inability to control health and disease progression; 
and (d) greater control of the study may produce an unnatural, less generalisable 
study and results (Houser, 2008). 
Parahoo (2006) and Roberts and Taylor (2002) identify both external and 
internal validity and the subsequent threats they may pose. Internal validity can 
include factors that may affect the study on an internal level (Parahoo, 2006). 
Moreover, they may both mutually and independently affect the outcome of the 
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study (Parahoo, 2006). Therefore, the authors advise that a researcher consider 
possible design flaws and measure the internal validity of a study to remove or limit 
undesirable outcomes (Brennan & Croft, 1994; Parahoo, 2006). Internal threats 
include both subject and measurement changes and can involve procedures and 
instruments and changes to observation (Roberts & Taylor, 2000). Observational 
changes may comprise experimenter effects on participants and the study (Roberts & 
Taylor, 2000). The researcher acknowledges the possibility of experimenter effects 
as the PI undertook all stages of the study, thus, there is the possibility that validity 
of the study may have been threatened. Additionally, extraneous variables, those 
variables that may influence study outcomes, were also considered in the design of 
this project (Roberts & Taylor, 2002). Roberts and Taylor (2002) recommend control 
of these variables by selecting participants who have similarities in variables or by 
including the subgroup within the study to assess for dependent variable differences. 
An important consideration made in this study included the selection of participants 
who underwent PCI only. Additional internal threats in this study identified by the PI 
may have also resulted from participant withdrawal, randomisation and the unequal 
participant numbers in study groups, and type-two error potential due to a small 
participant sample size. 
For a study to have external validity, findings need to be generalisable to the 
population or reflect population validity (Roberts & Taylor, 2002). Parahoo (2006) 
and Roberts and Taylor (2002) highlight that, to ensure external validity is achieved, 
participant selection should take place in the general population. The authors identify 
the difficulty in selecting participants in the healthcare setting and recommend that, 
as the findings may not be applicable to the entire population, they may be 
generalisable to the population and particular area of healthcare studied (Parahoo, 
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2006; Roberts & Taylor, 2002). To ensure greater external validity in the present 
study, randomisation took place in the hospital setting where patients underwent 
primary or elective PCI. By recruitment of participants in the hospital setting this 
aimed to ensure that findings would be applicable to the group of patients who 
underwent PCI. Additionally, a reactive effect as a result of the study may have also 
occurred and will be addressed in Chapter 6 (Houser, 2012, p. 264). The PI has 
considered the reactive effect and that enrolment in this study may have facilitated 
positive changes in study participants (irrespective of the intervention), particularly 
in standard-care group participants (Houser, 2012). Lastly, to ensure greater external 
validity or ecological validity, the study was undertaken in the hospital setting, 
which was identified as important so that findings could be generalised to 
participants in this setting (Houser, 2012). 
3.2 Participants, Procedure, and Timeline 
3.2.1 Sample and Power 
The sample size for Phase One comprised 33 participants who underwent PCI 
from the two hospital sites. A sample size calculation was undertaken based on a 
study by Yohannes, Doherty, Bundy, and Yalfani (2010) who investigated the 
benefits of CR on anxiety, depression, and physical and psychosocial wellbeing. As 
the present study’s primary outcome was to enhance SE and reduce participant 
anxiety, the calculation of the sample size using standard deviations for anxiety as 
displayed by Yohannes et al. (2010) was warranted. The first part of the calculation 
revealed that 58 participants per study group were required to ensure a statistical 
power of 90%, to detect an effect, and to decrease the chance of error. Then, 
accounting for a design effect of 1.7 units of variance, 10% attrition, and 90% power, 
109 participants were required per study arm. The PI rounded this up to 110 
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participants per study group or 220 participants in total. To maximise and ensure 
steady participant recruitment, the PI prepared a recruitment plan (see Table 3.1). On 
days where the PI was recruiting at hospital site two, telephone contact was made 
with the CNM at site one to verify if there were any potential study participants. 
Table 3.1. Recruitment Plan: Hospital Sites 
Day Site(s) 
Monday Site one: 07:00 am–10:30 am 
Site two: 11:00 am onwards if nil or if few participants reviewed at site 
one 
Tuesday Site one: 07:00 am–10:30 am 
Site two: 11:00 am–13:00 am 
Wednesday  Site one: 07:00 am–10:00 am 
Site two: 10:30 am–13:00 am 
Thursday Site one: 07:00 am onwards 
Site two: visit site if nil or if few participants reviewed at site one 
Friday Site one: 11:30 am onwards 
Site two: 07:00 am–11:00 am  
Note: If no participants meet inclusion criteria or participants already reviewed at one site, PI to visit 
other site. 
 
In order to join in the study, potential participants were required to satisfy the 
inclusion criteria. Inclusion criteria are defined as “Guidelines for choosing subjects 
with a predetermined set of characteristics that include major factors important to the 
research question” (Houser, 2008, p. 217). Conversely, exclusion criteria remove 
potential candidates from participation in a study (Houser, 2008). Houser (2008) 
highlights how the development of inclusion criteria helps to reduce study biases but 
advises not to be too extensive nor too specific as this may lead to the introduction of 
extraneous variables or significantly reduce accessibility to potential participants. 
The study’s criteria for inclusion or exclusion were as follows: 
Inclusion Criteria 
 aged 18 years and above; 
 informed consent for primary or elective PCI signed by patient and 
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cardiologist; 
 have undergone a primary or elective PCI; 
 understand or speak the English language; and 
 have post-discharge telephone access (mobile phone and/or landline). 
Exclusion Criteria 
 children and/or young people (i.e., < 18 years of age); 
 inability to understand or speak the English language; 
 overseas resident: 
 unable to be followed up due to return to home country; 
 on vacation in Australia for less than 12 months; 
 patients suffering from a mental illness/cognitive impairment and 
unable to legally consent; 
 pregnancy; 
 people in existing dependent or unequal relationships; 
 people highly dependent on medical care; and 
 have no telephone communication access. 
Importantly, a cognitive impairment/mental illness in this study was not 
grounds for exclusion. If any participant had been unable to satisfy the following 
criteria, they would have been excluded: “unable to weigh the risks and benefits of 
participation; unable to make informed decisions; and be unable to fulfil the 
requirements of obtaining informed legal consent” (Polit & Beck, 2010, p. 131). 
3.2.2 Study Setting 
Participants were recruited from one large metropolitan private and one public 
hospital to determine the effect of the intervention at two different sites. Cardiologist 
consent was granted from directors at both sites, with written approval given to 
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approach patients. A National Ethics Application Form (NEAF) was completed and 
submitted to all Human Research Ethics Committees (HRECs) involved. A Site-
Specific Agreement (SSA) was submitted to the Research Governance Office (RGO) 
at one of the sites, while research agreements were established and agreed on for 
each site and one hospital research institute. 
The private hospital site where the study was undertaken was a 250-bed acute 
care facility specialising in advanced surgical procedures and general medicine. The 
hospital had a technologically advanced intensive care unit (ICU), Coronary Care 
Unit (CCU), Cardiac Catheterisation Theatre (CCT), Day Surgery Unit, and 
Endoscopy unit. The hospital annually performed approximately 403 PCI procedures 
(Foster, K [Research manager], personal communication, July 26, 2013). 
The public hospital site was a tertiary-level, public hospital facility, with a 
953-bed capacity (Queensland Government, 2011, p. 71). This facility offers all 
adult care specialties, excluding obstetrics (Queensland Government, 2013, p. 4). 
This site is a leader in medical research and teaching and admits approximately 
82,000 patients per annum (Queensland Government, 2013, p. 4). The hospital has a 
strong cardiology division that performed approximately 875 PCI procedures 
between 2011 and 2012 (Queensland Government, 2013, p. 38). 
Meetings with hospital medical, nursing, research executive and CR teams 
took place on several occasions prior to and post ethical approval to ensure support 
for the PI and that sites and staff were adequately prepared and informed of the study 
and its requirements. Strong support from executive-level directors, unit managers, 
and CR facilities at both hospital sites was given to undertake this study. 
3.2.3 Recruitment and Consent 
Potential participants were identified on admission to hospital through 
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collaboration with ward staff at the sites. The recruitment process was as follows: 
 consultation with the CNM; 
 consultation with the CN in charge of the shift; and 
 consultation with the nurse caring for the patient. 
On the day of discharge from hospital—following the process of participant 
identification as presented above and on patient instruction by the CNM, CN, or 
RN—potential participants were approached and offered a participant information 
and consent form (PICF) in the presence of their nurse. Only one consent form was 
signed by participants and this included consent to participate and the following: 
 the release of medical information (i.e., medical and bedside progress 
chart); 
 access site digital image collection and use (i.e., health education and 
conference presentation); and 
 saliva sample collection. 
Patients were given time to review the documents. After reading the 
documents, if the patient agreed to speak with the PI to clarify or to sign the consent 
form they did so through their nurse or instructed the PI to return within a certain 
time frame (i.e., 30 minutes) had their nurse been unavailable. Participants, if 
agreeable, were consented to the study. 
Consent forms were photocopied for all participants and returned to them after 
signing. Study withdrawal without comment or penalty was emphasised during the 
consent process and highlighted in the PICF in full. Participation in Phase One of the 
study was voluntary. No incentives were offered to participate in Phase One; 
however, the potential benefits of participation (i.e., tailored post-discharge 
education and follow-up, and benefits for future PCI patients) were identified to 
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maximise participation. Additionally, the contribution to nursing and medical 
knowledge was also highlighted to participants. Car-parking vouchers were provided 
for on-site car parking to ease the burden of searching for a car-park space and to 
assist in overcoming any potential logistical barriers on return to the hospital site. 
The same sites (i.e., hospitals) were chosen for nurse-led clinic follow-up so that 
participants would be familiar with the surrounds. For ethics, privacy, and 
confidentiality reasons, all health facilities, participants, and personal details were 
de-identified and coded. On completion of the study, participants were given a 
certificate of thanks and mailed a summary of key results. 
3.2.4 Instruments, Validity and Reliability 
The instruments used in this study included the following: Individual data 
collection form (DCF) (see Appendix P); CSE Scale (see Appendix B); STAI (see 
Appendix C); Cardiac depression scale (CDS) (see Appendix D); Morisky 
Medication Adherence Scale (MMAS-8) (see Appendix P1); wound assessment tool 
(see Appendix Q); and a neurovascular assessment tool (see Appendix R). The PI 
obtained written permission from all authors to use these instruments (see Appendix 
S). 
Data were collected in paper format and managed electronically using IBM’s 
Statistical Package for the Social Sciences (SPSS) predictive analytic software 
(PASW) version 19 and Microsoft Excel. All data collected using the assessment 
tools were kept in each participant’s file, both in hard copy and saved electronically. 
Since completion of the study, hard copy and electronic data continue to be stored in 
a secure location at QUT in the School of Nursing (SON) for at least 12 months as 
per section 2 of the Revision of the Joint NHMRC/AVCC Statement and Guidelines 
on Research Practice Australian Code for the Responsible Conduct of Research 
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(NHMRC/AVCC, 2007) addressing data collected for the purpose of assessment. 
Data and ownership were discussed with hospital sites and agreed on in contracts. 
3.2.5 Cardiac Self-Efficacy Scale (CSE) 
The CSE Scale was used to assess how SE affects CHD patients’ physical 
function and role while controlling for anxiety and depression (Sullivan et al., 1998). 
The CSE has excellent internal consistency and good convergent and discriminant 
validity for the following two factors: control symptoms (CS); and maintain function 
(MF) (Sullivan et al., 1998). Alpha reliability for both factors were  = .90 for CS 
and .87 for MF (Sullivan et al., 1998). A moderate correlation was identified 
between the scales r(33) = .38, p < .05. The CSE was used in all participants at 
baseline and post-discharge, particularly after undertaking the nurse-led educational 
intervention. The CSE was used to measure whether or not perceived SE was 
enhanced by participating in the intervention in which participants are encouraged to 
make appropriate lifestyle adjustments and maintain positive health behaviours and 
activities post-intervention and post-PCI. The PI reviewed each CSE item to observe 
trends and obtain more detailed data on individual CSE items after attending the 
nurse-led intervention over time. Alpha reliability for individual scale items was high 
at α = 0.9. 
3.2.6 Anxiety and Depression Measurement: STAI, CDS, and Saliva 
Specimen 
Participant anxiety levels were measured along with an assessment of 
depression pre and post-discharge. The STAI for adults was used to collect data 
about patients’ anxiety, while the CDS assessed participants for depression. The 
STAI is a psychological tool measuring both state and trait anxiety (Kendall, Finch, 
Auerbach, Hooke, & Mikulka, 1976). The STAI was chosen as it was proven to be 
102 
uncomplicated and had a broad application in both clinical and non-clinical settings 
over time (Lam, Michalak, & Swinson, 2004). Furthermore, as it takes five to ten 
minutes to complete, it was identified as cost-effective and could be distributed to a 
large number of groups (as compared with other measurement tools). It was, 
therefore, selected to attain baseline, post-intervention, and post-discharge trait 
anxiety scores (Tilton, 2008). The STAI assesses both state and trait anxiety using 
two scales (Lane, Carroll, Ring, Beevers, & Lip, 2000). Both scales have good 
internal consistency, with an alpha value of α = 0.92 for the state anxiety and α = 
0.90 for trait anxiety scales. The trait anxiety assessment tool was used in the present 
study to measure pre- and post-test trait anxiety levels (Lane et al., 2000). Trait 
anxiety represents consistent and stable individual tendencies in response to 
threatening situations, it was, therefore, chosen as the main outcome measure for 
anxiety in the present study (Tovilović, Novović, Mihić, & Jovanović, 2009). 
The CDS is specific to the measurement of depression in cardiac patients and 
was created to distinguish between actual cardiovascular symptoms and depression 
(Davidson et al., 2008; Di Benedetto, Lindner, Hare, & Kent, 2007). Davidson et al. 
(2008) identify how patients who experience a cardiovascular event may experience 
feelings (which are very normal) such as “sadness and grief”; however, it is essential 
that these feelings be identified and differentiated so that depression is not 
overlooked (Davidson et al., 2008, p. 313). Davidson et al. (2008) and Di Benedetto 
et al. (2007) highlight the reliability and validity of the instrument and advise how 
significant depression is reflected by a higher score. Psychosocial data for depression 
using the CDS underwent initial validation and reported an alpha value of 0.90 
(Hare, 1996). Subsequent studies have reported high internal reliability in this 
instrument with a Cronbach's alpha of 0.93 (Birks, Roebuck, & Thompson, 2004). 
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Thus, the CDS was used to measure depression in all participants. The PI undertook 
a reliability test, with the resultant alpha value of α = 0.83. 
The collection of saliva to measure serum cortisol levels, in addition to the use 
of the STAI and CDS tools on discharge from hospital and at 1 month post-
discharge, was taken to measure stress levels in all participants. The literature 
highlights how saliva collection in the last decade has become a significant 
“diagnostic medium” (Streckfus & Bigler, 2002, p. 69). Serum cortisol is 
recommended to be measured in the morning (O’Donovan et al., 2010). O’Donovan 
et al. (2010, p. 1076) highlight how patients who are “clinically anxious” have higher 
levels of morning cortisol and higher levels of IL-6. Dahlgren, Kecklund, Theorell, 
and Akerstedt (2009, p. 1076) reinforce the early morning collection of cortisol 
particularly because it is a good indicator of stress and a person’s “psychological 
health and psychological well-being”. 
Participants were given strict instructions on the collection of saliva on the day 
of discharge from hospital. Although mornings are the recommended time to take 
serum cortisol, participants were advised to provide specimen number two at the 
same time of day that the baseline sample was taken (O’Donovan et al., 2010). This 
approach was recommended by the study’s clinical biochemist, who performed the 
salivary cortisol assays. The PI gave verbal and written instructions to each 
participant when obtaining the first saliva specimen as this was on the day of 
discharge from hospital. Participants were also provided with a specimen collection 
kit and written information with images detailing the procedures required to attain 
the second sample at 1-month post-discharge (see Appendix T). The kits in this 
study contained the following: 
 1 x salivette collection tube; 
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 1 x biological hazard bag; and 
 1 x prepaid, pre-addressed envelope. 
A clinical biochemist at QUT undertook the salivary cortisol assays for the 
purpose of the project. These samples were de-identified, coded (i.e., sample 
number, study ID, and date) and stored for the required period of time per the 
NHMRC/AVCC National Health and Medical Research Council 
(NHMRC)/Australian Vice-Chancellors’ Committee (AVCC) guidelines section 2.0, 
point 2.1.1 on data storage for a clinical trial (NHMRC/AVCC, 2007). All samples 
were disposed of according to QUT’s policy on the disposal of pathological waste 
(QUT, 2011). 
3.2.7 Cardiac Rehabilitation (CR) Program: Referral and Attendance 
Cardiac rehabilitation teams were contacted via telephone and/or e-mail on the 
day of the nurse-led clinic (i.e., face-to-face) if participants were not identified 
during hospitalisation. Contact was made with CR teams to ensure participants were 
referred to a CR program. An appointment was made for a first visit if the participant 
had not already been enrolled. The benefits of attending a CR program were 
highlighted to all intervention group participants who returned to the nurse-led clinic. 
Cardiac rehabilitation program attendance was tracked throughout the course of 
participant follow-up by means of self-report. Hospital readmission(s) and 
procedural-related complications were also tracked up until 3-months post-discharge 
by means of self-report. 
3.2.8 Medication Adherence and Compliance: Tracking and Validity 
To track medication-taking behaviours, adherence, and compliance, and as 
recommended by Morisky, Ang, Krousel-Wood, and Ward (2008, p. 348), “the first 
step to understanding adherence, or lack thereof, is assessing or measuring 
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adherence”. Thus, medication adherence was assessed using the MMAS-8 (see 
Appendix P1). The scale asks eight questions and requires only a ‘yes’ or ‘no’ 
response, scoring either one point for a yes response, and zero for no (Rigby, 2007). 
Items 5 and 8 were reverse-scored and with adherence identified as low (<6), 
medium (6-8), and high (8) (Morisky et al., 2008, p. 351). 
Medication-taking behaviours were assessed at various intervals for all 
participants using the MMAS-8. Assessment time frames were as follows: 
 time 1: day of hospital discharge; 
 time 2: day 5-7 post-discharge; 
 time 3: at 1 month post-discharge; and 
 time 4: at 3 months post-discharge. 
Participants were asked additional questions about the medications they were 
consuming, their medication knowledge, and regime. Although participants were 
followed up within 5–7 days post-discharge, a review of current medication 
knowledge and use of the MMAS-8 at each follow-up appointment assisted in 
identifying adherence issues. Furthermore, in recognising poor adherence, it was 
hoped that participating in the nurse-led clinic would reinforce the importance of 
taking medications and promote adherence. The MMAS-8 has good internal 
reliability and predictive validity demonstrated from previous studies undertaken 
(Krousel-Wood et al., 2009). Alpha reliability for the tool was  = .83, as compared 
with the previous 4-item scale at  .61 (Krousel-Wood et al., 2009, p. 59). This 
tool was used to measure medication adherence pre and post-intervention. 
3.3 Phase One: Timeline, Procedure, and Data Collection 
3.3.1 Timeline 
Participant recruitment, data collection, and analysis were undertaken by the PI 
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after ethical approval was granted. Participant recruitment at site one commenced in 
August 2012, while recruitment at site two commenced in October 2012. Participant 
recruitment ceased in April 2013, while follow-up continued until August 2013. Data 
cleaning and analysis were completed between April and September, 2013 (see 
Table 3.1). The breakdown of these periods is as follows: 
 
Table 3.2. Timeline for Participant Recruitment, Data Cleaning, and Analysis. 
Site Recruitment Data cleaning Data analysis 
Site 
1.  
August, 2012 to April, 2013 *On hold December 21, 
2012 until January 2, 2013. 
April 2013–
June 2013 
July 2013–
August 2013  
Site 
2.  
October, 2012 to April, 2013 *On hold December 17, 
2012 to January 14, 2013 due to area closures. 
 
3.3.2 Procedure and Data Collection 
Baseline data collection: Day of hospital discharge–all participants 
Following consent, baseline data were collected from all participants on the 
day of discharge from hospital. Data collection took approximately 30 to 45 minutes 
to undertake and occurred either at the patient’s bedside or in an allocated 
consultation room. Baseline data collected included the following: general patient 
demographics, medical history, primary survey, physical examination and medical 
record details (pertaining to their admission), and psychosocial assessment 
(questionnaires and saliva sample). An electrocardiogram (ECG) taken within 24 
hours of reviewing the patient was photocopied from the participant’s medical 
records at both sites. 
On baseline measurement, some salivettes were sent to the laboratory via 
postal mail while others were delivered via internal mail in a cool transport container 
to prevent bacterial contamination. Samples taken later on a Friday were either kept 
refrigerated until Monday and then posted immediately via internal mail, or hand-
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delivered to the site. All salivettes were packaged appropriately for transport. Prior to 
the purchase of salivettes, the PI, clinical biochemist, and colleagues trialled their 
use so they could identify with participants’ experiences and be able to answer any 
questions with regard to providing a salivary sample for cortisol analysis. 
The procedure for attaining salivary cortisol samples was as follows. 
Participants were required to: 
 not have eaten or food or consumed fluids within one hour prior to 
taking the sample; 
 rinse mouth with water (10 minutes prior to taking the sample); 
 chew the salivette for 60 seconds; 
 ensure the sample was placed in a biohazard bag after taking; and 
 ensure the sample was refrigerated (in the coldest part of the fridge 
immediately if participants did not have the time to post the salivette at 
the time it was taken). 
3.3.3 Nurse-Led Clinic: Physical Examination, Medical Records, and 
Instruments 
Education on wound care and neurovascular assessment was discussed with 
participants prior to discharge as they were required to undertake assessment at home 
and provide feedback face-to-face or via telephone. All participants were actively 
involved and took note of what was required for post-discharge period assessment. 
Validated tools were used to undertake wound site and neurovascular assessments 
with prior permission granted for use. 
Permission to access, photocopy, and de-identify medical records was agreed 
upon in both site contracts; however, site one withdrew permission shortly after 
commencement of participant recruitment. The PI was permitted to transcribe data 
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required from medical records into the data collection form (DCF) instead. Only, 
electrocardiograms were permitted to be photocopied. Access site assessment 
involved taking a digital image, site palpation, and performing a visual inspection. 
The access site image was taken and filed together with each participant’s DCF. 
Baseline assessment for psychological distress using the STAI and CDS were 
measured along with participant SE using the CSE. All questionnaires and their 
relevance were discussed with participants prior to their completion. Medication 
adherence was also assessed using the MMAS-8. Participants completed all 
questionnaires individually at baseline. The PI clearly discussed each questionnaire, 
its relevance to the study prior to completion, and the importance of taking time and 
answering honestly. The PI highlighted that if participants had any questions 
regarding completion of the questionnaires they should seek further clarification 
from the PI. After baseline data collection, participants underwent randomisation. 
Randomisation 
After consent and baseline data collection, participants were randomised to 
either the standard-care or intervention group. The randomisation procedure 
employed the method of blocking in, by which participant allocation occurred in 
blocks (Korosteleva, 2009). This method was chosen to ensure that both study 
groups were equal in size. Each number was individually placed in an opaque, lined 
envelope so that the number would not be permeable to light. The PI generated the 
random allocation sequence and placed the envelopes containing each number into 
one of two boxes for selection. For both sites, the numbers present in each envelope 
originally ranged from 1 to 110. As recruitment was slow and difficulties were 
encountered (i.e., slow recruitment and greater randomisation to the standard-care 
group with the larger blocks), the PI regrouped with the study team and it was 
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decided to block numbers into smaller groups of 10 to ensure equal randomisation. 
Recruitment slowed as a result of closure to clinical areas and outpatient 
departments. 
As part of the randomisation process, the RN caring for the participant selected 
an envelope in the presence of the PI and the patient. On occasions where an RN was 
unavailable, the participant selected the envelope in the presence of another staff 
member or witness. Selection of an even number placed participants in the 
intervention group while selection of an odd number placed participants in the 
standard-care group. The allocation sequence was withheld from all participants and 
hospital staff. The PI had originally planned on utilising a telephone randomisation 
service; however, purchasing the service would have exceeded the study’s budget. 
The date and time for follow-up was arranged with each participant on the day 
of discharge from hospital. A business card detailed the essential information 
regarding the first follow-up, including the location of the face-to-face post-
discharge clinic, date, and time. A courtesy phone call, e-mail, or short message 
service (SMS) was made by the PI from up to 2 days prior to all follow-ups to 
confirm appointments on request of the participant. All follow-up appointments were 
made at the end of each session. 
3.3.4 Standard-Care Group (n = 20) 
Follow-up: Current practice 
Current practice for participant standard-care involves the delivery of general 
education about the procedure, post-procedural cares, complication identification and 
management and activity throughout the patient’s hospital admission. Information 
given may include verbal and written education. Follow-up post-discharge usually 
includes CR team follow-up to arrange for course admission. Some facilities contact 
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their patients at 1-month post-discharge to collect information on the post-discharge 
period. Importantly, follow-up may differ for each site. Current research is now 
recommending telephone follow-up at 72-hours post-discharge and primary care 
physician review within the first week post-discharge (Rassaf et al., 2013; Tuso et 
al., 2013). Tuso et al. (2013) suggest that future studies track the effect of primary 
care physician follow-up in chronic disease patients. In the present study, 
participants (chronic disease sufferers) in the standard-care group were followed up 
post-discharge via telephone. Follow-up occurred at Time 2 (5–7 days), Time 3 (1 
month), and Time 4 (3 months). 
Standard-care group: Follow-up, study procedure, and requirements 
Telephone follow-up for Time 2 (day 5–7), Time 3 (1 month), and Time 4 (3 
months) took approximately 45 to 60 minutes. On commencement of all follow-up 
calls, participants were asked if there were any concerns or discomfort. Participants 
were also advised at this time to report any medical emergencies if they experienced 
any symptoms during the conversation. Examples of symptoms, such as chest pain 
and light-headedness, were explained. Participants were asked questions concerning 
their psychosocial status and physical health post-discharge using both open-ended 
questions and validated research questionnaires. The PI reconfirmed how the 
participant was feeling and if there were any initial concerns (i.e., chest pain at time 
of interview). Participants appeared, and were encouraged to be, open and honest in 
responding to open-ended questions regarding their psychological and physical 
health status. Most participants had recalled physical examination undertaken on 
baseline measurement and reported on their physical wellbeing with great attention 
to detail. Participants reported positively concerning the wound site (bruising, 
bleeding, lumps, or bumps), chest symptoms (if experienced), neurovascular 
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observations, activity, and diet (although diet was not a large focus) at telephone 
follow-up. 
At each follow-up, a digital photograph and completion of a diagram 
documenting the appearance of the procedural access site was requested, with only a 
small number of participants complying. Participants were given the option of 
returning diagrams and/or photographs via e-mail or postal mail and were supplied 
with prepaid, addressed envelopes so that they would not have to bear the cost. All 
participants were reminded at each telephone follow-up appointment to complete the 
diagram and take a photograph (if able to). 
Standard-care group participants were also required to provide a baseline 
salivary cortisol sample that would be measured for signs of stress. The saliva 
sample was usually collected by the PI on the day of discharge from hospital (had 
participants not eaten within the hour, which was a requirement for salivary cortisol 
collection). A second saliva sample was taken by participants at Time 3 (1-month 
post-discharge). Verbal and written instructions (with visuals) were supplied to all 
participants (see Appendix T). Participants were all reminded about the saliva 
sample on the day they were followed up and they also had been provided with 
details on the day of discharge and Time 2 (day 5–7) follow-up with the date and 
time for the second sample. Two standard-care group participants accidently took the 
second saliva sample at Time 2 (day 5–7) and were subsequently posted an 
additional salivette so that the measurement could be taken at Time 3 (1 month). 
Medication knowledge and adherence were also assessed using the MMAS-8 
assessment tool and CR attendance was assessed at each follow-up via self-report. 
Any concerns raised by the participant or identified by the PI (i.e., post-discharge 
complication) throughout the course of the study was actioned immediately (i.e., 
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contacted cardiologist or GP) as per the study’s risk protocols. Risk protocols were 
(a) site-specific; and (b) telephone follow-up for all participants (see Appendix U). 
3.3.5 Nurse-Led Educational Intervention: Study Intervention (n = 13) 
Intervention group participants underwent primary survey, psychosocial, and 
physical examination as identified earlier. Data were collected using validated 
questionnaires and self-report data to determine post-discharge health outcomes that 
included: physical outcomes, coping, emotional distress, and psychosocial support. 
Questionnaires included the following tools: CSE, STAI, and CDS, with the scales 
measuring SE and psychological distress. At 5–7 days post-discharge, intervention 
group participants were required to participate in a face-to-face nurse-led, 
educational clinic at the hospital site where they underwent their procedure. Clinic 
assessment and education took approximately 45 to 60 minutes. Participants received 
tailored education and support concerning the post-discharge period, recovery, cares 
and appropriate activities at the face-to-face clinic. Sessions incorporated both 
physical and psychosocial assessments and patient education provision. 
Overview of nurse-led clinic activities 
The following procedures were followed and undertaken on arrival at the clinic 
for all participants: 
 participant greeted and directed to an examination table for a physical 
examination; 
 physical examination: primary survey, vital signs (i.e., blood pressure, 
heart rate, temperature), an ECG, wound site assessment, and 
neurovascular observations; 
 comparison of vital signs and ECGs to participants’ baseline 
measurements; 
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 wound site inspection: palpation of the area for haematoma, visual 
inspection (skin colour to the area and surrounds, bruising, and 
bleeding) and auscultation (for bruit); 
 neurovascular assessment of lower limbs: sensory, motor function, and 
circulation assessment; 
 questionnaire completion; 
 nurse-led education delivered; and 
 opportunity for participants to ask questions. 
Initially on consultation, the PI undertook a primary survey to determine the 
urgency for priority review with their cardiologist or hospital emergency centre by 
observing the following: airway (A), breathing (B), circulation (C), 
disability/distress (D); exposure/environmental (E) (Estes, Cajella, Theobald, & 
Harvey, 2013). The primary survey was followed by a focused physical examination 
as detailed above. The PI encouraged participants to discuss how they felt physically 
during the first week recovering from their procedure. Participants were encouraged 
to voice concerns about their wound, vital signs, chest symptoms, and neurovascular 
status during this time. Most participants were happy to discuss their progress during 
the first week, their physical symptoms, and observations. A majority of participants 
were proactive and had automatic sphygmomanometers at home and were 
monitoring their own blood pressure and provided details on recent readings.  
Questions asked during this time included how they were feeling physically, if 
there were any concerns with respect to their access site (i.e., new or changes in 
lumps, bumps, stinging/pain, signs of infection or bruising), and new or continuing 
tingling or numbness to their lower limbs since the procedure (particularly access 
site limb). Participants appeared happy and were open in contributing physical 
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examination information, with most reporting they paid significantly more attention 
to their wound site and the healing process due to involvement in the study. The PI 
also listened to each wound site to assess for signs of a pseudoaneurysm as discussed 
in Chapter 2. No bruits were heard. 
Lastly, neurovascular observations were undertaken and recorded in a 
validated assessment tool (see Appendix R). Lower limbs were visually inspected for 
colour and pulses were palpated (dorsalis pedis and popliteal pulses and posterior 
tibial pulses). Capilliary refill was also assessed whereby the PI squeezed the nail-
beds of toes on both feet to check for a fast return to normal colour. Motor function 
was assessed by asking patients to plantar and dorsiflex feet and wiggle toes. 
Sensation was assessed whereby the PI ran a gloved index finger up the sole of each 
participant’s foot and gently squeezed each toe and in between toes. The PI, while 
undertaking all assessments, encouraged participants to observe and gave direction 
as they would be required to undertake individual physical examination at home. 
Nurse-led clinic: Questionnaire completion 
Following a physical examination and primary survey, participants completed 
questionnaires, except the MMAS-8 which the PI integrated completing through 
general conversation. The MMAS-8 was intentionally not handed to participants so 
that only three questionnaires were required to be completed, as opposed to four to 
reduce the amount of time required by patients to complete all assessment tools. 
Prior to each questionnaire, participants were again (as per baseline) given 
instructions and advised to ask questions at any time if there were any queries (the PI 
was present in the room during this time). Most participants discussed the 
similarities in questions of the STAI and CDS questionnaires or questioned how they 
were relevant to them, while others voiced that they could identify with the 
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questions. 
After completion of assessment tools, participants received the educational 
intervention—an informal interactive session between the PI and the participant (see 
Appendix V). Education was delivered verbally and displayed visually using 
Microsoft PowerPoint as an adjunct. Additionally, as identified earlier, the SE theory 
was used as the theoretical framework to guide this study, the CSE was used to 
assess SE for all study participants. Psychological assessments involved the 
measurement of anxiety and depression using two highly validated instruments, as 
identified. After questionnaire completion, the PI spoke with each participant and 
discussed general post-discharge period education, care, and management, with a 
focus on post-discharge emotions (i.e., what might be experienced), and 
psychological distress. As each participant’s experience of their procedure, 
hospitalisation, and early post-discharge period was different, the PI kept the 
educational session interactive. Participants were reminded throughout the session if 
they had any questions to feel at ease to ask at any time. 
As identified earlier, the STAI and CDS measured anxiety and depression. 
During the education session, participants were advised of the link between CHD, 
anxiety, and depression and why the questionnaires were undertaken. Furthermore, 
emotions surrounding participants’ experiences and those who have had a cardiac 
event were discussed (with their experiences highlighted as individual). Participants 
were educated regarding the emotional impact of PCI and cardiac events and what 
emotions were normal after the procedure and event; however, the main message 
delivered was that if participants experienced ongoing emotional distress, to seek 
help. The PI offered support services to all participants, had they been required for 
emotional distress. Support services included referral to: ‘BeyondBlue’, The 
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University’s Psychology Clinic and ‘Lifeline’. Finally, the PI discussed support 
networks and clarified each participant’s support person and encouraged speaking 
with these if participants were concerned or if they found it helpful to discuss their 
emotions and/or experiences. Two participants commented on the benefits of this 
discussion as the first time they had a PCI they had not been made aware of this and 
subsequently were anxious and later clinically diagnosed with anxiety. 
Education delivered was a combination of verbal and visual information, 
supported by written material. Written material included hospital-specific post-
discharge instructions. Essential written documentation supplied to all participants 
included a National Heart Foundation of Australia (NHFA) book to assist 
participants in their self-education and making positive lifestyle and health 
behavioural changes. The NHFA document contained information and education 
about CHD, diet, risk factor modification, exercise, and a chest pain action plan and 
magnet. As post-discharge angina and management was discussed during the 
intervention, the PI went through the steps of the action plan and provided a 
hypothetical scenario to each participant. Participants were then asked to guide the 
PI through the action plan, and the actions they would follow if angina were 
experienced at home. Participants were engaged during this scenario and most 
commented on the fact that they were not aware of dialling ‘112’ (the number 
displayed on the magnet) if calling for an ambulance from their mobile phones. 
Additionally, the PI recommended participants place the magnet on the fridge or 
somewhere nearby to the home telephone and/or charging facility for the mobile 
phone for quick and easy reference should it be required. 
Complication identification and management was also discussed and included: 
bruising, haematoma, bleeding, infection, and neurovascular complications. Closure 
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devices were also briefly mentioned for patients. Again, to encourage interaction, 
scenarios were worked through highlighting complication management, in particular, 
haematoma and bleeding. Participants were able to recall how much digital pressure, 
length of time required, and where to apply pressure (just above the incision) for 
bleeding and haematoma management. Recall for how to apply access site digital 
pressure was clear for participants as they had been awake during femoral arterial 
sheath removal. Importantly, throughout the course of the educational intervention, it 
was highlighted to participants that the ambulance service be notified for acute 
situations (i.e., unrelieved CP per NHFA action plan, active bleeding, or 
haematoma). Prior to study commencement, potential ambulance overuse was 
highlighted (i.e., calling for bruise discomfort or cold toes on neurovascular self-
assessment). For each complication identified, an example was given, with a 
pathway of who to contact. Finally, neurovascular complications were discussed at 
the clinic, with pre-documented complications present in several participants. 
Participants reported the following pre-existing injuries/complications, highlighting 
that they were not as a result of the procedure or hospitalisation and included: a 
previous ankle fracture, toe numbness, and gout. Any changes in neurovascular 
observations such as, tingling, pain, or numbness in the procedure site limb 
warranted investigation and was emphasised to all participants. 
Medication knowledge, education, and adherence were assessed and discussed. 
The three main messages were: (a) take all medications as prescribed, (b) never to 
cease administration abruptly, and (c) always maintain supply of medication at 
home. Participants’ medication knowledge about the major medication groups (that 
PCI and ACS patients are usually discharged on) was also identified and this 
knowledge was briefly discussed. Participants were advised to bring along their 
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medications and/or lists; however, only some participants did so. 
The importance of CR attendance and course compliance was also discussed. 
The PI identified why participants should attend—who can attend (patient and 
family), who would be present (i.e., patient groups and speakers), and what the 
program would entail—with the aim of enrolling those who had not been approached 
at the end of the clinic. Most participants had attended previously and declined re-
enrolment. First-time participants were enrolled either prior to discharge or at the 
clinic. A saliva sample was taken at 1-month post-discharge to perform a salivary 
cortisol assay for physiological signs of emotional distress and was posted to the 
QUT laboratory for testing. The PI contacted intervention group participants again at 
Time 3 (1 month), and Time 4 (3 months) via telephone for further collection of data 
concerning their psychosocial wellbeing and physical health post-PCI, although the 
Time 3 (1 month) follow-up point was the study’s key endpoint. Intervention group 
participants were given the opportunity to ask questions during the clinic session and 
follow-up. The PI contacted each participant’s cardiologist and/or GP via e-mail 
and/or postal mail on study enrolment. No adverse events (AEs) or serious adverse 
events (SAEs) were experienced. 
Follow-up periods and justification 
As identified above, the follow-up periods after randomisation and consent on 
the day of discharge were Time 2 (day 5–7), Time 3 (1 month), and Time 4 (3 
months). Follow-up at Time 2 (5–7 days) and Time 3 (1 month) was selected due to 
the short length for hospitalisation and, thus, the need to repeat education, knowing 
the strong link between psychological distress (i.e., anxiety and depression) and a 
cardiovascular event at this time (AIHW, 2011; Davidson et al., 2008; Holt et al., 
2013; Lane et al., 1999; Lauck et al., 2009; Turner et al., 2010; NVDPA, 2012). 
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Furthermore, as the PI sought preliminary data to determine the anxiety-reducing 
effect of the intervention on participants, early follow-up for signs of psychological 
distress, as recommended by the AIHW (2011) and Das and O’Keefe (2006), was 
undertaken. Time 3 (1 month) was chosen as the primary endpoint and a satisfactory 
follow-up time as most participants had not seen their cardiologist or commenced a 
CR program (BHF, 2009; Cupples et al., 2010; Goble & Worchester, 1999; NHF, 
2010; Trotter et al., 2011; Wenger, 2008). First, this approach allowed for more 
accuracy in the assessment of the effects of the intervention on participant anxiety. 
Second, as referral and attendance to CR is often low, one of the secondary aims of 
this project was to ensure 100% attendance (Cupples et al., 2010; Heartwire, 2011). 
Third, as new ACS patients are commenced on an average of six new medications 
and with compliance issues highlighted in the literature, early medication education 
and the encouragement of compliance through education was warranted (Aroney et 
al., 2006; Morisky et al., 2008; Rudd et al., 1993). 
Final participant follow-up at Time 4 (3 months) was also important to this 
study as it is identified in the literature to be a high-risk period (Curtis et al., 2009, 
pp. 303–307; Sherev et al., 2005). Many studies follow participants suffering 
psychological distress long-term (Birket-Smith, Hansen, Hanash, Hansen, & 
Rasmussen, 2009). Studies’ follow-up have ranged from 6 months to 6 years (Birket-
Smith, Hansen, Hanash, Hansen, & Rasmussen, 2009). Studies of cardiovascular 
interventional origin and clinic provision include a 12-month follow-up marker to 
assess for patient readmissions to hospital post-PCI (i.e., CP), and health status 
(Grumann, Diehl, Bode, & Moser, 2007; Schadewaldt & Schultz, 2011). First-
generation drug eluting stents became a topic of discussion within the literature with 
late stent thrombosis/restenosis occurring up to 12 months post-PCI (Palmerini et al., 
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2013; Grumann et al., 2007). Second-generation drug eluting stents are continuing to 
be investigated in larger trials and appear to have a lower risk of the aforementioned 
complications; however, it is acknowledged that larger, more well-powered studies 
are required to comment on this effect (Palmerini et al., 2013). As identified earlier, 
because this study was to fulfil the requirements of a PhD, with limited funding and 
time, the PI was required to perform the last follow-up on post-PCI patients at Time 
4 (3 months) rather than any time frame beyond this point. 
3.3.6 The Nurse-Led Clinic Intervention Details: Intervention Group –
Face-to-Face, Nurse-led Clinic (Time 2) 
Measures 
At Time 2 (day 5–7), intervention group participants were followed up as 
prearranged. As identified earlier, content in the intervention group visit included a 
comprehensive physical examination, primary survey, and specific neurovascular 
and wound assessments. Physical examination ensured that patients were monitored 
for any post-procedural complications. Complications that may occur post-PCI as 
discussed in Chapter 2 may include any of the following: haematoma, 
pseudoaneurysm, access site infection and contrast-induced pyrexia, and chest pain 
(CP) (Levine et al., 2003, p. 130; O’Grady, 2007, pp. 25–30). Participants’ self-
efficacy (SE) was measured using the CSE (Appendix B) while anxiety was 
measured using the STAI (see Appendix C). Depression was measured using the 
CDS (see Appendix D). Participants’ medication-taking behaviours using the 
MMAS-8 were also assessed (see Appendix P1). Additionally, new medications, 
management, and adherence, along with the promotion and referral of participants to 
CR, were discussed. Appointments to attend CR were made on the day of the nurse-
led clinic if an appointment had not yet been arranged by the CR team during 
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hospitalisation. Course attendance and compliance was tracked via participant self-
report. 
Throughout the course of the study, the PI assessed participants in both groups 
using quantitative and qualitative self-report techniques. Questions asked of 
participants were open-ended questions and assessed for psychological distress and 
post-PCI health and wellbeing as recommended by Das and O’Keefe (2006). Das 
and O’Keefe (2006) highlight the importance of screening patients with CVD for 
psychosocial distress due to the strong association between psychosocial health and 
CVD; therefore, participants in the present study were asked questions concerning 
psychological distress. Furthermore, to assess for risk of psychological distress, the 
Das and O’Keefe (2006) recommended screening and asking simple open-ended 
questions, this was therefore applied to participants throughout the present study 
(Das & O’Keefe, 2006). As similar questions were asked in the STAI and CDS, only 
some of these suggested questions as recommended by Das and O’Keefe (2006) 
were adopted for assessment of psychological distress and risk in the present study. 
Other questions evaluated participants’ health knowledge. 
The face-to-face visit took place at clinical consultation rooms at the hospital 
in which the PCI procedure was undertaken, at Time 2 (day 5–7). Approval to 
undertake the clinic in consultation rooms was granted by both sites. These rooms 
were all in close proximity to emergency centres and participants’ cardiologists in 
the event that an urgent review was required. One site provided nurse practitioner 
support, should any participant require urgent review. As identified earlier, site-
specific and telephone follow-up risk protocols were created so that the appropriate 
procedures (both actions and reporting) could be followed should an AE or SAE 
occur (see Appendix U). Participants attending the clinic were offered car-parking 
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vouchers if they had driven to the facility. Some participants elected to park in 
surrounding streets and declined a car park voucher, although supply of vouchers 
was highlighted prior to clinic attendance. 
Nurse-led clinic and achieving efficacy beliefs 
It was hoped that by participating in the nurse-led clinic post-PCI participants’ 
efficacy beliefs, or beliefs relating to successfully carrying out a certain behaviour or 
control concerning aspects of their lives and functioning, would be enhanced and/or 
achieved (Bandura, 1993). Positive efficacy beliefs may in turn affect an individual’s 
thought processes, feelings, and thus, their motivation and behaviour (Bandura, 
1993). In the present study, it was hoped that participation in the nurse-led clinic 
may enhance SE by encouraging positive efficacy beliefs. Efficacy beliefs may be 
met through the four following information sources: mastery, vicarious experience, 
verbal persuasion, and physiological feedback (Bandura 1995, 2004, p. 195; 
Holloway & Watson, 2002, pp. 109–111). Through the repetition of education and 
provision of early post-discharge support, it was hoped that post-PCI anxiety and 
depression symptoms could be reduced and effective self-management achieved by 
enhancing SE by meeting efficacy beliefs. 
The nurse-led clinic was, therefore, modelled around the aforementioned 
information sources so that both primary and secondary aims could be achieved. As 
identified, the nurse-led clinic provided the participants with the skill to achieve 
efficacy beliefs as it used both verbal and visual means of education. The nurse-led 
clinic provided verbal, written, and electronic means of education, with a practical 
component. Scenarios were provided for participants to work through with the PI 
(i.e., talking through CP action plan), while practical skill demonstrations (i.e., 
access site complication management) were offered with encouragement to 
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participate in undertaking of the skill. Thus, with the nurse-led clinic modelled 
around the four information sources, it was hoped that efficacy beliefs may be 
achieved through both performance accomplishment, observational learning (i.e., the 
PI demonstration and CP action plan scenarios), verbal persuasion (i.e., trust and 
confidence in the PI as educator), and physiological feedback (i.e., reduction in 
anxiety or control of negative emotions). 
3.3.7 Standard-Care Group 
Measures 
Although randomised to the standard-care group for this study, participants 
received usual education and follow-up given to patients by the hospital sites and 
secondary prevention services as highlighted above. As identified earlier, this group 
were followed up and required to undertake various assessments, including the CSE, 
STAI, CDS, and MMAS-8, and provide a saliva sample on the day of consenting and 
at 1 month post-discharge. The CSE was used to assess SE in the standard-care 
group pre and post-discharge from hospital. The STAI and CDS allowed for the 
measurement of trait anxiety or signs of depression pre and post-discharge versus 
intervention and standard-care groups. Saliva was measured to assess participant 
stress levels pre and post-discharge as compared to intervention group participants. 
Additionally, the MMAS-8 was undertaken to determine individual and group 
medication adherence as well as behaviours between groups. Tracking of CR 
attendance occurred while post-discharge complications (i.e., procedure access site, 
chest pain) were assessed over the course of the study at each follow-up point. A risk 
protocol was in place for standard-care group participants so that immediate action 
could be taken if an AE or SAE occurred. 
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All groups: Time 3 (1 month) and Time 4 (3 months) 
At Time 3 (1 month) and Time 4 (3 months), participants in both groups were 
required to complete all assessment tools—CSE, STAI, and CDS. In addition, 
participants in all groups were also required to undertake a MMAS-8, as identified 
earlier. Cardiac rehabilitation attendance and compliance were also assessed with 
reasons for attendance/non-attendance requested, along with complication 
identification and management. Participants had the opportunity to ask questions 
concerning their post-procedural health, wellbeing, and concerns. The PI also asked 
questions of participants throughout the course of the study. Assessment at Time 3 (1 
month) and Time 4 (3 months) occurred via telephone and took approximately 45 to 
60 minutes in total. Participants were made aware of follow-up times and duration on 
the day of consenting. All follow-up telephone visits were arranged at the end of 
each follow-up session. At Time 4 (3 months), participants in the intervention group 
were asked questions about the educational intervention and its effectiveness in their 
recovery. These questions were present in the DCF and consisted of a mix of 
structured open and closed-ended questions (see Appendix P). 
3.3.8  Phase One – Both Study Groups: Early withdrawal, participant 
withdrawal and lost to follow-up 
As identified, in the consent process, participants were advised of their 
freedom to withdraw at any time from the study without comment or penalty. 
Participants were provided with contact details (i.e., telephone and email) so that 
they were able to communicate with the PI throughout the course of the study 
(questions, concerns or withdrawal).  
Early withdrawal 
No participants in the present study were withdrawn by the PI; however, the 
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following conditions were in place if early withdrawal was required: 
 unexpected illness (i.e., suffering acute psychological/psychiatric 
distress, diagnosis of fatal illness, poor progression of current illness, 
requiring major surgery) 
 as a result of participation or possibly as a result of participation in the 
study (i.e., acute psychological/psychiatric distress). 
Early participant withdrawal would have been formally and immediately 
reported to the study monitor, HREC, university had it been required. The following 
processes were in place for participants lost to follow-up. 
Lost to follow-up 
Participants lost to follow-up were contacted in accordance with the following 
protocol: 
 Maximum of: 
o two telephone calls to landline or mobile phone 
o two emails 
o two certified letters. 
 Telephone message — to be clear and detailed: 
o state: name, position, date, and organisation and study 
o request: participant to return the call between business hours, 
Monday to Friday 
o advise: PI will follow up with certified letter via postal mail. 
 
As identified, consent to retain and use all participant study data for analysis 
was attained given the application of the intention-to-treat principle. The principle of 
intention-to-treat is discussed in section 3.4.  
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3.4 Phase One: Data Analysis 
As highlighted above, the intention-to-treat principle was used in analysing 
study data. This principle has been identified as a “strategy for the analysis of 
randomised controlled trials that compares patients in the groups to which they were 
originally randomly assigned” (Hollis & Campbell, 1999, p. 670). The intention-to-
treat principle was applied to participant withdrawals, participants lost to follow-up, 
protocol deviations, and treatment received (Hollis & Campbell, 1999). Hollis and 
Campbell (1999) highlight two important objectives of the intention-to-treat 
principle which include: (a) similarity in treatment groups, with exception of 
randomisation; and (b) allowance for clinician non-compliance and deviations 
(Hollis & Campbell, 1999). Although the randomisation process assists decreasing 
study bias, the intention-to-treat principle ensures all participants are included in the 
analysis, therefore offering greater validity to the study and results while reducing 
the risk of study error (Montori & Guyatt, 2001). 
The PI undertook initial exploration of the data and this included descriptive 
statistics. First, data cleaning was used to identify any abnormal and repeated values 
and outliers. Descriptive tests and visual inspections were undertaken using SPSS in 
the cleaning process. Descriptive statistics were used to summarise study 
participants’ characteristics while frequencies were used to establish the distribution 
of data. Effect-size calculations were completed to determine the effect of the nurse-
led clinic on intervention group participants versus standard care and are displayed in 
Chapter 4. Additionally, reliable change index (RCI) calculations were also 
completed to determine the therapeutic outcomes of the nurse-led clinic versus 
standard care. Reliable change index calculations provided further detail regarding 
the percentage of participants who experienced improvements or ‘recovered’ (i.e., 
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returning to normal functioning) after attending the nurse-led clinic. Statistical 
analysis of participants’ demographics and clinical characteristics were employed by 
means of descriptive statistics and are presented as frequencies, percentages, means, 
and standard deviations and are presented in the results chapter. Descriptive statistics 
were used to describe the groups (i.e., standard care and intervention) and individual 
participants recruited to the study. Characteristics such as gender, age and/or 
differences, risk factors, medical history, education, and marital status are presented 
as descriptive statistics. 
SPSS version 19 and Microsoft Excel were used to undertake data entry and 
analysis, as identified earlier. Effect-size (ES) calculations and RCI calculations 
were used to determine the effectiveness of the nurse-led clinic and feasibility for a 
Phase Three study. See Table 3.3 for further detail: 
 
Table 3.3. Research Questions Tested 
Research Question/Outcome(s) Test 
Changes in participant SE over time 
Effect size (ES) or Cohen’s d 
Reliable Change Index (RCI) 
Frequencies 
Changes in anxiety scores over time 
Changes in salivary cortisol levels over time 
Changes in depression scores over time 
Changes in medication adherence scores over time 
CR attendance 
Descriptive statistics: Frequencies 
Complications (i.e., wound site bruising, haematomas, 
CP) 
 
3.4.1 Interim Analysis, Auditing, and Reporting 
With a statistics background, the team’s associate supervisor reviewed and 
monitored data independently at multiple occasions. An interim analysis was 
performed around the midpoint of the study and at the end of data collection. 
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Additionally, the study was audited by the Research Governance Office (RGO) from 
one of the study sites. Participant files were randomly selected for review and 
viewed in the presence of the Principal Supervisor, the PI, and the Postgraduate 
Research Coordinator. Auditors also ensured the security of electronic files (i.e., 
password protection). No actions were required post review. 
3.4.2 Ethical Approval, Risk, and Strategies 
Ethical approval was sought from the following four committees according to 
Section 1.8 of the Revision of the Joint NHMRC/AVCC Statement and Guidelines 
on Research Practice Australian Code for the Responsible Conduct of Research 
(NHMRC/AVCC, 2007, p. 11): (a) Hospital HRECs, (b) Medical Institute HREC, 
and (c) QUT. Section 1.8 states that “as a responsible researcher, appropriate and 
prior written authorisation concerning ethical approval, participant safety and 
additional organisations will be sought” (NHMRC/AVCC, 2007, p.11). The ethical 
principles of integrity, respect for persons, justice, and beneficence were adhered to 
at all times (NHMRC/AVCC, 2007). QUT’s ‘Code of Conduct for Research D/2.6’ 
was also regularly reviewed to ensure appropriate conduct for the duration of the 
study. Section D/2.6 covers ethical considerations, policies, and procedures for 
research and were strictly followed (QUT Code of Conduct for Research, D/2.6, 
Manual of Policies and Procedures [MOPP], 2009). 
As identified in the NEAF, the PI works as a RN at one of the hospital sites. 
The PI coordinated with the CNM that, when working as a RN on the ward, she 
would be allocated non-PCI patients where possible. This strategy was to eliminate 
the possibility of potential study discussion; to avoid placing any pressure on the 
patient to participate, if approached on the day of discharge (day participants were 
recruited); or undue inducement. As identified earlier, participants were approached 
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to participate in the study by the ward CNM or RN taking care of them so they 
would not be placed under any pressure to participate. When indicating interest in 
study participation, the CNM or RN would inform the PI who then approached the 
participant. Participants were fully informed and given a written PICF, which was 
signed and witnessed during the consent process. All participants were given a 
photocopy of their signed PICF. Participants were informed of anonymity 
procedures and their ability to withdraw at any time without comment or penalty. 
Please see Appendix W for the Phase One consent form and HREC approval. 
3.4.3 Limitations 
There were several limitations to the study identified by the PI and research 
team. They are as follows: 
 Study wait times: Wait times for ethical approval to the 
commencement of the study were prolonged. Following NEAF 
approval, it took 12 months for the approval of the SSA, site risk 
management strategies, and to secure clinic office space to undertake 
the study. Additional delays to recruitment were experienced for one 
month from December 2012 to January 2013 as both sites experienced 
planned area and ward closures. 
 Self-report: The PI identified the possibility of measurement error 
with the collection of self-report data. To reduce the potential for 
measurement error, the PI was careful to give clear instruction to all 
participants regarding the completion of each questionnaire. Care was 
also taken to explain the questionnaires, answer any questions, and 
advise of the respective responses during telephone follow-up to 
reduce the risk of measurement error. Additionally, participants were 
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encouraged to respond honestly and take their time to complete 
questionnaires. Finally, with pre and multiple post-test self-reporting 
using the same tools, questions and responses may have been recalled 
by participants and answers modified, therefore changing the study’s 
outcome. This effect is known as the “Testing effect” (Grove, Burns, 
& Gray, 2013, p. 199). 
 Measurement effect: Is also likely that this effect could have occurred 
in this study whereby participants (i.e., standard-care group) changed 
certain behaviours, felt better, or had overall improvements as a result 
of participating in the study (LoBiondo-Wood & Haber, 2010). 
LoBiondo-Wood and Haber (2010, p. 172) highlight how 
administering pre-intervention tests can “prime” participants and 
encourage them to think about what is being measured and facilitate 
change. 
 Low statistical power: There is great potential for a type II error in 
this study as the PI was unable to recruit participant numbers for 
several reasons, as identified earlier. In the early stages of the study, as 
stated previously, a sample size calculation was undertaken to 
potentially avert type II error occurring; however, the sample size 
could not be achieved. Given that the present study was undertaken as 
a pilot, results should be considered cautiously, pending replication in 
a future study, as described in Phase Three. Recommendations to 
enhance participant recruitment in future research will be addressed in 
Chapter 6. 
A Consort Flow chart was created to track participant flow throughout the 
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course of the study alongside a detailed Excel spreadsheet documenting participant 
recruitment, reasons for declining enrolment, loss to follow-up, and why exclusion 
criteria were met (see Figure 3.2 and Table 3.4). The trial was registered with the 
Australian New Zealand Clinical Trials Registry (ANZCTR) and assigned a clinical 
trial registration identification number, 12612000971831. 
 
Figure 3.2. CONSORT Flow Diagram: The ‘REALITY CHEC’ Project©. 
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As presented in the CONSORT Flow chart above, the PI screened 188 
potential participants during the recruitment phase, with 97 not meeting the inclusion 
criteria and 58 declining to participate due to the reasons outlined in Table 3.4. 
Table 3.4. Reasons for Declining and Excluding Participation 
Declining Participants (n = 58) Excluded Participants (n = 97): Justification 
face-to-face nature of the study (preference for 
telephone follow-up) 
general inconvenience of returning for follow-
up 
geographical location/isolation 
transportation issues 
going on leave 
too busy 
inability to drive for 2-4 weeks as advised by 
specialist 
limited support networks 
illness 
too much required of them to participate 
participated in research in the past and not eager 
to participate again 
for additional surgery 
not of interest 
nil reason offered 
medical treatment of CAD only 
no appreciable disease 
multiple co-morbidities: Full medical cares 
staff advice not to approach 
for CABG surgery 
staging of PCI 
registered in another site clinical trial 
confusion 
failed PCI 
further ongoing hospitalisation and investigations 
for recurrent seizures 
 
Participants who met inclusion criteria and consented to participate, justified 
their participation as follows: participation in previous clinical trial(s), participant(s) 
or a family member had undertaken a Master’s or PhD, participants felt if it would 
benefit others and themselves, and participants generally enthusiastic to participate. 
As highlighted earlier, the PI solely undertook extensive screening at both hospital 
sites over several months and, as a result, was not able to meet the sample size 
calculated. The pilot study undertaken, however, greatly informed the PI for a 
proposed Phase Three, multi-centre study that will be discussed in greater detail in 
Chapter 5. 
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3.5 Phase Two: Descriptive Evaluation of the Nurse-Led Clinic 
In Phase Two of the present study the PI undertook semistructured interviews 
to analytically explore study participants’ and healthcare professionals’ feedback of 
the nurse-led, educational intervention. After obtaining ethical approval to undertake 
Phase Two, intervention group participants and healthcare professionals were 
approached to provide detailed feedback regarding the nurse-led clinic so that the 
“acceptability, feasibility and preliminary effectiveness” of the pilot, as highlighted 
by Sidani and Braden (2011, p. 155), could be appraised. The program evaluation 
discussed the overall educative effectiveness of the nurse-led clinic (i.e., educational 
content and method of delivery), repetition, and timing of education delivered. All 
participants were asked to critique the nurse-led clinic and report on positive and 
negative aspects, while also offering suggestions for improvement. The PI discussed 
the potential of the clinic to achieve primary aims to increase SE, while reducing 
participant anxiety. The PI also discussed the potential for the nurse-led clinic to 
reduce depressive symptoms, encourage CR attendance, and its potential 
effectiveness in increasing medication knowledge and adherence, while encouraging 
effective self-management. Moreover, the PI sought feedback regarding its overall 
application in a real-world setting (i.e., Phase Three study). 
The PI undertook an analytic evaluation of participants’ interview transcripts 
adopting aspects of Charmaz’s (2006, p. 28) analytic techniques and Brinkmann’s 
(2014) abductive approach to facilitate the PI’s interpretation and understanding of 
participants and healthcare professionals’ view of the nurse-led clinic, cardiovascular 
and psychological health, wellbeing and self-management, CR attendance, 
medication adherence and knowledge. Furthermore, using aspects of this technique 
allowed the PI to link analytical findings from Phase Two to Phase One preliminary 
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findings. Figure 3.3 presents the flow of Phase Two. 
 
 
Figure 3.3. Phase Two Flow of The ‘REALITY CHEC’ Project©. 
HREC Protocol Variation 
Submission 
 &  
Ethical Approval 
The ‘REALITY CHEC’ Project 
Phase Two 
Re-consent Intervention Group 
Participants  
(n = 6) 
 
Recruit & Consent Healthcare 
Professionals 
(n = 10) 
Participant Interviews 
(a) Telephone only 
Interview Transcription 
Healthcare Processional 
Interviews  
(a) Face-to-face only 
Interview Transcription 
Evaluation: Analytical findings 
Evaluation: Analytical findings 
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3.5.1 Phase Two: Research Aim and Questions 
As identified, the main aim of Phase Two was to analytically explore both 
healthcare professionals’ and intervention group participants’ feedback of the nurse-
led clinic. 
Together, the Phase Two aim and research questions presented below guided 
the semistructured interviews constructed for participant and healthcare professionals 
(see Appendix X). 
Participant interviews: Research questions 
 Did attending the intervention meet the participant’s needs? 
 How did the intervention meet the participant’s needs? 
 Were there additional participant needs to be met? 
Health care professional interviews: Research questions 
 What was the overall impression of the educational value and timing 
(i.e., day 5–7 post-discharge) in terms of clinic effectiveness? 
 Were the methods of delivery effective (i.e., PowerPoint, written 
material, verbal)? 
 What were healthcare professionals views concerning the practical 
component (i.e., beneficial to participants?)? 
 Could the intervention assist in increasing SE and reducing anxiety, 
and in what way? 
 Were the messages of CR attendance importance made clear? 
 Were the messages of CR encouragement (to attend) made clear? 
 How could CR be packaged to encourage attendance for both first-
time patients and those who have had repeat procedures? 
 Were the messages of medication attendance made clear? 
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 Were the basic cardiac medication groups discussed in the clinic clear 
and not overwhelming? 
 How do healthcare professionals feel with regards to online medication 
access and the caution placed on it? 
 Were the messages of complication identification and management 
made clear? 
 What were the highlights of the information presented? 
 In what way could the nurse-led clinic be enhanced? 
3.5.2 Phase Two: Randomised Controlled Clinical Trial (RCT) Pilot 
Evaluation 
As identified, Phase One modelled an RCT to determine the efficacy in 
undertaking a Phase Three multi-centre study. In Phase One, the PI undertook 
experiential and theoretical work to gain an understanding of the research problem, 
and how to effectively create an intervention to suit the needs of the study population 
(i.e., PCI patients). Phase Two of the study drew on the interpretive paradigm and 
adopted a descriptive-evaluative method adapting analysis techniques used by 
Charmaz (2006) to analyse data obtained through participant and healthcare 
professional interviews. The purpose of using this approach was to determine the 
effectiveness of the nurse-led clinic and to inform the research and, therefore, 
facilitate enhancements that could be applied to the Phase Three study protocol. 
Clarke and Dawson (1999) advise how evaluation research informs and facilitates 
improvements; thus, it was chosen to guide the study’s second phase and particularly 
in the data analysis process. 
Sidani and Braden (2011) highlight the importance of a Phase Two to the 
development of a study. The authors encourage the evaluation of a Phase One pilot 
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study so that potential problems may be managed and enhanced for all future 
participants. Sidanin and Braden (2011) highlight how evaluation of an intervention 
should place importance on gaining participants’ and investigators’ feedback on the 
pilot in order to (a) evaluate the ease and operation of undertaking the intervention, 
(b) determine the reliability or fidelity of the intervention to achieve a successful 
study and outcomes, (c) determine the participants’ experiences and contentment 
with the intervention, and (d) develop means to the achievement of study outcomes. 
Drawing on the interpretive paradigm to evaluate Phase Two data facilitated a 
greater depth of understanding of interview material, as a richness is placed on 
participants’ words and experiences (Guba & Lincoln, 1981). 
In addition to the adoption of the work of Charmaz (2006) to organise data 
coding and evaluation, an abductive approach as identified by Brinkmann (2014) 
was assumed to further evaluate and gain an understanding of Phase Two interview 
data. Brinkman (2014, p. 722) highlights how abductive reasoning is an ongoing 
process with no “hard and fast line between life, research, theory and methods”. 
Brinkmann (2014) further highlights how abduction is not data or theory motivated 
and is essentially a breakdown in personal understanding or reasoning with respect to 
a situation, inquiry, and the relationship. 
3.5.3 Phase Two: Sample and Procedure 
Sample one: Intervention group participants 
All intervention group participants (n = 6) at the private hospital site were 
approached initially via postal mail and then contacted via telephone during the 
recruitment stage of Phase Two. Six intervention group participants consented to 
participate, while two declined due to illness or unavailability due to work 
commitments. A purposive sampling technique was used in selecting all study 
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participants. Patton (1990, 1999) explains how this method of sampling gathers rich 
data in its process and participants. The PI was unsure how many participants would 
be required to achieve information-rich data as well as facilitating a full analysis of 
the study phenomena. Becker (2012) identifies that there are no set rules in 
qualitative research for sample size requirements. Charmaz (2012) recommends that 
researchers consider both the research purpose, depth of investigation, and the 
epistemology when considering interview sample size, while Back (2012) asserts 
that the number of interviews undertaken should represent the truth. Adler and Adler 
(2012, p. 8) also advise that the collection of data can occur until the point of 
“empirical saturation”; however, they do caution that reaching the point of saturation 
is often not feasible. Therefore, with the aforementioned recommendations taken into 
account, healthcare professional interviews were ceased at number 10, while 
participant number 6 was the final interview for intervention group participants. 
Sample two: Healthcare professionals (n = 10) 
A total of 10 healthcare professionals working in the cardiology field were 
recruited for interviews in Phase Two of the study. Participants consisted of staff 
members from the ward, cardiac catheterisation theatre (CCT), hospital executive 
nursing team and a cardiology group. The staff skill mix comprised of RNs, CNs, 
one DON, one CNM, and two leading cardiologists. Participants were all recruited 
from the private hospital site after the study variation and ethical approval was 
granted at this hospital, a medical institute, and QUT HREC. 
Setting 
All healthcare professionals’ interviews in Sample Two were undertaken at the 
hospital site at a time convenient for each participant. Intervention group participants 
in Sample One undertook interviews via telephone only. The PI was allocated a 
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private office at QUT to undertake telephone follow-up. No other person was present 
in the office at the time of follow-up. 
3.6 Instruments, Validity and Reliability 
3.6.1 MP3 Recorder and Participant Interviews 
An MP3 recorder was used to audio record all interviews. Recording allowed 
for the transcription of participant interviews and for the descriptive evaluation 
analysis to be undertaken. The PI was the only person in possession of the MP3 
recorder at all times. When not in use, the recorder was locked in a filing cabinet on 
campus at the university. Recordings were only heard by the PI and the transcriber. 
All recordings were kept anonymous during recording and were coded to ensure 
participant confidentiality (i.e., 001). 
3.6.2 Validity and Reliability 
Qualitative research views validity and reliability in terms of “truth value” 
(Guba & Lincoln, 1981, p.105; 1985, p. 294). Guba and Lincoln (1981, 1985) also 
highlight that the internal validity in qualitative research is measured and termed 
‘credibility’ as opposed to the quantitative term, ‘internal validity’. Moreover, in 
qualitative research, when a phenomenon or phenomena are acknowledged as one’s 
own, internal validity has been said to have been achieved (Guba & Lincoln, 1981, 
1985). 
Further to achieving validity, it is essential that the interviewer have the skill to 
elicit rich data (Appleton, 1995). Appleton (1995) encourages pre-pilot interviews be 
undertaken to enhance interviewer technique, and importantly, increase the validity 
and reliability of the data. The PI had undertaken several patient interviews in 
previous studies; however, to ensure data validity and reliability, the PI conducted 
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pre-interview role plays with the Principal Supervisor so that interview technique 
could be critiqued and feedback provided. Lastly, Appleton (1995) adds how study 
tools used can also enhance reliability and validity. Consequently, the PI utilised an 
MP3 player to record participant interviews to achieve this goal (Appleton, 1995). 
Further to achieving qualitative research validity, there are four criteria 
established by Guba and Lincoln (1981) that are used to determine qualitative 
research validity. All criteria are used interchangeably and are as follows: 
“Trustworthiness; credibility; reliability; and rigour” (Morrow, 2005, p. 250; Pitney, 
2004, pp. 26–28). Guba and Lincoln’s (1981) criteria for ensuring a study’s 
trustworthiness were adopted by the PI to achieve greater reliability and validity in 
the research and findings. 
Credibility is used to assess if a researcher has accurately interpreted study 
participants and their voiced experiences (Guba & Lincoln, 1981; Morrow, 2005; 
Theobald, 2001; Tobin & Begley, 2004). In ensuring credibility of study findings, it 
is recommended that “member checks” or review of transcripts be undertaken by 
participants (Guba & Lincoln, 1981, p. 314). In this study, all participants reviewed 
their interview transcripts for accuracy. No changes were requested by participants. 
The second term, transferability, refers to the generalisation of findings to one’s own 
situation, in particular, the reader (Morrow, 2005). Morrow (2005, p. 252) argues 
that the results of a study should be presented so that the readers may partially or 
completely identify with some aspects of the study. Furthermore, Morrow (2005) 
highlights that if readers are able to relate to findings then transferability is 
considered achieved. It is hoped that participants and future PCI patients reading a 
publication or summary of the study’s results may be able to identify with findings 
(or aspects of), thus achieving transferability. The term dependability refers to the 
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identification of the research process, steps and documentation and validation in an 
audit trail and confirms the trustworthiness of a study (Morrow, 2005; Twycross & 
Sheilds, 2005). The PI kept detailed documentation regarding the study and 
processes with audits being performed internally and externally. Participant 
confidentiality was maintained at all times. 
Confirmability refers to the authenticity of the study’s results and whether 
interpretation actually reflects the true findings (Guba & Lincoln, 1981; Morrow, 
2005). It is highlighted that when interpreting findings the researcher should assume 
neutrality and view the data objectively (Guba & Lincoln, 1982). Maintenance of 
confirmability can be ensured when evidence of bias elimination is seen (Theobald, 
2001). A confirmability audit was undertaken to ensure maintenance of 
confirmability. The confirmability audit was carried out by the Principal Supervisor 
who reviewed Phase Two data and compared it against the researcher’s interpreted 
findings. 
3.7 Timeline, Procedure and Data Collection 
3.7.1 Timeline 
The timeline for all participant interviews and data analysis is presented in 
Table 3.5. It took approximately 2.5 months to undertake all interviews, 
transcription, and analytical evaluation of transcripts. Organising a convenient date 
and time for each interview to be undertaken was challenging with parties on annual 
leave, at work, or unavailable due to other commitments. The PI expressed flexibility 
in arrangements with all participants so that they did not feel under pressure to make 
an appointment at an inconvenient time. 
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Table 3.5.  Phase Two Timeline 
Interviews: Commenced Interviews: Completed Data Analysis 
Thursday 13 June 2013 Friday 9
 
August 2013
 
Monday August 12–Friday 
August 30 2013 
 
3.7.2 Participant Recruitment 
Phase one participants: Intervention group participants approached 
After ethical approval, participants were approached via mail and subsequently 
telephoned to assess interest in participating in the study (see Appendix Y). If in 
agreement, a time and date was arranged with participants to undertake one 
telephone interview regarding the nurse-led clinic they attended at Time 2 (day 5–7), 
its educational benefits, and assistance in the post-discharge period and beyond. All 
participants were thanked and mailed a $25.00 store voucher for their participation 
after each interview was undertaken. 
Healthcare professionals 
Healthcare professionals who were interviewed were approached by the PI to 
participate and were offered an information and consent form and a detailed 
explanation about the requirements after reviewing the PICF. Fourteen healthcare 
professionals were approached during the recruitment phase, with 10 participants 
consenting. Work and/or family commitments were identified as reasons for not 
being able to participate. As identified earlier, a purposive sampling technique was 
used in selecting participants for Phase Two of the study. 
Once participants consented to the study, a time and date suitable for both 
parties was arranged for interviews. At the time of interviews, the PI revealed the 
nurse-led intervention, methods of delivery (i.e., visual, verbal and written), timing 
and length of intervention (i.e., day 5–7 post-discharge), and assessment tools used. 
The main aims of the study were identified, in addition to the rationale for 
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undertaking the intervention within 5 to 7 days (Time 2) post-PCI. Grounds for the 
study identified included: potentially low SE to manage in the post-discharge period, 
anxiety and psychological distress surrounding procedure and post-discharge period, 
recommendations for repetition of education (and early post-PCI), and poor 
information retention and absorption (during hospitalisation). Furthermore, with 
limited nurse-teaching time and cardiology and CR follow-up between 4 and 8 
weeks post-discharge, it was vital that PCI patients had post-discharge nurse-led 
support, especially for those with limited or no social support networks. At the end 
of each interview, participants were thanked and presented with a $25.00 store 
voucher for their participation. 
Data collection: Intervention group participants 
All participants who were previously involved in the intervention were 
reapproached to partake in the study after ethical approval of the study variation was 
granted. Potential participants were initially notified via mail of Phase Two and then 
subsequently via telephone. As identified earlier, six participants agreed to re-
consent while two declined participation. A date and time convenient for participants 
was chosen for the telephone interview. The interview was also recorded on an MP3 
player. Telephone follow-up was chosen so that participants would not be 
inconvenienced as they were required to attend a face-to-face clinic in Phase One of 
the study (Polit & Beck, 2010). Moreover, as scripted consistent telephone follow-up 
is reportedly a good predictor of hospital readmission, it was chosen as the 
communication method (D’Amore et al., 2011). Lastly, as participants had already 
met and communicated with the PI on previous occasions, the time to undertake 
interviews was short (i.e., maximum of 45 minutes to 1 hour required); therefore, the 
method deemed most suitable by both parties was a telephone follow-up (Polit & 
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Beck, 2010). 
Data collection: Healthcare professionals 
A semistructured interview method was chosen to explore healthcare 
professionals’ thoughts about the intervention and to allow for flexibility in the 
interview and thus greater depth and clarity in the data (Britten, 1995; Dearnley, 
2005). Interview questions were open-ended, semistructured, and pre-written to 
guide the interviewer, but also to allow for interviewer divergence (Britten, 1995; 
DiCicco-Bloom & Crabtree, 2006). The PI chose to undertake semistructured 
interviews as they facilitate greater understanding of the participant and words 
(Theobald, Worral-Carter, & McMurray, 2005). Moreover, as new themes may arise 
throughout the course of an interview, the open and “loose structure” may allow for 
further exploration of these while ensuring data consistency and reliability (Britten, 
1995, p. 251; Roberts & Taylor, 2002). 
As identified earlier, data were recorded on an MP3 player and forwarded to a 
professional transcribing service. All healthcare professionals’ interviews took 
approximately 30 to 45 minutes to both reveal and explain the nurse-led intervention 
and undertake interviews in a face-to-face format. Face-to-face interviews were 
chosen as the study materials were highly confidential and could not be forwarded 
electronically. As document protection and copyright measures were in place, no 
material could be forwarded electronically to the interviewee for alternate interview 
methods (i.e., Skype or telephone). Additionally, as a face-to-face interview format 
allows for questions to be clarified and richer data attained, personal interviews were 
undertaken with healthcare professionals (Polit & Beck, 2010). Confidentiality was 
maintained and reinforced at all times with coding used to identify and protect 
participants. Interviews were recorded to ensure greater interviewer–interviewee 
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interaction and richer data while ensuring research validity. Furthermore, recording 
interviews was chosen solely to avoid the distraction of documenting field notes, 
thus enhancing interviewer—interviewee communication and eliciting richer data 
(Goffman, 1989; Liamputtong & Ezzy, 2005). 
Evaluation of transcripts for analytical findings 
Phase Two, as identified in the present study, was more descriptive-evaluative 
in nature and approached analysis from a higher analytical standpoint to interpret 
findings from the data. To ensure a greater depth to analysis and interpretation of 
raw data, an abductive approach was chosen in that it facilitates further breakdown 
and understanding of data (Brinkmann, 2014). Greater understanding is achieved as 
it draws connections and facilitates understanding of events or circumstances 
through the further breakdown of an individual’s interpretation (Alvesson & 
Karreman, 2011; Brinkmann, 2014). Lipscombe (2012, p. 249) identifies the 
positives and negatives of abductive reasoning and highlights that, in order to 
achieve abduction while requiring a degree of subjectivity, an individual requires 
great “reflective abilities”. Haig (2005) also identifies additional requirements in 
undertaking abductive reasoning to include both logic and psychological processes. 
Interpretation and analysis of participants’ voiced experiences and feedback was 
ongoing and developed throughout the course of the analysis process through 
abduction to better understand the data and the relationship between the “situation 
and inquiry” in that it involves a breakdown in understanding (Brinkmann, 2014). 
Brinkman (2014, p. 722) advises how the goal of abduction is to understand through 
“sense-making” with the use of theories and methods. In addition to the use of 
Brinkmann’s (2014) abductive reasoning to facilitate understanding of data and, as 
identified earlier, Charmaz’s (2006) analytic steps and techniques were adopted and 
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used to review the data and better interpret, understand, and link findings between 
categories in Phases One and Two and between healthcare professionals and 
participants as detailed in Chapter 4. Although a grounded theory standpoint, the 
steps facilitated the understanding of participants’ experiences through their 
narratives (Charmaz, 2006). 
As identified, participants and healthcare professionals undertook 
semistructured interviews that sought detailed information regarding the nurse-led 
clinic for purposes of improvement. Over half of the raw data files recorded were 
transcribed by a transcription service to ensure a quick turnaround while the PI 
continued to undertake interviews. The PI undertook the other half of interview 
transcription to maintain research rigour and ensure participant confidentiality 
(Dearnley, 2005). As recommended by Dearnley (2005), recordings were carefully 
coded to ensure participant confidentiality. Copies were printed for all participants to 
review while electronic copies were saved by the PI. All raw transcribed data were 
examined closely by the PI with the adoption of Charmaz’s analytical steps to code, 
evaluate and relate data. 
Charmaz’s (2006) steps included: 
 coding interviews and personal accounts; 
 development of categories; 
 writing notes/memos categories; 
 linking of categories and connecting results between study phases; 
 abductive reasoning/evaluation of findings (i.e., researcher’s 
interpretation of findings); 
 findings interpreted through the key constructs of the SE Theory (i.e., 
does a relationship exist/not exist?). 
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By following this process, the PI was able to attain a greater depth of 
understanding of analytical data while also using Brinkmann’s (2014) abductive 
approach to further interpret analytical findings. Furthermore, analytical findings 
generated from participants’ narratives were identified and associations were made 
between Phase One and Two data and the theoretical framework highlighted. 
Ethical considerations 
Written informed consent was obtained from all participants. To enhance 
interviewer skill and technique and to calm pre-interview nerves, role plays were 
undertaken by the PI prior to commencement of interviews (Morse & Field, 1996). 
The only potential risks identified by the PI for Phase Two included psychological 
distress as a result of discussing emotions surrounding the procedure and the post-
discharge period recovery. The following strategies were employed to ensure the 
aforementioned risks were minimised: (a) full written and informed consent prior to 
interviews, (b) coding of interview recordings and transcripts, (c) withdrawal without 
comment or penalty highlighted, and (d) support offered should participants become 
distressed. Lastly, as the PI had connections to all participants (previous contact with 
intervention group and employment at the site), confidentiality and privacy were 
reinforced both verbally and highlighted in the PICF. Furthermore, withdrawal 
without comment or penalty was reinforced to all intervention group participants. 
Limitations and strategies 
Potential limitations in Phase Two may have included interviewer bias in the 
interpretation of findings, as discussed earlier in Phase One (Creswell & Plano 
Clark, 2010). Furthermore, interviewer effects may have contributed study biases 
(Lavrakas, 2013). The PI acknowledges that having a presence during follow-up 
(i.e., both telephone and face-to-face) may have potentially affected participants’ 
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responses. Prior to undertaking the interviews, the PI considered seeking assistance 
from the research team to undertake all interviews; however, as this strategy can 
introduce other biases into the study, the PI undertook the role (Lavrakas, 2013). 
Potential ethical conflict was identified pre-interview as work colleagues were 
interviewed in Phase Two. Strategies in place to reduce this potential ethical 
limitation included: (a) advising participants to answer the questions honestly, 
irrespective of the relationship; (b) advising potential participants not to feel pressure 
to agree to participate; (c) advising participants that declining participation would 
not incur any comment or penalty; and (d) a clear explanation of study requirements 
during recruitment was given. Lastly, the fact that Phase Two interviews were only 
undertaken at the private hospital site may have also presented as a limitation to the 
study, with findings therefore only generalisable to patients at the private site. Future 
studies will ensure that all participants be reapproached to ensure greater 
applicability of findings. 
3.8 Summary 
This chapter discussed the methods, study development, research design, and 
aims for Phase One, while the methods used to explore and understand Phase Two 
analytical findings were presented. Justification for undertaking the study in two 
phases was also identified along with the instruments used, study participants, 
settings, and methods. Ethical concerns and potential limitations were raised while 
strategies were identified to minimise risk. Chapter 4 presents the study’s 
preliminary results while identifying relationships between the findings in both study 
phases.
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Chapter 4: Results 
This chapter details the results of the study from Phases One and Two. Results 
are presented in line with the research questions identified in Chapter 1. Sample 
demographics are provided, followed by results addressing the primary and 
secondary aims and research questions. 
4.1 Phase One: Nurse-Led Clinic 
4.1.1 Randomised Controlled Clinical Trial 
Sample demographics 
A total of 33 participants were recruited to Phase One of the Pilot Study. The 
mean age of all participants was 65.03 years (SD = 9.76, 45–81). There were more 
male participants (81.8%, n = 27) than females (18.2%, n = 6) involved in this study. 
Of the 33 participants, 78.8% were married (n = 26) and 21.2% (n = 7) were not 
married. Most participants (84.8%, n = 28) were born in Australia, with 93.9% (n = 
31) of participants speaking English as a first language at home. Most participants 
attained a secondary school education or less (54.5%, n = 18) with 45.5% (n = 15) of 
participants indicating they had attained a post-secondary school education. Overall, 
demographic and risk factor data evidenced appeared to be similar between 
intervention and standard-care group participants (see Appendix A1, A2).   
Sample: Risk factors, procedure and health behaviours 
Of the 33 participants involved in this study, 69.7% (n = 23) reported a family 
history of coronary heart disease (CHD), while the remainder reported no family 
history (30.3%, n = 10). Three percent of participants (n = 1) reported they had been 
diagnosed in the past with anxiety while 9.1% (n = 3) had been diagnosed and had 
been or were receiving treatment for clinical depression. Familial 
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hypercholesterolaemia (in first-degree relatives) was reported by 60.6% (n = 20) of 
participants, with 78.8% (n = 26) reporting being treated for high cholesterol (i.e., on 
oral hypocholesterolaemics). Gender (i.e., being male) presented as a risk for most 
participants with 81.8% (n = 27) of participants being male, while all participants 
100% (n = 3) were at risk due to their age alone. Of the other risk factors for CHD, 
no-one reported or recalled being diagnosed with CKD (100%, n = 33). A history of 
hypertension was reported by 57.6% (n = 19) of participants while 21.2% (n = 7) of 
participants identified a history of atrial fibrillation. All participants (100.0%, n = 33) 
underwent PCI either as a primary case (i.e., emergency) or electively. Access to the 
coronary arteries for all participants occurred via the right and/or left femoral artery 
(100.0%, n = 33). Approximately 12.1% (n = 4) of participants were clinically 
diagnosed with type 1 or type 2 diabetes mellitus. Blood glucose readings on 
baseline data collection ranged from 4.5 to 13.1 mmol/L. 
Participants’ weight recorded on baseline ranged from 50.0 kg to 137.0 kg. Of 
interest was that 66.7% (22) of participants’ baseline body mass index (BMI) 
readings were >25 kg/m². Waist measurements taken on baseline ranged between 
80 cm to 135 cm and were taken according to the World Health Organization 
(WHO) recommendations (WHO, 2008). Approximately 97% (n = 32) of 
participants reported being active to some degree on a daily basis. Approximately 
81.8% (n = 27) of study participants reported consuming alcohol while 18.2% (n = 
6) reported consuming alcohol socially and 18.2% (n = 6) reported no alcohol 
consumed.  
Overall, baseline data collected displayed significant modifiable and non-
modifiable risk factors for CHD. Areas of concern, as identified above, included 
family history, waist measurements, BMI, weight, gender, age, diabetes, alcohol 
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consumption, and a history of smoking. Participant risk factor and demographic data 
compared similarly between both groups.  
Access site, baseline complications and vital signs 
Prior to research investigations, haematomas were identified and managed in 
15.2% (n = 5) of participants by clinical staff. Haematomas occurred either 
immediately after the PCI procedure or post-femoral arterial sheath removal. No 
bruits were diagnosed on or prior to baseline data collection. Nursing staff had 
recorded post-procedural access-site bleeds in 9.1% (n = 3) of patients. All patients 
achieved successful haemostasis after application of either digital pressure or a 
device. Access-site pain was reported by 12.1% (n = 4) participants post-procedure. 
Femoral arterial sheath removal post-PCI occurred in 90.9% (n = 30) of participants. 
The remaining 9.1% (n = 3) of participants had closure devices in situ (i.e., angioseal 
or femoseal). There were no signs of infection in participants on baseline visit and no 
new neurovascular complications recorded. Pre-existing neurovascular 
complications in the lower limbs as a result of prior trauma (pre-hospitalisation) 
were identified in 24.2% (n = 8) of participants. No participants experienced chest 
pain or discomfort at baseline visit. Baseline systolic blood pressure readings 
recorded were less than 140mmHg in 78.8% (n = 27) of participants, while the 
remaining 21.2% (n = 6) had a systolic blood pressure equal to or greater than 
140mmHg. All participants’ diastolic blood pressure readings were less than 
90mmHg on baseline measurement. 
On baseline data collection, 93.9% (n = 31) participants reported they were 
able to recall all prescribed medications. When asked to recall and describe 
medications, only 27.3% (n = 9) participants were able to do so accurately (i.e., 
without prompting or viewing a list). On the day of discharge from hospital, cardiac 
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rehabilitation (CR) teams had visited 30.3% (n = 10) of participants. Approximately 
6.1% (n = 2) of participants reported they had been informed about CR from a 
source other than the CR team. After baseline data collection, two key areas of 
concern emerged and included: (a) medication knowledge, and (b) CR perceptions. 
The following subsections present descriptive data concerning complication 
identification and management and risk factor modification, physical activity and 
vital signs (i.e., blood pressure, pulse rate, blood oxygenation) throughout the course 
of the study and participant follow-up.  
Complication identification 
There were no reported post-discharge access site bleeds, bruits, or infections 
in either group. Neurovascular observations remained intact for all participants with 
the exception of those reporting pre-existing neurovascular impairments. No 
medication complications were experienced and reported by participants; however, 
some medication doses were reportedly adjusted by cardiologists or GPs as required 
over time as advised by participants. 
Angina: All participants 
All participants (i.e., intervention and standard-care groups) were asked about 
episodes of angina and actions taken as part of a duty of care at the commencement 
of each follow-up communication. Participants did not experience any angina at the 
time of any follow-up throughout the course of the study; however, episodes were 
recalled being experienced in between follow-up times and reported to the principal 
ivestigator (PI). From baseline assessment on the day of discharge from hospital to 
Time 2 (day 5–7), 36.4% (n = 12) of participants reported experiencing angina (see 
Table 4.1).  
Participants who reported their responses to angina management within the 
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first week post-discharge were to rest and/or self-administer glyceryl trinitrate 
sublingual spray (also known as anginine). Two participants reported they did not 
have anginine with them at the time they experienced their chest pain symptoms. 
One intervention group participant was referred to their cardiologist on the day of 
follow-up as they had experienced an episode of severe angina on the way to the 
nurse-led clinic. The participant did not require hospital admission. Chest pain action 
and management will be discussed in Chapter 5. Between Time 2 (day 5–7) and 
Time 3 (1 month), 39.4% (n = 13) of participants reported angina while 30.3% (n = 
10) of participants experienced angina between Time 3 (1 month) and Time 4 (3 
months). No angina was experienced at Time 4 (3 months) (see Appendix Z). 
Overall, angina reduced over time in all study participants. 
Table 4.1. Summary of Post-Discharge Angina as a Percentage of the Sample 
  Study Participants 
Time  % (n) 
Time 1–2 36.4% (12) 
Time 2 – 
Time 2–3 39.4% (13) 
Time 3 – 
Time 3–4 30.3% (10) 
Note. Time 1–2 = Between day of discharge and day 5–7 follow-up; Time 2 = Day 5–7 follow-up; 
Time 2–3= Between day 5–7 and 1 month follow-up; Time 3 = 1 month. 
4.1.2 Femoral Arterial Access Site(s): Images, Diagrams, Bruising, and 
Haematoma — All Participants 
Femoral arterial sheath removal and complications 
Approximately 93.9% (n = 31) participants underwent digital femoral arterial 
sheath removal post-PCI. The remaining 6.1% (n = 2) participants had collagen 
closure devices (i.e., Femoseal or Angioseal) implanted to achieve haemostasis. The 
length of time to achieve haemostasis for participants who had digital pressure 
applied ranged from 6 to 33 minutes. One participant experienced a vasovagal 
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episode during arterial sheath removal, while another required further pressure to the 
femoral access site using an adjunct in addition to digital pressure (i.e., Femstop) to 
achieve haemostasis. 
Femoral arterial access sites: Descriptions and images 
At Time 1 (day of discharge), 100% (n = 33) of access sites were 
photographed by the PI. At Time 2 (day 5–7), 16 wound sites were photographed. 
This consisted of 100% (n = 13) intervention group participants and 15% (n = 3) of 
standard-care group participants. Images and/or descriptions were requested of all 
participants (i.e., intervention and standard-care group) as a duty of care (i.e., in the 
event of a major complication) and to review post-PCI access site wound healing. 
One standard-care participant provided an image at Time 3 (1 month), while no 
intervention group participants provided images at this time. There were no images 
provided at Time 4 (3 months) as participants voiced their access sites had 
completely healed. 
Femoral arterial access sites: Haematoma 
On baseline measurement, 3.0% (n = 1) of participants experienced a 
haematoma, while 27.3% (n = 9) participants experienced and reported a haematoma 
at Time 2 (day 5–7). Times 3 (1 month) and 4 (3 months) saw a reduction in the size 
and number of haematomas developing, indicating recovery. Table 4.1 displays a 
summary of haematoma complications over the course of the study. 
Table 4.2. Summary of Haematoma Complications as a Percentage of the Sample 
  Study Participants (N = 33) 
Time % (n) 
Time 1 3.0% (1) 
Time 2 27.3% (9) 
Time 3 12.1% (4) 
Note. Time 1 = Baseline; Time 2 = Pre-intervention (day 5–7); Time 3 = 1 month.   
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Bruising: All participants 
Access-site bruising was recorded in 48.5% (n = 16) participants on day of 
discharge, with mean measurements recorded between 4.88cm wide and 6.84 cm in 
length (see Table 4.3 and 4.4). Time 2 (5–7 days) identified 39.4% of participants 
with bruising, while the area of bruising increased in size with a mean size of 7.78 
cm width, and 9.57 cm in length (see Table 4.1). Bruises began to fade between 
Time 2 (5–7 days) and 3 (1 month), and Time 3 (1 month) and 4 (3 months), 
respectively, with participants reporting bruises unmeasurable as they were fading 
and very faint in colour. 
Table 4.3. Summary of Bruising Complications as a Percentage of the Sample 
  Study Participants (N = 33) 
Time % (n) 
Time 1 48.5% (16) 
Time 2 39.4% (13) 
Time 3 6.1% (3) 
Note. Time 1 = Baseline; Time 2 = Pre-intervention (day 5–7); Time 3 = 1 month. 
Table 4.4. Summary of Mean Bruising Measurements in Centimetres 
Time Bruise Dimensions (cm) 
Time 1 4.88: 6.84 
Time 2 7.78: 9.57 
Time 3 – 
Note. Time 1 = Baseline; Time 2 = Pre-intervention (day 5–7); Time 3 = 1 month. Time 3 bruises 
reported as faded and unmeasurable by participants. 
4.1.3. Modifiable Risk Factors 
Weight, BMI, and waist measurements 
Mean weight in intervention group participants increased by 0.6 g between 
Time 1 (day of discharge) to Time 3 (1 month), while a mean reduction of 0.013 g 
was demonstrated in standard-care group participants. Between Time 3 (1 month) to 
Time 4 (3 months) a mean weight reduction of 0.128 g and 1.009 g was 
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demonstrated in intervention group and standard-care group participants, 
respectively. It was noted that mean BMI slightly increased in intervention group 
participants between Time 1 (day of discharge) to Time 3 (1 month), while standard-
care group participants saw a small reduction in BMI of 0.0864 kgm² between Time 
1 (day of discharge) to Time 3 (1 month). Time 3 (1 month) to Time 4 (3 months) 
demonstrated slight reductions in BMI of 0.1 kgm² and 0.19 kgm² for intervention 
group and standard-care group participants, respectively. 
Corresponding with mean increases and reductions in weight and BMI, mean 
waist measurements in intervention group participants increased by 2.0 cm between 
Time 1 (day of discharge) and Time 3 (1 month), while standard-care group 
participants’ mean waist measurement increased by 2.1 cm. Between Time 3 (1 
month) to Time 4 (3 months) intervention group participants demonstrated a mean 
reduction of 1.92 cm, while standard-care group participants’ mean waist 
measurement were reduced by 2.8 cm. 
Physical activity 
Physical activity was measured via self-report only as the PI sought data 
concerning pre-procedural physical activity engagement; how soon post-PCI 
participants resumed or newly commenced physical activity; and what activity (if 
any) they were engaging in. Additionally, the PI was interested in whether 
participants’ physical activity aligned with post-procedural education and if 
participants were motivated to change their behaviour (i.e., resume or commence 
physical activity).  
Prior to hospital admission 100% (n = 33) of participants reported undertaking 
some degree of physical activity. Levels of intensity ranged from light to high, with 
the frequency of exercise engagement ranging from 1 to 7 days per week. Most 
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participants reported undertaking aerobic activity, while others undertook a 
combination of aerobic and resistance training. At Time 2 (day 5–7) 24.2% (n = 8) of 
participants reported being inactive, while 63.60% (n = 21) were engaged in light 
activity, 6.10% (n = 2) undertaking physical activity at a moderate intensity, and one 
participant (3.03%) reported recommencing high intensity physical activity and 
attending a group mountain hike. At Time 3 (1 month) 27.27% (n = 9) of participants 
were undertaking light activity and identified undertaking walking or attending a CR 
program, while 57.57% (n = 19) reported an increase their intensity from light to a 
moderate level.  
Participants reported attending the gym, cycling, hiking, swimming, or 
walking three to five times per week for at least 30 minutes to 1 hour. One (3.03%) 
standard-care group participant had not recommenced any activity as they were 
finding it difficult to initiate. Two (6.06%) intervention group participants reported 
not commencing physical activity as one had been experiencing frequent episodes of 
angina and the other participant reported runs of rapid atrial fibrillation (AF). Both 
aforementioned participants were receiving medical treatment for their angina and 
AF. At Time 4 (1 month), 57.57% (n = 19) of participants were still actively 
participating in moderate intensity physical activity, while 21.21% (n = 7) were 
undertaking light intensity, and 6.06% (n = 2) undertaking high intensity physical 
activity. Two (6.06%) intervention group participants reported being inactive at 
Time 4 (3 month) follow-up due to illness and recent hospitalisation. 
Smoking status 
 Participants’ smoking history, recency and behaviours were measured via 
self-report. A history of smoking was reported by 51.5% (n = 17) of participants at 
Time 1 (day of discharge). All past smokers had ceased this behaviour prior to 
158 
baseline data collection as a result of either a prior or recent diagnosis of CHD. At 
Time 2 (day 5-7), Time 3 (1 month) and Time 4 (3 months) all past smokers 51.5% 
(n = 17) reported maintaining abstinent.  
Vital signs: Systolic blood pressure (SBP), diastolic blood pressure (DBP), heart 
rate, respirations, and oxygen saturation 
Mean systolic blood pressure (SBP) at Time 2 (day 5–7) for all participants 
remained stable at 128.27 mmHg, while mean diastolic blood pressure (DBP) at 
Time 2 (day 5–7) was 68.20 mmHg (see Tables 4.5 and 4.6). 
Table 4.5. Summary of Mean Scores: Systolic Blood Pressure Readings (mmHg) 
 All participants 
Time N Minimum Maximum M(SD) 
Time 1 33 100 158 125.58(14.923) 
Time 2 15 106 155 128.27(17.388) 
Note. Time 1 = Day of hospital discharge; Time 2 = Pre-intervention (day 5–7); Systolic blood 
pressure expressed as millimetres of mercury (mmHg). 
Table 4.6. Summary of Mean Scores: Diastolic Blood Pressure Readings (mmHg) 
 All participants 
Time N Minimum Maximum M(SD) 
Time 1 33 50 88  69.88(9.443) 
Time 2 15 55 90 68.20(10.605) 
Note. Time 1 = Day of hospital discharge; Time 2 = Pre-intervention (day 5–7); Diastolic blood 
pressure expressed as millimetres of mercury (mmHg). 
Mean heart rate at Time 2 (day 5–7) was 62.85 beats per minute (bpm) (see 
Table 4.7), while mean respirations were 17.1667 respirations per minute (see Table 
4.8). Mean oxygen saturation level at Time 2 (day 5–7) was 97.25% on room air, 
while mean temperature was recorded at 36.05 Degrees Celsius (see Tables 4.9 & 
4.10). 
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Table 4.7. Summary of Mean Scores: Heart Rate (bpm) 
 All participants 
Time N Minimum Maximum M(SD) 
Time 1 33 49 81 65.97(9.071) 
Time 2 13 49 91 128.27(14.387) 
Note. Time 1 = Day of hospital discharge; Time 2 = Pre-intervention (day 5–7); Heart rate expressed 
as beats per minute (bpm). 
Table 4.8. Summary of Mean Scores: Respiration Rate (breaths per minute) 
 All participants 
Time N Minimum Maximum M(SD) 
Time 1 33 14 19 16.97(1.045) 
Time 2 12 16 18 17.1667(0.71774) 
Note. Time 1 = Day of hospital discharge; Time 2 = Pre-intervention (day 5–7); Respiration rate 
expressed per minute. 
Table 4.9. Summary of Mean Scores: Oxygen Saturations (%) on Room Air 
 All participants 
Time N Minimum Maximum M(SD) 
Time 1 33 95 99 96.82(1.261) 
Time 2 4 96 98 97.25(0.957) 
Note. Time 1 = Day of hospital discharge; Time 2 = Pre-intervention (day 5–7); Oxygen saturations 
expressed as a percentage (%) on room air. 
Table 4.10. Summary of Mean Scores: Temperature (°C) 
 All participants 
Time N Minimum Maximum M(SD) 
Time 1 32 35.8 37.0 36.21(0.2770) 
Time 2 4 36.0 36.1 36.05(0.0577) 
Note. Time 1 = Day of hospital discharge; Time 2 = Pre-intervention (day 5–7); Temperature 
expressed as degrees Celsius (°C).  
Electrocardiogram (ECG) 
There were no significant ECG changes in participants on follow-up at the 
post-discharge nurse-led clinic. At Time 1 (day of discharge), 66.70% (n = 22) of 
participants presented in a normal sinus rhythm, while 3.03% (n = 1) presented with 
AF, 24.24% (n = 8) were recorded in sinus bradycardia, one participant (3.03%) in a 
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sinus tachycardia and one participant 3.03% with sinus arrhythmia. Of those 
recorded in a normal sinus rhythm, 9.09% (n = 3) were captured in a first-degree 
heart block. At Time 2 (day 5–7), a 12-lead ECG was taken by the PI, with no 
remarkable ECG changes recorded in intervention group participants. One 
participant (3.03%) who at baseline presented in a normal sinus rhythm, was 
captured in a sinus bradycardia at 50 bpm. The ventricular rate captured on baseline 
ECG was recorded at 59 bpm. At Time 2 (day 5–7), 18.18% (n = 6) participants 
were captured in a normal sinus rhythm, while 18.18% were recorded in a sinus 
bradycardia. One participant (3.03%) remained in AF from baseline measurement. 
Cholesterol and blood glucose level readings 
Inspection of mean scores for cholesterol and blood glucose levels evidenced 
the following for times 1 (Baseline) to Time 4 (3 months). Mean total cholesterol for 
all participants at Time 1 (day of discharge) was 4.191 mmol/L and ranged between 
2.5 mmol/L to 6.5 mmol/L. Post-PCI total cholesterol was only available for one 
participant and measured 5.9 mmol/L. Mean blood glucose levels at Time 2 (day 5–
7) 8.267 mmol/L and ranged between 6.0 mmol/L and 10.8 mmol/L. Time 3 (1 
month) mean BGLs ranged from 4.0 mmol/L to 13.4 mmol/L, with a mean of 7.75 
mmol/L. The mean BGL at Time 4 (3 months) was 7.567 mmol/L. Levels ranged 
between 6.4 mmol/L to 9.0 mmol/L. Overall, a broad range of results were observed 
after closer inspection of mean ratings for cholesterol and blood glucose levels. 
Results for the study’s primary aims are presented below.   
4.1.4 Primary Aims: Results 
A multivariate analysis of the data could not be conducted as the sample size 
recruited was less than originally anticipated; however, the PI, as identified in 
Chapter 3, undertook two analyses: (1) Effect Size (ES), and (2) Reliable Change 
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Index (RCI) calculations. Effect size (ES) and RCI calculations were undertaken to 
demonstrate the potential effect and importance of the intervention on primary and 
secondary research aims and to identify the potential for a Phase Three study. 
Furthermore, RCI calculations were undertaken to determine if a reliable change 
occurred while the therapeutic outcomes of randomisation to the intervention group 
were also reviewed to determine if participants were better or worse after attending 
the nurse-led clinic. 
Descriptive statistics are also presented for primary and secondary aims. 
Although participants were followed up over a period of 3 months in the present 
study, a primary endpoint of 1 month (Time 3) was chosen to gauge the effect of the 
intervention versus standard care. The primary endpoint of 1 month (Time 3), as 
identified in Chapter 2, was selected as the literature also identified 1 month to be the 
best time to determine effects of interventions on psychological distress while also 
limiting the impact of non-relevant stressors and events. Furthermore, the clinical 
biochemist who undertook salivary cortisol assays recommended that 1 month (Time 
3) after attending the nurse-led clinic would be the best time to determine if the 
intervention was effective in reducing stress in participants as demonstrated by a 
reduction in salivary cortisol levels. Results for follow-up to the primary endpoint 
(Time 3) are presented below. 
4.1.5 Results: Cardiac Self-Efficacy Scale (CSE)  
Cohen’s d – Population effect size 
Overall, results did not demonstrate strong support for study hypotheses with a 
reduction in overall CSE evidenced in intervention group participants. Cohen (1992, 
p. 157) identifies the indexes and values for ES as small (0.20), medium (0.50), and 
large (0.80). Attending the nurse-led clinic had a moderately reducing effect on CSE 
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in intervention group participants, d = 0.60. Randomisation to the standard-care 
group alone did not demonstrate any effect on CSE, d = -0.19. Full calculations of 
Cohen’s d for both groups of participants are detailed in Appendix B1. Overall, ES 
calculations suggest a moderately reducing effect of the intervention on overall CSE 
in intervention group participants as compared with standard-care group participants 
where no effect on CSE is evidenced. 
Reliable change index (RCI) 
Calculations to determine a reliable change in participants over time were 
undertaken for both groups according to the Jacobsen criterion. In order to report a 
reliable change, the following criteria must be satisfied: RCI > + 1.96, p < .05. 
Reliable Change Index (RCI) calculations were undertaken to determine if there was  
any change and the degree of change, in study participants over time after receiving 
the intervention (i.e., Time 2 [day 5–7] to Time 3 [1 month]). Please see Appendix 
C1 for full calculations and RCI values for study participants demonstrating a 
reliable change (Fisher & Durham, 1999, p. 1429). 
A positive reliable change was evidenced in one participant in the intervention 
group and one in the standard-care group, with an RCI of 2.84 and 2.14, 
respectively. For the CSE questionnaire, a positive RCI >+1.96 indicates that a 
reliable change has occurred. Full calculations for participants 082 and 005 are 
presented in Appendix C1. The RCI for intervention group participant 082 is 
significant at 2.84 (>+1.96) after attending the nurse-led clinic. Of interest is a 
positive reliable change in CSE that occurred in participant 005 after randomisation 
to the standard-care group. The RCI for participant 005 is significant at 2.14 
(>+1.96) and will be discussed in Chapter 6. 
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Cut-off point ‘c’ 
Treatment outcomes determine the effect of an intervention on participants’ 
recovery. Full ‘recovery’ or return to normal functioning is established when an RCI 
of > +1.96 is achieved and participants’ questionnaire scores move from above to 
below the calculated cut-off value. As a cut-off point (i.e., ‘c’) for clinically 
significant change for CSE was not available, the PI calculated this to be 2.68 as per 
Fisher and Durham (1999) (see Appendix B1 for full calculations). This cut-off point 
suggests that CSE scores of >2.68 will fall within the normal distribution, thus 
indicating clinically significant change. 
Treatment outcomes 
Of the intervention group participants, 7.7% (n = 1) recovered, 23.1% (n = 3) 
improved, and 61.5% (n = 8) had poorer CSE post-intervention. One participant 
withdrew prior to attending the intervention and data for Time 2 (day 5–7) and Time 
3 (1 month) were, therefore, unavailable. Standard-care participants saw 5.0% (n = 
1) participant recover, while 45% (n = 9) improved and 45% (n = 9) worsened (see 
Table 4.11). 
Table 4.11. Pre- to Post- Intervention CSE Standardised Recovery Rates 
Group Frequency (Percentage) 
 Worse No Change Improved Recovered 
Intervention (n = 13) 8 (61.53%) 0 (0%) 3 (23.10%) 1 (7.70%) 
Missing (n =1)     
Standard Care (n = 20) 9 (45%) 1 (5.0%) 9 (45%) 1 (5.0%) 
Total (N = 33) 17 (51.52%) 1 (3.03%) 14 (36.40%) 2 (6.10%) 
 
Overall, ES calculations demonstrated a moderately reducing effect of the 
intervention on participants attending the nurse-led clinic. Reliable change index 
(RCI) calculations undertaken demonstrated a reliable change in only one 
intervention group participant. Tabulation of treatment outcomes revealed 
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improvements and recovery in approximately one-third of participants over time, 
while over half of intervention group participants’ CSE worsened. 
Overall mean cardiac self-efficacy (CSE) scores 
Mean CSE scores for intervention group participants at Time 2 (day 5–7) were 
2.48 units and 2.35 units for standard-care group participants (i.e., each scale item 
scored 0 to 4). Time 3 (1 month) scores for overall CSE were 2.11 units and 2.45 
units for intervention and standard-care group participants, respectively. See 
Appendix D1 for further detail regarding overall mean CSE scores. 
Cardiac self-efficacy (CSE): Time 4 (3 months) 
An inspection of the means shows that an increase in overall CSE scores was 
demonstrated in intervention group participants at Time 4 (3 months), while 
reductions were evidenced between Time 2 [day 5–7] and Time 3 (1 month). 
Standard-care group participants’ overall CSE scores demonstrated reductions at 
Time 4 (3 months), while enhancements were evidenced between Time 2 (day 5–7) 
and Time 3 (1 month). 
Cardiac self-efficacy (CSE): Items 
As overall mean scores did not demonstrate increases in total CSE, each CSE 
item was explored to examine if effects occurred for specific areas of confidence as a 
result of attending the nurse-led clinic. (Please see Appendix C1 for a full list of 
mean scores for each of the 16 CSE items from baseline measurement until Time 4 
for both groups of study participants.) Selected items below show increases in CSE 
items at the primary endpoint (Time 3). In general, an inspection of the means shows 
that increases in mean CSE item scores were evidenced in intervention group 
participants at Time 3 (1 month) in the following areas: 
 confidence to lose weight 
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 confidence to change diet 
 confidence in knowing how much physical activity is good (for them) 
 confidence to maintain usual work activities 
 confidence to control breathlessness by taking medications. 
4.1.6 Results: State–Trait Anxiety Inventory (STAI) Y-2 Form, Trait 
Anxiety 
Cohen’s d population effect size (ES) 
Effect size (ES) for the STAI Y-2 Form demonstrated a moderately reducing 
effect of the nurse-led clinic on intervention group participants’ trait anxiety, d = 
0.50. Randomisation to the standard-care group did not see an effect on trait anxiety, 
d = 0.16. Effect size (ES) calculations for study participants are presented in 
Appendix E1. Overall, participation in the nurse-led intervention demonstrated a 
moderate reduction in trait anxiety while randomisation to the standard-care group 
did not have an effect on trait anxiety. 
Reliable change index (RCI) 
Five participants in the intervention group and two participants in the standard-
care group demonstrated a reliable change. Full calculations for participants 
demonstrating reliable change are detailed below. Appendix F1 contains full RCI 
values for study participants. For the STAI-Y2 questionnaire, a negative RCI > -1.96 
indicates that a reliable change (P < 0.05) has occurred. Furthermore, to ensure a 
reliable change, as per Fisher and Durham (1999), an 8-point difference on the 
STAI-Y2 was necessary. Lastly, in the calculation of the RCI, values detailed for the 
STAI-Y2 form were utilised as calculated by Fisher and Durham (1999, p. 1429) 
(see Appendix E1). 
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Reliable Change Index (RCI): Intervention and standard-care group 
participants 
Five intervention group participants demonstrated a negative reliable change in 
trait anxiety scores over time. Full calculations are displayed in Appendix F1. A 
significant reliable change of - 3.99 was evidenced in participant 010 over time after 
attending the nurse-led intervention, while a reliable change of -2.74 and -4.24 were 
demonstrated in participants 006, and 066 respectively. Participant 020 demonstrated 
a reliable change of -1.99, while a significant reliable change of -6.48 was evidenced 
in participant 106 over time.  
A negative reliable change was also evidenced in two participants randomised 
to the standard-care group over time. Participants 039 and 023 demonstrated a 
reliable change of -2.50, and -2.99 in trait anxiety, respectively (see Appendix G1 for 
full calculations). Reliable change in both groups of participants will be discussed in 
greater detail in Chapter 6. 
Cut-off point ‘c’ 
As identified earlier in this chapter, treatment outcomes and full recovery are 
determined when the RCI are > +1.96 coupled with the movement of questionnaire 
scores from above to below the calculated cut-off value. The cut-off point for the 
STAI-Y2 form was identified by Fisher and Durham (1999, p. 1429) as being < 46 
(see Appendix G1). Thus, post-intervention scores falling within this cut-off point 
are identified as the normal distribution and indicate clinically significant change. 
Treatment outcomes 
Of the intervention group participants, 15.4% (n =2) achieved recovery, 53.8% 
(n = 7) improved, 15.4% (n = 2) experienced no change, and 7.7% (n = 1) 
demonstrated worse trait anxiety post-intervention (see Table 4.12). Standard-care 
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participants saw no participants recover and 30% (n = 6) participants worsen; 
however, 55% (n = 11) demonstrated improvements in trait anxiety over time (see 
Table 4.12). Three (11%) participants in the standard-care group experienced no 
change in trait anxiety. 
 
Table 4.12. Pre- to Post- Intervention STAI Y-2 Form Standardised Recovery Rates 
 
Group  
Frequency (Percentage) 
Worse No Change Improved Recovered 
Intervention (n = 13) 1 (7.70%) 2 (15.40%) 7 (53.85%) 2 (15.40%) 
Missing (n =1)      
Standard Care (n = 20) 6 (30%) 3 (15%) 11 (55%) 0 (0%) 
Total (N = 33) 7 (21.20%) 5 (15.15%) 18 (54.54%) 2(6.10%) 
 
Overall, randomisation to the nurse-led clinic demonstrated a moderate effect 
(d = 0.50) in participants over time while randomisation to the standard-care group 
had no effect (d = 0.16). A reliable change was evidenced in 5 (RCI = > +1.96, P = 
0.05) intervention group participants compared with two standard-care group 
participants. Preliminary evidence demonstrates reliable change and positive 
therapeutic outcomes in intervention group participants compared with standard care 
group participants over time. 
Mean trait anxiety scores 
Mean baseline scores for the STAI-Y2 form or trait anxiety questionnaire for 
intervention group participants was 38.33 while the mean baseline score for the 
standard-care group was 34.37 (i.e., scale range 20 to 80). Mean scores for 
intervention group participants at Time 2 (day 5–7) was 36.75 (pre-intervention) 
while standard-care group participants demonstrated a mean anxiety score of 30.95 
at Time 2 (day 5–7). Between Time 2 (day 5–7) and Time 3 (1 month), a mean 
reduction of 6.83 units in trait anxiety was identified in intervention group 
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participants versus 1.48 units in standard-care group participants. A total mean 
reduction of 8.41 units was seen in intervention group from baseline measurement 
until Time 3 (1 month), and 4.9 units in standard-care group participants. Thus, 
inspection of those means show that, overall, a larger reduction in mean trait anxiety 
scores (i.e., based on decreases in mean trait anxiety scores) was seen in intervention 
group participants from baseline and Time 2 until Time 3 (1 month), after attending 
the nurse-led clinic. Table 4.13 presents a summary of mean trait anxiety scores.  
Table 4.13. Summary of Means for Scores on the STAI Questionnaire: Trait Anxiety (Y2 
Form)   
  Intervention Group Standard-Care Group 
Time M(SD) M(SD) 
Time 1 38.33 (13.28) 34.37 (8.84) 
Time 2 36.75 (14.10) 30.95 (9.43) 
Time 3 29.92 (12.66) 29.47 (8.13) 
Note. CSE = Cardiac Self-Efficacy Scale. Time 1 = Baseline; Time 2 = Pre-intervention (day 5–7); 
Time 3 = 1 month. 
Trait Anxiety: Time 4 (3 Months) 
Mean trait anxiety scores for both groups of participants increased at Time 4 (3 
months) with intervention group participants scoring 37.75 units and standard-care 
group participants scoring 37.72 units, respectively. It was interesting to note that a 
reduction in mean trait anxiety was evidenced in both groups between Time 1 
(Baseline), Time 2 (day 5–7) and Time 3 (1 month) while an increase was 
demonstrated at Time 4 (3 months). These results will be discussed in greater detail 
in Chapter 6. Please see Appendix H1 to view Time 4 (3 months) results. 
4.1.7 Secondary Research Questions: Results 
Stress and salivary cortisol assays 
Of the sample, participants’ mean baseline salivary cortisol levels were 
0.10 ug/dl for intervention group participants and 0.16ug/dl for standard-care group 
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participants, respectively. At measurement two (Time 3, 1 month), mean cortisol 
levels were 0.092ug/dl for intervention group participants and 0.134 ug/dl for 
standard-care group participants. Mean salivary cortisol levels for intervention group 
participants decreased by 0.008 units and 0.026 units for standard-care group 
participants. Overall, inspection of these means demonstrate a greater mean 
reduction in cortisol assay levels in standard-care group participants over time. See 
Table 4.14 for a summary of mean salivary cortisol assay measurements. Reference 
ranges for salivary cortisol were adopted from Salimetrics® (Salimetrics®, 2010). 
Overall, assay results for both groups of participants fell within reference ranges; 
however, standard-care group participants presented with slightly higher cortisol 
levels. Furthermore, inspection of the means show that salivary cortisol levels fell at 
a greater rate over time in standard-care group participants as opposed to 
intervention group participants. Findings will be discussed in greater detail in 
Chapter 6. 
Table 4.14. Summary of Mean measurements for Salivary Cortisol Assays (ug/dl) 
Time/Group  Intervention group (ug/dl) Standard-care group(ug/dl) 
Time 1 0.10 0.16 
Time 2 0.092 0.134 
Note: Expected morning reference ranges for adults mornings for adults 0.094–1.551 ug/dl; and 
afternoon 0.359 ug/dl. 
Personal referral 
A number of interactions with participants required action by the PI to initiate 
referral to a general practitioner (GP) as participants either reported emotional 
distress and/or their assessment tool scores indicated they may be at risk. Some 
participants were also referred to their cardiologists by the PI as they were unable to 
distinguish between anxiety symptoms and angina. 
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Time Two follow-up: Day 5–7 post-discharge 
Referral of 12.1% (n = 4) of participants to their GPs and/or cardiologists at 
Time 2 (day 5–7) for follow-up was actioned based on their post-discharge feelings 
reported, coupled with assessment tool scores (i.e., feeling emotional and/or teary). 
At Time 2 (day 5–7) follow-up, one participant voiced they had felt angry the first 2–
3 days post-discharge after which the negative feelings subsided. One of the 
aforementioned participants was referred to both a cardiologist and GP as they were 
unable to distinguish whether the symptoms experienced were anxiety or chest pain-
related symptoms; thus, communication with both the specialist and GP was initiated 
by the PI. 
Time Three follow-up: 1-month post-discharge 
Referral at Time 3 (1 month) occurred as a result of patient symptoms reported 
to the PI. One participant (3.0%) was referred to their GP as they were feeling 
emotional while 9.1% (n = 3) participants reported experiencing angina between 
Time 2 (day 5–7) and Time 3 (1 month). Of the three participants experiencing 
angina referred to their cardiologist, one participant underwent immediate cardiology 
review after reporting to the PI that they were experiencing intermittent light-
headedness and chest heaviness while exercising; a new coronary artery lesion was 
discovered and stented as a result. One participant had access-site discomfort and 
was referred to their GP. Lastly, one participant was referred for lower limb 
swelling, mottling and calf redness, and had an audible wheeze (that could be heard 
during telephone conversation). As the participant had a history of deep vein 
thrombosis, the PI recommended urgent GP or emergency centre examination. The 
participant took the PI’s advice and had a family member drive them to a local 
emergency centre for review. They did not require hospitalisation and were 
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discharged home with medications. One standard-care group participant’s 
antiplatelet medication was depleted (Clopidogrel) at Time 3 (“for a couple of days”) 
and then had the stock replenished. Although not an intervention group participant, 
as the PI is ethically responsible for all participants, the importance of this 
medication was highlighted. 
Time Four follow-up: 3 months post-discharge 
Only 3.0% (n = 1) participant was referred to their GP at Time 4 (3 months) 
and the cardiology rooms at one hospital site at Time 4 (3 months) as they reported 
increased frequency of their chest pain and shortness of breath. Furthermore, this one 
participant also reported consuming an entire bottle of glyceryl trinitrate tablets for 
angina over a period of 1 week while they had been heavily involved moving house. 
On contact with the hospital site, it was recommended that the PI notify the GP for 
immediate consult; however, the PI had already actioned this. Again, the standard-
care group participant who did not replenish their script for their antiplatelet 
medication (clopidogrel) at Time 3 (1 month) reported they, again, had not had their 
script dispensed and as a result had missed one dose of the medication. This 
participant also reported missing other medications at times. Medication adherence 
and compliance will be discussed in Chapter 6. 
4.1.7 Cardiac Depression Scale (CDS): Cohen’s d - Population Effect 
Size (ES) 
Effect size (ES) calculations undertaken demonstrate a small reducing effect 
on depressive symptoms in both intervention (d = 0.26) and standard-care group (d = 
0.37) participants (see Appendix I1 for full ES calculations). 
4.1.8 Cardiac Depression Scale (CDS): Reliable Change Index (RCI) 
One participant in the intervention group and one participant in the standard-
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care group demonstrated a negative reliable change in depression scores over time. 
Full calculations for participants demonstrating a reliable change are detailed in 
Appendix K1. For the CDS questionnaire, a negative RCI > -1.96 indicates that a 
reliable change (p < .05) has occurred.  
A reliable change of -1.97 was evidenced in intervention group participant 010 
after participation in the nurse-led clinic while standard-care group participant 013 
demonstrated a significant reliable change of -5.4. Results will be discussed in 
further detail in Chapter 6. 
Cut-off point ‘c’ 
Redfern, Ellis, Briffa, and Freedman (2007) identified the cut-off point ‘c’ for 
depression as > 90. Thus, the cut-off point for clinically significant change and 
treatment recovery in the present study was identified as <90. 
Treatment outcomes 
Table 4.15 displays the standardised recovery rates for participants involved in 
this study. It was noteworthy that the breakdown of treatment outcomes 
demonstrates 7.7% (n = 1) of participants experiencing recovery, 61.5% (n = 8) 
improving, and 23.10% (n = 3) with worsening CDS scores after participating in the 
intervention. Similarly, standard-care group participants demonstrate 5.0% (n = 1) 
recovery, 70% (n = 14) improved, and 25% (n = 5) worse over time. 
Table 4.15. Pre- to Post- Intervention CDS Standardised Recovery Rates 
 Frequency (Percentage) 
Group  Worse No Change Improved Recovered 
Intervention (n = 13)     
Missing (n =1) 3 (23.10%) 0 (0.0%) 8 (61.54%) 1 (7.69%) 
Standard Care (n = 20) 5 (25%) 0 (0%) 14 (70%) 1 (5.0%) 
Total (N = 33) 8 (24.24%) 0 (0%) 22 (66.66%) 2 (6.06%) 
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Overall, only a small ES was demonstrated in both intervention and standard-
care group participants. Reliable change was evidenced in one participant in each 
group. Similarly, over half of the participants in both groups demonstrated 
improvements and one in each group achieved recovery. 
Aim 2(a): Mean Cardiac Depression Scale (CDS) Scores 
Reductions in mean CDS scores were evidenced at each time point for both 
study groups (i.e., scale range 26 to 182). Intervention group participants’ mean CDS 
scores reduced from 73.83 (Time 2, day 5–7) to 65.83 (Time 3, 1 month), while 
standard-care group participants’ mean CDS scores for Time 2 (day 5–7) and Time 3 
(1 month) were 68.58 and 58.26 units, respectively. A summary of mean CDS scores 
are presented in Appendix K1. 
4.1.9 Cardiac Depression Scale (CDS): Time 4 (3 Months) — 
Descriptives 
Inspection of the group means show that the intervention group participants 
displayed higher mean baseline CDS scores than did the standard-care group 
participants. Slight increases in CDS scores were identified at Time 4 (3 months) in 
intervention group participants. Overall, based on inspection of the means, a greater 
reduction in mean CDS scores were identified in standard-care group participants 
from baseline measurement and Time 2 (day 5–7) until Time 4. Please see Appendix 
J1 to review Time 4 (3 months) CDS results. 
Overall, changes in depressive symptoms were only small and occurred in both 
groups. Effect size (ES) calculations, coupled with RCI, treatment recovery 
assessment, and review of mean CDS scores demonstrate similarities in intervention 
and standard-care group participants’ treatment outcomes over time. 
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Aim 2(b): Cardiac Rehabilitation (CR) Attendance 
Overall, 15.4% (n = 2) intervention group participants (who were referred to 
CR by the PI) attended a CR program while 30% (n =6) participants in the standard-
care group attended CR. One (5.0%) standard-care group participant withdrew from 
the program prior to commencement due to work commitments, while one (7.70%) 
intervention group participant withdrew and committed to a telephone rehabilitation 
program run by their private healthcare provider. Reasons for non-attendance and 
compliance will be discussed in Chapter 5. 
4.1.10 Results: Aim 2(b) – Morisky Medication Adherence Scale – 8 Item 
(MMAS-8) and Medication Recall 
Cohen’s d: Population Effect Size (ES) 
Overall, it can be concluded that the nurse-led clinic had no effect on 
intervention group participants’ medication adherence. No effect was demonstrated 
on medication adherence in intervention group participants d = 0, while 
randomisation to the standard-care group evidenced a small effect on medication 
adherence, d = -0.22 (see Appendix L1). The following section presents results for 
reliable change and treatment outcomes in study participants in relation to 
medication adherence. 
Reliable Change Index (RCI) 
No participants in the intervention or standard-care group demonstrated 
reliable change in medication adherence over time. For the MMAS-8, a positive RCI 
> 1.96 would have indicated a reliable change (P < 0.05) in study participants. The 
SE and Sdiff were calculated for all participants. Following this, RCI were calculated 
for each individual participant. 
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Cut-off point ‘c’ 
The cut-off point for the MMAS-8 was identified by Lee et al. (2013) as > 6. 
Thus, post-intervention scores falling within this cut-off point are identified as the 
normal distribution and indicate clinically significant change. 
Treatment outcomes 
Of the intervention group participants, none achieved recovery, 15.4% (n = 2) 
improved, 61.5% (n = 8) experienced no change, and 15.4% (n = 2) demonstrated 
poorer medication adherence over time (see Table 4.16). Similarly, among standard-
care participants none recovered, 15% (n = 3) improved, 75% (n = 15) participants 
remained stable (i.e., no change), and 10% (n = 2) participants worsen (see Table 
4.16). 
Table 4.16. Pre- to Post- Intervention MMAS-8 Standardised Recovery Rates 
 Frequency (Percentage) 
Group  Worse No Change Improved Recovered 
Intervention (n = 13) 
Missing (n = 1) 
2 (15.38% ) 8 (61.53%) 2 (15.38%) 0 (0.0%) 
Standard Care (n = 20) 2 (10%) 15 (75.0%) 3 (15.0%) 0 (0.0%) 
Total (N = 33) 4 (12.12%) 23 (69.70%) 5 (15.15%) 0 (0.0%) 
 
Overall, preliminary evidence demonstrates no effect of the intervention on 
medication adherence, with a non-significant ES, no reliable change in any 
intervention group participants, and only minor improvements. Effect size 
calculations in standard-care group participants demonstrated a small effect on 
medication adherence. Recovery over time was not evidenced in either groups. Data 
for medication adherence in intervention group participants were similar for those in 
the standard-care group. 
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MMAS-8: Time 2 (Day 5–7) to Time 3 (1 Month) — Mean Medication 
Adherence Scores 
Based on inspection of means for both groups the intervention group 
participants’ mean medication adherence scores were maintained at 7.71 from Time 
2 (day 5–7) to Time 3 (1 month); whereas standard-care group participants’ mean 
scores increased from 7.76 units to 7.89 units (see Appendix M1) (i.e., scale range 
0–8). Overall, a larger mean increase in medication adherence was demonstrated in 
standard-care group participants over time. 
At Time 1 (day of discharge), when intervention group participants were asked 
to recall current medications, 92.3% reported they were able to do so. However, 
when asked by the PI to recall their medication details (name, dose, and action, 
without prompting), only 23.1% of participants could do so. At Time 3 follow-up, 
92.3% agreed they knew what medications they were taking. An improvement was 
seen where 38.5% of participants recalled current medications, actions, and doses.  
Approximately 95% of standard-care group participants reported being able to 
recall their medications on baseline assessment; however, when asked to verbalise 
specific details (i.e., frequency, dose, action) about their medications, only 30% were 
able to recall this information. It was interesting to note that, at Time 3 (1 month), 
100% of standard-care group participants reported knowing about their medications; 
however, only 25% could recall and verbalise their medication details. Medication 
recall was not assessed at Time 2 as this time point was only 5–7 days post-discharge 
and, given the event of hospitalisation itself and coupled with discharge home, the PI 
deemed that it would be best to review recall post-intervention at Time 3 (1 month) 
and Time 4 (3 months). Overall, in response to the PI’s questions about medication 
details, intervention group participants demonstrated greater knowledge and recall of 
medications after attending the nurse-led clinic. 
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Medication adherence and knowledge: Time 4 (3 months) 
Based on inspection of mean scores, increases in mean medication adherence 
scores were identified at Time 4 (3 months) in both groups. Medication adherence 
scores for Time 4 (3 months) are listed in Appendix L1. At Time 4 (3 months), 
92.3% of intervention group participants reported knowing the medications they 
were consuming while 80% of standard-care group participants reported they had 
adequate knowledge about their medications. There were 53.8% of intervention 
group participants who were able to recall specific details regarding their medication 
as opposed to 35% of standard-care group participants. 
The following section reports on the results of semistructured interviews 
undertaken with 16 participants. Participants included intervention group participants 
and experienced healthcare professionals working with PCI patients. All participants 
were interviewed to evaluate the effectiveness of the nurse-led clinic and with 
particular focus on the study’s primary and secondary aims. Furthermore, participant 
and healthcare professional feedback was sought in a Phase Two study and used in 
conjunction with aspects of Phase One outcomes to enhance the nurse-led clinic and 
inform a Phase 3 multi-centre study. 
4.2 Phase Two: Nurse-Led Clinic Program Evaluation and Analytical 
Findings 
Phase Two explored the experiences of six intervention group participants and 
10 healthcare professionals. Intervention group participants were invited to 
undertake a semistructured interview and to offer feedback regarding their 
experiences of attending the nurse-led clinic, while also providing constructive 
feedback to enhance the intervention for the benefit of future participants. Healthcare 
professionals were shown the clinic intervention with the aim of seeking constructive 
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criticism and recommendations to gauge the effect of the nurse-led clinic on 
participants’ SE, psychosocial wellbeing, and ability to facilitate effective self-
management. It was hoped that feedback provided by healthcare professionals could 
assist in enhancing and further developing the nurse-led clinic for implementation as 
a Phase Three, multi-centre study for future application in the healthcare setting. 
As further analytical data regarding the process of the nurse-led clinic 
implementation and function were required, an implementation or process analysis 
was undertaken. Questions asked about the intervention concerned the operation of 
the nurse-led clinic. The implementation analysis facilitated further identification of 
the study’s strengths and weaknesses, explicit identification of the intervention, and 
its comparison to current standard care. Furthermore, potential barriers to 
implementation and, importantly, healthcare professional and participant feedback 
regarding the intervention and its effects on primary and secondary aims were 
sought. Importantly, as identified earlier, analytical evaluation, interpretation and 
understanding of participants’ data (i.e., from interview transcripts) were undertaken 
using aspects of the work of Charmaz (2006) and Brikmann (2014).  
4.2.1 Phase Two: Participant Background and Demographics 
All participants involved in Phase Two were born in Australia and spoke 
English as their first language. Six participants who undertook the nurse-led clinic 
went on to participate in Phase Two. One participant had experienced previous PCI 
procedures, while it was the first PCI procedure for one other participant. Of the six 
nurse-led clinic participants who consented to Phase Two interviews, five had 
previously attended a CR program. One participant had undergone their first PCI and 
had never attended a CR program prior to this procedure. Of the healthcare 
professionals participating in Phase Two face-to-face interviews, two were highly 
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experienced cardiologists, five cardiology ward nurses, one cardiac catheterisation 
laboratory nurse, and two managerial-level nursing staff. Healthcare professional 
interviews highlighted impressions of the nurse-led clinic, cardiac rehabilitation, 
medication adherence, delivery mode, timing, and repetition of education after being 
taken through the nurse-led clinic component. Analytical findings for participant and 
healthcare professional interviews are presented below. 
4.2.2 Analytical Findings 
Support enhances recovery 
A sense of strong clinical support was identified by participants. Supportive 
concepts centred around post-discharge clinic information and confidence in the 
clinician and follow-up. Most participants reported confidence in the nursing health 
professional after attending the nurse-led clinic. Participants also highlighted the 
benefits of attending follow-up with a health professional in the post-discharge 
period and the reassurance they felt it provided, particularly concerning post-
discharge physical recovery and symptom management (i.e., chest symptoms and 
access site bruising). Thus, with the literature highlighting an increase in the 
prevalence of anxiety and depression in patients with CAD, post-PCI, and those who 
experience a coronary event, early post-procedural follow-up (i.e., within the first 
week post-PCI) was warranted and noted by both participants and healthcare 
professionals (Colquhoun et al., 2013; Rassaf et al., 2013; Trotter et al., 2010; Wade, 
Cheok, Shrader, Hordacre, & Marker 2005; Zuidersma, Conradi, van Melle, Ormel, 
and de Jonge, 2012).  
While the intervention had a moderately reducing effect on participant anxiety, 
as evidenced in Phase One, only a small reducing effect on depression was 
demonstrated. Furthermore, reductions in psychological symptoms were not 
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accompanied by an expected increase in SE, as highlighted in the literature 
(Bandura, 1977, 2004; O’Neil, Berk, Davis, & Stafford, 2013). O’Neil et al. (2013) 
suggest that increased baseline depressive symptoms may influence SE enhancement 
and, thus, health outcomes, suggesting a possible explanation as to the results 
achieved in the present study (O’Neil et al., 2013). It was noteworthy, however, that 
participants verbalised personal enhancements in self-confidence or SE to manage 
post-discharge as opposed to CSE tool results. Further exploration of the present 
study’s results will be undertaken in Chapter 6, with a greater depth of explanation 
offered to better understand the study’s results and to enhance future research. 
Intervention group participants reported that speaking with an experienced 
cardiac nurse was both reassuring and beneficial. Moreover, while feeling supported, 
participants also reported being well treated in the post-discharge period. Participants 
who had previously undergone a PCI procedure commented on the potential benefits 
of early post-discharge follow-up in terms of reassurance and repetition of education. 
Although participants who had a repeat PCI procedure reported they had the 
knowledge to self-manage, repeating and reinforcing education early post-PCI was 
highlighted as positive. 
Participants reported feeling relaxed knowing they were going to attend a 
clinic and be followed up multiple times (via telephone) by a health professional. 
One participant commented on not being concerned about complications as they had 
full confidence in the healthcare professional (and their knowledge) and felt that they 
could contact the health professional for further advice. Perhaps the repetition of 
education and subconscious awareness of follow-up with the healthcare professional 
provided participants with feelings of confidence or enhanced SE (as identified 
above) to engage in post-discharge cares and management, although not evidenced in 
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self-report tools in Phase One. 
Knowing you were there, I felt like I could pick up the phone and call you at 
any time.... Very reassuring. (Particiapant020) 
Participants appeared to view the relationship as nurse–patient, as opposed to 
investigator–patient or researcher–patient, with reference to the PI as a nurse. Trust 
is and was an important factor held by the PI in undertaking the intervention and 
following up with participants. Participants appeared relaxed in their body language, 
and voice, seeming to trust in the professional relationship during the course of the 
study. It was essential in both roles assumed (i.e., as a RN and PI) that participants 
felt a sense of trust, both in the education provided and nursing assessment (i.e., 
physical and psychological), while maintaining patient confidentiality and having 
faith in the PI to protect them (i.e., physically, ethically). Trusting relationships are 
important in nurse–patient interaction (Dinc & Gastmans, 2013). Patients are highly 
vulnerable and most often have to trust the nurse as they spend a large proportion of 
the time interacting with the patient (Dinc & Gastmans, 2013). It was, therefore, 
important in the present study to establish a rapport and, thus, a trusting relationship 
with participants to ensure their needs (i.e., post-PCI) could be met and so they felt 
comfortable and confident in themselves and the PI (i.e., enhanced SE) (Falvo, 
2004). Moreover, it was hoped that the PI was able to demonstrate confidence in 
knowledge and skill so that participants would gain confidence and trust in the PI, 
which would then lead to enhanced SE in undertaking tasks such as post-PCI cares 
and self-management (Holloway & Watson, 2002). 
Knowing that there were further follow-up telephone calls also presented as a 
positive to participants where they could ask questions of the healthcare professional 
and thus be less bothersome to their specialists. Participants sounded at ease during 
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telephone interviews and reported feeling relaxed and confident in themselves 
regarding the management of their health (i.e., CAD) and spoke positively about the 
future. Overall, participants reported great confidence or SE to self-manage in 
interviews. 
It’s good to talk to someone like that with a bit more knowledge and give 
some different ideas of how to improve your life if you’re not really 
comfortable about what’s going to happen when you leave hospital. 
(Participant 054) 
Well, you explained a lot to me and you told me I suppose you know you 
made me aware that I was going to do the rehab course, which I think has 
been fantastic. I think well you looked at my wound, you explained what had 
happened to me in the operation as everyone has an individual experience I 
suppose. And you made me feel as though you were there for me. 
(Participant 020) 
Positive feedback was also provided on the timing of the nurse-led clinic 
implementation in relation to hospital discharge and the benefits of such timely 
intervention for future post-PCI patients. While timeliness was discussed, some 
participants and healthcare professionals offered suggestions for earlier post-
discharge follow-up, coupled with a shorter length of time (e.g., 30 to 45 minutes 
maximum). Given the short length of stay and potentially emotionally overwhelming 
post-discharge period, both participants and healthcare professionals proposed earlier 
follow-up and a shorter duration for clinic follow-up (BHF, 2011; Cupples et al., 
2010; Dafoe et al., 2006; Grace et al., 2012; Heart Foundation, Western Australia, 
2012; Lacey et al., 2010; Pack et al., 2013). The literature identified in Chapter 2 
suggests follow-up from 72 hours up to 1 week post-procedurally (Chow et al., 2010; 
Rassaf et al., 2013; Wong et al., 2006). This suggestion was based on potential first-
time PCIs, the emotionality surrounding the procedure (i.e., realisation of the gravity 
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of the situation), and for those who may experience complications early in the first 
week post-discharge. Healthcare professionals reinforced early follow-up in the first 
week post-discharge to reassess for post-discharge complications and to reiterate 
education undertaken in the hospital setting. Furthermore, and as highlighted by 
healthcare professionals anecdotally, as some remote and rural participants often stay 
at accommodation close to the hospital site for anywhere up to 3 days post-
discharge, earlier face-to-face follow-up may be undertaken so that education can be 
revisited and reinforced. Furthermore, earlier post-discharge follow-up with remote 
and rural patients was recommended by healthcare professionals so that patients 
could ask any questions that may have arisen since discharge and so that they may 
also have a peace of mind and further understand the physical and emotional 
recovery post-PCI. Moreover, as remote and rural PCI patients are faced with 
geographical isolation (to CR programs), even in their own communities they face 
access issues (i.e., to closest CR facility) (Demiris, Shigaki, & Schopp, 2005; 
Harrison & Wardle, 2005).  
Other issues such as ailing health and poverty also pose as a problem in the 
underutilisation of CR services in the community (Demiris et al., 2005; Harrison & 
Wardle, 2005). It is, therefore, essential that this group be captured and undertake 
early post-discharge, nurse-led follow-up. Furthermore, the reiteration of post-PCI 
education, health assessment (i.e., physical and psychological), and reassurance 
provided by attending a nurse-led clinic prior to returning home to enhance SE, 
reduce anxieties and improve self-management skills may be of great benefit with 
the aforementioned issues identified. 
Coming to understand the situation 
Participants developed a sense of self- and physical awareness after attending 
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the nurse-led clinic. Participants reported feeling calm about their procedure; 
however, it was not until the post-discharge period that the gravity of their cardiac 
event and procedure became clear. Given the short duration of hospitalisation, it is 
comprehensible that some PCI patients come to realise the significance of their 
procedure in the post-discharge period and may become distressed (BHF, 2011; 
Cupples et al., 2010; Dafoe et al., 2006; Grace et al., 2012; Heart Foundation, 
Western Australia, 2012; Lacey et al., 2010; Pack et al., 2013). Self-management for 
PCI patients, as identified, includes complication identification and management 
(i.e., chest pain, access site, medication allergies), medication adherence and 
compliance, activity recommencement, and making lifestyle and behavioural 
changes.  
Participants reported that this awareness and realisation led to a sense of 
determination to initiate post-discharge lifestyle changes. Changes were made in the 
areas of diet and exercise, resulting in subsequent weight loss post-clinic attendance. 
Participants retrospectively reported being too busy prior to their procedure and, 
since undergoing their PCI and attending the post-discharge clinic, had learned to 
relax and enjoy their families and lives. 
Although not a large area of focus of the nurse-led clinic, participants in the 
present study were regularly questioned regarding their daily diet and exercise 
intensity and frequency at each follow-up appointment. Participants were referred to 
the healthy food pyramid in the National Heart Foundation of Australia’s (NHFA) 
book provided to them, My Heart, My Life, for dietary recommendations. Activity 
and exercise recommencement education was also offered at the nurse-led clinic 
with detail regarding exercise recommencement up until CR program 
recommencement. Participants reported enhancements in activity and intensity over 
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time post-discharge. Weight was also discussed at each follow-up appointment, with 
participants asked to offer their current weight, hip, and waist measurements to track 
weight gain and loss over time. Success was reported by some participants, while 
others maintained their weight. Currently, after attending a CR program, 60% of 
patients fail to maintain healthy and new lifestyle and behavioural after 
approximately 6 months and reportedly revert to old behaviours (Janssen, De Gucht, 
van Exel, & Maes, 2013). Participants in the present study were interviewed at 
approximately 6-months post-discharge, with a majority reporting (anecdotally) that 
they were still committed to new changes or maintaining healthy behaviours 
previously made. This may have been due to the fact that some were still 
undertaking CR programs.  
I am probably not eating any butter at all, apart from what is in cooking, what 
is already in the meal. I wouldn’t add butter to any toast or scones or 
whatever I make. I have probably cut down dramatically on the salt. 
(Participant 020) 
I’ve made an enormous change in my lifestyle. I’ve slowed down from 100 
miles an hour to 50 miles an hour. I decided to do a lot of travelling which 
I’m doing at the moment and I have done. (Participant 106) 
Just occasionally I thought, I must hurry up and do more and more things 
because I don’t know how much longer my life is. But of course at my age it 
is good to have a reality check to make sure you just don’t sit down and 
waste a single moment. (Participant 020) 
Prior to attending the nurse-led clinic, some participants reported feeling 
shocked in the early post-discharge period, while others were not concerned at all 
due to their confidence in the procedure, modern medicine, and/or their specialist. 
Initial euphoria was reported by some participants post-PCI, while others 
commented on their calmness and feeling in control throughout the procedure and 
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post-discharge period. Overall, a majority of participants in the present study 
experienced shock and the realisation that changes were to be made became evident 
in the early post-discharge period and were reinforced at the clinic. 
I felt fairly anxious about it all initially but after talking and also having a 
few doctor friends come in and talk about what was going on, I don’t know 
whether that helped or hindered me but I still had a few days of anxiousness 
but it calmed down pretty quickly. (Participant 054) 
About 2–3 days after discharge almost euphoric and over the weekend it hit 
like a brick wall. I felt a bit despondent knowing this was around and like I 
missed a bullet. I am very lucky. I had been feeling a little teary and 
emotional. (Participant 031) 
As identified in Chapter 2, the short length of stay and experience of PCI 
and/or cardiac event in its entirety is emotionally overwhelming and can precipitate 
an anxious post-discharge period (Astin et al., 2005; Carroll, 2005; Jaarsma et al., 
1995; Kriztofferzon et al., 2007; Lane, 1999; Roebuck et al., 2001). Reasons for 
initiating lifestyle changes surrounded a yearning to “be around longer” for their 
family. It was interesting that, among the minority reporting no concerns, some 
commonly identified health misconceptions were noted, particularly as participants 
reported that they had been “fixed” (Carroll, 2005; Young & Murray, 2011). Other 
participants identified feeling happy that blockages had been found and managed and 
reported confidence to make positive lifestyle adjustments and maintain good health 
post-PCI (i.e., self-manage). Participants’ emotions and realisation of the gravity 
surrounding their procedure and diagnosis as well as post-procedural misconceptions 
were evident. 
Bit of a shock that I’ve got this thing inside my veins forever. I don’t want to 
take tablets forever, but I will. I’m a bit lucky though that I’m still alive 
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(Participant 001) 
Couldn’t ask for a better present. Very happy. Fixed (Participant 067) 
Hoping stents haven’t moved, but very happy and we found very early as 
opposed to the latter. (Participant 083) 
Self-awareness enhances self-management 
General awareness and reiteration of education at the nurse-led clinic resulted 
in greater focus on symptom recognition and management, particularly angina 
symptom recognition and management. With patients often delaying taking action in 
their chest pain management, post-PCI nurse-led education was warranted 
(Gallagher et al., 2012). Participants were confident in their ability to manage their 
post-discharge cares, particularly concerning their access site and complications after 
attending the clinic (see Table 4.17). The amount of pressure and time required to 
manage a post-discharge bleed or haematoma was linked to in-patient femoral 
arterial sheath removal, while positioning during a complication was reinforced at 
the nurse-led clinic. With this association made, and as participants were awake 
during sheath removal and interacting with the nurses, they easily recalled the 
amount of pressure and time required to manage a bleed or haematoma, feeling 
confident to self-manage a post-discharge bleed if required. Furthermore, the 
importance of revisiting basic education to enhance awareness of their procedure, 
heart disease and post-PCI care was acknowledged. Although most participants had 
undergone this procedure in the past and attended a CR program, participants 
highlighted the importance of revisiting education. As identified in Chapter 2, the 
literature reinforces the importance of patient follow-up and education, with 
emphasis placed on timeliness, particularly for patients with chronic disease such as 
those with CAD who have undergone PCI or experienced a coronary event (i.e., 
being the within the first week) (Rassaf et al., 2013; Tuso et al., 2013). 
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Participants reported a greater awareness of and attention to medication 
adherence and administration after attending the nurse-led clinic. Medication 
adherence was high on baseline measurement in Phase One; however, participants 
reported being more conscious of taking their medications, especially anticoagulants 
that worked to prevent in-stent thrombosis and stenosis. As identified earlier in this 
chapter, small quantitative improvements in medication adherence were also 
recorded as measured by the MMAS-8. With medication adherence notably 
problematic in patients with chronic disease, it was essential to identify the general 
groups of medications participants were most commonly prescribed post-PCI, while 
highlighting why adherence is critical (Fernandez et al., 2007; Haynes, Ackloo, 
Sahota, McDonald, & Yao, 2008). Participants’ perceptions concerning their self-
awareness after attending the clinic were highlighted in Phase Two interviews. 
I think when it’s a matter of personal health I don’t think you could be 
reminded too often at all as to what you should do and what I find is with the 
number of people that I talk to that are going through similar things quite 
frankly how little some people even know or understand about what’s 
causing it and what steps they have to take to try and prevent it. (Participant 
014) 
I did take up more walking than I had been doing and found that beneficial. 
That was one of the main things that I did and lifestyle for good. (Participant 
082) 
I am very careful to take medications at the same time every morning and I 
haven’t missed any. (Participant 020) 
Healthcare professionals commented on the simplicity, yet succinctness of the 
medication education component offered at the nurse-led clinic, the detail offered to 
patients, and the effectiveness and simplicity of grouping and discussing cardiac 
medications participants may be discharged with post-PCI. Furthermore, with the 
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three main messages of adherence reinforced visually and verbally by the PI, 
healthcare professionals reported clarity in the messages of medication adherence 
(i.e., maintaining adequate supply; not discontinuing medications abruptly; continue 
taking medications as advised by cardiologist). The education delivered was reported 
as clear and concise, with interviewees highlighting how it may lead to patients’ 
greater confidence in managing at home. Additional suggestions offered by 
healthcare professionals for future clinics included warning about internet content 
and speaking to a doctor if contemplating medication cessation. 
Yes, I thought that was well done and I’ve already mentioned that I think 
medications is one of the really critical factors that they need to understand 
the value and the risks around it and what they should and shouldn’t do and I 
thought you looked like you had a good cover of that. (Healthcare 
professional, 002) 
Yes, I think breaking it down into the groups of medications because 
generally patients are confused about what their medication is called and 
what it’s for. So breaking it down into the different groups of medications of 
what they are meant to do for them is really helpful for them and just 
reiterating to them what they are because I think they’re thrown so much 
information or thrown so many medications that sometimes I knew that 
they’re all over confused about why they’re taking them. (Healthcare 
professional, 004) 
Healthcare professionals commented on their overall impressions after the 
nurse-led intervention was shown and explained to them, reporting their likes, and 
offering recommendations to enhance the clinic. The overall visual appeal, stages, 
and order in which the clinic and education was undertaken were positively 
commented on, as well as how the clinic was undertaken in a face-to-face setting and 
as an outpatient nurse-led clinic. Nurse-led clinics and outpatient support (i.e., home 
visits, telephone follow-up, outpatient clinics) for patients who have experienced a 
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cardiovascular event have been trialled and are highlighted in literature (Alfakih et 
al. 2009; Carroll et al., 2007; Schadewaldt & Schultz, 2011; JBI, 2010). As identified 
in Chapter 2, cardiovascular nurse-led clinics appear to be successful in achieving 
short-term goals; however, in order to achieve long-term goals and outcomes, further 
follow-up with patients is recommended (Schadewaldt & Schultz, 2011; JBI, 2010). 
As the present study aimed to act as a bridge between hospital discharge, specialist 
follow-up, and CR commencement, it aimed to achieve short-term aims, while 
preparing patients for their long-term goals (i.e., health behaviour changes, risk 
reduction, lifestyle, exercise prescription) which are major CR goals.  
As identified earlier in this chapter, considerations for future studies included 
telehealth options for patients in remote and rural locations. Healthcare professionals 
also commented on the appeal of the visual presentation and interactivity (i.e., slide 
presentation and ability to ask questions throughout the session), highlighting to the 
PI how it could appeal to and cater for different learners and learning styles. Blevins 
(2014, p. 59) recognises the different learning styles and requirements of adults in 
the healthcare setting for nurse educators (i.e., visual, auditory, kinaesthetic) and 
highlights how approximately 80% of the adult population are visual learners.  
Furthermore, Blevins (2014) highlights the generational distinctions to 
consider in adult learning and teaching, which was a consideration in undertaking the 
nurse-led clinic. Blevins (2014) highlights how adult patient education  should focus 
largely on teaching style as opposed to course content and in accordance with the 
following six principles which adult learning is based: (a) need to know, (b) self-
concept, (c) experiences, (d) readiness (i.e., to learn), (e) learning orientation, and (f) 
motivation (Blevins, 2014). 
Recommendations to shorten the timing of the clinic was also identified to 
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limit patient distraction and loss of concentration. Important areas of discussion 
identified by healthcare professionals included the NHFA Chest Pain Action Plan, 
wound site visuals, and the education offered in the form of scenarios and role play. 
Lastly, healthcare professionals identified its adaptability to ACS patients and those 
who have undergone other cardiovascular procedures such as permanent pacemaker 
and implantable cardioverter defibrillator implantation, electrophysiological studies, 
and ablation procedures. 
A lot of patients will think “I’ve got a stent, I’m fixed, I’m not going to get 
chest pain again, I don’t need these medications” etc. and you actually are 
going through the plan with them and then doing a scenario and getting them 
to talk through the plan, that really stood out. I think that’s great because we 
don’t do that when the patient’s in hospital. (Healthcare professional, 001) 
It looks clear and it goes through step by step. I see that it allows for the 
people to ask questions and that’s good. They might think of a question later 
on and I can see that it offers a number of different steps for them to think 
about and probably highlights to them something that they might not have 
already thought about while they were having their procedures because it 
would be mind boggling. (Healthcare professional, 004) 
I think it’s quite comprehensive and a lot of it’s about a lot of very 
commonsense stuff that often doesn’t occur to the patient, so I think the 
program that you’ve designed does cover a lot of ground. (Healthcare 
professional, 009) 
Repetition of education for PCI patients was highlighted by all interviewees as 
essential and described as being effectively undertaken in this study. Patients and 
healthcare professionals identified timing and setting as important, given the 
distraction of a hospital ward, psychological distress, coupled with a short 
hospitalisation and limited time for nurse–patient teaching. The timing of this nurse-
led intervention at day 5–7 post-discharge was also commented on as effective in 
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that the distraction of a hospital ward was removed and would possibly enhance 
nurse–patient teaching and patient learning. With recommendations for PCI patients 
to be reviewed within the first week post-procedurally and then 3 to 6 monthly for 
the first 12 months, the time chosen for follow-up in the present study, and as 
identified by both healthcare professionals and patients, was highlighted as effective 
(Rassaf et al., 2013). Furthermore, it was hoped that early follow-up and repetition of 
education would enhance SE, symptoms of anxiety, and depression and, thus, 
enhance post-discharge self-management and maintenance of positive health 
behaviours. Not only was repetition of education highlighted as important, but the 
fact that it was and can be led by a knowledgeable healthcare professional was also 
identified as essential as it may enhance patient learning and allay any possible 
anxieties held by participants during this time. 
My impression was it was good standard cardiac rehabilitation information. I 
would have thought all that had been very clearly given to them by cardiac 
rehabilitation staff while they were in-patients but then we also all know that 
sometimes that information doesn’t get absorbed at that time so it would be 
very sound reiteration of whatever they should have had. If they didn’t have 
it then it’s vitally important that they receive that information. (Healthcare 
professional, 002) 
I think it’s a great idea, especially the five to seven days follow-up. I think 
our patients do need that emotional support when they go home. Obviously 
any sort of big procedure that they have, it does hit home and any education 
that they can get outside after being discharged is a great idea because it’s 
just going to reduce their anxieties; and it should be led by the nurses who do 
work in cardiology all the time I think because that’s what we’re doing 
constantly. (Healthcare professional, 005) 
In addition to, or as opposed to, taking access site photographs, participants 
were offered picture diagrams of a wound site and area to colour and describe their 
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perceptions of the site, wound healing and recovery. A majority of bruising appeared 
within the first week post-discharge, and began to subside by Time 3 (1 month) 
follow-up. At Time 4 (3 months), participants voiced full recovery of access sites. 
Participants who had previously undergone a PCI procedure reported on this 
occasion having a greater awareness of their access site(s) (as opposed to previous 
PCIs) as they were required to report on wound site recovery. As identified in 
Chapter 3, participants were required to take photographic images and/or describe in 
their own words and colour on a wound site diagram how their wound was 
recovering post-procedurally. Most reported undertaking regular observations of 
their wound site(s), keeping note of swelling, bruising, discharge and odour, which 
was evident in their documentation on their wound site diagrams. Participants’ 
observations and documentation of their wounds were clear and detailed. Effective 
self-management appeared evident with patients engaging in their post-discharge 
care. Bodenheimer et al. (2002) highlight the importance of encouraging self-
management through patient empowerment. The authors reinforce how effective 
self-management is essential, particularly in chronic disease, as patients are 
assuming both carer and healthcare professional roles (Bodenheimer et al., 2002). 
Patient empowerment and, thus, effective self-management can be achieved through 
the offering of information (as opposed to ordering) and allowing patients to accept 
their role in their personal health management and actively participate in problem-
solving (Bodenheimer et al., 2002).  
The nurse-led clinic aimed to encourage effective self-management through 
patient education (i.e., information giving) so that participants had the knowledge to 
both care for themselves and problem solve (i.e., in the event of a complication). As 
a nurse and PI, it was of great interest and importance to receive the verbal feedback 
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accompanied by an image and/or diagram of the wound sites in the post-discharge 
period. With a short length of stay (i.e., an uncomplicated PCI), unless a patient is 
readmitted with a post-discharge wound site complication, healthcare professionals 
are unable to fully ascertain post-procedural wound site recovery and the anxieties 
that may present during this time of observation and management. Thus, at such an 
anxious time, it was essential to discuss post-PCI physical and emotional recovery to 
both gain an understanding of patients’ experiences and to offer information so that 
they may manage and work through post-discharge health matters. Again, and as per 
Barlow et al. (2002) discuss, enhancements in self-management see increases in SE. 
Although, SE was not enhanced in intervention group participants in the present 
study, it appears as though self-management was. These results will be discussed 
further in Chapter 6. The following access-site descriptions were offered by 
participants of their recovery between Times 1 to 4 with or without the support of a 
diagram or photograph. 
Table 4.17. Access-Site Descriptions: Time 2 (day 5–7) to 4 (3 months) 
Participant 
ID 
Time 2 Time 3 Time 4 
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Participant 
ID 
Time 2 Time 3 Time 4 
PT019 “The wound bruising was the 
size of a 50 cent piece and 
fading. Colours: Outer blue, 
green and inner yellow 
discolouration”. (see Appendix 
N1). 
“The wound site is clear except 
for a small red spot”. 
“Not a mark on 
me”. 
PT105 “No lumps, bumps or bruises.” “Slight bruising of skin; pale 
blue colour; No bleeding or 
swelling; Tender under left arm 
pit”. (see Appendix N1) 
“All healed. No 
problems”. 
PT054 Nil site concerns per 
participant. 
“Both left and right wounds 
appear totally healed, but for 
very, very slight shading on the 
left side associated with healing 
bruise. No lumps or residual 
haematoma evident” (see 
Appendix N1). 
“Took a long 
time to heal. 
Nothing visible 
any more”. 
PT010 “No site concerns”. “At this time, there is no 
evidence of having had the 
procedure at all. There is no 
bruising, no marks at the wound 
site and no lumps or bumps. All 
is as normal” (see Appendix N1). 
“All clear. No 
scarring or 
lumps. No 
bruising”. 
PT082 Nil participant comments. “The cut in my groin has 
completely healed and bruises 
are gone and I have no after 
effects at all”. 
“Healed up 
perfectly”. 
 
Pressure on the patient - Attending cardiac rehabilitation (CR) 
Throughout the course of the study, the PI asked all participants to comment 
about CR and offered referral for intervention group participants at day 5–7 post-
discharge. While some participants were unsure of the nature of CR, a majority had 
attended a course in the past and/or had accurate perceptions of the program and its 
benefits. While all participants highlighted the importance of CR and the information 
provided during the course, there was a reluctance to accept referral for some first-
time attendees, and more so to re-attend. Declining attendance at CR is common 
with approximately 30 to 60% of first-time attendees declining referral after an AMI 
(Cooper, Jackson, Weinman, & Horne, 2005). At baseline data collection, 
participants appeared eager to attend CR; however, within the first week post-
discharge, participants’ views on attendance changed. It was concerning to hear that 
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a large proportion of patients placed CR attendance second to work and other 
commitments. Reasons for declining CR attendance included: 
 busy life 
 adequately enough informed from past attendance (i.e., up to 10 years 
since attendance) 
 family commitments 
 group activities not of interest 
 co-morbidities affecting attendance 
 belief CR possibly ineffective 
 not contacted by CR team 
 distance (i.e., geographical isolation) 
 surgical procedure preventing early attendance. 
As identified in the literature, some of the major barriers to CR attendance 
include referral, geographical isolation, health, and affordability. The literature has 
highlighted the barriers to CR referral and attendance, with researchers trialling 
alternate methods to the delivery of CR (i.e., home-based, telehealth, online, early 
enrolment) (Maclure, 2011; Neubeck et al., 2009; Niebauer, Mayr, Tschentscher, 
Pokan, & Benzer, 2012; Pack et al., 2013; Wenger, 2008). It was, therefore, an 
important component of the present study to enrol participants in CR. Although 
attendance could not be controlled, enrolling all participants (i.e. both first-time and 
repeat PCIs), as the first step was vital in overcoming the aforementioned barriers. 
First-time potential attendees’ comments regarding CR attendance are depicted 
below: 
Depends on when it is. I have to babysit. (Participant 019) 
I lead a busy life, so no, don’t think I will go. (Participant 105) 
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Think with my background of fitness instruction, I could do this myself. 
(Participant 083) 
Not into group things, so may not go. (Participant 031) 
Not sure what it is about. Probably not effective anyway. (Participant 018) 
Have changed my diet and am aware of need to make changes. GP will check 
cholesterol. I am quietly confident the problem is fixed. Won’t attend CR at 
this stage. (Participant 067) 
While participants (i.e., both first-timers and repeat PCIs) offered reasons for 
attendance and non-attendance, most participants held firm beliefs that all PCIs 
should attend CR, irrespective of the number of revascularisation attempts. Emphasis 
was placed on re-attendance, particularly if the program had not been revisited for 
several years. Areas of CR highlighted to be of benefit post-PCI, as perceived by 
participants, comprised of the following: 
 exercise (i.e., how to commence/recommence) 
 diet (i.e., required changes) 
 general wellbeing 
 self-management 
 physical health benefits 
 how to make and maintain lifestyle adjustments. 
Perceptions of CR appeared accurate for those who had never attended CR, 
while some reported they were unsure. It was interesting that the perceptions 
highlighted by participants did in fact reflect the benefits of CR as reported in the 
literature and included risk factor and lifestyle modification and maintenance, 
education, structured physical activity (Blair et al., 2011; Grace et al., 2012; NHFA, 
2004). Participants who had previously attended a CR program reported that they 
could no longer recall specific course content and structure; however, diet and 
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exercise were identified as a main constituent of the course and was highlighted by 
participants. Excerpts from all first-time participants concerning CR information 
recall, perceptions and some misconceptions were discussed with participants. An 
important finding regarding CR perceptions included the thought that CR 
predominantly involved exercise and dietary changes, and thus, may therefore be 
undertaken at home without the need to attend a program. Other first-time 
participants were highly motivated to attend in light of their recent coronary event 
and procedure. 
I assume how to look after yourself so you don’t overwork and put your heart 
under stress. (Participant 105) 
I presume, better eating and exercise. Would like to attend with my wife. 
(Participant 059) 
What you should and shouldn’t do. What to look out for, symptoms, what to 
eat and lifestyle. (Participant 067) 
Just how to look after yourself in terms of exercise and diet post operation. I 
have a good routine. See how I go. I may attend (a program). (Participant 
017) 
As highlighted earlier, those who had undergone previous revascularisation 
procedures and attended a CR program in the past felt confident to manage or alter 
their lifestyle and risk factors without the support of a CR team. Magalhães et al. 
(2013) highlight how adherence to lifestyle and behavioural changes may reduce 
after Phase II CR and identify that this may be due to patient’s initial motivation to 
make changes following their procedure and/or cardiovascular event. As identified 
earlier, after attending a CR program, most patients revert to their old behaviours by 
approximately 6 months (Janssen et al., 2013). Koelewijn-van Loon et al. (2009, p. 
E267) identify that approximately 20 to 90% of patients with CVD actually adhere to 
lifestyle advice. Furthermore, Koelewijn-van Loon et al. (2009) recommend 
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appropriate intervention focusing on cognitive–behavioural and affective elements, 
while also appropriately informing and sharing risk-reduction options and decision-
making. It is interesting that participants in the present study aim to undertake their 
own rehabilitation and make positive lifestyle modifications learnt on previous 
occasions at CR given that there is a poor maintenance of new behaviours.  
Given poor participant re-attendance to CR in the present study, it might be 
useful to consider secondary prevention as a non-negotiable for all post-PCI patients 
(i.e., not just first-time PCIs). Furthermore, strengthening the message of CR 
attendance during hospitalisation by medical and nursing staff may encourage 
secondary prevention attendance and re-attendance. Additionally, it may be 
beneficial to consider the utilisation of cognitive–behavioural therapy in conjunction 
with post-discharge CR to achieve cardiovascular risk reduction, behaviour change, 
and maintenance. To ensure that new behaviours and lifestyle changes are being 
adhered to, Magalhães et al. (2013) recommend 3-monthly face-to-face exercise and 
education coupled with monthly telephone communication and online patient 
activities post-Phase II CR.  
Various studies as identified in Chapter 2 have trialled alternate modes of CR 
attendance for patients who have experienced a cardiac event and/or PCI (i.e., Skype, 
telephone, mobile phone; home-based) due to the problematic nature of CR and, 
furthermore, in anticipation that program attendance and adherence could be 
increased and sustained (Blair et al., 2011; Cupples et al., 2010; Gallagher et al., 
2013; Heartwire, 2011; Karmali et al., 2014; Varnfield et al., 2014). As identified 
earlier, some participants believe that they can self-rehabilitate and are of the opinion 
that CR is similar to attending a gym and, thus, decline enrolment (Cooper et al., 
2005). Some patients may miss or forget (i.e., if previously attended) the purpose of 
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CR in that CR assists in both physical and psychological recovery from a cardiac 
event and/or procedure. Reinforcement of these messages should be undertaken by 
ward nursing staff and cardiologists during hospitalisation and will be offered as 
recommendations to all hospital sites with cardiology units. The belief that CR is 
identical to attending the gym is noted in the literature and should be corrected in 
patients who believe they can self-rehabilitate solely through exercise (Cooper et al., 
2005). 
As highlighted previously, it is interesting to observe and hear the initial 
enthusiasm participants expressed to attend or re-attend CR early on during 
hospitalisation (i.e., on baseline data collection). While participants initially 
appeared eager to partake in CR, as early as the first week post-discharge, reasons 
for their inability to attend were identified. One standard-care group participant with 
an exercise prescription background who declined CR enrolment when contacted by 
a CR team member felt they could undertake their own cardiac rehabilitation. Within 
weeks after being discharged, the participant was referred by the PI to their 
cardiologist after reporting what appeared to be exertional angina while undertaking 
exercise at the gym. On follow-up, the participant reported having been admitted for 
a further PCI for a different coronary artery. A change was observed in this 
participant from baseline data collection. The participant was eager to enrol in a CR 
program and undertake the full course as opposed to self-rehabilitating as originally 
intended. Although not verbalised, perhaps experiencing PCI in such close proximity 
to their index procedure shocked the patient into attending CR. As highlighted earlier 
in this chapter, healthcare professionals reinforced the need to exert greater pressure 
to refer to people CR, with the use of shock tactics suggested to encourage some 
participants. 
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Did it in 1998. Have very bad arthritis and painful to exercise which is why I 
haven’t gone back. Took through how to exercise, diet, guest speakers, trying 
to get mobile again. Think I will. (Participant 067) 
It’s just an extra thing I will have to do on my list and I don’t see why I 
should attend as no big problems. I don’t have any cardiac issues. 
(Participant 077). 
I had been 3 years ago and have the knowledge to rehabilitate myself again. 
(Participant 089) 
I don’t think it did much for me. I wouldn’t go again. (Participant 066) 
Messages of CR encouragement in the nurse-led clinic were highlighted by 
healthcare professionals as positive; however, given most patients had repeat 
revascularisation procedures, greater emphasis was requested to ensure those who 
believed they did not require to re-attend and even undertake CR for the first time 
were enrolled. Analytical findings from interviewees included that, although the 
onus to commence CR and make changes was on PCI patients (be they first-time 
PCI patients or having previously undergone the procedure), they still needed to 
attend due to the significant physical and psychological benefits of attending. 
Furthermore, it was noted that, if participants are returning for further treatment for 
their CHD (i.e., another PCI), then clearly they need to revisit a CR program. Most 
healthcare professionals commented on the use of greater force or emphasis to 
encourage attendance, while some suggested scare tactics as an option. Suggestions 
for short refresher courses were offered as a recommendation for those candidates 
who had undergone multiple PCIs and did not feel they needed to revisit the full-
length course again. The message of CR attendance at the nurse-led clinic was 
reported to be clear by healthcare professionals; however, greater emphasis to 
convince patients to attend was reported as necessary. 
I think the onus should be put on them to ensure that they go because it’s for 
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their health benefits. It’s a long-term health benefit. We can encourage 
people to go but you can’t make them go. But I think it needs to be 
encouraged as much as possible. But at the end of the day the patient has a 
choice but all we can do is present it in the most positive light that we can do 
and the benefits that they’re going to get for it. (Healthcare professional, 006) 
I think as far as my practice goes emphasising cardiac rehab is a critical thing 
for these patients, particularly the ones who say they don’t need it, who need 
it, who need the support, they’re in denial, they don’t change their lifestyle so 
getting some encouragement to go there and a little bit of pressure is actually 
a good idea. Then they are always grateful. (Healthcare professional, 008) 
The aforementioned findings in relation to secondary prevention perceptions, 
misconceptions, and, thus, non-re-attendance are important and warrant further 
investigation. It was particularly intriguing that participants could highlight the 
importance of attendance and re-attendance and then decline enrolment and this may 
influence healthcare professionals (i.e., cardiologists and nurses) to rethink their 
approach to in-patient CR encouragement. Furthermore, the misconceptions of what 
CR involves should be highlighted (i.e., similar to attending the gym) with the 
differences identified so that participants may understand that CR is more than just 
exercising. Furthermore, while PCI is minimally invasive, it is still a significant 
procedure and is often underestimated. Moreover, if repeat revascularisation is 
warranted, so too is CR, particularly if CR was declined after the index procedure or 
if a significant amount of time has lapsed since the participant’s first CR program 
attendance. These results will be discussed in greater detail in Chapter 6. 
Overall, the semistructured interviews reinforced the value of offering a nurse-
led clinic. Furthermore, Phase Two interviews highlighted the importance of 
undertaking early post-discharge follow-up the first week after undergoing PCI. 
Moreover, based on Phase One and Two findings, a Phase Three multi-centre study 
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is recommended. Changes to the current study protocol arising from the findings of 
Phases One and Two may include: 
 Earlier follow-up within 3 to 5 days post-discharge 
 shorter duration for nurse-led clinic: 30 to 45 minutes 
 it would be preferable if all research assistants (RAs) undertook 
accredited training in CBT   
 use of telemedicine (i.e., telephone and/or Skype/FaceTime follow-up) 
 nil contact with standard-care group participants 
 automatic CR referral (i.e., without option) 
 assistance of community GPs, nurses, or nurse practitioners to 
undertake post-discharge physical and psychological assessment (i.e., 
ECGs, access-site images, STAI, CDS). 
The aforementioned changes to the study will be presented in greater detail in 
Chapter 5 in the form of a study protocol with justification for changes provided. 
The protocol will detail the new approach to the nurse-led clinic (i.e., follow-up 
times, clinic duration, assessment tools) that have been informed by Phases One and 
Two. 
4.3 Summary 
This chapter presented details regarding participant background and 
demographics for Phases One and Two. Results for questionnaires and salivary 
cortisol assays were presented as raw data for Phase One, while analytical findings 
from both participant and healthcare professional interviews were presented for 
Phase Two. Overall, the result of the Phase One pilot did not demonstrate significant 
effects of the nurse-led intervention on the study hypotheses. The results of Phase 
Two, however, did identify support and positive benefits of the potential 
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effectiveness of the nurse-led clinic on some of the primary and secondary aims. 
Grounds for a Phase Three, multi-centre study have been highlighted in this chapter. 
A detailed Phase Three study protocol illustrating the development of the 
intervention with justification will be presented in Chapter 5.
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Chapter 5: Phase Three Development & Clinical 
Research Protocol 
5.1 Introduction 
This chapter presents Phase Three of the study in the form a clinical trial 
protocol. The chapter commences with the identification of study changes between 
Phases One and Three. The study aims, objectives, hypotheses, risk assessment, and 
management strategies are also described. Phase Three has reconceptualised the 
Phase One pilot study to a randomised controlled clinical trial (RCT) and has been 
modified to be delivered via electronic visual medium by a cardiology nurse trained 
in cognitive–behavioural therapy (CBT). The study protocol details the Phase Three 
intervention, design and conduct of a multi-centre study based on the findings arising 
from Phases One and Two, critical reflection and observations made by the PI and in 
the current literature. Standard care versus the nurse-led, educational intervention for 
Phase Three is also presented in significant detail throughout the chapter. 
5.1.1 Phase Three Changes: The Nurse-Led Clinic 
Changes to the nurse-led clinic between Phases One and Three include earlier 
follow-up as highlighted by study findings, critical reflection by the PI, and as 
reinforced by current literature (Trotter et al., 2011; Tuso et al., 2013; Yan et al., 
2011; Wong et al., 2006). Participant follow-up in Phase Three will occur between 
day 3 to 5 post-discharge. These changes were influenced by Phase One and Two 
findings and the current literature that highlighted this time as vital for post-
discharge follow-up (Günal et al., 2008; Rassaf et al., 2013; Trotter et al., 2011; Tuso 
et al., 2013; Yan et al., 2011; Wong et al., 2006). Importantly, the follow-up method 
was adapted from face-to-face and on-site, to using an electronic visual medium as 
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the mode of communication. The mode of follow-up was changed as a result of the 
PI’s recruitment experiences and Phase Two recommendations. Aspects of health 
assessment will be undertaken during follow-up; however, participants will be 
verbally and visually guided by the RA using Skype or FaceTime (i.e., finding a 
pulse, access-site assessment). Unlike Phase One, an electrocardiogram (ECG) will 
not be undertaken on review due to the mode of follow-up and the expense of 
providing each individual participant with a portable ECG monitor. Additional 
improvements to the nurse-led clinic include the provision of a list of reputable 
medication websites. 
Where participants originally (i.e., in Phase One) undertook all assessment 
tools at the commencement of follow-up, in Phase Three, all questionnaires will be 
undertaken at the end of follow-up by each participant. The RA will remain online to 
explain and clarify questionnaire items; however, the participant will have a print 
version of the questionnaire available and undertake them individually, as opposed to 
Phase One where the PI read all questionnaire items to each participant during the 
follow-up visit and documented their responses. Cardiac rehabilitation (CR) referral 
will be automatic in Phase Three study as a result of Phase One and Two findings, 
coupled with the PI’s observations after undertaking the nurse-led clinic and 
participant follow-up. If participants have not attended CR in > 2 years, they will be 
referred to undergo the course again to refresh and confirm current, evidence-based 
cardiac rehabilitation course content. Recommendations for short courses are 
highlighted in Chapter 7. Justification for Phase Three changes are presented in 
Chapter 6. 
Differences in Phase Three baseline assessment, as compared with Phase One, 
include that patients will no longer need to provide a salivary cortisol specimen due 
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to the costly undertaking in equipment and analysis. Baseline data collection will 
still occur face-to-face. Patients who undergo coronary angiography with diagnosed 
coronary artery disease (CAD) will be approached for Phase Three; whereas in Phase 
One, only percutaneous coronary intervention (PCI) patients were approached. It is 
anticipated that participants who are diagnosed with CAD will also benefit from the 
nurse-led clinic in that they will be provided with nurse-led support in the early post-
discharge period. Given that it is a recommendation to screen those with CAD for 
psychological distress (i.e., anxiety and depression), all participants with CAD will 
be screened over time (Colquhoun et al., 2013). 
Phase Three Protocol 
The Phase Three protocol was carefully considered and developed in response 
to critical reflection, after undertaking each study phase (i.e., participant follow-up), 
and further reflection on the study plan, procedure, and Phase One and Two findings 
(see Appendix O1). As highlighted briefly in Chapter 4, to maximise the opportunity 
for participation in the study and to be available for potential participants in remote 
and rural communities who may forgo post-procedural education due to geographical 
isolation, the inclusion criteria will extend to those who undergo coronary 
angiography, who are diagnosed with CAD, as well as individuals undergoing PCI. 
Phase Three will be undertaken over the course of 12 months, using an electronic 
visual medium to follow participants’ progress. In Phase One, the limitations of a 
PhD timeline did not permit medium- to long-term measurements of psychological 
distress and self-efficacy (SE). Furthermore, Phase Three will engage in minimal 
contact with standard-care group participants to gauge an effect of the nurse-led 
clinic on psychological distress and SE in intervention group participants versus 
standard care alone. Cardiac rehabilitation and attendance appeared to be 
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problematic, with changes to the referral approach made for Phase Three. 
Additionally, given the primary aims are to reduce psychological distress and 
enhance SE and self-management, all RAs involved will undergo training in 
cognitive–behavioural therapy (CBT). Cognitive–behavioural therapy is “an 
evidence-based psychological approach, practiced by a range of professionals for the 
treatment of mental health and other personal and family problems” (Sheldon, 2010, 
p. 3). Sheldon (2010) highlights how CBT facilitates self-analysis of thought 
processes, emotional responses and behaviour by encouraging change through 
ongoing monitoring and evaluation. Training in CBT may assist participants in the 
Phase Three study to achieve their post-procedural goals, overcome obstacles, and to 
facilitate behaviour change by challenging negative thoughts and/or beliefs regarding 
their post-procedural health and wellbeing. It is hoped that participation in the nurse-
led clinic facilitated by a nurse with CBT training may lead to patients’ enhanced SE 
and an outcome whereby effective self-management can be achieved and 
maintained. 
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5.2 Study Summary 
Title 
A randomised controlled clinical trial of a nurse-led 
educational intervention held within 3 to 5 days post-discharge to 
reduce psychological distress and enhance self-efficacy (SE) in 
patients who have undergone percutaneous coronary intervention 
(PCI) or coronary angiography.  
THE ‘REALITY CHEC PROJECT’ II  
Short Title The ‘REALITY CHEC’ Project_II 
Protocol Number NLED_INT_2015 
Phase Phase III  
Methodology Randomised Controlled Clinical Trial  
Study Duration Dates TBA 
Study Centre(s) Four hospital sites 
Objectives 
The primary objectives of this study are to reduce psychological distress (anxiety 
and depression), while enhancing SE in patients who have undergone coronary 
angiography or PCI 
Number of 
Participants 
N = 220 (n = 55 per hospital site)  
Diagnosis and 
Main Inclusion 
Criteria 
Main disease state: Coronary artery disease (CAD) 
Procedures: 
 Diagnostic: Coronary angiography (with diagnosed CAD) 
 Interventional: Percutaneous coronary intervention (PCI) 
Inclusion criteria: 
 aged 18 years and over 
 informed consent for primary or elective PCI signed by patient and 
cardiologist 
 diagnostic procedure: Coronary angiography with diagnosed CAD 
 Interventional procedure: Primary or elective PCI 
 understand or speak English language 
 post-discharge telephone access, mobile and internet access  
Study Product, 
Dose, Route, 
Regimen 
Nurse-led clinic education and clinical follow-up within 3 to 5 days post-
discharge from hospital 
Duration of 
administration 
Visit 1: Baseline (Randomisation) — Day of hospital discharge 
Visit 2:Within 3–5 days post-discharge from hospital (Electronic visual medium 
[i.e., FaceTime/Skype]) (45–60 minutes) 
Visit 3: At 1 month post-discharge (30–40 minutes; electronic visual medium) 
Visit 4: At 3 months post-discharge (Electronic visual medium) 
Visit 5: At 6 months post-discharge (Electronic visual medium) 
Visit 6: At 12 months post-discharge (Electronic visual medium) 
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Reference therapy 
 Intervention versus Standard care alone 
 Intervention group: Electronic visual medium, FaceTime or Skype 
(Using iPad; iPad Mini; Home Personal Computer [PC]; or Laptop) 
Note: RA to undergo training in Cognitive–Behavioural Therapy (CBT); RA 
employed will have a minimum of 5 years cardiology experience or be a Clinical 
Nurse (CN). 
Standard-care group: 
 Usual hospital care post-PCI/Coronary angiography 
 Nil contact with research assistant (RA) or principal investigator (PI) 
Statistical 
methodology 
Multivariate linear regression 
 
5.2.1 Study Aims 
The aim of this project is to evaluate the effectiveness of a nurse-led clinic 
offered to patients within 3 to 5 days post-coronary angiography (i.e., diagnosed 
CAD and PCI) or PCI (Appendix O1). 
The study’s primary and secondary aims are as follows and will be explained 
in greater detail throughout the chapter: 
Primary Aim: 
1 Evaluate if a post-discharge, nurse-led clinic providing education and support 
can reduce symptoms of psychological distress, while increasing self-efficacy 
(SE) and encouraging effective self-management. 
Secondary Aims: 
2 Evaluate if the nurse-led clinic can achieve 100% referral to a CR program 
post-education, through the use of an automatic referral system on study 
enrolment. 
3 Evaluate if individualised medication education can enhance participants’ 
SE, and improve post-discharge medication adherence. 
4 Evaluate if a post-discharge, nurse-led clinic can enhance patients’ SE and 
encourage effective self-management in patients.  
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Study objectives 
The objective of this study is to evaluate if a post-discharge, nurse-led clinic 
providing education and support can reduce symptoms of psychological distress 
while increasing SE. It is also anticipated that training RAs in CBT may assist in 
altering participants’ health misconceptions and encouraging positive thoughts and 
behaviours concerning their diagnoses (i.e., CAD) and post-PCI health. In doing so, 
it is hoped that by attending the nurse-led clinic participants’ SE will be enhanced 
and they may engage in in effective self-management. 
Primary Hypothesis 
H°: Attending a post-discharge, nurse-led clinic providing education and 
support within 3–5 days post-coronary angiography or PCI will not reduce 
symptoms of psychological distress or improve SE, nor facilitate effective self-
management in intervention group participants. 
Study design 
The study design is a randomised controlled clinical trial. 
Standard-care group (n = 110) 
Current practice for participant standard care involves the delivery of general 
education about the PCI procedure, post-procedural cares, activity and complication 
identification and management throughout the patient’s hospital admission. Current 
standard education may include both verbal and written education. Follow-up post-
discharge usually includes the cardiac rehabilitation team (CR) who arrange for 
course admission. Some facilities contact their patients at 1-month post-discharge to 
collect information about the post-discharge period. In the ‘REALITY CHEC’ 
Project, participants in the standard-care group will only be contacted via email or 
short message service (SMS) to remind them to complete their questionnaires at the 
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appropriate time frame. Follow-up for standard-care group participants will be at 3–5 
days, 1 month, 3 months, 6 months and 12 months and will take approximately 15 to 
30 minutes for them to complete all questionnaires at each time point. Participants 
will be asked questions concerning their psychosocial status and physical health 
post-discharge by use of both open-ended questions and validated assessment tools. 
Assessment tools will be posted to each participant the week prior to questionnaire 
completion. Participants will also be sent a reminder text message or email to 
complete the questionnaires. Questionnaires include the following: State Trait 
Anxiety Inventory (STAI), Cardiac Self-Efficacy Questionnaire (CSE), Cardiac 
Depression Scale (CDS), Morisky Medication Adherence Scale (MMAS-8 Item). A 
reply-paid, pre-addressed envelope will be enclosed for the return of all 
questionnaires. At each follow-up until 3 months, a digital photograph of the 
participant’s access site(s) will be required of the participant. Digital photographs 
may be returned via email or post. Medication knowledge and adherence will also be 
discussed along with CR attendance. 
Nurse-led clinic: Study intervention (n = 110) 
Intervention group participants will be required to undertake a component that 
involves the use of an online, electronic visual medium (i.e., Skype or FaceTime). 
The nurse-led clinic will take approximately 45 to 60 minutes. Participants will 
receive tailored education and support concerning the post-discharge period, 
recovery, cares, and physical activity. Both verbal and written education and 
questionnaires will be supplied on discharge from hospital (i.e., randomisation), with 
participants instructed to open only on the day of the nurse-led clinic. Participants 
will undergo psychosocial and physical assessment. Data will be collected using 
validated questionnaires and self-report data to determine post-discharge health 
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outcomes including: physical outcomes, coping, emotional distress, and psychosocial 
support. Questionnaires include the following: STAI, Cardiac Self-Efficacy 
Questionnaire (CSE), CDS, and Morisky Medication Adherence Scale (MMAS-8 
Item). Questionnaires may be returned to the RA via postal mail in the enclosed 
reply-paid envelope. Medication knowledge, education and adherence will also be 
assessed and discussed, along with CR attendance, and adherence. Participants will 
be educated on the importance of attending CR and will be enrolled in a program on 
the day of the clinic if they have not already been registered. 
Research assistants will contact intervention group participants using an 
online, electronic visual medium (i.e., FaceTime or Skype) at 1 month, 3 months, 6 
months, and 12 months post-discharge for further collection of data concerning their 
physical health and psychosocial wellbeing. Participants will have the opportunity to 
ask questions regarding their recovery, health and wellbeing. Participants will be 
mailed questionnaires one week prior to each follow-up visit and be instructed not to 
open the envelope until the date highlighted. Each envelope will be labelled as 1 
month, 3 months, 6 months, and 12 months. Participants will be sent a reminder text 
message or email two days prior to their follow-up and reminded to complete their 
questionnaires after each online visit. 
Study setting 
This study is a Phase Three, multi-centre study and will be undertaken at 
approximately four hospital sites—two private and two public hospitals. 
Approximately 55 participants will be recruited from each hospital site. 
Study population 
Approximately N = 220 participants will be recruited from two private and 
public hospitals. Participants will be randomised to either the intervention group 
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(nurse-led, educational intervention) or standard-care group (control group) using an 
interactive voice response system (IVRS). Randomisation will occur after baseline 
data collection on the day of discharge from hospital for both coronary angiography 
and PCI patients. 
Eligibility criteria 
Inclusion criteria: aged 18 years and above, informed consent for coronary 
angiography and primary or elective PCI signed by patient and cardiologist, having 
undergone coronary angiography and a subsequent diagnosis of CAD, having a 
primary or elective PCI, understands or speaks English, has post-discharge telephone 
access (i.e., mobile phone or landline), has internet access (i.e., for use of online, 
interactive medium). 
Exclusion criteria: children and/or young people (i.e. < 18 years), inability to 
understand or speak English, an overseas resident and unable to be followed up due 
to return to home country, on vacation in Australia for < 12 months, suffering from a 
mental illness/cognitive impairment and unable to legally consent, pregnant, in 
existing dependent or unequal relationship(s), highly dependent on medical care, has 
no telephone communication or internet access. 
5.2.2 Study Outcomes 
Primary outcome 
With anxiety and depression highlighted as a national and global health 
priority, the primary outcome for this nurse-led educational intervention is to and 
reduce symptoms of anxiety and depression (Department of Health & Ageing, 2010; 
WHO, 2000, 2014). It is hoped that, if identified early, participants may be referred 
for further ongoing assessment and management of anxiety and depression. 
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Secondary outcome(s) 
The following secondary outcomes will evaluate: 
1 if using an automatic referral system can achieve 100% referral to a CR 
program 
2 if the nurse-led clinic can encourage medication adherence through 
individualised patient education, encouraging effective self-management, and 
enhancing SE 
3 if, by improving patients’ SE, the nurse-led clinic can assist in the early 
detection, prevention and effective self-management of post-discharge 
complications. 
5.2.3 Study Procedures 
Recruitment of participants 
Once ethical approval has been granted, potential participants will be identified 
on admission to hospital through collaboration with ward staff at the sites identified. 
The recruitment process will be as follows: 
 consultation with the nurse unit manager (NUM) 
 consultation with the nurse in charge of the shift 
 consultation with the nurse caring for the patient. 
On the day of admission to hospital, and following the process of participant 
identification as presented above and provided the patient expresses to their nurse 
that they agree to speak with the RA, potential participants will be approached and 
offered a participant information and consent form (PICF) in the presence of their 
nurse. The consent process will cover release of medical information (i.e., medical 
and bedside progress chart), and image release (i.e., wound site) to the immediate 
research team for educative purposes only (i.e., teaching, conference education, 
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publication, specialist viewing). Patients will be given time to review the documents. 
If the patient wishes to speak with the RA after reading the documents to clarify or to 
sign the consent forms, they may advise their nurse who will contact the RA. 
Participants, if agreeable, will be consented to The ‘REALITY CHEC’ Project. 
Baseline data will be collected and participants will be randomly assigned to a study 
group (i.e., online medium or standard-care group). The following conditions will 
apply to a participant who has undergone coronary angiography (i.e., diagnosed 
CAD) or PCI procedure and the RA may only approach the patient if: 
 the patient is in agreement 
 the cardiologist is in agreement 
 the patient is pain free 
 the patient is not under the influence of any sedation (i.e., morphine, 
fentanyl, midazolam, diazepam, oxazepam, temazepam). 
If potential participants meet both inclusion criteria and the aforementioned 
conditions, the RA may inform and consent the potential participant. 
Participant recruitment, screening and consent 
Participants will be recruited from referring physicians, and via advertisement 
within the hospital (i.e., flyers, brochures). Study brochures will be disseminated to 
potential study participants on admission, prior to their procedure. Approval for 
brochures will be sought from the hospital and university Human Research Ethics 
Committee (HREC) and Institutional Review Boards (IRBs). 
Participant identification and consent process 
 After following the formal process of participant identification and if 
the patient wishes to consent to participation, a witness (i.e., nurse or 
relative), together with the RA or PI, will undertake formal written 
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consent. The nurse caring for the patient or a relative may be present at 
the time of consenting. 
 The RA or PI will highlight the voluntary nature of participation and 
that withdrawal of participation may occur at any time throughout the 
course of the study without penalty. 
 The RA or PI will highlight that there will be no penalties for declining 
participation in the study. 
 All data collected about participants will be used for the purpose of the 
study. Participant’s personal information will be de-identified and be 
stored in accordance with National Health and Medical Research 
Council (NHMRC) guidelines. 
 The RA or PI must advise the participant that, on withdrawal, any data 
collected up until that time will be used for analysis. 
5.2.4 Participant Withdrawal/Early Withdrawal of Participants 
Participant withdrawal 
Participants may withdraw at any time from the study prior to the completion 
date without comment or penalty. Participants will be given contact details of the RA 
who will be contactable via telephone or email and individuals may withdraw at any 
time throughout the course of the study without comment or penalty. Participant 
withdrawal will be reported immediately to the PI, study monitor and HREC. 
Early withdrawal 
Participants will be withdrawn from the research project by the RA for any of 
the following reasons. These conditions will apply for both the participant and their 
families: 
 unexpected illness (i.e., suffering acute psychological/psychiatric 
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distress, diagnosis of fatal illness, poor progression of current illness, 
requiring major surgery) 
 as a result of participation or possibly as a result of participation in the 
study (i.e., acute psychological/psychiatric distress). 
The RA will report formally and immediately to the study monitor, HREC, 
university and PI. 
Lost to follow-up 
Participants lost to follow-up will be contacted via the following methods: 
 Maximum of: 
o two telephone calls to landline or mobile phone 
o two emails 
o two certified letters. 
 Telephone message — to be clear and detailed: 
o state: name, position, date, and organisation and study 
o request: participant to return the call between business hours, 
Monday to Friday 
o advise: RA will follow up with certified letter via postal mail. 
Data collection and follow-up for withdrawn participants 
The research team will obtain participants’ permission to attain their survival 
data until the final follow-up visit. During the consent process, participants will be 
advised of their data retention for analysis. Survival data on all participants 
withdrawn and lost to follow-up will be sought via the hospital sites and/or 
cardiology groups/clinics. Participants will not be directly contacted. 
Consent forms will be photocopied and returned to participants immediately 
after signing. Participants reserve the right to withdraw their involvement in the 
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study at any time and without penalty. Withdrawal of participation will be 
emphasised during the consent process and highlighted in the PICF in full. 
Participants will be offered a $25.00 store gift voucher to participate in the study. 
Vouchers will be posted to each participant after final follow-up and will be 
documented in the PICF (i.e., 12 months). Participants will not incur any out-of-
pocket expenses. All health facilities, participants and personal details will be de-
identified and coded on randomisation. On completion of the study, participants will 
be mailed a letter of thanks for their participation in the study, a summary of key 
findings and their gift voucher. 
Randomisation 
After consent and the collection of baseline data, participants will be 
randomised to either the standard-care or intervention group. As identified earlier, 
randomisation will be undertaken using IVRS to ensure equal and ethical 
randomisation to all groups. All sites will be blinded to the randomisation of 
participants. 
5.2.5 Study Procedure 
Day of hospital discharge: Baseline data collection 
Following consent, baseline data will be collected from all participants on the 
day of discharge from hospital. Data collection will take approximately 30 minutes 
to collect and will occur in a private consultation room or at the patient’s bedside. 
Data to be collected will include the following: general patient demographics, 
medical history, physical assessment (i.e., waist measurement, vital signs) and 
medical record details pertaining to their current hospital admission. A recent and 
de-identified electrocardiogram (ECG) taken on admission will be photocopied from 
participants’ medical records. Access-site assessment will involve capturing a digital 
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image, site palpation and performing a visual inspection. Table 5.1 details specific 
information concerning the study and procedure for both standard-care and 
intervention group participants from admission through to the final follow-up at 12 
months post-discharge from hospital. 
Table 5.1. Baseline Data Collection 
On admission: Baseline Data Collection — All participants 
Assessment Tool/Instrument/Method 
General 
Information/ 
Health history 
(Medical 
records) 
1. General information, demographics and medical history. 
2. Research assistant (RA) to make copies of procedure related medical 
records for the purpose of the study only (To be de-identified). 
Items will include: 
 consent for coronary angiography 
 consent for PCI 
 (PCI) procedure (inclusion criteria) 
 observation chart 
 ECG 
 medical history form or verbal medical history 
 procedure report only 
 medication chart or verbal list of medications from patient 
 progress notes relevant to admission (i.e., procedure report, notes 
concerning any post-procedural complications) 
Psychosocial Anxiety: State Trait Anxiety Inventory (STAI) Questionnaire 
Depression: Cardiac Depression Scale (CDS) Questionnaire 
Self-Efficacy: Cardiac Self-Efficacy Questionnaire (CSE) 
Medication Adherence: Morisky Medication Adherence Scale — 8 Item 
(MMAS-8) Questionnaire 
Physical 
 
 Physical assessment: Primary and secondary survey 
 Primary survey: Airway, Breathing, Circulation, Disability, Exposure 
(environment) (A, B, C, D, E) 
 Secondary survey: Head-to-toe and physical assessment 
 Neurovascular assessment, waist measurement 
 Access site: Wound assessment — Visual inspection and palpation and 
access site photograph 
 Chest pain (CP) assessment: National Heart Foundation of Australia 
(NHFA), Chest Pain Action Plan 
 
After baseline data collection, participants will undergo telephone 
randomisation and be assigned to either the standard care or the study intervention 
group. 
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5.3 Study Intervention (n = 110) 
The nurse-led educational intervention will be delivered by an RA within 3–5 
days post-discharge from hospital. The RA will be a qualified cardiology RN, with a 
minimum of 5 years’ experience, or a CN with a cardiology background. It would be 
preferable if study RAs were accredited in CBT to assist the participant in 
identifying and reducing psychological distress, enhancing SE, challenging negative 
thoughts, achieving individual health-related goals, and facilitating effective self-
management. Training will be provided if RAs do not have accreditation in CBT to 
ensure that accreditation conditions and criteria are met. As identified, the 
intervention group will undertake the nurse-led clinic online using either Apple’s 
FaceTime application or Skype. Undertaking the intervention using this application 
will enable the RA and participant to visually and verbally interact to view access 
sites and wound healing and facilitate instructed physical self-assessment. For this 
study, participants will undergo psychosocial and physical assessment. Psychosocial 
data will be collected using questionnaires and self-report tools regarding post-
discharge health, coping, psychological distress (i.e., anxiety and depression), and 
psychosocial support. Each participant will be provided with assessment tools one 
week prior to each study follow-up time in a labelled A4 envelope. The assessment 
tools will be labelled to remind participants when they are to complete the 
questionnaires. Participants will also be sent a text message or email reminder two 
days prior to the specified date of questionnaire completion. 
As identified, intervention group participants will attend a nurse-led 
educational clinic using an online visual medium to communicate (i.e., FaceTime or 
Skype). All participants will receive an instruction manual regarding the use of 
FaceTime and Skype for their specific electronic device. The nurse-led clinic will 
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take approximately 45 to 60 minutes to undertake. Intervention group participants 
who do not have an Apple iPhone (containing FaceTime application), iPad, iPad 
mini, laptop or home personal computer will be lent an iPad mini for the duration of 
the study. Participants will receive tailored education (i.e., verbal and written 
documentation) and support concerning the post-discharge period, recovery, cares 
and appropriate activities post-PCI. Medication knowledge, education and adherence 
will also be discussed, along with CR attendance and activity recommencement. 
Post-discharge physical activity education delivered will include exercise and 
activities permitted post-procedurally until the commencement of a CR program. 
Physical assessment (i.e., primary and secondary survey) will be undertaken via an 
online visual medium (i.e., FaceTime, Skype). If the RA suspects any post-discharge 
complications (i.e., psychological distress, bleed, wound site infection), by following 
the study’s risk protocol they will ensure that they are referred to the appropriate 
person for clinical assessment and management. 
Research assistants will contact all intervention group participants again at 1 
month, 3 months, 6 months, and 12 months post-discharge using the aforementioned 
online medium for further collection of data concerning participants’ psychosocial 
wellbeing and physical health post-PCI. Participants will also be given the 
opportunity to ask questions they may have concerning their health and wellbeing 
post-PCI. All questionnaires will be completed at the end of each follow-up. 
The RA will make contact with each participant’s cardiologist and GP via 
email for all private patients. Research assistants will only contact GPs for 
participants recruited from public hospitals. Cardiologists and/or GPs will be 
contacted on participant enrolment, on the occurrence of any adverse events (AEs) or 
serious adverse event (SAEs), and on completion of the study. Data collection for 
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participants in the nurse-led clinic will occur between 3 to 5 days post-discharge 
from hospital and at 1, 3, 6, and 12 months. A greater depth of explanation for 
changes is discussed in Chapter 6. 
Table 5.2. Study Intervention Group Summary 
Study intervention group summary: Intervention at Day 3 to 5 days post-discharge, plus 
Follow-up:1, 3, 6 and 12 months post-discharge 
Assessment Tool/Instrument/Method 
Note: Primary survey: A, B, C, D, E. Ask participant if any immediate 
concerns (i.e., chest pain). 
Tools/Assessment 
Note: Participant to 
complete at end of 
each follow-up 
Anxiety: State Trait Anxiety Inventory (STAI) Questionnaire (Trait 
Anxiety Inventory) 
Depression: Cardiac Depression Scale (CDS) Questionnaire 
Self-Efficacy: Cardiac Self-Efficacy Scale (CSE) Questionnaire 
Chest Pain (CP) assessment: Chest pain assessment and CP action plan 
Medication adherence: Morisky Medication Adherence Scale — 8 Item 
(MMAS-8) 
Access-site assessment: Wound care pathway/assessment tool 
Neurovascular assessment: Neurovascular assessment tool  
  
Educational 
intervention 
(3–5 days post-PCI) 
Note: Refer patients to hospital-specific information where appropriate 
Secondary Survey: Head-to-toe and physical assessment 
Physical and 
Psychosocial 
assessment integrated 
throughout 
intervention 
Access site, neurovascular assessment/Wound care: 
Digital photograph of site to be taken by patient (multimedia messaging 
service [MMS], digital photograph. Patient to email or post to RA)
Visual observation and palpation of site by participant with verbal 
instruction and guidance by RA (i.e., what to look and feel for)
Tool: Wound care pathway — Applied Wound Management (Wounds UK, 
2010) 
Neurovascular assessment: To follow access site assessment
Tool: Neurovascular assessment tool
Education:  
 discuss post-discharge wound care/access site management
 encourage reference to hospital-specific brochure on post-
discharge cares 
Chest pain (CP)/Discomfort: 
 introduce CP assessment, education and management:
 assess for CP within 3 to 5 days and current CP at time of follow-
up 
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Study intervention group summary: Intervention at Day 3 to 5 days post-discharge, plus 
Follow-up:1, 3, 6 and 12 months post-discharge 
Assessment Tool/Instrument/Method 
Chest Pain (CP) education: 
 Follow Chest Pain Action Plan. Guide participant through signs 
and symptoms; action / management (i.e., if experiencing CP or 
complication at home); and offer scenarios for patient to work 
through 
Medication adherence and compliance: 
 Assess patient’s understanding of own medications, medication 
taking behaviours, compliance and education 
Medication knowledge and awareness: 
 assess: Medication knowledge (i.e., current medications) 
 medication name, indication (i.e., ask participant what the 
medication is for if they do not know the name), dose, frequency 
Medication education: 
 discuss main groups of medications generally prescribed post-PCI 
or on diagnosis of CAD 
 discuss medication adherence (highlight the importance of), 
compliance, and management 
 RA to educate participants on the importance of all medications 
currently being taken 
 highlight the importance of anticoagulants/platelet aggregation 
inhibitors (i.e., aspirin, clopidogrel) and continuation until 
cardiologist advises otherwise 
Caution: The use of some internet material 
 Note: Offer participants a list of reputable medication websites to 
view 
Secondary prevention: Cardiac rehabilitation (CR) and activities 
 assess participant’s perceptions regarding CR (pre-attendance)
 clarification regarding their procedure (i.e., coronary angiogram or 
PCI) 
 discuss their procedure, the outcome (i.e., PCI or medical 
management) and what it means for them now 
Secondary prevention: CR re-attendance (> 2 years) 
 automatic referral for all participants who have not attended CR in 
5 years or greater 
 Note: Reinforce that CAD is a chronic disease 
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Study intervention group summary: Intervention at Day 3 to 5 days post-discharge, plus 
Follow-up:1, 3, 6 and 12 months post-discharge 
Assessment Tool/Instrument/Method 
Education: 
 reinforce and promote the importance of CR attendance:
 make appointment and track attendance (i.e., CR units will be 
telephoned to ask of participant attendance)
 discuss post-discharge physical activity recommencement with 
participant (i.e., what activities/exercise permitted until 
commencement of CR program) 
 provide participant with a hospital-specific CR brochure and 
activity recommencement guide
 for reference: Use hospital-specific brochure/booklet on discussion 
of activity recommencement or My Heart, My Life 
Research assistant (RA) questions: 
 Mixture of structured, open and closed-ended questions 
concerning: Quality of life, support networks, stress and coping 
post-PCI or coronary angiography (i.e., after diagnosis of CAD) 
Participant knowledge: 
 Post-procedural cares, activity, CR (expectations), medications, 
complications and management. Effectiveness of follow-up post-
PCI 
Participant questions/issues/concerns: 
 Participants may have concerns/questions to ask the RA 
5.3.1 Standard-Care Group (n = 110) 
Hospital standard care 
Standard care at all hospital sites involves the hospital staff providing 
education to patients concerning the procedure and general post-procedural cares. 
Standard care delivered involves management of the access site, and identification 
and management of complications such as access-site bleed, haematoma (i.e., 
size/appearance), chest pain and medication complications. Closer to discharge, a 
CR nurse reviews each in-patient to ensure they are educated about their procedure, 
diagnosis, medications and the need to make lifestyle changes, while offering 
enrolment in a CR program. Post-discharge follow-up usually includes CR contact to 
arrange for course enrolment. Importantly, standard care and follow-up for patients 
may vary for each hospital site. 
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The ‘REALITY CHEC’ project changes: Standard-care group 
As compared with Phase One follow-up, there will be no formal 
communication with the PI. Participants in this group will be followed up by the RA 
post-hospital discharge via telephone, email or short message service (SMS) as a 
reminder to complete all documentation provided and return to the PI. Follow-up 
will be between 3 to 5 days, 1 month, 3 months, 6 months, and 12 months. 
Completion of documentation will take approximately 30 minutes. Participants will 
be asked questions concerning their psychosocial health status and physical health 
post-discharge, using both open and closed-ended questions and questionnaires. 
Additionally, at each follow-up until 3 months post-discharge from hospital only, a 
digital photograph of participant’s access sites will be requested. Phase One access-
site follow-up displayed full recovery in all images requested of participants at this 
time point, hence no further images will be sought throughout the course of the 
Phase Three study. Participants may return access site images via email or post to the 
RA. Medication knowledge and adherence will also be discussed along with 
attendance to CR, activity recommencement and CP experienced post-discharge 
from hospital and on follow-up. 
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Table 5.3. Standard-Care Group Follow-Up 
Standard-Care Group At 3–5 days post-discharge, 1 month, 3 months, 6 months, and 12 months 
post-discharge 
Assessment Tool/Instrument/Method 
 Nil formal communication with participants. RAs only to communicate 
with participants to remind on the completion of assessment tools 
Psychosocial 
 
Anxiety: State Trait Anxiety Inventory (STAI) Questionnaire (Trait Anxiety only) 
Depression: Cardiac Depression Scale (CDS) Questionnaire 
Self-Efficacy: Cardiac Self-Efficacy Scale (CSE) Questionnaire 
Medication adherence: Morisky Medication Adherence Scale — 8 Item (MMAS-
8) Questionnaire 
Physical 
assessment 
Note: All physical assessment will be documented by standard-care group 
Participants to complete data collection form (DCF) provided 
Chest pain assessment (CP) assessment and action taken (i.e., if any experienced) 
Complication identification: 
 Participant to document in DCF provided and actions taken (i.e., self-
management, GP, emergency services required) 
Access site: Wound & Neurovascular assessment 
 Access site photograph (camera, mobile phone or device camera). To 
email, send via MMS, or post in the mail.  
 
Any concerns raised by the participant or identified by the RA (i.e., post-
discharge complications, psychological distress) throughout the course of the study 
will be actioned immediately (i.e., contact cardiologist and/or GP) and reported in 
accordance with the study’s risk protocol. 
Safety considerations: Risk management and clinical governance 
The research team will adhere to the study protocol throughout the course of 
the project. The study protocol includes a risk protocol that will be reviewed and 
approved by cardiology directors and the Nursing Executive at each of the sites 
where the clinics will be undertaken. The protocols will be available to all research 
team members taking part in the clinical trial and have been adapted from Phase One 
risk protocols (see Appendix W). 
A risk management plan is in place to protect both study participants and 
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research team members from any AEs or SAEs that may be experienced both at 
study sites (i.e., on recruitment) and at the participant’s home. 
 Hospital orientation and competency-based assessments will be 
undertaken to ensure the safety of participants and research team 
members. 
 AEs and SAEs will be reported to the appropriate site Human 
Research Ethics Committees (HRECs). 
 An interim audit may be conducted by site Research Governance 
Offices at any time on request. 
 Regular debriefing with site contacts and research team members will 
occur to ensure patient safety is being maintained. 
Ethical considerations 
The study will be conducted according to the ‘Declaration of Helsinki’, Good 
Clinical Practice, per the Revision of the Joint NHMRC/AVCC Statement And 
Guidelines On Research Practice Australian Code For The Responsible Conduct Of 
Research, and the QUT Code of Conduct for Research D/2.6 and per the laws of the 
country in which the study will be undertaken (NHMRC, 2007; QUT Code of 
Conduct for Research, D/2.6, MOPP, 2009). The ethical principles that include 
integrity, respect for persons, justice and beneficence will be strictly adhered to at all 
times (NHMRC/AVCC, 2007). 
Significance 
This intervention is a new approach to the continuum of care for all patients 
post-coronary angiography (i.e., with diagnosed CAD) and post-PCI, providing vital 
support in the early post-discharge period. Implementation of the nurse-led clinic 
will aim to reduce anxiety and depressive symptoms early in the post-discharge 
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period. Furthermore, this study aims to improve SE through the reduction in anxiety 
and encouragement of effective self-management through the use of a person-centred 
approach. Additionally, by training RAs in CBT, it is hoped that healthier thoughts 
and participant outcomes may be encouraged (i.e., health and behavioural goals) and 
that any negative beliefs may be challenged. It is also hoped that depression may be 
detected early and participants may be referred (i.e., to GP for referral to 
psychologist or psychiatrist) for early intervention. 
Clinical trial registration 
The study will be registered with the Australian New Zealand Clinical Trials 
Registry (ANZCTR). 
Collaborative arrangement evidence 
A collaborative agreement between the research team and all hospital sites has 
been made through the Office of Commercial Services at the university. 
Insurance 
The university has adequate insurance to cover the research team over the 
course of the study. 
Investigational agent 
This will be a nurse-led clinic, providing education, support and screening for 
psychological distress within 3 to 5 days post-discharge from hospital utilising an 
online, visual medium (i.e., FaceTime and Skype). 
Primary study endpoints 
The primary endpoint for this study is reduced post-discharge anxiety levels, 
enhanced SE, and the reduction of depressive symptoms. 
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5.3.2 Statistical Plan 
Sample size determination 
A sample size calculation was undertaken to determine the sample for the 
proposed study. The number of participants required to determine an effect of the 
intervention is N = 220 (n = 110 per group). Thus, as a multi-centre study (four sites) 
will be undertaken, n = 55 participants per site will be recruited. 
Stopping rules 
The study will be stopped if participants, primarily as a result of participation 
in the study, experience acute psychological/psychiatric distress requiring immediate 
treatment (i.e., hospitalisation). The study’s risk protocol will be adhered to should 
any participant experience an acute psychological /psychiatric event requiring 
hospitalisation. Such an event will be reported to the study monitor, all HRECs, 
specialists, and GPs. 
Safety monitoring 
The PI will oversee the safety of the project at all sites and report on all AEs 
and SAEs. A risk protocol, as identified, is in place to ensure appropriate reporting. 
An independent data and safety monitoring board may audit the sites and data 
storage practices at any time on request. Interim analyses will be undertaken 
throughout the course of the study by an independent data monitoring committee. 
5.3.3 Data Handling and Record Keeping 
Confidentiality 
Personal information and all data will be kept confidential and stored at the 
university site in a locked filing cabinet. All personal information collected will be 
de-identified RAs. Electronic data stored will be password protected. 
Research team members authorised to access data will include: 
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 Principal investigator 
 Research manager 
 Research assistants (entering data). 
Should any participant withdraw from the study, all data up until the time of 
withdrawal will be held by the research team for data analysis. The retention of data 
collected for participants withdrawing from the study will be highlighted during the 
consent process. 
5.3.4 Study Monitoring, Auditing, and Inspecting 
Auditing and monitoring 
Study auditing and monitoring will be permitted by site research governance 
office (RGO) officials and QUT monitors. Items to be audited and monitored will 
include: 
 source documents and case report forms: random files may be selected 
 instruments (i.e., assessment tools, salivary cortisol specimen 
collection containers) 
 data storage (i.e., where and level of security) 
 electronic data (i.e., ensure password protected). 
Funding source 
The PI will apply for a National Heart Foundation of Australia (NHFA) 
research grant to fund the study. 
Conflict of interest 
There are no conflicts of interest to declare in this study. 
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Participant stipends or payments 
Participants will all be given a $25.00 store voucher on completion of the 
study. 
Publication plan and commercialisation 
Results from this study will only be published by the PI and Queensland 
University of Technology (QUT). Results may not be published by any third party 
without written consent from both the PI and the university. One hospital site where 
Phase One was undertaken has requested a detailed plan to regarding the detailed 
structure of the nurse-led clinic so that they may implement such a clinic at their site. 
As a result, the PI has met with QUT’s Bluebox™ to discuss Phase Three and 
potential research commercialisation. Agreements will be made with any 
organisations prior to the provision of information concerning the nurse-led clinic 
structure and implementation. 
5.4 Summary 
This chapter presented the development of Phase Three of the ‘REALITY 
CHEC’ Project that arose from Phase One and Two findings and as a result of the 
depth of time engaged in the study by the PI, coupled with observations made and 
critical reflection undertaken. The Phase Three nurse-led clinic, as identified, will 
therefore be undertaken by using electronic visual modes of communication and be 
available to both coronary angiography (i.e., with diagnosed CAD) and PCI 
participants, so that a greater number of patients may benefit from the support 
provided by the nurse-led clinic. As highlighted, follow-up will continue over a 12-
month period and be undertaken by a nurse trained in cognitive–behavioural therapy 
so that participants may be more formally supported in achieving their goals and 
changes in behaviour over time. Moreover, study follow-up over 12 months will 
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enable screening and referral of participants with psychological distress over time 
and may facilitate reductions in anxiety, enhancements in SE, and encourage 
effective self-management. Due to the problematic nature of CR program referral 
acceptance, those who have previously attended (> 2 years) will be automatically 
referred. Chapter 6 will discuss the findings of the study in relation to the theoretical 
framework and current literature. Phase Three study changes will also be discussed 
in greater detail in the following chapter, with explanation provided for 
modifications which were informed by the research process and current literature.
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Chapter 6: Discussion 
This chapter discusses in detail the study’s results for Phases One and Two 
with respect to the theoretical framework, current literature, primary, and secondary 
research aims. Findings will be compared and contrasted against the literature with 
similarities and differences identified. Furthermore, the development of Phase Three 
will be highlighted. 
6.1 Phase One Discussion 
This section discusses participant demographics together with the study’s 
primary and secondary aims for Phase One. Anxiety and CSE questionnaire results 
will be examined with the literature, while explanations for the results will be 
offered. Overall, although it was expected that this intervention would achieve 
primary and secondary aims, results have not demonstrated strong support for the 
study’s hypotheses. For the primary aim of increasing SE and reducing trait anxiety, 
CSE and trait anxiety were both moderately reduced in intervention group 
participants, while standard-care group participants demonstrated small 
enhancements in CSE and no effect on trait anxiety. For secondary aims, depression 
scores demonstrated reductions in both groups, while re-attendance to cardiac 
rehabilitation (CR) was minimal, and medication adherence remained stable over 
time. Post-operative complications experienced by participants were minimal, 
expected, and successfully self-managed by all participants over the course of the 
study. Overall, the results for these particular constructs did not meet expectations 
after undertaking the intervention and will be discussed throughout this chapter. 
6.1.1 Demographics 
Participants recruited to the study were predominantly male. The prevalence of 
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CHD in males is well-recognised in the literature with current data revealing CHD to 
be twice as high for males than females (AIHW, 2012). The AIHW identifies a 
greater hospitalisation of males as opposed to females, thus accounting for the 
greater ratio of males to females treated for CHD (2012). Furthermore, 
approximately 61% of patients hospitalised with CHD were 65 years of age and over 
(AIHW, 2012, p. 268), with the mean age of participants in the present study being 
65.03 years of age. Both medical and behavioural risk factors for CHD reported by 
participants were consistent with those identified in the literature (NHFA, 2014). 
Risk factors included (see Table 6.1): 
Table 6.1. Risk Factors for CHD as Reported by Participants in the Present Study 
Risk factors Medical  Behavioural 
 Hypertension 
Hypercholesterolaemia 
Type 1 and Type 2 Diabetes 
Obesity 
Mental health status 
Smoking (Recent and history) 
Alcohol consumption 
Inactivity 
Dietary inadequacies  
Source. Adapted from Nichols, Petersen, Alston, & Allender (2014) Australian Heart Disease 
Statistics, NHFA, 2014. 
6.1.2 Primary Aim 
Self-efficacy (SE) and anxiety 
Although it was expected that participants in the intervention group would 
show increased SE and reduced anxiety as related to the primary aims, this was not 
demonstrated in the present study. Results of the study, as evidenced by effect size 
calculations, showed little improvement in CSE over time in intervention group 
participants, with a moderately reducing effect on CSE, d =0.60. No effect was 
demonstrated in standard-care group participants, d = -0.19. On closer inspection of 
CSE items, mean ratings, not based on formal testing demonstrated improvements in 
some aspects of CSE. Mean CSE ratings will be discussed in greater detail later in 
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the chapter. These results may be reflective of many issues surrounding the 
intervention, delivery, interpretation, and completion of the questionnaire. Issues that 
may have impacted on the results may have included: failure of the intervention, 
general misunderstanding, recall bias, interviewer error, and questionnaire timing. 
As noted above, there are various explanations that elucidate the results of the 
study; however, it is possible that the intervention alone failed to produce the 
expected results. A longer study of 6 to 12 months with frequent clinic sessions may 
benefit participants more in terms of enhancing SE. The suggested Phase Three 
study, as discussed in Chapter 5, following participants until 12-months post-
discharge may determine and facilitate the medium- to long-term effects of the 
nurse-led intervention on SE. With nurse-led clinics offering small short-term 
benefits (between 6 and 12 months) in risk factor modification, patient outcomes, 
quality of life and patient targets, the benefits were apparent (JBI, 2010; Schadewaldt 
& Schultz, 2011). While endeavouring to offer early nurse support, nurse-led clinics 
offer “sustained encouragement” and “early assessment” to reduce patient risk 
factors (Schadewaldt & Schultz, 2011, p. 211). Although the pilot study did not 
demonstrate effectiveness in achieving all study objectives, preliminary evidence, 
particularly from Phase Two, supports a Phase Three, multi-centre study being 
undertaken to determine the medium- and long-term (i.e., over 12 months or more) 
effects of the nurse-led clinic on SE, psychological distress, and self-management in 
both PCI patients and patients diagnosed with diagnosed CAD. The JBI (2010) 
highlight how nurse-led interventions have demonstrated effectiveness in achieving 
short- and medium- term patient objectives and while some long-term outcomes may 
be achieved (i.e., modifiable risk factors) further investigations and approaches to 
achieve long-term patient outcomes are highlighted. The recommendations as 
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highlighted by Schadewaldt and Schultz (2011) and JBI (2010) reinforce the 
importance of undertaking long-term follow-up investigating the effectiveness of a 
Phase Three, nurse-led clinic on the aforementioned outcomes (i.e., >12 months). 
Carroll (2005) highlights how nurses are paramount in assisting patients with 
their personal health goals and in encouraging lifestyle changes, particularly post-
PCI. Perhaps, and as identified earlier, longer follow-up and a more intense 
intervention (i.e., RN trained in cognitive–behavioural therapy [CBT] to undertake 
the nurse-led clinic) would be of benefit to participants, with a greater focus and time 
to set and achieve goals (although discussed with participants). The combination of 
CBT coupled with health professional post-discharge support and education may 
assist patients in dealing with problematic beliefs (i.e., health misconceptions, not 
wanting to quit smoking) that may impact on positive behaviour change, 
maintenance, and effective self-management. Various methodological explanations 
for the present study’s outcomes were considered and are provided later. 
The CSE tool was originally designed to assess CSE in heart failure patients 
and has since been adapted by the original authors to suit the broader cardiovascular 
patient population; however, questions more specific to heart failure present in the 
questionnaire appeared to be misinterpreted by some participants (Sullivan et al., 
1998; Sarkar et al., 2007). For example, some participants had reported 
breathlessness on baseline measurement, but at Time 2 (day 5–7) reported they had 
never experienced breathlessness and responded as ‘not applicable’. 
Misinterpretation of questionnaires is common for individuals as identified by 
Roberts and Taylor (2002). Subsequently, limited clarification of misinterpretation 
often leads to invalid or incomplete data, as noted in the present study, potentially 
affecting the results (Roberts & Taylor, 2002). On baseline assessment all 
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participants undertook questionnaires individually after pre-completion instructions 
were given. Intervention group participants completed questionnaires individually 
again at day 5–7 post-discharge (Time 2), while standard-care group participants 
completed the questionnaire via telephone from day 5–7 post-hospital discharge 
onwards. 
Questionnaire delivery (i.e., timing) after the nurse-led clinic attendance may 
also have been problematic. Questionnaires were completed at the commencement of 
follow-up at day 5–7 (Time 2) post-discharge to measure SE and any changes from 
the baseline visit for both groups of participants. Subsequent questionnaires 
undertaken at 1 month (Time 3) and 3 months (Time 4) were measured at the end of 
each follow-up session. In retrospect, it may have been more appropriate to measure 
CSE immediately post-intervention at day 5–7 post-discharge (Time 2) to gauge the 
effect of the nurse-led clinic on SE. 
An explanation to account for effect size (ES) and reliable change on CSE may 
be attributed to the high level of anxiety measured by the STAI in intervention group 
participants. Carroll (2005, p. 12) highlights how “negative psychological states” 
may affect learning and lifestyle changes and, in particular, how anxiety is 
heightened on discharge from hospital in patients with CHD. Thus, higher levels of 
anxiety may have contributed to the reduction in learning in the nurse-led clinic, 
therefore attributing to only a small percentage of participants’ CSE recovering and 
improving, as evidenced in CSE and RCI calculations. Dehdari et al. (2008) identify 
how both SE and anxiety affect the adoption and maintenance of good health 
behaviours in cardiac patients, which may explain the results. 
The theoretical framework and literature highlights that an increase in SE 
should see a reduction in anxiety (Bandura, 1977, 1995; Dehdari et al., 2008). The 
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present study had a moderate reduction in trait anxiety in the intervention group over 
time, while no effect was demonstrated on anxiety in standard-care group 
participants, as measured by the STAI Y2 Form. Only a small percentage of 
intervention group participants saw improvements and recovery in CSE as evidenced 
by RCI calculations. It was interesting that intervention group participants appeared 
more anxious on baseline measurement compared with standard-care group 
participants. This was reflected in mean trait anxiety scores, which were higher in 
intervention group participants than standard-care group participants. Furthermore, 
trait anxiety as evidenced in ES and RCI calculations had a moderately reducing 
effect on trait anxiety in intervention group participants and recovery in a small 
percentage post-intervention; no effect on trait anxiety was evidenced in standard-
care group participants and no participants achieved recovery. Improvements in 
anxiety were evidenced, however, in a similar percentage of both groups of study 
participants. As noted in the literature, it is difficult to reduce anxiety in patients who 
have high baseline trait anxiety—this finding was important (Muris, Mayer, & 
Merkelbach, 1998). Notably, trends observed in mean ratings for CSE and anxiety at 
Time 3 (1 month) demonstrated enhancements in CSE, and reductions in anxiety. 
Possible conclusions, which will require testing in the form of a Phase Three study 
drawn from these findings, may indicate that: 
 given the seriousness of the circumstances, the procedure itself (i.e., 
PCI) may have been life-changing for participants; and 
 the intervention may potentially be effective in reducing trait anxiety 
post-procedurally. 
Updegraff and Taylor (2000, p. 3) highlight how stressful life events may have 
a positive or negative effect on an individual. The authors identify three specific 
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areas from their review of literature on individuals’ perceived benefits from life 
events. Positive changes were reported in the areas of: (a) “self-concept”, where 
individuals believe they are stronger from their experience; (b) “relationships with 
social networks”, where relationships are enhanced as individuals request the support 
of their family and friends; and (c) personal growth and life priorities”, where 
personal changes and change in priorities in life occur (Updegraff & Taylor, 2000, p. 
5). 
The positive effects of stressful life events may be sustained long term, and 
may benefit the individual as they may have a better understanding of themselves, 
their social support system, personal priorities, and their life (Updegraff & Taylor, 
2000). Conversely, negative effects can be experienced as a result of stressful life 
events and may include “depression, anxiety and cognitive disruptions” (Updegraff 
& Taylor, 2000, p. 11). Authors identify how negative effects may include: 
“psychological arousal, distractibility, and other negative effects” that may persist 
for days to years post-event (Updegraff & Taylor, 2000). 
While expert opinion and the literature suggest positive effects on anxiety and 
depression, when stressful or life change events are perceived negatively they may 
impact on psychological distress (Smith, Johnson, & Sarason, 1978). Furthermore, 
Sarason et al. (1978) suggest that those with a negative perspective on life events 
tend to suffer anxiety and depression. Nakatani et al. (2013) undertook a study of 33 
participants, post-breast cancer surgery to investigate the association between 
psychological distress and psychological traits. Results revealed a propensity for 
patients who negatively viewed life events to both view and react negatively to 
certain circumstances on diagnosis, and treatment of breast cancer (Nakatani et al., 
2013). Although a different context to the focus of the present study’s intervention, it 
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is demonstrated how life events and trait anxiety can negatively impact on 
psychological distress, causing a “psychological distress-enhancing effect” (Nakatani 
et al., 2013). 
Muris et al. (1998) undertook a 2.5 hour behavioural intervention on 36 
women with spider phobias to determine if trait anxiety could predict outcomes in 
phobic disorder therapy. The authors highlight how patients with high trait anxiety 
levels in medical settings are often slower in their recovery, experience greater 
discomfort, and are more likely to be distressed than those with lower trait anxiety. 
Although a psychological intervention, results showed a significant correlation 
between high trait anxiety and limited effect of the intervention. In the present study, 
intervention group participants, although presenting with high trait anxiety may have 
benefited from attending the nurse-led clinic. Although the intervention was not a 
cognitive–behavioural intervention, a moderate effect was noted in the reduction of 
trait anxiety, while full recovery was evidenced in two intervention group 
participants. Reductions in mean ratings for trait anxiety from Time 2 (day 5–7) to 
Time 3 (1 month) was larger than that of standard-care group participants at this 
time. Lastly, although the overall reductions in mean ratings for trait anxiety from 
baseline measurement was greater in standard-care group participants, intervention 
group participants presented with higher trait anxiety. The smaller overall reductions 
in mean ratings for trait anxiety in intervention group participants may have been 
due to slower recovery and potentially as a result of greater distress suffered in this 
group of patients. These findings will need to be tested in a Phase Three study to 
confirm the accuracy of these preliminary results. 
While PCI is less invasive, Dehdari et al. (2008) undertook a study comparing 
anxiety and SE and social support in 150 CABG versus PCI patients and CR referral. 
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Dehdari et al. (2008) highlight how patients in their study were more anxious (as 
opposed to CABG patients), with greater state and trait anxiety scores identified, as 
did participants in the present study (compared to standard-care group participants). 
The authors also identified how the outcome of PCI is anxiety provoking and 
uncertainty surrounding this procedure and the future may lead to less control and 
poor coping (Dehdari et al., 2008). Furthermore, some participants in the study with 
high levels of anxiety also had poorer social support networks (Dehdari et al., 2008). 
It may be possible that intervention group participants in the present study had 
poorer social support networks and, therefore, greater trait anxiety than standard-care 
group participants. Thus, with greater trait anxiety, overall SE enhancements were 
not evidenced. Mean ratings for some CSE items demonstrated enhancements only at 
a single-item level when reviewed. 
Sipötz et al. (2013) assessed emotional distress in 163 PCI patients over 24 
months using the MacNew Health-Related Quality of Life Questionnaire and the 
Hospital Anxiety and Depression Scale. Corresponding with the present study, the 
researchers found improvements in MacNew “intra-individual change” up to 1-
month post-PCI, physical and social improvements at 6 months, and maintenance 
from 6 months until 24 months (Sipötz et al., 2013, p. 5). This study identified 
similar conclusions to the present study regarding participants’ experiences of PCI 
and identified the life-changing effect in participants after undergoing PCI. The 
authors recommended a time frame between 1 month to 6 months maximum in 
reviewing PCI patients and to measure the effects of the procedure on their HRQOL. 
Although the present study did not review the HRQOL, it did investigate 
psychological distress and the effects of the nurse-led clinic on CSE and trait anxiety 
as the primary aim. Furthermore, as participant follow-up over 12 months in the 
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present study was not feasible due to the time constraints of a PhD, patients were 
therefore reviewed over 3 months, with the primary endpoint at 1 month post-
discharge from hospital. 
In the present study, as identified earlier, reductions in trait anxiety were 
moderate in intervention group participants as evidenced in effect size calculations. 
Preliminary evidence demonstrates reliable change, and positive therapeutic 
outcomes in intervention group participants compared with standard-care group 
participants over time for trait anxiety. Effect size calculations for CSE saw 
moderate reductions in intervention group participants, while standard-care group 
participants did not demonstrate any increases in CSE. Recovery and improvement 
in CSE in a small percentage of participants was also evidenced in RCI calculations, 
while a larger percentage worsened. When reviewed at an item level, some CSE 
items showed improvements in mean ratings in intervention group participants’ SE, 
while overall CSE mean ratings saw improvements between Time 2 (day 5–7) and 
Time 3 (1 month) in standard-care group participants. 
Mean CSE ratings were also reviewed, with overall reduction in CSE of 5.84 
units from Time 2 (day 5–7) (pre-intervention) to Time 3 (1 month) (post-
intervention) evidenced. Overall mean CSE ratings in standard-care group 
participants reduced by 1.89 units over time from their baseline measurements. 
Cardiac Self-Efficacy (CSE) questionnaire items, as identified, were reviewed to 
observe if there were any increases over time for SE in more specific areas rather 
than a global assessment across multiple behaviours/areas. Small enhancements were 
demonstrated in mean ratings concerning participants’ confidence in their ability to 
change their diet, and lose weight. Furthermore, participants’ confidence in knowing 
how much physical activity to undertake improved, while participants’ confidence to 
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maintain usual activities at work and to control their breathlessness by taking their 
medications was enhanced. These results are interesting and are reflected in 
participants’ qualitative feedback as detailed in the Phase Two interviews, whereby 
study participants reported making changes concerning diet, weight loss, physical 
activity, and their medication regime and adherence. While ES calculations 
demonstrated an overall reducing effect in intervention group participants, small 
increases in mean ratings for some CSE items were evidenced. 
Katch and Mead (2010) reviewed strategies to encourage self-management in 
those with CVD. Katch and Mead (2010) identified that programs aiming to enhance 
SE to be most effective in encouraging disease and self-management. As per the 
present study, intervention group participants’ CSE as evidenced in ES calculations 
was not affected after attending the nurse-led clinic; however, when reviewed at an 
item level, five main CSE areas demonstrated small increases in mean ratings. 
Weight loss was a topic frequently discussed by intervention group participants 
throughout follow-up and most reported how this was progressing well for them, 
with overall body weight being gradually reduced over time due to changes in 
dietary intake and physical activity. Thus, as increases in mean ratings in some areas 
of CSE were evidenced, intervention group participants reported greater confidence 
to continue and maintain these changes over time, as reinforced by participant 
interviews as part of Phase Two. In light of these preliminary findings, and after 
undertaking critical reflection and Phase Two evaluation, the PI recommends that a 
well-powered, Phase Three, multi-centre study be undertaken to determine actual 
effect of the nurse-led clinic on SE and psychological distress. 
Small trends in mean ratings were also observed in CSE item confidence to 
control breathlessness by taking medications post-intervention (Time 3, 1 month) 
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whereas standard-care group participants saw a decline in CSE to control their 
breathlessness at Time 3 (1 month). Intervention group participants saw 
enhancements in mean ratings for medication adherence from Time 1 (baseline), 
while they were maintained at Time 3 (1 month). Medication adherence is reinforced 
in Phase Two of the study whereby intervention group participants reported greater 
adherence and care in taking and learning about their medications as a result of 
attending the nurse-led clinic. As identified earlier, CSE to change diet, knowing 
how much physical activity was appropriate, and confidence to maintain usual 
activities at work all increased after attending the nurse-led clinic as evidenced by 
mean ratings (Time 3, 1 month). Phase Two interviews demonstrated small 
enhancements in these areas with participants reporting greater focus on dietary 
intake and enhancing physical activity so that they could return to their work and 
activities. 
As patients are discharged from hospital and given that there is generally a 
short length of stay following PCI, it is a highly anxious time; information 
absorption may be obstructed and, as there may be limited time for nurse teaching, 
patients often seek information and self-educate post-discharge (Francombe & Knott, 
2013; Neubeck et al., 2011). Although in seeking education patients are being 
proactive, internet self-education may also present as a negative and cause the 
patient additional distress, create health misconceptions concerning the post-
discharge period, their cardiovascular health, and return to activities (Francombe & 
Knott, 2013). Thus, undertaking the present pilot study was essential so that 
participants could receive correct post-discharge information (verbal, visual, and 
written), be able to ask questions, and raise post-discharge concerns regarding their 
recovery. 
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While trends evidenced were maintained over a short period, due to PhD time 
constraints, this nurse-led clinic concept for PCI and CAD patients may act as a 
potentially effective support between hospital discharge, CR and cardiology follow-
up and warrants further investigation. Furthermore, it may assist in the adherence 
and compliance to a CR program if CBT is offered in a Phase Three study. 
Moreover, given that patients with high trait anxiety may be less susceptible to 
interventions further demonstrates the importance and necessity to trial a larger scale 
study over a longer period of time (Muris et al., 1998). 
6.1.3 Depression 
Although the study did not demonstrate effectiveness in achieving the 
secondary hypotheses, a small reducing effect was demonstrated on depression in 
both intervention and standard-care group participants. Additionally, a reliable 
change was evidenced in a small percentage of participants in both groups, along 
with improvement, recovery, and worsening of depression as highlighted in 
standardised recovery rates. Mean depression ratings for the Cardiac Depression 
Scale (CDS), as identified in the results chapter, were higher in intervention group 
participants at baseline and reduced at each follow-up. The strong association 
between depression and CHD is reinforced by Colquhoun et al. (2013) as well as by 
Bhattacharyya, Molloy, and Steptoe (2008), with diagnoses often missed during 
hospitalisation in patients due to a strong focus on the coronary event (AIHW, 2011; 
Davidson et al., 2008; Lane et al., 1999; Parissis et al., 2006; Turner et al., 2010). 
Routine screening for depression is recommended on hospital presentation, at 
follow-up and again 2–3 months post-coronary event, and routinely annually 
(Colquhoun et al., 2013). The present study screened participants at each follow-up 
visit and, as recommended by Colquhoun et al. (2013), any signs of depression were 
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to be referred for treatment if required. As mild depressive symptoms may resolve, 
depression in CHD patients is usually longstanding, and, therefore, warrants further 
investigation into the effectiveness of long-term nurse-led support and follow-up on 
long-term physical health and psychological distress (Colquhoun et al., 2013). As 
identified in Chapter 4, 9.1% (n = 3) of participants in the present study had been 
diagnosed in the past with clinical depression and were being treated (two 
intervention group and one standard-care group participant). As identified earlier, the 
PI highlighted longer participant follow-up to determine the effect of the nurse-led 
clinic on psychological distress. 
Zuidersma et al. (2013) reviewed the effectiveness of self-report on depressive 
symptoms, and clinical depression in 2,704 patients post-MI. Patients were screened 
over 3 months post-MI, recommending longer follow-up post-discharge (as opposed 
to screening during hospitalisation). The study by Zuidersma et al. (2013) highlights 
the present study’s follow-up and screening time up until 3 months post-discharge to 
detect actual clinical depression. Zuidersma et al. (2013) recommend screening to 
distinguish between life-changing depressive symptoms to the actual recognition of 
clinical depression post-coronary event (requiring five symptoms to be present for a 
minimum of 2 weeks, and affecting a patient’s daily living). As various patient 
factors (i.e., physiological and psychosocial), outcome expectations and socio-
structural factors and SE may affect an individual’s ability to set goals and achieve 
behaviour change it was important to screen for depression at Time 4 (3 months). 
While the study’s primary endpoint was at Time 3 (1 month), it was deemed 
essential to continue follow-up in light of the potential to detect psychological 
distress and ensure physical health maintenance (i.e., complications, medications, 
and lifestyle factors). 
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Rymaszewska, Kiejna, and Hadrys (2003) undertook a study measuring pre-
surgical depression and state and trait anxiety in 53 CABG candidates over 3 
months. Rymaszewska et al. (2003) identify how high levels of depression and state 
and trait anxiety measured pre-CABG surgery may predict post-procedural 
psychological outcomes and recommend pre-procedural screening to identify those 
at risk and arrange referral for appropriate treatment. The CABG surgery candidates 
had findings similar to the present study and demonstrate a reduction in depressive 
symptoms over time. Mean CDS scores for patients in the present study were <84 at 
all times post-discharge and were <66 at Time 3 (1 month). Hare et al. (2011) 
identify a score of >84 as with depression, and a CDS score >95 indicating major 
depression. It was interesting that on baseline measurement, 38.5% of intervention 
group participants in the present study had scored ≥84, while 61.5% of participants 
scored <84. Furthermore, on baseline measurement, 25.0% of participants scored 
>84, while 75.0% scored <84 on the CDS. Rymaszewska et al. (2003) demonstrated 
how 67.9% of patients did not have any depressive symptoms pre-operatively, while 
28.4% presented with mild depressive symptoms, and 3.80% presented with 
moderate depression. At Time 2 (day 5–7) in the present study, there were no 
changes in the percentages of all participants with and without depressive symptoms. 
Similarly, at Time 3 (1 month), the percentage of standard-care group participants 
with depressive symptoms reduced to 10%, while intervention group participants 
with depressive symptoms reduced to 15.4% (n = 2). Post-operatively, Rymaszewska 
et al. (2003) reported 71.7% of patients were symptom free, while 18.9% had mild 
depression and 9.4% had moderate depressive symptoms. At 3-month follow-up, 
Rymaszewska et al. (2003) identified how 73.6% of patients presented without 
depressive symptoms, while 17% presented with mild symptoms, and 9.4% with 
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moderate depressive symptoms. Depression, as identified in the study’s theoretical 
framework, coupled with socio-structural factors (i.e., anxiety, depression, poor 
social support), outcome expectations (i.e., weighing up the positives and negatives 
of performing a behaviour), and low SE or efficacy beliefs may be an impediment to 
achieving post-operative goals and behaviours (Bandura, 1977, 2004). Therefore, the 
reduction in depressive symptoms identified in participants in the present study is 
important in that it may have contributed to participants feeling confident to 
effectively manage their post-discharge health, as highlighted in Phase Two 
interviews. Although SE reductions as evidenced in CSE effect size and reliable 
change calculations in the present study do not reinforce the SE theory, the PI 
encourages the undertaking of a well-powered Phase Three study to determine the 
effectiveness of the nurse-led clinic on SE and depression. 
The ‘Identifying Depression as a Comorbid Condition (IDACC)’ study 
recruited 669 cardiac patients between 2000 and 2002 (Wade et al., 2005). 
Participants had experienced either an MI, unstable angina, cardiac arrhythmias, 
heart failure, PCI or CABG surgery, and were followed over a 12-month period. 
Individuals were either screened and treated for depression, or randomised to a 
standard-care group without any treatment. This study saw large reductions in 
depressive symptoms in all treatment arms (GP, case conference, and telephone), 
with the psychiatrist telephone follow-up arm achieving significant reductions in 
depressive symptoms in those with moderate to severe depression over a 12-month 
period post-hospitalisation. The IDACC trial not only reinforces the importance of 
screening all cardiac patients for psychological distress; however, it also highlights 
the need for post-discharge follow-up, screening, and referral for treatment (if 
required). As the prevalence of depression in this group of patients is high, the need 
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for the present pilot and future Phase Three is warranted, with preliminary findings 
demonstrating small reductions in depressive symptoms over time and reliable 
change. It was notable that standard-care group participant 013 experienced a 
significant reliable change; however, the significance may have been attributed to a 
changed dose of anti-depressive medication. The participant reported medication 
levels had been sub-therapeutic, and after adjustment of the dose, the participant 
reported they had begun to feel the therapeutic effects. Participant 013 was elated, in 
that they had not felt this good in a long time. Lastly, as interdisciplinary team 
communication can be problematic (as encountered in the IDACC trial), nurse focus 
and referral of this group of patients for psychological treatment until the time of CR 
commencement or over 12-months post-discharge is warranted (Wade et al., 2005). 
Overall, although the study did not achieve primary and secondary objectives, the 
present study’s findings demonstrated a small reduction in mean ratings for 
depression in intervention group participants over time. Standard-care group 
participants also experienced a small effect and reliable change. 
As identified, mean ratings for depression also reduced over time for both 
groups of participants in the present study, with intervention group participants 
displaying higher baseline mean scores after closer inspection. It is important that a 
Phase Three study be undertaken to further explore the potential and effect of the 
nurse-led, educational intervention on the reduction of psychological distress, 
enhancement of SE, and encouragement of effective self-management, behaviour 
change and maintenance. As SE, psychological state, social support, and other 
factors influencing SE may affect patient goal-setting and achieving outcomes, 
although only held once the nurse-led clinic and its preliminary findings demonstrate 
efficacy to undertake a future Phase Three study. As detailed in Chapter 5, the Phase 
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Three study aims to examine the effect of a nurse-led clinic on psychological 
distress, efficacy beliefs, and self-management. Furthermore, it was proposed in 
Chapter 5 that all RAs involved in undertaking the nurse-led clinic be trained in CBT 
so that study participants’ negative thoughts and behaviours may be challenged. The 
beliefs surrounding CBT include how cognition affects a person’s emotions and 
behaviours and, conversely, how emotions and behaviours both affect cognition 
(Lewin, Furze, & Donnison, 2008). As the Phase Three study aims to enhance SE, 
reduce psychological distress, and encourage effective self-management and 
behaviour change, it is essential that CBT techniques be used to assist in the change 
of behaviour through change in thought process (Lewin et al., 2008). 
Lewin et al. (2008) explain the effectiveness of CBT in chronic disease 
management and how it focuses on three levels of cognition to achieve change. 
These levels of cognition include: 
 “core beliefs”: unconditional beliefs held that may be positive or 
negative 
 “assumptions or rules” conditional, more accessible cognition that 
guides a person’s behaviour 
 “automatic thoughts and images”: most accessible and highly 
influential on a person’s mood; they occur very often throughout the 
day. 
In addition, a trusting relationship is also essential in achieving effective 
therapy with the authors highlighting the counsellor needs to show authenticity and 
be non-judgemental while communicating and feeling empathy (Lewin, 2008). 
6.1.4 Self-Management 
Research suggests that self-management programs may be equally as 
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beneficial as cognitive–behavioural interventions (Barlow et al., 2002). Barlow et al. 
(2002) highlight that patients with chronic illness who do not volunteer to participate 
should be flagged and further support offered as they may find the notion of self-
management and transition somewhat difficult. It is recommended that self-
management interventions follow participants over a longer period to measure 
psychosocial, disease, and cost-related outcomes (Barlow et al., 2002). Barlow et al. 
(2002) identify how self-management programs may be undertaken by various health 
professionals (including nurses) and “lay tutors”. Self-management programs aim to 
enhance knowledge, encourage symptom management, engage in self-management 
behaviours learnt (in the program), enhance SE, and address health-related issues, 
such as psychological distress as did the present study (Barlow et al., 2002). 
Although secondary aims sought to encourage effective self-management in 
intervention group participants, it is important to address how effective self-
management is not only affected by psychological factors, but also SE. Thus, as 
primary aims focused on enhancing SE and reducing anxiety, engaging in the nurse-
led clinic, receiving education concerning post-discharge cares, health maintenance 
and goal-setting, may have led to small increases in CSE item mean ratings. 
Additionally, participating in the nurse-led clinic also acted to reduce depressive 
symptoms and, thus, encouraging effective self-management behaviours as 
evidenced in preliminary trends and in Phase Two self-report. However, as the study 
was undertaken as a pilot, with study objectives not achieved as expected, and as full 
formal analyses were not able to be undertaken, these results must be confirmed in a 
Phase Three study. 
Barlow et al. (2002) highlight that although effective (as compared to receiving 
standard care), not all outcomes are achieved in self-management programs. Overall, 
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the present study demonstrated a moderately reducing effect on CSE and trait 
anxiety in intervention group participants, while CSE in standard-care group 
participants evidenced a small increasing effect and minor reductions in trait anxiety. 
A small reducing effect was demonstrated on depressive symptoms in both groups. 
Participants spoke frequently regarding their personal self-management, with 
reference given often to chest pain and management, access sites, lifestyle and 
dietary changes made (and subsequent weight loss), exercise, and medication 
adherence. 
6.1.5 Secondary Aims: Salivary Cortisol 
Salivary cortisol assays 
Overall, there were no significant expected reductions in salivary cortisol assay 
results in the present study for intervention and standard-care groups. Standard-care 
group participants’ salivary cortisol assay results demonstrated a larger reduction in 
mean cortisol level ratings than the intervention group over time. Hellhammer, Wūst, 
and Kudielka (2009), and Hjortskov, Garde, Ørbæk, and Hansen (2004) identify how 
salivary cortisol is widely used as a biomarker of psychological distress. As 
identified in the Chapter 4, a reduction in mean cortisol and psychological distress 
ratings was evidenced from baseline assessment and at Time 3 (1 month), although 
all mean cortisol levels measured (including baseline measurements) fell within the 
reference ranges for cortisol levels (Salimetrics®, 2010). It was interesting that while 
mean anxiety and depression ratings observed were higher in intervention group 
participants at baseline, mean salivary cortisol assay results presented highlighted 
standard-care group participants as experiencing greater stress than intervention 
group participants. Although results differed, as mean anxiety and depression ratings 
reduced, so did salivary cortisol at Time 3 (1 month). Hellhammer et al. (2009) 
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identify a variety of factors affecting salivary cortisol that may include: gender, 
medications, environment, the presence of medical personnel; and the medical 
diagnosis. Moreover, Hellhammer et al. (2009, p. 164) highlight a poor association 
between salivary cortisol and stress measured in self-report “stress questionnaires”. 
The authors identify how self-reported stress differs as it measures “theoretical stress 
concepts and foci” and may be affected by gender and personality. The differences 
between self-report tools and salivary cortisol assay readings as identified by 
Hellhammer et al. (2009) may account for the differences seen in anxiety and 
depression tools used in the present study. 
Hjortskov et al. (2004) undertook a systematic review of the literature to 
investigate the association between self-reported stress and self-report measures in 
workplace stress. Results of the review revealed no association between salivary 
cortisol measured versus self-reported stress in study participants. The authors offer 
several explanations for this finding, suggesting inconsistencies in: (a) cortisol 
sampling techniques and times, (b) effects of chronic stress, (c) difference in cortisol 
during work versus off days, (d) stressors (i.e., type), (e) self-report tools, and (f) 
study designs (Hjortskov et al., 2004). Although Hjortskov et al. (2004) reported no 
association between salivary cortisol and self-reported stress, the authors do identify 
the possibility of a correlation between cortisol and more specific stress 
measurement tools, with anxiety highlighted. The present study used a more specific 
measurement tool for anxiety as recommended by Hjortskov et al. (2004). As mean 
ratings for trait anxiety reduced, so did salivary cortisol levels. Thus, while overall 
reductions in mean ratings for salivary cortisol levels were identified and are 
comparable with mean reductions in trait anxiety ratings, mean cortisol level ratings 
appeared to be slightly higher in standard-care group participants. As per Hjortskov 
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et al. (2004), reductions in mean ratings in both cortisol and anxiety demonstrate 
preliminary evidence that differences between objective and self-report measures 
may exist. A larger, well-powered study must be undertaken with formal testing to 
comment on study effect and significance. 
6.1.6 Medication Adherence 
Overall, medication adherence in the present study was not consistent with the 
study’s hypothesis and did therefore not increase in intervention group participants 
after attending the nurse-led clinic. In standard-care group participants, however, 
small enhancements in medication adherence were noted. Medication adherence is a 
significant issue in patients with CVD, with approximately 50% of patients 
following with their prescribed medication regime (Coleman, 2012; Haynes et al., 
2008). Admission for PCI (i.e., both primary and elective) can be overwhelming, 
with a short length of stay, and a multitude of new medications prescribed, patients 
may feel overcome with emotions, which may affect medication adherence (Young 
& Murray, 2011). Young and Murray (2011) highlight the importance of measuring 
medication adherence while also continuing in-patient education (for post-discharge 
management) given the short length of stay (Young & Murray, 2011). Jackevicius, 
Li, and Tu (2008) identify how medication non-adherence can occur at a primary and 
secondary level, with most patients secondary non-adherers. Primary non-adherence 
has been reported in approximately 1–21% of patients and requires further 
investigation on outcomes, while secondary non-adherence is widely reported on, 
particularly in the management of dyslipidaemia and hypertension (Jackevicius et al., 
2008). 
Effect size calculations demonstrated nil effect on medication adherence in 
intervention group participants, while in standard-care group participants, a small 
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increasing effect was evidenced. Standardised recovery rates displayed in Chapter 4 
clearly illustrated a large percentage of intervention group participants maintaining 
medication adherence behaviours, with small percentages of participants worsening 
and improving. Reliable change calculations demonstrated maintenance of adherence 
to their current medication regime, while a small percentage of participants in both 
groups of participants improved. Increases in mean medication adherence ratings 
were seen in intervention group participants from baseline to Time 1 (baseline), and 
were maintained from Time 2 (5–7 days) to Time 3 (1 month), then enhanced from 
Time 3 to 4, although mean ratings for both groups were at a medium adherence 
level from baseline to time 4 (upper end of high medium adherence). The greater 
increase in medication adherence in standard-care group participants over time may 
have been attributed to CR attendance (6 attended, while 1 discontinued), and/or 
cardiology review. It is noted, however, that 23 participants in total declined CR 
attendance as they had either attended in the past and reported that they could recall 
information received, had exercise knowledge, and/or a medical background. Of 
note, the longest time that a participant had not attended a CR program was 10 years. 
Cardiac rehabilitation attendance will be discussed later in this chapter. Standard-
care group participants may have actively sought post-discharge education or 
alternately, the education that they were provided with may have assisted in their 
recovery and thus, had an effect on medication adherence. Participation in a study 
alone can lead to changes in behaviour and is known as the Hawthorne effect, which 
may have also contributed to the improvements in measured variables over time 
(Polit & Beck, 2010). 
When asking participants if they knew what medications they were consuming, 
as identified in Chapter 4, most reported they could do so; however, when 
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medication knowledge and recall was assessed (i.e., medication name, action, dose, 
and frequency), most participants could not recall all details, and required prompting, 
and/or requested to view a list. Importantly, intervention group participants’ ability 
to recall the aforementioned medication details was enhanced over time with 23.1% 
recalling information at baseline measurement, to 38.5% recalling post-intervention, 
and 53.8% recalling their medication details at final follow-up post-discharge 
compared with 30%, 25%, and 35% in standard-care group participants recalling 
medication details throughout the course of follow-up. Although standard-care group 
participants reported greater adherence in taking their medications throughout the 
course of follow-up (as measured by the MMAS-8), intervention group participants, 
while also slightly improving in adherence as evidenced on inspection of mean 
ratings, after attending the nurse-led clinic, had better medication knowledge and 
recall. 
As identified in the literature, medication adherence, particularly in chronic 
disease is poor (Fernandez et al., 2007; Haynes et al., 2008). Medication adherence 
in all participants in the present study remained stable in a majority of participants 
over time and enhanced in a small percentage in both groups of participants; 
medication recall and knowledge was only enhanced in the intervention group 
participants. Similar results are reinforced in a study of 270 PCI patients by 
Fernandez and colleagues (2007). High medication adherence was reported by 
participants; however, medication knowledge gaps were identified (i.e., poor storage 
knowledge) and medications were reported as discontinued, skipped, or missed. 
Medication knowledge has been identified as a reason behind poorer adherence with 
several factors affecting medication adherence and compliance such as: (a) poor 
knowledge, (b) medication and medicine beliefs, (c) personal experience and beliefs, 
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and (d) family and friends’ experiences (Vermeire, Hearnshaw, Van Royen, & 
Denekens, 2001). The authors also highlight that a major determinant of compliance 
is knowledge and patient attitude (Vermeire et al., 2001). These findings are 
reflected in the present study where intervention group participants’ medication 
knowledge and adherence at baseline measurement was at the lower end of medium 
for adherence. As time passed, medication knowledge enhanced, while adherence to 
their medication regime was maintained for a large percentage of participants. 
Vermeire et al. (2001, p. 337) advise that “adherence-aiding” approaches to 
medication compliance and adherence are more effective when merged and 
recommend strategies to include knowledge enhancement, information recall, and 
enhancing motivation. Vermeire et al. (2001) also highlight the benefits of one-on-
one education and counselling, and highlight how written material combined with 
verbal education encourages medication compliance as opposed to literature only. 
They also recommend interventions that combine education and behavioural 
strategies to enhance compliance, and adherence issues. The present study delivered 
verbal education to complement written pharmacological information delivered in 
hospital, while presenting visual information via a PowerPoint presentation. As 
reinforced above, poor medication adherence is common and determined by a range 
of factors. As medication knowledge appeared to be enhanced in the present study, it 
may have been attributed to the delivery mode, and methods used in the nurse-led 
clinic. Although standard-care group enhancements were also seen, this group were 
less anxious, and may have simultaneously sought education post-PCI outside of the 
hospital setting (i.e., internet or the literature). Importantly, as identified earlier, 
although most participants had previously participated in CR, medication adherence 
scores remained at the upper end of medium for the MMAS-8 after attending the 
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nurse-led clinic. Additional factors affecting medication adherence may include 
depression, socioeconomics, and lifestyle (Colquhoun et al., 2013; Katch & Mead, 
2010; Zuidersma et al., 2013). 
Haynes et al. (2008) undertook a comprehensive review of 93 RCTs in the 
literature to determine the effects of long and short interventions on medication 
adherence and the effects of treatment. The authors identify the effectiveness of 
some short interventions on medication adherence; however, highlight that complex 
long-term intervention studies may be more effective in achieving outcomes (Haynes 
et al., 2008). Haynes et al. (2008) report that while significance in some outcomes 
and adherence were achieved, they were not large effects. Overall, intervention 
group participants did not demonstrate increased medication adherence after 
participation in the intervention. What was demonstrated was maintenance in 
adherence to medication regimes, and enhancements in medication knowledge. 
Notably, mean ratings for medication adherence were increased in standard-care 
group participants only, while overall medication knowledge reduced. Potentially, 
effective medication self-management in intervention group participants may have 
encouraged sustained adherence, which may explain maintenance of regimes. 
Further investigation of the effects the nurse-led clinic on medication knowledge is 
recommended. Furthermore, a Phase Three study may assist in determining if 
increases in mean ratings in CSE items contribute to effective medication adherence, 
knowledge and effective self-management. 
6.1.7 Cardiac Rehabilitation (CR): Referral, Attendance, and Adherence 
As identified, 74% (23) of participants in the study declined CR as they had 
either attended a CR program in the past or believed they had the knowledge to 
commence their own rehabilitation at home. The reasons that participants declined 
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CR enrolment were due to exercise instruction qualifications, or medical knowledge 
(i.e., bachelor’s degree level health knowledge). Among the intervention group 
participants, two accepted referral (onw had attended CR in the past), while six 
standard-care group participants agreed to referral to a CR program. Reasons for 
non-attendance were that participants were either too busy, had been in the past and 
could self-rehabilitate, had adequate knowledge (i.e., qualified exercise instructor, 
health degree) or due to illness or surgery (i.e., severe rheumatoid arthritis or 
underwent a total knee replacement). Convincing participants to re-attend proved to 
be problematic in this study. Notably, one intervention group participant who had 
attended CR in the past and had accepted CR enrolment cancelled from the course 
and undertook and adhered to a private health-fund driven, telephone follow-up CR 
program. Reasons given were that it was convenient as they could rehabilitate from 
home and would not have to travel to attend the program. Thus, a more flexible 
approach to CR course mode attendance for future programs is recommended in 
view of the results of the present study. 
The demand for home-based and/or alternate delivery mode for CR is a trend 
noted and evident in the literature, with current research suggesting similar health 
outcomes to that of a clinic-based CR program (Clark et al., 2013; Cupples et al., 
2010; Hall & Lorenc, 2010; Varnfield et al., 2011). Although participants had 
attended a CR program in the past, most believed they had the knowledge to 
continue rehabilitation from home (it had been 10 years since attending CR for one 
participant). These results are reinforced by the literature where referral, attendance, 
and adherence to a CR program is identified as poor (Dafoe et al., 2006; Pack et al., 
2013; Varnfield et al., 2011; Zuidersma et al., 2013). As identified in Chapter 2, the 
issues affecting the uptake of CR and self-management may include geography, 
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psychological distress, social support, community issues, funding, and organisational 
issues (Cupples et al., 2010; Dafoe et al., 2006; Katch & Mead, 2010; Lichtman et 
al., 2008; Varnfield et al., 2011; Zuidersma et al., 2013). Geography, time 
constraints, and reliance on family for transportation were identified as deterrents 
among patients attending a program in the present study. 
Effective self-management and, thus, attending or re-attending CR, may have 
been affected not only by patient factors such as physiological and psychological 
states, but also by their beliefs and SE level at the time (Bandura, 1977, 2004). 
Although most first-time PCI patients attended CR, there is the issue of repeat PCIs’ 
non-attendance (especially those who have not been in several years). Further studies 
may be required to investigate CR needs and delivery mode for repeat PCIs; in 
particular, the effectiveness of a CR short course, timing, and frequency. Research 
questions could be posed about course length, content, flexibility, and frequency of 
repeat attendance (e.g., bi-annually after first course attendance), as well as the 
efficacy of repeating CR clinics on SE, psychological distress, and effective self-
management. Yu et al. (2004) highlight the effectiveness of CR in enhancing a 
patient’s quality of life (QOL) post-AMI and elective PCI. The authors identify the 
lasting effects of CR on QOL at 2 years post-CR (Yu et al., 2004). Given the benefits 
of CR on QOL and maintenance, it would be advantageous to trial a biannual CR 
short course and measuring the effects on QOL, SE, psychological distress, self-
management, behaviour change. 
Potential participants gave similar reasons for declining participation in the 
present study on recruitment and concerning CR attendance as is highlighted in the 
literature. The PI, as identified, approached 91 participants, with 64 declining due to 
geographical limitations, time constraints, or reliance on others for transportation to 
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the nurse-led clinic. As CR and post-discharge nurse-led follow-up and support are 
important to recovery and the adoption of positive health behaviours, alternate 
options for attendance (i.e., electronic delivery and nurse-led clinics) are warranted. 
Recruitment issues, predominantly geographical isolation in the present study, 
assisted in informing the Phase Three study. As identified in Chapter 5, rather than a 
face-to-face intervention, the Phase Three study will be undertaken using an 
electronic visual medium so that a broad range of patients may partake in the nurse-
led clinic. In the literature, an intervention study on diabetes and lifestyle 
management (i.e., diet, weight, exercise) had to abandon recruitment after five 
months (Jelinek et al., 2012). The authors highlight various reasons for poor 
recruitment that include complacency, distress, study design, and lack of clinician 
support (Jelinek et al., 2012). After reflecting on the study by Jelinek et al. (2012) 
coupled with Phase Two interviews, the PI was able to redesign the study. In doing 
so, future participation in the Phase Three study will be less time-consuming, require 
no travel arrangements, and facilitate ease of recruitment in that participants may 
undertake the intervention from home. 
6.1.8 Complication Identification and Management 
Described below are the complications experienced by participants throughout 
the course of the study. Complications experienced were minimal; however, they 
included small haematomas, bruising, and angina. 
Haematoma and bruising 
Participants reported confidence in self-management of post-discharge 
haematomas at each follow-up. Participants remained aware of their access- site 
wound and felt especially confident in effectively managing any potential 
complication. At the nurse-led clinic, and on discharge from hospital, participants 
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were educated on normal, expected post-discharge haematoma size, while also being 
informed on when and how to take action. Notably, participants recalled the amount 
of digital pressure required should their haematoma increase beyond the sizes that 
were normal, and all recalled to lie flat and call for an ambulance if required. Recall 
of actions (i.e., pressure required) for haematoma management may be attributed to 
both the hospital experience and the nurse-led clinic. Patients recalled the removal of 
femoral arterial sheaths by nursing staff, in particular, the pressure and length of time 
required at the site to achieve haemostasis. Thus, femoral arterial sheath removal 
coupled with the repetition offered at the nurse-led clinic may have assisted in 
encouraging confidence to effectively self-manage access sites and potential 
complications. The nurse-led clinic reinforced access site education and specific 
information concerning site pressure, position, length of time for pressure, and 
calling for an ambulance. No actions were required from a nursing perspective as 
small haematomas post-PCI are common (Wong et al., 2006). 
Mild and major bruising was identified in the present study, and is a common 
post-PCI complication (Cosman et al., 2011; Wong et al., 2006). Cosman et al. 
(2011) highlight how early post-discharge bruising after cardiac catheterisation 
and/or PCI is not well documented and undertook a study investigating access site 
complications via telephone at 5–7 days post-discharge. As identified, participants 
were observant and noted any access-site changes (i.e., bruising, haematoma). 
Cosman et al. (2011) identified that a majority of patients experience significant 
bruising post-discharge and the importance of nurse education and preparation for 
discharge. The authors identified (via self-report data) reports bruising in 
approximately 68.6% of access sites after undergoing cardiac catheterisation and/or 
PCI in their study, with major bruising identified in 47% of participants (i.e., > 7.5 
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cm) (Cosman et al., 2011, p. 1349). In the present study half of the participants 
developed bruising at Time 1 (baseline), with the mean bruising size 7.78–9.57 cm. 
The extent of bruising increased from normal bruising to major bruising between 
Time 1 (baseline) and Time 2 (day 5–7) in the present study. By Times 3 (1 month) 
and 4 (3 months), bruising was minimal and disappearing. 
Overall, no haematomas were experienced by participants. Currently, access 
site education appears to be well attended to in hospital, with participants recalling 
wound site complication management and, in particular, the pressure required to 
effectively manage a haematoma. While position and length of time were reinforced 
at the nurse-led clinic, participants reported confidence to effectively self-manage a 
post-discharge haematoma. Almost half of participants experienced major bruising 
that became evident at Time 2 (day 5–7). Participants were not concerned but 
expressed astonishment at the extent of their bruising and were offered education and 
reassurance from the PI at the nurse-led clinic. Bruising began to disappear between 
Time 2 (day 5–7) and Time 3 (1 month). Participants reported feeling confident that 
they could effectively self-manage and action any access site complication. 
Angina 
Post-PCI angina experienced by participants in the present study is supported 
by the literature, with approximately 20–30% of patients in The ‘REALITY CHEC’ 
Project reporting post-discharge angina at their first clinical review, and up to 40% at 
3 months post-procedurally (Marzilli, Huqi, & Morrone, 2010). The literature 
highlights that up to 50% of patients in the post-PCI population will experience 
angina post-procedurally with symptoms ultimately increasing (Marzilli et al., 2010, 
p. 27; Wong et al., 2006, p. 583). Actions taken by participants varied from rest and 
anginine administration, to rest without anginine. Some participants reported they 
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did not have anginine with them at the time they experienced their chest discomfort, 
while others carried it on them at all times. One participant presented at a hospital 
emergency department and was released later that afternoon, while others contacted 
their GP or cardiologist to arrange for follow-up. 
Management of angina varies among patients, with the literature highlighting 
delayed action and management as found in some participants in the present study 
(Farooq, Quereshi, & Squire, 2007; Gallagher et al., 2012). Gallagher et al. (2012) 
also highlight that, although patients can be educated regarding angina self-
management, the knowledge gap needs to be investigated and the potential to correct 
the knowledge misconceptions must be gauged. Furthermore, even with CR 
programs in place, correcting misconceptions may still not be possible and requires 
further investigation (Gallagher et al., 2012). Thus, intervention group participants in 
this study may have delayed actions and angina self-management even though 
management strategies were provided using the NHFA’s “Chest Pain Action Plan” 
and hypothetical scenarios. At Time 3 (1 month), six of the participants experiencing 
angina were intervention group participants. All reported resting, while three 
reported taking anginine in addition to resting, while two participants made 
immediate contact with their GP and cardiologist. Symptoms disappeared within a 
few seconds to 10 minutes and included twinges, niggles, heaviness, and shortness of 
breath. One participant reported tolerating symptoms for up to 3 hours while pain 
was experienced at a level of 2–3 out of 10. Another participant self-administered a 
bottle of anginine over a period of 1 week and still did not access medical treatment. 
Delays in calling an ambulance or accessing medical assistance are very common 
with patients tolerating CP for up to 3 hours in developed countries (Gallagher et al., 
2012). 
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Farooq et al. (2007) highlight how most participants tolerate angina and 
withstand their symptoms, often delaying hospital admission, or GP consultation. 
Rasmussen, Munck, Kragstrup, and Haghfelt (2003) undertook a study investigating 
the time it took from the onset of angina until participants accessed medical 
treatment, with the aim to determine reasons for delayed access (Rasmussen et al., 
2003). Of the 377 participants, the mean time to access medical treatment was 2.85 
hours (Rasmussen et al., 2003). Patients self-medicated and waited for symptoms to 
abate, while also identifying that they did not want to be a burden on the healthcare 
system as reasons for delaying access to medical assistance (Rasmussen et al., 2003). 
Delaying time to hospitalisation is reinforced in the present study where some 
participants attempted to tolerate their symptoms. Self-management of angina and 
symptoms in most patients was reported effective as identified by a majority of 
participants in both groups. Most intervention group participants commented on 
further clarity offered in reviewing the “Chest Pain Action Plan” followed by a 
clinical scenario. Participants voiced that the education received, coupled with the 
“Chest Pain Action Plan”, was clear, concise, and could be followed in the event of 
angina. Particular attention was directed at the phone number (“112”) to dial if 
calling from a mobile phone. Most intervention group participants reported they 
were not aware that a different telephone number was to be dialled if “000” was not 
effective from their mobile phone. Participants’ confidence to effectively self-
manage angina post-intervention may have been enhanced as a result of chest pain 
education as reported by participants. As most patients had PCIs in the past, most 
were able to identify their CP symptoms immediately, and were effective in their 
self-management. Those who significantly delayed treatment or who consumed 
anginine in excess were referred to their cardiologist or GP for follow-up. 
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Potentially, participants who were not successful in their self-management may have 
been suffering greater psychological distress and/or a lower SE at the time of their 
angina, therefore feeling less confident to self-manage their discomfort and delaying 
access to medical treatment. While most participants had good social support 
networks, poor social support may also reduce SE and lead to poorer confidence to 
set and achieve goals and, thus, make positive health behavioural changes. 
The following discussion of Phase Two results identifies the analytical 
findings from the nurse-led clinic program evaluation. Analytical findings include 
(a) support enhances recovery, (b) coming to understand the situation, (c) self-
awareness enhances self-management, and (d) pressure on the patient—attending 
cardiac rehabilitation (CR). Analytical findings offer rich data from participants’ 
own experiences of undertaking the nurse-led clinic. Findings are presented with 
respect to the literature and Phase One findings. 
6.2 Phase Two: Discussion 
6.2.1 Analytical Findings: Support Enhances Recovery 
This finding, as identified in Chapter 4, emerged in response to the support 
offered by the PI who undertook all nurse-led consultations. The importance of 
follow-up with a healthcare professional was highlighted by participants as 
beneficial to recovery, and during the post-discharge period. The degree of 
reassurance felt was reflected in participants’ comments. Participants’ voiced that the 
sense of reassurance surrounded knowing that any post-discharge questions could be 
asked, and that they would not have to inconvenience their specialist or GP for 
advice. Schadwaldt and Schultz (2011) and The JBI (2010) identify the effectiveness 
of cardiology nurse-led clinics. Schadewaldt and Schultz (2011) highlight that the 
level of support provided by the nurse determines success in achieving patient goals 
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and behaviour change. The authors highlight the significance of nurse-led clinics (as 
opposed to clinics run by non-nurses) on behaviour, risk factor modification, and 
treatment for CHD (JBI, 2010; Schadewaldt & Schultz, 2011). 
Nurse–patient relationships and communication plays an important part in-
patient support, motivation to change behaviours, and recovery, particularly in 
vulnerable situations such as being hospitalised (Liljeroos, Snellman, & Ekstedt, 
2011). Liljeroos et al. (2011) explored the nurse–patient relationship and 
communication in 10 MI patients with a trusting and positive relationship reported, 
as well as a sense of feeling valued. The study by Liljeroos et al. (2011) reinforces 
Phase Two findings where participants felt comfort in the presence of their nurse to 
share their views on making lifestyle adjustments, which may have enhanced 
participants’ motivation to make modifications. This finding is important as 
participants reported nurse support as strengthening their motivation to change and 
adopt healthy behaviours. The discussion and responses of the nurses in identifying 
the benefits of adopting healthy behaviours may have also acted to enhance 
motivation to change (Liljeroos et al., 2011). Participants in the present study 
identified the PI’s support as essential in that it was reassuring during the early post-
discharge period, where they felt it was a period of unknown. Offering patient 
support as the healthcare professional may have benefited the patients in many ways, 
including allaying any anxieties. While a small reducing effect was evidenced on 
CSE, anxiety was moderately reduced along with a small effect on depression scores. 
Although, overall CSE was not enhanced, small reductions in some mean CSE items 
were identified. Potentially, the reduction on anxiety and depression may have 
offered participants the clarity to set and reach health goals, and more effectively 
manage their post-discharge health. 
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Moore et al. (2002) report the success of nurse-led care in a RCT of 203 lung 
cancer patients and demonstrated very high satisfaction with nurse-led follow-up (as 
measured by a satisfaction scale). Participants were so satisfied that they declined 
post-study GP follow-up, wanting to continue with the nurse-led clinic (Moore et al., 
2002). Success was achieved in the areas of physical symptom management and 
emotional status, with the participants reporting no reduction in quality of life 
(Moore et al., 2002). Furthermore, this proved to be safe and cost-effective, while 
reducing the burden on outpatient departments, GPs, and specialists (Moore et al., 
2002). It is interesting that the Queensland (QLD) Government together with the 
Department of Health have developed a ‘Strategic Plan’ that aims to both enhance 
the health of all Queenslanders, while reducing the burden on the current healthcare 
system (QLD Government, 2013). As part of the plan it is anticipated that more 
nurse-led clinics will be initiated to facilitate access to specialists and diagnostic 
areas, reduce hospital admission, provide access to rural, remote and indigenous 
communities, and to set in place a new model of care and delivery for nursing (QLD 
Government, 2013). As reinforced by Moore et al. (2002) nurse-led clinics are 
effective in achieving various goals, including patient health and wellbeing (QLD 
Government, 2013). The study by Moore et al. (2002) coupled with the evidence 
reported by the QLD Government (2013) reinforces the importance of the present 
study, where nurse-led clinics and follow-up may achieve positive outcomes and 
patient satisfaction. Furthermore, in achieving patient satisfaction, symptom and 
emotional relief, a more trustful relationship may develop. Patient satisfaction and a 
trustful relationship may have been demonstrated in the present study. The evidence 
of a trustful relationship may be reflected in Phase One and Two findings, where 
effect size, RCI calculations and anxiety and depression mean ratings reduced over 
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time. Moreover, participants also reported satisfaction, support, and confidence in 
the PI while simultaneously reporting greater confidence to undertake post-discharge 
cares and to self-manage. While overall CSE was not enhanced, small enhancements 
in trends of some CSE items were observed. Furthermore, a moderate reduction in 
trait anxiety and small reduction in depression as evidenced in ES calculations may 
have been attributed to the support offered by the PI as verbalised in Phase Two 
interviews. A well-powered Phase Three study, however, may offer far more 
conclusive evidence to support the link between supportive relationships in 
enhancing SE, reductions in psychological distress and effective self-management. 
Importantly, in situations of vulnerability, establishing a trustful relationship 
can be difficult (Liljeroos et al., 2011). Negative relationships are common in nurse–
patient relationships where power imbalances may develop, and the need to 
encourage patient-centred communication is paramount. Patient-centred 
communication was used in the present study to enhance and develop a positive 
nurse–patient relationship (McCabe, 2004). The PI used effective communication 
techniques in the delivery of education, not only to facilitate the comprehension and 
application of information delivered but to also develop client rapport and, thus, a 
positive nurse–patient relationship (Falvo, 2004). Falvo (2004) argues that achieving 
a good rapport with patients is an essential part of the healthcare professional–patient 
relationship, highlighting that it creates respect, shows care, and creates trust. 
Effective participant education and a good nurse–patient relationship in the present 
study could not have been achieved if the PI did not use the following patient 
education components: (a) recognition of verbal and non-verbal cues, (b) accuracy 
and appropriateness in response to participant signs, and (c) offering feedback and 
support (Falvo, 2004). The successful use of the aforementioned skills is essential in 
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attaining correct information, encourages patient expression, and assists in the 
recognition of patients’ misperceptions (Falvo, 2004). Thus, overall, in applying 
effective communication strategies to the present study, a good rapport and trust was 
developed with the PI, therefore achieving a positive nurse–patient relationship and 
patient satisfaction. 
The finding that support enhances recovery in the present study after attending 
the nurse-led clinic, was an important finding. Through the analysis of trends in 
Phase One and analytical findings from Phase Two data, it was noted that when 
patients reported support and satisfaction with the nurse-led clinic, it appeared to 
coincide with an increase in knowledge, greater compliance, and adherence with 
self-care. Hill (1997) identifies the importance of patient satisfaction, particularly in 
chronic disease. Hill (1997, p. 347) highlights how patient satisfaction is measurable 
and determines successful healthcare professional–patient relationships, compliance, 
and whether or not medical opinion is sought. It has been argued that the level of 
satisfaction in care received is similar to QOL in those suffering chronic disease and, 
if satisfaction is felt in the healthcare professional–patient relationship, it is almost 
equal to reporting good QOL (Hill, 1997). Overall, the support provided by the PI at 
the nurse-led clinic was reported as effective by participants, offering reassurance in 
education and physical assessment and, thus, the confidence to manage in the early 
post-discharge period. 
With a short hospitalisation following PCI and limited nurse teaching time, 
participants raised the issue of an emotionally filled post-discharge period. The 
importance of repetition and timing for delivery of the educational intervention at 
day 5–7 post-discharge was advocated by both participants and healthcare 
professionals. Furthermore, healthcare professional education and follow-up was 
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commented on, suggesting that patients should find this reassuring, thus facilitating 
learning, and allaying potential post-discharge anxieties. As highlighted in Chapter 
4, both participants and healthcare professionals identified the potential to offer 
education earlier given the short length of stay, emotionality surrounding the post-
discharge period, potential for post-discharge complications and to provide early 
post-discharge education and support to those geographically isolated and due to 
return home (BHF, 2011; Chow et al., 2010; Cupples et al., 2010; Dafoe et al., 2006; 
Demiris et al., 2005; Harrison & Wardle, 2005; Grace et al., 2012; Heart Foundation, 
Western Australia, 2012; Lacey et al., 2010; Pack et al., 2013; Rassaf et al., 2013, 
Wong et al., 2006). Thus, as recommended by both intervention group participants, 
healthcare professionals, and as reinforced by the literature, follow-up for a Phase 
Three study, will occur at 3 to 5 days post-discharge. 
Coming to understand the situation 
Participants reported becoming more aware of their health and self after 
attending the nurse-led clinic, while also identifying and communicating the gravity 
of their procedure and the need to make lifestyle adjustments, such as making dietary 
changes, engaging in exercise, and losing weight. Dullaghan et al. (2013) undertook 
semistructured interviews with 15 participants who were treated for an AMI and 
explored whether treatment urgency influenced behaviour change and illness 
perceptions. They found that participants who experienced a primary PCI (PPCI) and 
STEMI (with thrombolysis) viewed the procedure as “life-threatening”, knew they 
faced a serious situation and treatment was rapidly required (Dullaghan et al., 2013, 
p. 4). Conversely, participants who experienced a NSTEMI (not as fast as PPCI and 
STEMI treatment) did not report their experience as traumatic and, therefore, 
believed their diagnosis and medical condition was insignificant (Dullaghan et al., 
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2013). Most participants in Dullaghan et al.’s study reported the significance of the 
event, while also reporting the speed of the procedure and recovery time. Participants 
in the present study underwent elective and primary PCIs, but they still viewed and 
reported their diagnosis as serious. Dullaghan et al. (2013) highlight that their group 
of PPCIs and STEMIs were more motivated to modify current lifestyle choices for 
positive behaviours with the view of long-term maintenance. It was interesting that 
all of these patients had full intentions of attending a CR program, as opposed to 
participants in the present study (although it is not known whether these patients 
were first-time PCIs as compared to participants in The ‘REALITY CHEC’ Project). 
The NSTEMI group identified that changes needed to be made post-event but did not 
report confidence in achieving them. Although participants in the present study 
realised the significance of their procedure and seriousness of their diagnosis, this 
was not the case for all PCI patients. It must, therefore, be highlighted that timing 
(for treatment), type of treatment, and diagnosis may greatly affect patients’ 
perceptions post-cardiac event (Dullaghan et al., 2013). 
As participants in the present study reported making lifestyle changes, the 
importance of lifestyle modification and effects on CVD is strongly supported in the 
literature (AIHW, 2012; BHF, 2012; Katch & Mead, 2010; NVDPA, 2012). 
Specialists often recommend modification of risk factors and lifestyle change post-
PCI—such as weight loss, exercise and dietary changes, along with smoking 
cessation. Katch and Mead (2010) identify how making these changes, coupled with 
symptom management (i.e., physical, psychological) can be difficult for patients and 
recommend enhancing SE in order to encourage these changes. Although SE, as 
evidenced in ES calculations reduced, trends identified in some CSE items, and in 
self-report appeared to be enhanced in the present pilot study. Undertaking a Phase 
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Three study may assist in the measurement of the relationship between SE and self-
management. As inspection of mean ratings demonstrated enhancements in some 
CSE items in Phase One and, coupled with the Phase Two findings, may suggest that 
the realisation of their procedure and cardiac event, combined with attending the 
clinic may have enhanced participants’ motivation to modify their lifestyle 
behaviours post-discharge. Overall, after undergoing the procedure, receiving both 
verbal and written education (i.e., during hospitalisation and post), as well as the 
support and education provided at the nurse-led clinic, CSE trends concerning 
weight reduction, dietary intake, exercise, stress management evidenced in 
preliminary findings in Phase One and in self-report data attained in Phase Two 
appeared to be enhanced in some participants. Again, a Phase Three study will 
provide a more rigorous test of the relationship. 
Self-awareness enhances self-management 
Participants in the present study identified that after attending the nurse-led 
clinic, greater awareness surrounding symptoms, potential complications and 
management was realised. Angina and haematoma identification and management 
was raised frequently by participants. Furthermore, greater adherence and 
compliance with medications was also reported by intervention group participants 
during participant interviews. Barlow et al. (2002) highlight the effectiveness of self-
management interventions with short follow-up; however, the authors suggest 
follow-up should occur over a longer period of time (i.e., years specified). Barlow et 
al. (2002) highlight how most self-management programs, such as the present study, 
are aimed at chronic disease management, enhancing SE, and patient knowledge, 
while encouraging positive behaviours. Katch and Mead (2010, p. 34) identify that 
self-management in the area of medication adherence needs to be of a “high level” to 
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abide by strict regimes. Factors affecting medication self-management include 
socioeconomics, cognition, lifestyle factors, and personal choice that is based on 
previous experience and individual beliefs (Katch & Mead, 2010). Katch and Mead 
highlight that, in order to achieve overall effective self-management and medication 
self-management, SE needs to be enhanced. Although not consistent with Phase One 
findings, participants did verbalise in Phase Two feeling more confident to self-
manage with respect to their post-procedural health and wellbeing. Some CSE items, 
as identified earlier, showed promising trends in certain areas of SE. Additionally, 
participants reported an increase in self-management capabilities, predominantly 
medication adherence, knowledge, symptom, and complication management. 
Importantly, there are barriers to achieving effective self-management, 
particularly in patients with CVD (Katch & Mead, 2010). Katch and Mead (2010) 
highlight expense, time (for treatment and recovery), rehabilitation, and medication 
management as significant patient barriers, particularly in those with multiple co-
morbidities. The authors identify how physical restrictions, coupled with poor 
coping and psychological distress act as barriers to effective self-management, while 
the absence or limitations of health insurance may also affect patient healthcare in 
lower socioeconomic groups. Thus, the authors recommend overcoming self-
management barriers and identify enhancing SE as the tool to assist this process, 
while encouraging patients’ engagement in their own care (Katch & Mead, 2010). 
The authors, as per the present study, identify the effects of psychological distress of 
CVD and highlight how this can not only affect morbidity and mortality, but health 
and illness beliefs, treatments, and behaviours (Katch & Mead, 2010). Katch and 
Mead (2010) recommend interventions to increase SE; these are essential in patients 
with CVD as they not only enhance patient outcomes, but also their QOL. The 
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present study aimed to enhance patients’ SE so that psychological distress could be 
reduced, and secondly to encourage effective self-management. Although ES did not 
demonstrate enhancements in CSE, participants verbalised greater confidence to 
manage in Phase Two interviews, while some CSE items showed promise in mean 
ratings, as identified earlier. 
As previously outlined, medication adherence and compliance among patients 
is an issue, with approximately 50% of patients not adhering or complying with their 
medication regime (Brown & Bussell, 2011). With a variety of factors influencing 
medication adherence—such as poor health literacy, limited involvement in health 
decision-making, polypharmacy, poor communication and information, being cared 
for by a group of doctors, healthcare access issues—it is certainly understandable, 
why medication non-adherence and compliance occurs (Brown & Bussell, 2011). 
Chapter 4 presented study results, with great value placed on the medication 
education component identified by healthcare professionals. Participants identified 
that the intervention was easily understandable, succinct, while three important 
messages regarding medications were delivered. Messages included: to maintain 
supply, not discontinuing medications in an abrupt manner, and continuing 
medications as prescribed. Additional suggestions were included to warn post-PCI 
patients regarding internet content and speaking with a doctor if considering 
medication cessation. 
Chronic disease sufferers are more at risk of ignoring steps to change in that 
their motivation and intentions may be affected by their disease state and may often 
lead to healthcare professionals assuming an authoritative role, or conversely, 
assuming defeat (Patterson, 2001). Healthcare professionals have greater knowledge 
of health and patient behaviour, and may have greater effect on involving patients in 
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their health care, thus leading to greater adherence, and compliance (Patterson, 
2001). Low adherence is most often due to a variety of factors, predominantly due to 
the lack of “behavioural skills”, limited understanding, or possibly as they may be 
experiencing psychological distress (Patterson, 2001). Falvo (2004) advises how 
important it is for the patient to remain adherent and thus compliant with their health 
and how it not only benefits the patient, but healthcare as an organisation, and 
society. By modifying health behaviours and becoming adherent, patients may 
effectively prevent the onset of illness, associated complications, resultant disability, 
and mortality (Falvo, 2004). As identified in the literature, medication adherence and 
compliance is a significant problem, particularly in the cardiac population where 
statin and antihypertensive therapies are the most non-adhered to in this group of 
patients (Brown & Bussell, 2011; Falvo, 2004). Thus, it was important to encourage 
the message of adherence and compliance to participants in the present study, while 
offering a basic overview of medications. Nunes et al. (2009) highlight the 
importance of patient decision-making in their medication taking regimes, and while 
this may be the case, the onus is on the healthcare professional to ensure that 
patients’ decisions are informed. The present study provided medication education 
information while encouraging questions and allaying medication misconceptions to 
facilitate current and future medication choices (Nunes et al., 2009). 
The internet now plays a major role in health and medication education 
(Coleman, 2003). While this is a positive step toward health education, the varying 
quality of information provided is reportedly of great concern (Coleman, 2003). 
Healthcare professionals in the present study, as identified earlier, highlighted 
warning about internet medication education and recommended reinforcing the 
message to consult with a GP prior to making any decisions regarding cessation. 
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With no control of what information is posted, coupled with poor evidence base and 
sometimes erroneous information presented, misinterpretation is likely (Coleman, 
2003). There is potential in using the internet to educate and accurately inform 
patients on their medication and encourage compliance; however, patients must be 
educated on where to find quality information (Coleman, 2003). 
Thus, as messages of medication adherence and education were highlighted by 
healthcare professionals, intervention group participants’ medication knowledge in 
Phase One increased, while adherence was maintained between Time 2 (Day 5–7) 
and Time 3 (1 month). Intervention group participants reported they were more 
adherent and compliant in their medication taking, while their knowledge and mean 
ratings for CSE reflected enhancements in taking medications to control 
breathlessness. Thus, as mean ratings for medication adherence measured by the 
MMAS-8 at Time 3 (1 month) remained stable, further studies are required to 
investigate long-term medication adherence and CSE to take medications in PCI 
patients after attending a nurse-led clinic. 
Participants and healthcare professionals reported full confidence in the 
education provided and in the PI as nurse-educator, while healthcare professionals 
also reinforced the benefits of repetition and variation of information to support 
different learning styles. The principles of learning are relevant to the area of health 
education and patient teaching and were used in the development of the nurse-led 
clinic (Miller & Stoeckel, 2011). First, as identified by healthcare interviewees in the 
present study, clinic education accommodated different types of learners. Miller and 
Stoeckel (2011) highlight how each individual learns differently, identifying verbal 
and visual learners, while others may need to apply what is learnt in a practical 
setting. Thus, it was important to take learning into consideration and incorporate 
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this into the present study, offering visuals, verbal education, while complementing 
the session with interactive scenarios to encourage deeper, more lifelong learning. 
Miller and Stoeckel (2011) recommend tailoring education so that the teaching style 
and delivery method best suits the learning style of the individual. Importantly, with 
Bandura’s SE theory as the underpinning theoretical framework guiding the study 
and given the social cognitive theory of learning was applied with the aim to enhance 
SE, it was important to consider that participants may not instinctively change 
behaviours by either internal or external influences. Wiles (1997) highlights the 
importance of instilling confidence in the patient, as this is interpreted in terms of 
competence in the management of follow-up care. Moreover, it was conceded that 
participants may learn and change behaviour by being proactive, observing, and 
imitating (Miller & Stoeckel, 2011). 
Recency in information delivery is highlighted by Miller and Stoeckel (2011), 
and also identified by healthcare professionals and participants in the present study. 
Miller and Stoeckel (2011) highlight that when information is repeated, and the more 
clients are exposed to it (or undertake a competency), this will enhance recall. Thus, 
it was important to undertake the nurse-led clinic within the first week post-
discharge as participants are educated in the hospital setting, and are discharged 
home with written material. The PI, to enhance information understanding and 
retention, presented a small amount of information for each topic area (as opposed to 
large quantities) as it was identified that individuals primarily recall earlier items 
presented, and up to “five to seven” pieces of information (Miller & Stoeckel, 2011, 
p. 82). While presenting smaller quantities of information, spacing the delivery of 
information, and encouraging revision of written material, it was hoped that 
participants’ understanding could be enhanced, and information thus retained. 
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Repetition of education is reiterated in the literature with recommendation for PCI 
education to continue into the post-discharge period (Tuso et al., 2013). 
Association and application of skill was practised in complication 
identification and management scenarios provided at the nurse-led clinic, where for 
example, haematoma or bleeding would require firm pressure over the access site 
(Miller & Stoeckel, 2011). Participants were encouraged to recall (and were 
successful in recalling) the amount of pressure required to achieve access site 
haemostasis as an association with their procedural arterial sheath removal. 
Participants were both shown and advised of the site of pressure and length of time 
required; however, in offering association, participants were able to retain, recall, 
and apply the information as it was significant to them (Miller & Stoeckel). 
Lastly, to ensure that participants knew how their learning was progressing, 
questions were permitted throughout the course of the clinic, while discussion was 
also encouraged to determine the success of information delivered. Questions and 
discussions were supported to ensure that feedback was provided to participants, and 
it was immediate, and corrections were offered (Falvo, 2003). Feedback of 
information allows for positive reinforcement of desired behaviours, while correction 
(where necessary) is essential, as it identifies areas requiring further effort. Thus, as 
patient misconceptions can occur, correction was offered (Falvo, 2003). 
Pressure on the patient attending cardiac rehabilitation (CR) 
As identified in Chapters 2 and 4, CR referral, attendance, and course 
compliance is an issue both nationally and internationally (Balady et al., 2011; 
Meillier, Nielsen, Larsen, & Larsen, 2012). In the present study, difficulty was 
encountered in referring patients who had already attended CR in the past (one 
participant had not attended CR since first attending 10 years prior). Some first-time 
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participants also withdrew from the program as they reported being too busy; 
however, the main difficulty was encouraging program re-attendance. Healthcare 
professionals recommended various tactics to encourage re-attendance, which 
included “pressure” on the participant, and providing shorter courses. Various 
initiatives have addressed the referral, uptake, adherence, and compliance regarding 
CR; however, program re-attendance after multiple revascularisation attempts is not 
widely documented. Phase 3 of CR, also known as the maintenance phase, is offered 
after the initial post-discharge program (Phase 2) is accomplished and may vary 
accordingly in length and content (Goble & Worcester, 1999). Participants may 
receive doctor or nurse follow-up calls, exercise programs, education, and 
psychosocial support (Goble & Worcester, 1999). Bock, Carmona-Barros, Esler, and 
Tilkemeier (2004) highlight the benefits of Phase 3 CR on ongoing physical activity, 
and exercise behaviours. The authors suggest that both engagement in a Phase 2 CR 
program (and the longer duration), will lead to exercise maintenance practices 
beyond the program (Bock et al., 2004). Thus, it is important that participants 
originally attend and adhere to CR to ensure that they are motivated to continue 
maintenance and positive self-management practices. Hospital readmissions and 
repeat revascularisation may be reduced if patients with CHD continue to attend CR 
maintenance programs after completing a Phase 2 program (Bock et al., 2004). 
To ensure the uptake of CR (with barriers identified), and ongoing 
maintenance, the NHFA developed a set of nine key action areas to ensure that CR 
barriers are overcome (NHFA, 2010). The action areas involve collaboration at all 
levels and include governmental organisations, individuals, healthcare professionals, 
and healthcare consumers while endeavouring to improve the health of those with 
CVD (both new and previously diagnosed) (NHFA, 2010). The actions aim to 
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promote CR programs while improving accessibility, enhancing patients’ overall 
health and wellbeing, and reducing morbidity and mortality rates. The key action 
areas are important in terms of encouraging re-attendance to CR of patients with 
CHD (NHFA, 2010). The first of these two action areas aims to encourage CR 
attendance as ongoing care for all patients with CVD and CHD, promoting flexible 
delivery, and availability for all levels of healthcare (NHFA, 2010). Action area 
three is important as it ensures that CR is “integrated into the patient journey”, and 
rather than undertaken as an option is integrated into primary care services, the 
community and acute care services (NHFA, 2010, p. 10). In doing so, action area 
three identifies the need to encourage physical activity in the prevention and 
maintenance of chronic disease to encourage effective self-management (NHFA, 
2010). Thus, with CR re-attendance presenting as an issue, recommendations for 
maintenance program encouragement, or short, biannual refresher courses for CHD 
patients who have had multiple PCIs may also assist in achieving all key action areas 
(Bock et al., 2003; NHFA, 2010). In encouraging and attending and adhering to CR 
and Phase 3 courses, it is hoped that patients’ self-management skills will be 
enhanced, hospital readmissions and potentially future revascularisation procedures 
reduced (Bock et al., 2003; NHFA, 2010). 
Low SE or efficacy beliefs, coupled with psychosocial (i.e., poor support 
network) and physiological state (i.e., patient factors), outcome expectations and 
socio-structural factors may have also contributed to participants declining CR 
referral, attendance, or adhering to a program. Intervention group participants in the 
present study demonstrated lower mean ratings for CSE (i.e., overall scores and 
items) at Time 2 (day 5–7) (where CR referral was encouraged). Although some 
participants reported recalling education, low SE coupled with their psychological 
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state at Time 2 (day 5–7) may have potentially led to their decision to decline 
participation (although it was highly encouraged). Participants’ poor outcome 
expectations may also have contributed to the decision to decline CR participation as 
they weighed up the positives and negatives of attending CR, linked with their 
individual beliefs that they may or may not achieve their desired outcome (i.e., CR 
attendance will not assist in recovery) (Prodaniuk, Plotnikoff, Spence, & Wilson, 
2004). Although most participants voiced they had the knowledge, this is an 
important finding and warrants further investigation in future studies. As highlighted 
earlier, potential for a study investigating the benefits of repeating short biannual 
refresher courses in CR on SE, psychological distress, effective self-management, 
behaviour change and maintenance is warranted. 
6.3 Phase One and Phase Three Study: Critical Reflection for 
Improvement 
The Phase One pilot study, as identified, was undertaken to determine the 
efficacy for a Phase Three, multi-centre study. On critical reflection after 
undertaking Phase One, and after receiving detailed feedback in Phase Two from 
healthcare professionals and intervention group participants, the following changes 
were made to facilitate a more effective Phase Three study as highlighted in Chapter 
5 (see Table 6.2). Changes include: 
 extending the nurse-led clinic to patients who have undergone 
diagnostic coronary artery angiography and have received a diagnosis 
of CAD; 
 longer participant follow-up to determine the medium- and long-term 
effectiveness of the nurse-led clinic on SE, psychological distress, 
health behaviour and self-management; 
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 online, electronic visual mode of delivery; 
 no further salivary cortisol samples; 
 no PI or RA contact; and 
 use of telephone randomisation service. 
Table 6.2. Phase Three Study Changes 
Phase One Phase Three Differences and why? 
PCI patients only Coronary angiography 
patients with diagnosed 
CAD and PCI patients 
 To benefit all groups of patients with 
coronary artery disease (i.e., with and 
without coronary intervention). 
Follow-up: 5–7 
days, 1 month, 3 
months 
Note: Limited by 
PhD study 
timeline. 
3–5 days, 1 month, 3 
months, 6 months, 12 
months 
Earlier post-discharge follow-up. 
 Longer follow-up to measure 
enhancements in SE, reductions in 
psychological distress, effective self-
management, behaviour change and 
maintenance. 
Face-to-face Online, electronic visual 
medium 
Electronic follow-up 
 To offer services to a broader population. 
Saliva sample No saliva sample for 
future studies  
Use of self-report assessment tools only to 
measure anxiety and depression. 
 Why no salivary cortisol sample? Due to 
expense of laboratory equipment and to 
process. 
Principal 
Investigator (PI) 
contact 
No PI or research 
assistant (RA) contact 
 To determine the effectiveness of the 
intervention versus standard care alone. 
Phase One all groups had contact with the 
PI. 
Blocked 
randomisation 
Interactive Voice 
Response Systems 
(IVRS): Telephone 
randomisation 
 To ensure equal randomisation 
 To ensure hospital site staff are blinded to 
randomisation 
 So that RAs do not have to search for 
staff to witness randomisation. 
 
On critical reflection, it was identified that the nurse-led clinic should be 
offered to patients who undergo coronary angiography. Furthermore, the PI decided 
that coronary angiography patients who are diagnosed with CAD may benefit, 
particularly if there are current unhealthy behaviours (i.e., diet, lifestyle) requiring 
change, new medications commenced, health misconceptions, and potential disbelief 
in their diagnosis. The overall effectiveness of the Phase One nurse-led clinic cannot 
be commented on at this stage; however, preliminary evidence as demonstrated in 
ES, RCI calculations, and frequencies suggest the efficacy in undertaking a future 
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Phase Three, multi-centre study. It has been highlighted that basic education alone 
may be ineffective in facilitating behaviour change and effective self-management, 
with more intensive methods of education and follow-up required to achieve such 
goals (Jovicic, Holroyd-Leduc, & Straus, 2006; Mejia, Richardson, Pattenden, 
Cockayne, & Lewin, 2014). Therefore, in addition to education and nurse support 
with a person- centred approach, all RAs will be professionally trained in CBT. 
Using CBT techniques will encourage participant goal-setting towards overall 
individual goals in small steps that may facilitate enhancements in SE (Jovicic et al., 
2006; Mejia et al., 2014). Cognitive–behavioural therapy, as identified, may assist 
participants in overcoming negative thoughts and facilitate goal-setting and therefore 
enhance SE, reduce symptoms of anxiety and depression and assist participants in 
achieving effective self-management, behaviour change, and maintenance. 
The limitation of time in the present study did not enable long-term goal 
achievement. The present study engaged participants in goal-setting and covered a 
variety of material concerning the procedure, post-discharge period, medications, CR 
and lifestyle and change; however, study time restrictions, sample size, and contact 
with both groups of participants may have presented as limitations to this study. As 
identified throughout this chapter, additional limitations consisted of participant 
recruitment and randomisation methods, sample size, various obstacles to the study 
implementation, the study protocol. Similarly, ambiguity in questionnaire clarity 
(i.e., for participants) and timing of administration may have resulted in the 
weakness evident in the present study in the relationship between the SE theory and 
psychological distress (which typically is evidenced as a strong relationship) 
(Bandura, 1977, 1995; Dehdari et al., 2008). Furthermore, as education alone may 
not facilitate behaviour change, recommendations to use more intense methods are 
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highlighted. Shortridge-Baggett (2002) identifies that the influences required to 
achieve behaviour change may include: knowledge, skill, beliefs, attitude and 
support networks. Thus, the Phase Three study will engage participants in CBT over 
a 12-month period (Meija, et al., 2014). 
While the present study may not have been effective in enhancing overall SE, 
after critical reflecting on Phase One, the feedback received in Phase Two, and as 
reinforced by the current literature, a nurse-led clinic for both PCI and coronary 
angiography patients with diagnosed CAD delivered via an online mode of education 
is necessary. Nurse-led education and support (i.e., CBT training) is vital given the 
psychological distress experienced post-discharge from hospital (Colquhoun et al., 
2013; Dehdari et al., 2008; Sipötz et al., 2013). Furthermore, as highlighted in 
Chapter 2, this nurse-led clinic (i.e., Phase One) and Phase Three study is unique and 
vital given the current healthcare climate and demands placed on it (QLD 
Government, 2013).  
6.4 Summary 
This chapter has discussed the results of the research phases in detail, while 
comparing and contrasting with current literature. Chapter 6 also highlighted how the 
underpinning theoretical framework guided the research. The importance of 
undertaking a Phase Three, multi-centre study was highlighted, while Phase One and 
Phase Three studies were compared and contrasted and the changes described in 
detail. Chapter 7 summarises and concludes the study, while presenting strengths, 
limitations, and recommendations for future research.
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Chapter 7: Conclusions 
This chapter summarises Phases One and Two findings in relation to the 
theoretical framework, identifies the generalisability of study results, and addresses 
the theoretical and practical implications of the study. Chapter 7 also discusses the 
potential benefits and implications of undertaking a Phase Three, multi-centre study 
as noted in Chapter 6 and how this may contribute to future research. Lastly, this 
chapter addresses the study’s strengths and limitations and proposes  
recommendations for future research and clinical practice. 
7.1 Integration of Findings: Phases One and Two 
Overall, the Phase One pilot study was not supportive of the study hypothesis 
that the nurse-led clinic intervention would enhance self-efficacy (SE) and reduce 
anxiety. Preliminary findings as evident in ES calculations and mean ratings, 
combined with Phase Two interview outcomes, produced encouraging findings and 
highlighted the importance of early post-discharge education, support, and screening 
for psychological distress in patients who undergo PCI or who have experienced a 
coronary event. These findings highlight the benefits of early education and support 
and the importance of offering different educational delivery modes, including 
telehealth. 
Overall, initial evidence from both study phases suggest that a post-discharge, 
nurse-led clinic offering education and support within the first week post-PCI may 
be effective. Recommendations also highlight the importance of undertaking a well-
powered, Phase Three, multi-centre study to test the efficacy of a nurse-led clinic. 
Although the present study demonstrated some preliminary evidence only of a short-
term effect on some preliminary findings, the Phase Two analytical findings point to 
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the potential benefits of nurse-led clinics. Further studies, however, are needed to 
investigate the effects of an earlier commencing nurse-led clinic (i.e., 3–5 days) for 
all patients with CHD, with a longer patient follow-up (i.e., >12 months). Moreover, 
to ensure health behaviour change and maintenance in patients who have 
experienced a coronary event and for those with diagnosed CHD, it may be of 
benefit to utilise cognitive–behavioural therapy (CBT) techniques to assist 
participants in the initial management of psychological distress (i.e., anxiety, 
depression), risk reduction, health behaviour change, maintenance, and achieving 
effective self-management. 
7.1. Primary Aim 
As identified earlier, findings with respect to the primary aim do not 
demonstrate evidence to support the effectiveness of a nurse-led clinic on reducing 
post-discharge SE. Notably, however, anxiety was moderately reduced in 
intervention group participants. Overall, CSE evidenced a moderately reducing 
effect in intervention group participants, while nil effect was demonstrated on CSE 
in standard-care group participants. Only one participant in each group achieved a 
reliable change. Inspection of the mean ratings showed that some areas of CSE for 
the intervention group participants were enhanced between Time 2 (day 5–7) and 
Time 3 (1 month). Areas of mean CSE increases included: confidence to lose weight, 
make dietary changes, knowing how much physical activity was appropriate, 
confidence in maintaining usual activities at work, and controlling breathlessness by 
taking medications. These are important findings because goal-setting, changing 
health behaviours, and making lifestyle modifications can be effective in patients 
with chronic disease (Bodenheimer et al., 2002). Although patients with chronic 
disease tend to be more engaged in their care, all identified outcomes may not be 
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achieved (Bodenheimer et al., 2002). 
After undergoing PCI and/or a coronary event, patients may suffer 
psychological distress, and as a consequence may also experience reduced SE or 
confidence to self-manage (Bandura, 1995; Sipötz et al., 2013; West et al., 1995). 
Furthermore, patients’ motivation and ability to make positive health behavioural 
changes may be obstructed by patient factors such as psychosocial support, 
physiological health state, and low SE beliefs (Bandura, 1977, 2004). Phase Two 
qualitative interviews reinforce the Phase One study findings on CSE items 
identified above. After a coronary event and/or PCI, emphasis is placed on the 
modification and maintenance of lifestyle and behavioural risk factors (Chow et al., 
2010). Findings in the present study demonstrate areas of post-PCI focus in goal-
setting and confidence, while reinforcing the educational content received at the 
nurse-led clinic. Thus, it is important that these areas of patient focus, combined with 
areas of low SE, are concentrated on in future nurse-led clinics where education is 
limited to five to seven key areas (Falvo, 2004). 
Standard care alone did not have any effect on CSE in participants; however, 
visual inspection of the means showed that, over time, enhancements in mean ratings 
for some CSE items were evident at Time 3 (1 month). There are several reasons that 
may explain enhancement in mean ratings at this time for standard-care group 
participants  including post-discharge self-education, cardiac rehabilitation (CR) 
attendance, cardiologist and/or GP follow-up, the Hawthorne effect, or possible 
interviewer effects. A recommendation for future studies is limiting PI contact with 
standard-care group participants during follow-up. Furthermore, longer follow-up on 
a larger group is also suggested to determine the effects of the nurse-led clinic, as 
highlighted in Chapters 5 and 6. 
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An important finding identified in the present study was the moderately 
reducing effect on trait anxiety in intervention group participants compared to 
standard-care group participants, who did not experience an effect on trait anxiety. A 
reliable change for trait anxiety was evident in five intervention group participants 
and two standard-care group participants, respectively. While reductions in mean 
ratings for trait anxiety were evident in both groups over time, a greater reduction 
was observed in intervention group participants at Time 3 (1 month). This finding is 
interesting and, as identified in Chapter 6, individuals with high trait anxiety are less 
susceptible to the effects of interventions and slower to achieve recovery (Muris et 
al., 1998). Although Muris et al. (1998) highlight the effect of cognitive–behavioural 
interventions on high trait-anxiety individuals, the present study did not utilise CBT. 
The fact that a moderately reducing effect occurred in relation to trait anxiety was an 
important preliminary finding in the present study. 
As noted above, the reduction in trait anxiety may have occurred as a result of 
various factors as identified in Chapter 6 and include: potential life-changing effect 
of the PCI procedure, nurse-led clinic, change in self-concept, and strong support 
networks. These findings reinforce the need to undertake a Phase Three, multi-centre 
study to determine the significance and relationship between CSE and anxiety in the 
present study, as identified in Chapter 5. 
The literature identifies a relationship between psychological distress and SE 
(Bandura, 1995). Although overall CSE was not reduced in intervention group 
participants, preliminary evidence of a potential relationship between CSE items and 
anxiety were identified in participants after involvement in the nurse-led clinic 
(Bandura, 1995). While ES calculations for anxiety demonstrated no overall effect 
on anxiety or CSE on receiving standard care alone, reductions in mean ratings for 
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trait anxiety and some CSE items were observed over time at Time 3 (1 month). 
Reasons for these trends may be the aforementioned explanations (i.e., self-
education, sample size, interviewer effect, positive support networks). The potential 
for a greater effect of the nurse-led clinic on CSE and anxiety may have been limited 
by participants’ higher baseline trait anxiety levels (Muris et al., 1998). Overall, the 
preliminary and short-term findings in the present study are not supported by the SE 
theory literature where SE beliefs lessen or remove anxiety (Bandura, 1995). 
While study follow-up was limited to 3 months post-discharge (Time 4), 
preliminary findings from Phase Two indicated the potential short-term effectiveness 
of nurse-led clinics on patient targets or goals. The potential for behavioural change, 
maintenance of patient goals, and QOL may be limited in the setting of a nurse-led 
clinic; however, the literature does recommend long-term follow-up (i.e., > 12 
months) to determine the effects of a clinic on achieving health goals and reduction 
on cardiovascular risk (JBI, 2010; Schadewaldt & Schultz, 2011). Thus, given the 
achievement of some participant goals, and change in some CSE beliefs, the present 
study is important as it makes an important contribution around targeted 
modifications in the context of ongoing cardiovascular health maintenance (Chow et 
al., 2010). 
Thus, as the present pilot study aimed to act as a support between hospital 
discharge, CR commencement, and cardiologist follow-up, preliminary findings 
encourage a Phase Three study. As argued, investigation of the long-term 
effectiveness of nurse-led interventions on behaviour change, health management, 
and outcomes in patients with chronic disease is warranted (JBI, 2010; Schadewaldt 
& Schultz, 2011). The first week post-discharge is both a physically and emotionally 
vulnerable time for post-PCI patients; therefore, where patients are discharged home 
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with or without social support, the nurse-led clinic may potentially act as a source of 
support for these patients. 
Healthcare professionals interviewed in Phase Two identified the potential for 
the nurse-led clinic to enhance SE and reduce psychological distress as a result of 
early post-discharge follow-up (i.e., day 5–7 post-discharge), nurse-led education, 
support, and repetition of vital post-discharge education. These participants also 
emphasised the importance of a cardiology nurse-led clinic to provide information 
that may not have been fully understood during hospitalisation due to distractions, 
anxiety, and limited nurse-teaching time. The nurse-led clinic was able to provide a 
service to participants that was face-to-face, one-on-one (with family or a support 
person in attendance on occasion) and without the distraction of the hospital setting 
to facilitate learning. It was considered essential that any nurse selected to undertake 
a future post-PCI nurse-led clinic has experience in the cardiology field to ensure the 
application of person-centred care. Furthermore, being person-centred, patients may 
have full trust and confidence in the nurse so that SE may be enhanced and 
psychological distress may be reduced. 
Intervention group participants, after undertaking Phase Two interviews, 
reinforced their confidence and trust in the PI. Participants reported trust in the 
nurse-led clinic and feeling supported, less anxious and more confident. Thus, as 
trust is important, it may have facilitated an effective nurse–patient relationship and 
enhanced nurse–patient communication (Liljeroos et al., 2011). Moreover, a trusting 
relationship with participants may have encouraged goal-setting, lifestyle change, 
and maintenance of healthy behaviours, the enhancement of some SE beliefs, and led 
to participants reporting less anxiety. 
Healthcare professionals highlighted the importance of a one-on-one, 
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interactive, face-to-face, nurse nurse-led clinic that could deliver and reiterate 
general health-specific information. These participants also recommended a 
telehealth nurse-led clinic that could be part of a Phase Three study. This group 
identified how the nurse-led clinic may potentially act to increase PCI patients’ 
confidence to undertake post-discharge care and identify and manage complications. 
Furthermore, the health professional participants suggested that a nurse-led clinic 
may also assist in addressing and establishing the importance of health behaviour 
change and maintenance. These are all important Phase Two findings and 
demonstrate the potential benefits of attending a post-PCI, nurse-led clinic. Although 
Schadewaldt and Schultz (2011) identify nurse-led clinics to be limited in achieving 
behavioural change, analytical findings as highlighted by interviewees in the present 
study indicate the potential for health behaviour change. 
The patient participants reported that, as they were involved in the study and 
were required to report on their wound and post-discharge cares (to the PI), they took 
greater care and were more aware of their access sites. Engaging participants in their 
wound care may have created a greater overall sense of awareness, enhanced some 
SE beliefs, and facilitated a moderate reduction on anxiety. Intervention group 
participants in Phase Two reported altering dietary intake, increasing physical 
activity, and reducing their body mass. This was supported in CSE items reviewed in 
Phase One, which demonstrated improvements in these areas after attending the 
nurse-led clinic. Thus, a long-term, well-powered, Phase Three study could 
investigate the potential relationship between these aspects in patients who have 
experienced PCI and who have been diagnosed with CHD 
Another important preliminary finding was the potentially life-changing or 
positive effects patients experienced as a result of their cardiac event and after 
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undergoing PCI. This finding is supported by the literature where positive effects are 
brought about by stressful life events and may be sustained over time (Updegraff & 
Taylor, 2000). Where negative effects such as psychological distress are also 
emphasised, participants in the present study appeared to respond positively to their 
life-changing experience (i.e., PCI). Thus, a combination of the nurse-led clinic and 
the positive effects of their PCI may have enabled participants to recognise the 
importance of modifying risk factors (i.e., dietary intake modification, increase in 
exercise) engaging in positive health behaviours and participating in post-discharge 
cares and management. Previous CR program attendance and strength in support 
networks, as identified in Chapter 6, may have also contributed to the 
aforementioned changes in health behaviours. An increase in some item SE beliefs 
and reduction in psychological distress may have also encouraged this change. 
However, given that the pilot study findings are only preliminary findings and 
overall CSE evidenced a moderately reducing effect, a Phase Three study is 
indicated. Undertaking a Phase Three study will allow further investigation to 
determine if the nurse-led clinic is effective in encouraging positive health 
behavioural changes by utilising CBT and offering the skills for effective self-
management through the reinforcement of health education, providing early post-
discharge support, and enhancing SE beliefs. 
7.1.2 Secondary Aims 
Secondary aims investigated the effect of the nurse-led clinic on depression 
due to the strong relationship between coronary events, post-discharge symptom 
emergence, and on post-discharge self-management (Colquhoun et al., 2013). As 
identified, only a small effect was evident on depression scores in both groups, as 
one participant in each group achieved ‘recovery’ or a return to normal functioning. 
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Reduction in mean ratings for depression scores were demonstrated in both groups of 
participants; however, where intervention group participants scored higher on mean 
trait anxiety (and depression scores), reduction of depressive scores over time may 
have been affected by high trait anxiety levels as measured by the STAI-Y2 form 
(Muris et al., 1998). Low SE may lead to an individual experiencing stress, anxiety, 
or depression; thus, small reductions in mean ratings for anxiety and depression may 
have been affected by low SE given that SE beliefs regulate emotions and affect 
coping (Bandura, 1995). 
Salivary cortisol as an indicator of stress evidenced higher mean ratings in 
cortisol levels in standard-care group participants as demonstrated in salivary cortisol 
assays; however, levels were maintained within normal reference ranges at all times. 
Conversely, where salivary cortisol levels were higher in standard-care group 
participants, self-report data reflected greater psychological distress on baseline 
measurement in intervention group participants where STAI-Y2 and CDS 
measurement tools demonstrated higher mean ratings for anxiety and depression. As 
discussed in Chapter 5, disparities between salivary cortisol assay levels and self-
report data are frequently reported in the literature, with multiple reasons given for 
the poor association (Hellhammer et al., 2009; Hjortskov et al., 2004; Vedhara et al., 
2003). It was interesting that while evidence appeared conflicting, as salivary 
cortisol levels reduced at Time 3 (1 month) in both groups, so too did mean ratings 
for STAI and CDS scores. 
It was notable that CR re-attendance was poor in patients who had attended CR 
in the past, which is an important finding in this study with an abundance of 
literature identifying how referral, attendance, and adherence continue to be 
problematic both nationally and internationally (BHF, 2011; Cupples et al., 2010; 
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Gallagher et al., 2013; Heartwire, 2011; Varnfield et al., 2011, p. S15). While there 
is a strong focus on achieving greater referral and attendance rates for first-time CR 
participants, patients who have undergone repeat revascularisation procedures and 
who believe that they have the knowledge would also benefit from re-attending. In 
the present study, where repeat PCI patients were offered attendance at CR, most 
participants declined as they believe they have the knowledge after having attended a 
course in the past. While those who had only recently completed a course (within the 
previous 1 to 2 years) may have had the knowledge, those who decline, and who 
have experienced multiple revascularisation attempts and are not involved in a 
maintenance program should be flagged. Furthermore, as re-attending a short course 
is not an option, the present study, the healthcare professional feedback in Phase 
Two, strongly suggests trialling short refresher courses for repeat PCI patients or 
biannual CR course re-attendance. If participants require repeat procedures, there 
may be a need to reassess and reinforce education on medication adherence, lifestyle, 
and health behaviours by means of CR in this group, as highlighted in the present 
study. 
Not only did the Phase One pilot study and Phase Two interviews highlight the 
potential and importance of trialling a CR short course for those with repeat PCIs, 
the need to more overtly encourage referral was identified. Participants and 
healthcare professionals all acknowledged the importance of attending CR; however, 
when a referral was offered, most participants declined as they believed they had the 
knowledge, limited time, or reported geographical constraints. Thus, as patients are 
aware of the importance of CR attendance, referral for re-attendance appears to be 
problematic for repeat revascularisation candidates, with the present study 
identifying the need to provide greater strength in referral. 
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Participant confidence in the ability to effectively self-manage post-discharge 
was identified in the study’s two phases. Phase Two analytical findings reflected a 
strong focus on access site management, CP identification and management, dietary 
intake, physical activity, and weight management. Similar CSE items (i.e., 
confidence to change diet) demonstrated small enhancements in mean ratings in 
intervention group participants in these areas. While overall CSE was not enhanced, 
the ability of the nurse-led clinic to potentially facilitate effective self-management 
was identified by healthcare professionals. These findings are important and 
reinforce the effectiveness of self-management programs as opposed to standard care 
alone, where participants may benefit through enhanced SE, knowledge, greater 
involvement in self-management, and personal health (Barlow et al., 2002). The 
present study undertook an interactive educational component offering verbal, 
visual, and written information while engaging patients in their learning, health 
management, and action planning (if complications were to arise). Importantly, 
confidence in self-management may also reflect the tendency for some chronic 
disease sufferers to be more motivated and engaged in their health and management, 
thus further encouraging participants to self-manage (Bodenheimer et al., 2002). 
There was no effect on medication adherence in intervention group participants 
in the present study, with maintenance evidenced in mean ratings. Medication 
knowledge appeared to be enhanced in intervention group participants at Time 3 (1 
month), while standard-care group participants’ knowledge decreased at this time. 
Whether or not the nurse-led clinic solely contributed to medication knowledge 
enhancements requires further investigation. To avoid overwhelming participants 
and as highlighted by Falvo (2004), medication education consisted of general 
information on the standard groups of medications PCI patients may be prescribed 
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and dispensed on discharge home. Although intervention group participants, as 
measured by the MMAS-8, maintained adherence at the upper end of moderate, 
knowledge also appeared to increase. These findings are important and reinforce 
current medication adherence literature. Nonetheless, it has been argued elsewhere 
that while medication adherence is identified as high in some chronic disease suffers, 
knowledge may be poor (Fernandez et al., 2007; Haynes et al., 2008). Thus, the fact 
that medication knowledge appeared to be enhanced in intervention group 
participants was an important preliminary finding. A Phase Three study may 
demonstrate the effectiveness of nurse-led clinics where the focus is on effective 
self-management in the enhancement of medication knowledge in post-PCI and 
CHD patients. 
In this study, Phase Two healthcare professional interviews also pointed to the 
importance and potential effectiveness of the medication education component of the 
nurse-led clinic. Issues concerning abrupt medication cessation and replenishment of 
supply were perceived as important by healthcare professionals as was the need for 
referral to a doctor on considering cessation. These participants also reinforced the 
nurse-led clinic’s message of taking medications as prescribed and that patients be 
warned about the poor quality of some internet education (if accessing online 
information). 
As 50% of patients are medication non-adherers, because of factors such as 
health literacy, polypharmacy, and poor communication affecting medication 
adherence, to avert secondary non-adherence, it was essential to discuss the 
aforementioned potential issues with participants in clinic attendance (Brown & 
Bussell, 2011; Jackevicius et al., 2008). Furthermore, as medication adherence and 
compliance may be affected by personal beliefs or experience, consultation with 
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friends, or by accessing supplementary information, it was essential that the nurse-
led clinic approach such issues. Phase Two findings identified the need to caution 
patients on internet health and medication information, while offering patients details 
on sourcing reputable health material so that they may engage in safe self-education 
(Coleman, 2003; Vermeire et al., 2001). Thus, as medication knowledge appeared to 
be enhanced and adherence maintained, the nurse-led clinic may have been effective 
in conveying these messages, as reflected in the findings from Phases One and Two. 
7.2 Theoretical Implications 
With factors such as anxiety, short hospitalisation coupled with poor 
information absorption and retention; and limited nurse teaching time identified in 
this study as affecting post-PCI patients, an intervention examining their self-
confidence beliefs or SE to successfully accomplish post-discharge period 
management and cares was warranted. Furthermore, with limited post-discharge 
support and medical contact, it has been estimated that patients wait between 7 and 
64 days to see their GP and/or cardiologist and to commence their CR course (BHF, 
2011; Cupples et al., 2010; Dafoe et al., 2006, p. 909; Grace et al., 2012; Heart 
Foundation of Western Australia, 2012; Lacey et al., 2010; Pack et al., 2013; Shakib 
et al., 2009). 
Bandura’s SE theory posits that efficacy beliefs or SE may enhanced by 
mastery, vicarious experience, and social persuasion, and an individual’s physiology 
and emotions (Bandura, 1995). While overall CSE evidenced a reducing effect, 
reductions in mean ratings in some areas of CSE were reduced. The nurse-led clinic, 
as identified, demonstrated a moderately reducing effect on anxiety. Reductions in 
psychological distress (i.e., anxiety and depression) appeared to be demonstrated in 
both study phases, while confidence to self-manage (i.e., medications) was 
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marginally evidenced in Phase One, but reinforced in Phase Two. While efficacy 
influences were applied in the present study, a Phase Three study is needed to 
determine if the application in the present nurse-led clinic may enhance overall SE 
by targeting efficacy beliefs. 
SE theory has been widely used to inform interventions in patients with 
chronic disease, and, thus was chosen as the theoretical framework to guide the 
present study (Barlow et al., 2002; Corbin & Strauss, 1988; Schadewaldt & Schultz, 
2011). While cardiology nurse-led clinics have been recognised and recommended in 
the literature, as highlighted in Chapter 2, there are no identical studies to The 
‘REALITY CHEC’ Project investigating the effects of early post-discharge support 
while awaiting CR and cardiology review on SE, psychological distress and self-
management (Campbell et al., 1998; Cossette, Frasure-Smith, & Lespérance, 2002; 
Jolly et al., 1999; Jones & West, 1996; Lapointe et al., 2006; Mainie, Moore, 
Riddell, & Adgey, 2005; Moher et al., 2001). The pilot study’s preliminary findings 
gave support for the potential of a nurse-led clinic to enhance some areas of CSE and 
to reduce anxiety. The findings of Phase Two also pointed to the potential 
effectiveness of a nurse-led clinic to enhance self-management (i.e., diet, weight, 
exercise). The literature emphasises the impact of SE on effective self-management 
and hence, small increases in CSE items, reflected in Phase Two findings were 
important (Bandura, 1995; Barlow et al., 2002). Participants in Phase Two expressed 
confidence to self-manage aspects of post-discharge care and make positive lifestyle 
changes (i.e., weight management, diet, physical activity, access site management, 
complication identification, and management). The SE theory adapted to the PCI 
population also allowed for the review of external influences such as patient factors 
on participants’ SE, goal-setting, and health management throughout the course of 
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the study, while also permitting the PI to assess what factors may have affected 
participants’ SE. 
An assumption of SE theory, where SE is that where SE is low, anxiety is 
enhanced (Bandura, 1986). While overall CSE was not enhanced, as identified 
earlier, when viewed at an item level there were small increases in mean ratings of 
some CSE areas and a moderately reducing effect on anxiety. Given these are 
preliminary results and that the study was significantly underpowered, a larger Phase 
Three study could examine the effectiveness and significance of the intervention on 
both primary and secondary aims. A future study could investigate the long-term 
effects of the nurse-led clinic on SE, and as highlighted by the JBI (2010) and 
Schadewaldt and Schultz (2011), nurse-led clinics have demonstrated short- to 
medium- term and some long-term success on patient outcomes. These authors argue 
that nurse-led clinics can assist patients in reaching goals and enhance their QOL and 
recommend long-term studies to determine the maintenance of long-term health 
behaviour changes and management (JBI, 2010; Schadewaldt & Schultz, 2011). In 
relation to secondary aims, a small effect on depression was evidenced in both 
groups on closer inspection of mean ratings, while greater medication knowledge 
was demonstrated in intervention group participants only. While the significance of 
these results cannot be commented on, given the nature of the study and sample size, 
results are promising and will be investigated further in the study’s third phase. 
7.3. Strengths and Limitations 
7.3.1 Study Strengths 
This study is innovative in that it was undertaken as a pilot, in two phases and 
modelled an RCT. The PI was able to collect data on multiple measures for both 
psychological and physiological outcomes from both study participants and 
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healthcare professionals. Psychological distress, as identified, is a common post-
cardiac event and may often be missed during hospitalisation (AIHW, 2011; 
Bhattacharyya, Molloy, & Steptoe, 2008; Colquhoun et al., 2013; Davidson et al., 
2008; Lane et al., 1999; Parissis et al., 2006; Turner et al., 2010). Four participants 
were flagged for medical referral in the present study, reinforcing the benefits of 
holding an early post-discharge nurse-led clinic. Trends, as evidenced on inspection 
of mean ratings and analytical findings (Phases One and Two combined), 
demonstrated participant confidence to accomplish tasks and positive health 
behaviours post-PCI while also reducing anxiety. Preliminary findings also suggest 
the nurse-led clinic may be effective in enhancing medication knowledge; however, 
other variables such as, self-education may have affected medication knowledge and 
must be investigated in a Phase Three study. The maintenance of medication 
adherence in intervention group participants and increase in knowledge after 
attending the nurse-led clinic were important preliminary findings, as 50% of 
patients are reportedly non-compliant and secondary non-adherers to 
antihypertensive and lipid-lowering therapies (Brown & Bussell, 2011; Jackevicius 
et al., 2008). 
Early post-discharge intervention and follow-up may be beneficial as patients 
are usually discharged within 6 to 24 hours post-PCI and wait from 7 to 64 days until 
they are reviewed (BHF, 2011; Cosman et al., 2011; Cupples et al., 2010; Dafoe et 
al., 2006, p. 909; Grace et al., 2012; Heart Foundation of Western Australia, 2012; 
Lacey et al., 2010; Pack et al., 2013). Providing early post-discharge nurse-led 
support and follow-up may assist patients in answering any post-discharge concerns 
regarding cares and self-management that they may have forgotten to ask during 
their hospitalisation, on discharge, or had given thought to during day 1–4 post-
303 
discharge. Benefits to the healthcare community and system include less demand. 
Post-PCI patients may ask vital questions of the RN at the clinic, as opposed to the 
patient arranging a GP or cardiologist appointment for this purpose. Furthermore, 
continuity of care will be maintained with appropriate actions (i.e., referral) should a 
patient raise concerns or the RN assess and deem referral an appropriate action. 
In addition to providing early nurse-led care, the application of a person-
centred approach to the delivery of patient care presents as another strength, 
particularly in chronic disease and patient management (Yu, 2014). The benefits in 
using this approach in the present study and in chronic illness include that it 
individualises the patient, encourages multidisciplinary team collaboration and 
allows the patient to more effectively manage in their daily lives (Dudas et al., 
2013). 
Further potential benefits of the nurse-led clinic include early post-discharge 
reiteration of education, clarification of misconceptions, and primary and physical 
examination to ensure no significant changes in health status (i.e., blood pressure, 
temperature, electrocardiogram [ECG]). Additionally, complication identification 
and management and screening for post-discharge psychological distress may be 
undertaken by a qualified cardiac RN. Thus, as a first contact in the early post-
discharge period (unless a GP appointment attended within the first week), the post-
PCI nurse-led clinic is, arguably, a beneficial post-discharge concept with 
preliminary evidence favouring a Phase Three study. 
7.3.2 Study Limitations 
The study has a strong theory base; however, while it is underpinned by 
Bandura’s SE theory (1977, 1995), the latter does not reflect the theory or support 
the primary hypothesis that an increase in SE and SE beliefs may lead to a reduction 
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in psychological distress. While overall CSE reflected a moderate reduction, only 
some CSE items were enhanced. While redesigned as a pilot study, the sample size 
for Phase One intervention presented as a limitation to this research. It was 
acknowledged that the time of year when recruitment commenced was a notably 
quiet period where wards and outpatient departments were closing thus limiting 
recruitment and sample size. Second, with a smaller sample size, the results of this 
pilot study may not be generalisable to the PCI patient population. As a 
consequence, data analysis did not permit the full range of tests and the PI was, 
therefore, unable to comment on significance levels, but rather ES, reliable change, 
and mean ratings for trends. A future powered study will allow for the control of 
potential confounders and generalisability to the study population.  
Randomisation at the commencement of the study was undertaken in large blocks 
and was later reduced to smaller groups to ensure equal randomisation. 
Blocking was identified as a study limitation and in future studies should be 
undertaken in smaller blocks or use telephone randomisation to ensure equal 
randomisation to all study arms. Participants reported that returning to the hospital 
(i.e., geography) should they be randomised to the intervention group was 
inconvenient and declined participation on these grounds. Potential participants 
reported they may have joined the study had they been able to select the option for 
telephone follow-up. Improvements observed in standard-care group participants 
may have occurred as a result of self-education, CR attendance, the Hawthorne 
and/or interviewer effects (i.e., supported RN telephone contact). Thus, as standard-
care group participants received post-discharge telephone follow-up, enhancements 
in CSE, reductions in psychological distress, and confidence in self-management 
may have also occurred as a result of telephone contact with the PI. 
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A Phase Two limitation was that interviews were only undertaken at one of the 
two hospital sites. The results of the interviews may, therefore, be relevant to the 
participants in this setting. As Phase Two post-PCI interviews were undertaken up to 
6 months post-discharge, the ability and depth of information participants were 
required to recall about the nurse-led clinic may have been vague for some. 
Additionally, as two participants declined participation in Phase Two, intervention 
group interviews may have limited the research in terms of depth of qualitative 
findings reported. Lastly, as Phase One assessment tools (i.e., STAI, CDS) were 
collected post-intervention at Time 3 (1 month), this may have presented as a 
limitation. Future studies should aim to collect data immediately post-intervention 
(i.e., Time 2, day 5–7) to gauge an immediate effect and then again at times 
reinforced by the literature to determine further change and maintenance of measures 
post-intervention. 
7.4 Recommendations 
The PI identifies and recommends that a larger scale study be undertaken and 
patients followed up for at least 12 months or more post-PCI to gauge the full effect 
of the intervention on SE, psychological distress, behaviour change, and self-
management. Furthermore, in post-PCI goal-setting, to achieve post-discharge self-
management, the PI aims to place a greater focus on patients’ goals while using CBT 
techniques to achieve goals and maintain positive health behaviours. Second, it 
would be beneficial to offer the option of different methods of communication with 
the nurse-led clinic such as Skype, FaceTime, or telephone intervention. Offering 
alternate modes of communication may also accommodate for participants who are 
unable to travel post-procedurally, who do not hold a driver’s licence, and for those 
who live in remote and rural settings. Offering online or telephone follow-up options 
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would be of benefit to patients in relation to convenience, and may facilitate study 
recruitment. Future nurse-led clinics should also be offered to patients who have 
been diagnosed with CHD, experienced a coronary event, and/or PCI as opposed to 
PCI alone. 
The present study demonstrates flexibility to be adapted and may benefit future 
participants, their SE, and emotional wellbeing, while encouraging positive lifestyle 
choices, health behaviours, and effective self-management. Furthermore, to gauge 
the full effect of the intervention and to minimise the potential for the Hawthorne 
and interviewer effects, follow-up with standard-care group participants should only 
occur via email, postal mail (i.e., to fill out questionnaires), or short message service 
(SMS) as opposed to full PI contact, as used in the present study. This clinic can be 
held within or outside the hospital setting (i.e., cardiology rooms or GP clinic), and 
be undertaken by a qualified RN. 
Cognitive–behavioural therapy accreditation is recommended; however, it 
should not be a prerequsite. Some CBT training should serve as a minimum 
requirement for the role of a facilitator. Family and support networks will be strongly 
encouraged from recruitment and significant others will be encouraged to attend the 
nurse-led clinic to receive education, provide support, and thereby better understand 
and support the patient in their recovery. Patients with limited or no support 
networks will be identified and flagged for increased risk of psychological distress 
and hospital readmission. Importantly, patients should be offered trustworthy 
internet material or relevant website addresses so that they may to engage in post-
clinic self-education. As a result of undertaking this study, further research 
investigating the life-changing effects (positive or negative) following PCI would be 
beneficial to both current and future PCI patients and healthcare professionals and 
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should be investigated. 
An important finding uncovered in the present pilot study concerning CR 
highlights the requirement for a further emphasis on the benefits of re-attending if 
PCI patients have participated in the past. Furthermore, with some patients requiring 
repeat revascularisation procedures, the importance of maintenance programs will be 
emphasised to both first-time and repeat PCIs. As CR attendance is vital to patients’ 
post-PCI health and wellbeing, a shorter refresher course should be trialled with 
different modes of attendance also offered (i.e., Skype, DVDs, FaceTime) or, 
alternatively, biannual attendance to CR programs. 
7.4.1 Implications for Research 
This study provides preliminary evidence that psychological distress may 
occur after a coronary event or procedure, as identified in the present study and the 
relevant literature (AIHW, 2011; Bhattacharyya et al., 2008; Colquhoun et al., 2013). 
Furthermore, it may demonstrate that high trait anxiety could be affected by 
educational and behavioural interventions (Muris et al., 1998). The present study 
provides some initial evidence to support the short-term benefits of nurse-led clinics, 
with long-term follow-up recommended (Schadewaldt & Schultz, 2011). Patients, 
healthcare organisations and professionals may benefit from further research 
investigating the long-term effects of nurse-led clinics on SE, psychological distress, 
and self-management given that nurse-led clinics may have some effects on long-
term health outcomes (JBI, 2010; Schadewaldt & Schultz, 2011). 
This pilot study is promising and provides evidence to support a Phase Three 
multi-centre trial to investigate the effects of the nurse-led clinic as it may be 
effective in enhancing areas of patients’ CSE and psychological distress, while also 
encouraging behaviour change and effective self-management. Significance of the 
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present study cannot be commented on given the study is a pilot only and 
underpowered. The present nurse-led clinic undertaken as a Phase Three study may 
assist patients by providing early post-discharge support, encouraging CR 
attendance, and enhancing knowledge by identifying personal goals in the early post-
discharge period. Lastly, this study may not only benefit post-PCI patients but all 
patients who have experienced a coronary event or who are diagnosed with CHD and 
should, therefore, be investigated in this group of patients for an effect. 
7.4.2 Implications for Clinical Practice 
A larger study of this nature may benefit the healthcare system in a number of 
ways. First, by reinforcing education, patients may be more informed about their 
healthcare requirements and management, which may subsequently reduce the strain 
on the healthcare system. Second, providing early post-discharge education and 
support may encourage patients to identify and manage post-discharge complications 
while highlighting the importance of seeking medical assistance. Achieving the 
aforementioned outcomes may be possible by enhancing SE, reducing psychological 
distress as a result of enhancing patients’ knowledge, encouraging goal-setting, and 
encouraging the adoption of positive health behaviours. The nurse-led clinic may be 
undertaken by a qualified cardiology RN in an outpatient department, through 
cardiology clinic rooms, or at a general medical practice room. Importantly, as 
participant recruitment may be difficult due to geographical issues, offering earlier 
(i.e., 3–5 days) face-to-face follow-up or telehealth options is recommended. The 
importance and benefits of the nurse-led clinic should be highlighted to cardiologists 
so that support may be gathered to establish a post-discharge follow-up clinic within 
the first week post-discharge in cardiology rooms or using an electronic visual 
medium (i.e., Skype or FaceTime). Moreover, 91 potential participants were unable 
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to partake in the study as they lived too far away but offered their availability via 
means of telephone follow-up. Thus, future patients should be provided with options 
for study involvement and follow-up as identified above. 
7.5 Summary 
While the pilot study did not demonstrate overall effectiveness of the nurse-led 
clinic, it did provide some initial evidence to suggest potential for a Phase Three, 
multi-centre study held within the first week post-PCI (i.e., 3–5 days). Although 
overall enhancements in CSE were not demonstrated in intervention group 
participants, selected CSE items demonstrated small increases in mean ratings over 
time. The intervention demonstrated a moderate effect on trait anxiety on study 
participants and was viewed as important to this study given that individuals with 
higher trait anxiety are less susceptible to intervention and treatment (Muris et al., 
1998, Tovilović et al., 2009). Reductions in mean ratings for anxiety and depression 
were identified in both groups of study participants. The following explanations were 
offered for enhancements in standard-care group, (a) post-discharge self-education, 
(b) effective support networks, (c) CR attendance, (d) the Hawthorne effect, and (e) 
interviewer effects (i.e., supported RN telephone contact). It was interesting that 
salivary cortisol levels demonstrated slightly higher levels in standard-care group 
participants, as opposed to self-report instruments, which demonstrated higher 
anxiety and depression scores in intervention group participants. Notably, however, 
mean ratings were identified at Time 3 (1 month) with reductions in mean trait 
anxiety (and depression) scores identified alongside reductions in salivary cortisol 
levels. 
Cardiac rehabilitation referral, attendance, and adherence still require effort 
from both healthcare professionals and patients, while continuation of the 
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maintenance stage requires further investigation. Whether it be 1 month or 10 years 
since CR attendance, the importance of education and maintenance of positive 
lifestyle changes and behaviours is essential. Phase Two interviews suggest greater 
persuasion and non-negotiable attendance or re-attendance to CR. An important 
finding arising from this study is the need for CR short courses for repeat 
revascularisation patients or biannual CR course attendance. This finding was also 
reinforced in Phase Two analytical findings and should be undertaken to support 
repeat PCI patients. Enhancements in medication knowledge were identified in 
intervention group participants while medication adherence remained stable based on 
inspection of mean ratings. Phase Two analytical findings highlighted the 
importance of medication education, detailing its potential effectiveness. 
Recommendations to caution participants on potentially incorrect internet education 
material and suggesting patients seek medical advice prior to self-cessation of 
medications also emerged from Phase Two analytical findings. 
The pilot nurse-led clinic was viewed positively by both participants and 
healthcare professionals in that it was person-centred and offered a tailored 
approach, while also providing options to suit learning styles to maximise support in 
the early post-discharge period. Participants voiced full confidence in the PI, and felt 
reassured with the nurse-led clinic and follow-up. The gravity of their procedure and 
surrounding events were brought to light in the early post-discharge period and after 
attending the nurse-led clinic. Participants reported greater self-confidence to 
effectively manage their health and make positive lifestyle choices as they gained an 
awareness after attending the clinic and undergoing their procedure. Phase One and 
especially Phase Two findings are promising and highlight the potential for a Phase 
Three, multi-centre study. While only some areas of SE were enhanced, the present 
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study shows promise in reducing psychological distress and encouraging effective 
self-management after experiencing a life-changing event. 
The results of the present pilot study may be used to develop a model of care 
that can be applied to the areas of cardiovascular nursing, CR nursing, CCT teams, 
and cardiology in both private and public organisations engaged in primary and 
secondary prevention. The present study’s results may also assist in refining and 
extending existing knowledge in the area of PCI, coronary angiography and CHD 
patient management—in particular, the early post-discharge period where there is 
often an increased risk of post-discharge psychological distress. Moreover, it is 
hoped that the present study can offer additional information regarding post-
discharge experiences, behaviours, and health management practices post-PCI. 
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 Appendix A: Supporting Literature 
Problem 
 
Authors  Aims/Discussion/Results Conclusions/Recommendations 
Hospitalisation 
time 
Laarman & Dirksen 
(2010, pp. 584–587) 
 
Discussion on the topical question of 
early discharge post primary PCI. 
 Early discharge may be beneficial to both 
patient and hospital; however, it should 
only be available to those identified as 
low-risk.  
Kaluski et al. (2008, 
pp. 345–348) 
 
Aim: To assess the feasibility of a 
decreased length of stay post-PCI in a 
quality improvement program in the 
US. 
 
Results: A decrease in length of stay 
from 48 hours to 30 hours between the 
years 2000–2006. 
 
 The authors highlight the success of the 
decrease in hospitalisation time to 30 
hours. 
 The authors highlight that although this a 
shorter length of stay proved successful, 
this will require close and effective 
management practices, in particular in 
patients with the following characteristics 
as safety can be severely compromised. 
Characteristics are as follows: 
 Poverty stricken; 
 Addictive disabilities; 
 Socially isolated; 
 Non-compliance; and 
 Several co-morbidities. 
 
Kotowycz et al. (2009, 
pp. 585–588) 
 
Aim: To assess the viability and safety 
of early discharge of 54 low-risk 
STEMI patients at 72 hours post-PCI. 
 
 
 
 It is concluded that early discharge of 
lower-risk STEMI patients can occur, 
however, it is recommended that this 
group of patients are followed up closely 
by an acute practice nurse. 
 
 3
1
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Problem 
 
Authors  Aims/Discussion/Results Conclusions/Recommendations 
Results: 
 74% discharged within 72 
hours; and 
 Median length of stay 55 hours. 
 Acute practice nurse follow-up 
100% of patients 
Within 3 days post-discharge 
74 % face-to-face follow-up; 
26% telephone communication; 
All patients had > follow-up 
sessions with the nurse. 
 
At 6 weeks post-discharge 
Medication compliance 
 Most patients were compliant in 
self-administering their 
medications 
 Only 15 of 27 patients in the 
intervention group attended CR 
once; 
 Only 14 of 27 control group 
patients attended CR; and 
 Approximately 63% of patients 
in the intervention group 
continued smoking versus 58% 
in the control group. 
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Problem 
 
Authors  Aims/Discussion/Results Conclusions/Recommendations 
 Chin et al. (2011, pp. 
1052–1061)  
Aim: To examine the CathPCI Registry 
and length of stay for Primary PCIs in 
115,113 patients and 958 hospitals from 
the years 2005–2009. 
 
Results: The mean length of stay 
between 2005–2009 decreased from 4 + 
3.0 to 3.6 + 2.7 days. There were no 
changes in in-hospital mortality. Patient 
stays longer than two days were high-
risk and suffered either of the 
following: cardiogenic shock, required 
blood transfusion or balloon pump 
insertion, post- PPCI complications or 
were of an older age group. Low-risk 
patients were discharged within 2 days 
from 45.6 % of hospitals reviewed. 
 
Conclusions/Recommendations: 
 Length of stay is decreasing for both 
patient types (i.e., PPCI and Elective 
patients). 
 
 Discharge is based on the following and 
differs between hospitals. 
 
 Discharge is dependent on: 
 
 a. The hospital; b. the patient (i.e., 
complications and risk); and c. the 
procedure. 
 
 Additional research on safety of early 
PPCI discharge recommended. 
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1
6
 
 Authors 
 
Aim/Discussion/Results 
 
Conclusion/Recommendations 
 
Post-
discharge 
period 
Yan et al. (2011, pp. 122–
127) 
Aim: To review DES trends and 12 
month outcomes in Australia in 9204 PCI 
patients between 2004 and 2008. 
 
Results: 
a. A decline in DES use (53.9% to 32%) 
over this time due to long term safety 
concerns (i.e., in-stent thrombosis, MI 
or death at >30 days and >12months). 
b. Increase in clopidogrel use (54.7% to 
98%). 
Recommendations/Conclusions: 
 
a. Increase in long-term dual antiplatelet 
treatment. 
 
a. AE’s: Low during this time. 
 
b. High procedural success rates 
 
 
 
 Tuso et al. (2013) Aim: Review of initiatives to reduce 
hospital readmission rates. 
 
 
Findings: 
 1/3 of 30 day readmissions within 
7 days after hospital discharge. 
  
 The first 7 days post-discharge a 
vulnerable period with reasons as 
follows: 
 
 Social issues – non-compliance; 
medication expenses and adverse 
reactions; low success rate of 
hospital treatment. 
 
Recommendations/Conclusions: 
1. Tailored, patient-centred approach, with 
focus on social setting will reduce 
hospital readmissions and assist in 
reducing healthcare costs. 
 
2. Focus should be on the patient and their 
social issues. 
 
3. Focus on disease prevention and timely 
treatment.  
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 Authors 
 
Aim/Discussion/Results 
 
Conclusion/Recommendations 
 
To reduce readmission rates: 
 Telephone follow-up within 72 
hours in high-risk patients to 
reduce readmission within one 
week post-discharge with focus 
on education and recent hospital 
admission. 
 Primary care physician review 
within the first week post-
discharge to reduce 30 day 
readmission.  
 Lane et al. (2000) Aim: To examine CHD and the 
relationship with anxiety and depression 
up to 12 months post-MI. 
 
Findings: 
 Grounds for concern post-MI 
 Mild to severe depressive 
symptoms suffered; 
 High levels of anxiety; 
 Intervention required for post-MI 
patients. 
 
 Lane et al. (1999) Aim: To identify the psychological 
needs of patients with CHD and MI. 
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 Authors 
 
Aim/Discussion/Results 
 
Conclusion/Recommendations 
 
Findings: 
 Psychological symptoms may be 
subside at 5–6 days post event in 
some patients; 
 Psychological distress may 
present in weeks post event. 
Why? Realisation of event 
recognised. 
Conclusions: 
 Routine screening for 
psychological distress; 
 Offer psychological referral; 
 Offer stress management; and 
 CR to be individually tailored. 
 Das & O’Keefe (2006) Aim: To investigate the effects of 
psychological distress on cardiovascular 
health. 
Findings and conclusion: 
 Associated with non-compliant 
behaviours 
 Stress is modifiable 
 Protective factors: Support, 
exercise, stress reduction 
education, humour, optimism, 
altruism, faith, pet ownership. 
 Screening for emotional distress 
should be undertaken. 
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 Authors 
 
Aim/Discussion/Results 
 
Conclusion/Recommendations 
 
 Turner et al. (2010) Aim: To investigate the relationship 
between anxiety, depression, social 
support and clinical outcomes in CR 
participants. 
 
Conclusion: 
 Patients requiring screening for 
emotional distress and 
intervention.  
 
  Barnason, Zimmerman, 
Brey, Catlin, & Nieven 
(2006, pp. 31–37) 
 
 
Aim: To study PCI patient recovery 
post-discharge from hospital. 
 
Findings: 
First 2 weeks after discharge 
 Depression and Anxiety; 
 Tiredness; 
 Chest pain; 
 Short of breath; 
 
At 6 weeks post-discharge 
 Tiredness; 
 Short of breath; 
 Lower limb oedema and 
discomfort; 
 Coronary artery re-stenosis. 
 
An understating of the differences in patients’ 
recovery is warranted as it may allow for 
improved patient outcomes through 
enhancements in the field. 
 
This study highlights that patients post cardiac 
events do suffer from psychosocial difficulties. 
Secondly it presents the significance of 
incorporating such content within secondary 
prevention programs. Lastly, the results highlight 
the need to employ a broad group of clinicians to 
assist patients in their recovery and beyond.  
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 Authors 
 
Aim/Discussion/Results 
 
Conclusion/Recommendations 
 
Arndt, Murchie, 
Schembri, & Davidson 
(2009, pp. 328–335) 
 
 
Aim: To explore the post-discharge 
psychosocial needs of patients who have 
experienced a cardiac event. 
 
Methods: 
 Survey 
 Journal 
 Focus Group 
 
Results: Four themes 
 Theme 1: “The need for 
provision of Hope”; 
 Theme 2: A Desire for Structure 
and Support”; 
 Theme 3: “An Appreciation of 
Support of Fellow Group 
Participants”; and 
 Theme 4: “The Need to Review, 
Process, Interpret Their Illness 
Trajectory” (Arndt et al., 2009, 
p. 332).  
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 Authors 
 
Aim/Discussion/Results 
 
Conclusion/Recommendations 
 
 Lauck et al. (2009, pp. 
190–199) 
 
 
Aim: To assess patients self-caring 
abilities and behaviour 2–5 days post-
discharge. 
Results: 
 A large number of patients 
followed discharge instructions; 
 Antiplatelet medication 
compliance: 97 % 
 Patient understanding of reason 
for antiplatelet medication: 
77.5% 
 Exercise: 
Under-exercising: 52% 
Over-exercising: 20.4%  
Discharge on the same day feasible, however, 
those patients “socially isolated” require 
identification and support during their recovery 
(Lauck et al., 2009, p.198). 
 Rudd et al. (1993, pp. 
659–666) 
Aim: To assess medication 
administration gaps in cardiovascular 
patients. 
 
Methods: Self-report; Electronic 
monitoring; Doctor monitoring; & 
Counting medications. 
 
Results: 
 Most participants compliant 
 Found subgroups of patients 
 Group 1: Near-optimal 
compliers 
50–60% compliant 
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 Authors 
 
Aim/Discussion/Results 
 
Conclusion/Recommendations 
 
 Group 2: Partial compliers 
30–40% compliant 
 Group 3: Non-compliers 
10 % compliant (p. 665). 
 Fernandez et al. (2007, 
pp. 53–61) 
Aim: The evaluation of long-term PCI 
patient medication adherence. 
  
Methods: 
 Self-report Questionnaire; and 
 MMAS-8. 
Results: 
 90.6% never missed medications 
per week; 
 7.5 % miss 1–3 tablets per week; 
 2% miss >4 tablets per week; 
 4% could not remember if they 
missed any; 
 2% cease medications if feeling 
well; 
 4.5% cease medications if 
feeling ill; 
 5 % cease medications if they 
are going on an outing; and 
 31.9% stored medications 
incorrectly. 
 
 Radcliffe, Harding, 
Rothman, & Feder 
Aim: To explore participants’ 
experiences of PCI in the UK. 
 The authors highlight participants’ 
disappointment with poor primary care 
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 Authors 
 
Aim/Discussion/Results 
 
Conclusion/Recommendations 
 
(2009, pp. 216–222) 
 
 
 
Methods: Interview at home or hospital 
13–90 days post-PCI. 
Results: 
 Patients were extremely satisfied 
with treatment they received by 
the interventionalist and carers. 
 Patients had expected they 
would have CABG surgery as 
opposed to PCI. 
 Post-discharge needs not met. 
 
post-discharge follow-up. 
 
 A large number of participants had 
questions of their condition and post-
discharge management/care. 
 Secondary prevention 
 
Foster, K, personal 
communication, 
November 15, 2010. 
Data: Complications post-PCI in the 
year 2008. 
 
Results: 
At 1 month post-PCI (n = 424) 
 Repeat coronary angiogram: 
2.8% 
 Repeat PCI: 2.4% 
 Mortality: 1.2% 
 Stroke: 0.2% 
 Puncture site complication: 2.4% 
 
 
 
 
At 12 months post-PCI (n = 392) 
 Repeat coronary angiogram: 
7.1% 
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 Authors 
 
Aim/Discussion/Results 
 
Conclusion/Recommendations 
 
 Repeat PCI: 5.9% 
 Mortality: 2.8% 
 Stroke: 0.5% 
 Puncture site complication:3.3% 
 
 Gallagher et al. (2013) Aim: To trial and examine the effect of 
an educational intervention on chest 
pain, knowledge and management in 
PCI and AMI patients attending CR 
between 2010 and 2011. 
 
Intervention: At baseline CR assessment 
and review of knowledge at 6–8 weeks 
on CR course completion. 
 
Results: 
Improvements in patients’ symptom 
knowledge and actions at 6–8 weeks 
post-intervention. 
 
Actions for CP management reported 
by patients included: 
 4% driving to hospital 
 14% having someone drive them 
to hospital 
 11% calling GP 
Post-intervention: 
Improvements in knowledge, actions at 
8 weeks post-intervention. 
Recommendations / Conclusions: 
 Tailored patient education on CP and 
management required. 
 Allows for misconceptions in CP 
knowledge and actions to be clarified. 
 Requirement for this education to be 
repeated due to low CR attendance rates 
with recommendations as follows: 
a. Post-discharge; 
b. medical rooms; and 
c. outside of CR. 
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 Authors 
 
Aim/Discussion/Results 
 
Conclusion/Recommendations 
 
 
 Bethell et al. (2006, pp. 
57–61) 
 
 
Aim: CR programmes followed for a 
period of 7 years (1998–2004) in the 
UK. 
 
Patients: Post- AMI, CABG, and PCI 
 
Results: Increase in patients treated over 
the course of the study. 
 
Rates of patients enrolled in CR 1998 – 1999: 
25% to 31.5%; 
 
Rates from 2002–2004: 
Decline 31.3% to 28.5%. 
 
National Service Framework aim for these 
patients: 
 85% enrolment rate to CR 
 Actual enrolment: 1/3 of patients and 
declining.  
 Dafoe, Arthur, Stokes, 
Morrin, & Beaton 
(2006, pp. 905–911) 
 
Problem: The absence of national 
benchmarks for patients requiring 
cardiovascular care and follow-up in 
Canada. 
 
Methodology: 
 Literature review 
 Value of CR; 
 Accessibility barriers and 
referral issues. 
 Review 
 Current guidelines of CR 
 Attendance leads to a reduction in 
morbidity and mortality; 
 Referral irregularities; 
 Poor utilisation of CR; 
 CR course issues (i.e., not patient specific 
enough and geographical location). 
 All patients with cardiovascular disease 
would benefit from CR. 
 Further guidelines need to be established 
as to what type of patient is classed as 
appropriate. 
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 Authors 
 
Aim/Discussion/Results 
 
Conclusion/Recommendations 
 
accessibility. 
 National survey 
 14 programs; and 
 information: referral and 
delay. 
 
Review of Pilot Study: 
 ‘The Ontario Cardiac 
Rehabilitation Pilot Project’. 
 Rolley, Salamonson, 
Dennison, & Davidson 
(2010, pp. 75–84) 
 
Aim: To review the literature and 
update nurses on current PCI patient 
management and practices from 
admission to post-discharge. 
 
Results: 
 PCI journey highlighted as 
important; 
 Limited information and policy 
and procedure available on PCI 
patient nursing management; and 
 Shorter length of stay acts as a 
barrier to the provision of 
discharge education and 
secondary prevention 
information. 
The authors encourage further nursing research so 
as to establish strong foundations and substantiate 
protocol development. 
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Appendix B: Cardiac Self-Efficacy (CSE) Questionnaire Sample Questions 
How confident are you that you know: 
 
1. When you should call or visit your Doctor about your heart disease? 
Responses: Not at all (0), Somewhat confident (1), Moderately confident (2), 
Very confident (3), Completely confident (4), N/A (9). 
 
2. How to make your doctor understand your concerns about your heart? 
Responses: Not at all (0), Somewhat confident (1), Moderately confident (2), 
Very confident (3), Completely confident (4), N/A (9). 
 
How confident are you that you can: 
1. Control your breathlessness by taking your medications? 
Responses: Not at all (0), Somewhat confident (1), Moderately confident (2), 
Very confident (3), Completely confident (4), N/A (9). 
 
2. Control your chest pain by taking your medications? 
Responses: Not at all (0), Somewhat confident (1), Moderately confident (2), 
Very confident (3), Completely confident (4), N/A (9). 
 
Source: Sullivan, M. D., Lacroix, A. Z., Russo, J., & Katon W. J. (1988). Self-efficacy and self-
reported functional status in coronary heart disease: A six-month prospective study. Psychosomatic 
Medicine. Copyright [1998] by the American Psychosomatic Society. Reprinted with permission. 
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Appendix C: State-Trait Anxiety Inventory For Adults Form Y2 Sample 
Questions 
 
Question     Responses 
d. I lack self-confidence (Y2)  Almost never (1) 
Sometimes (2) 
Often (3) 
Almost always (4) 
 
 
 
Source: Spielberger, C. D. in collaboration with Gorsuch, R. L. Jacobs, G. A. Lushene, R., & Vagg, P. 
R. (1983). The State-Trait Anxiety Inventory for adults. Menlo Park, CA: Mindgarden. Copyright 
[1968, 1977] by Charles D. Spielberger. Reprinted with permission. 
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Appendix D: Cardiac Depression Scale Sample Sheet (CDS) 
 
Source: Hare, D. L. & Davis, C. R. (1996). Cardiac depression scale: Validation of a new depression 
scale for cardiac patients. Journal of Psychosomatic Research, 40(4), 379–386. Copyright [1993] by 
D.L. Hare. Reprinted with permission. 
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Appendix E: Coronary Artery Plaque 
 
 
 
 
 
Source: The National Heart Foundation of Australia (2008). Coronary angiography. 
Author. Copyright 2008, Reprinted with permission. 
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Appendix F: STEMI Management – ‘A’ Grade Recommendations 
Table F1. STEMI management 
 Management: ‘A’ Grade Recommendations 
STEMI Electrocardiogram: 
Reperfusion therapy for STEMI: 
Consider early routine coronary angiography and revascularisation amongst 
patients receiving finbrinolysis, regardless of the success of pharmacologic 
reperfusion. 
Antiplatelet therapies should be continued for 12 months after the insertion of 
drug-eluting stents. 
The use of mechanical thrombectomy techniques to reduce thrombus burden 
during primary PCI should be considered. (Chew et al., 2011, p. 488). 
 
 
 
Note. Adapted from Chew et al. (2011). 2011 “Addendum to the National Heart 
Foundation of Australia/Cardiac Society of Australia and New Zealand Guidelines 
for the Management of Acute Coronary Syndromes (ACS) 2006.” by, Heart, Lung, 
and Circulation, 20, 487–502. 
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Appendix G: NSTEACS Management – Recommendations 
Table G1. NSTEACS Management 
 Management: ‘A’ Grade Recommendations 
NSTEACS Antithrombotic therapy for NSTEACS: 
a. For all patients with high-risk NSTEACS, consider methods to 
reduce bleeding risk: 
 Titrate antithrombotic agents to optimal dose for weight 
and renal function. 
b. For all patients with high-risk NSTEACS, assess bleeding risk 
individually according to the number and severity of bleeding 
risk factors. 
c. Use a standard management strategy for patients at low risk of 
bleeding: 
 Choose the most effective antithrombotic regimen (e.g. 
prasugrel or ticagrelor). (Chew et al., 2011, p. 488). 
 
 
Note. Adapted from Chew, D. et al. (2011). 2011 Addendum to the National Heart 
Foundation of Australia/Cardiac Society of Australia and New Zealand Guidelines 
for the Management of Acute Coronary Syndromes (ACS) 2006.” by, Heart, Lung, 
and Circulation, 20, 487–502. 
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Appendix H: Access sites: Coronary artery catheterisation 
 
 
 
 
Adapted from O’Grady E. (2007). A nurse's guide to caring for cardiac intervention 
patients (p. 2). Chichester: John Wiley & Sons. 
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Appendix I: Efficacy and Outcome Expectations 
 
 
 
 
Source: Bandura, A. (1977). Self-efficacy: Toward a unifying theory of behavioral change. Psychological Review, 84(2), 191–215. 
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Appendix J: Information Sources 
 
 
Source: Bandura, A. (1977). Self-efficacy: Toward a unifying theory of behavioral 
change. Psychological Review, 84(2), 191–215. 
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Appendix K: Theoretical Framework – The ‘REALITY CHEC’ Project© 
 
Adapted from: Bandura, A. (2004). Health promotion by social cognitive means. Health Education & Behaviour, 31(2), 143–164, and 
Corbin, J. & Strauss, A. (1988). Unending work and care: Managing chronic illness at home. San Francisco: Jossey-Bass.
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Appendix L: Cardiac Nurse-led Clinics versus present Pilot Study  
Study/Authors/Aim/Design Intervention versus Standard Care Group Comparison: Present Pilot Study 
Authors: Cosette, Frasure-
Smith, & Lesperance (2002) 
 
Title: Nursing approaches to 
reducing psychological distress 
in men and women recovering 
from myocardial infarction (MI) 
 
Aim: Investigation of nursing 
methods to reduce 
psychological distress in 
patients who have experienced 
an MI patients in the Montreal 
Heart Attack Readjustment 
Trial (M-HEART). 
 
Participants: N = 1376 
 Intervention group: 692 
 Standard care group: 
684 
 
 
Design: A secondary analysis 
of data set. 
 
Methods: 
Monthly telephone calls 
 Patients suffering 
 Post-MI: Home-based psychosocial nurse-led 
intervention 
 Tailored to individual 
 Total of 6–7 hours nursing contact (i.e., home 
visitation and telephone follow-up) 
 Identification of causative variables of distress 
 Approaches: cognitive 
 Educational 
 Listening/Reassurance/Encouragement 
 Advice 
 Other: left contact telephone number if concerns 
 
Standard care group 
 Doctor follow-up 
 
Results: n = 692 
 Nil effect on distress overall 
 Little effect on anxiety and depression in men (p 
= 0.13 and 0.061) 
 Nil effect on anxiety and depression in women (p 
= 0.56 and 0.66) 
 Nil effect on cardiac mortality in men (p = 0.94) 
 Cardiac mortality in women in intervention group 
(p = 0.064) (p.480) 
 
 
 
 
Phase One: 
Theoretical Framework: 
 Bandura’s Self-Efficacy (SE) 
Theory 
 
 Intervention: Face-to-Face visit 
 
 Delivery: Post-PCI At 5–7 days 
post-discharge from hospital 
 Primary aim: To determine if a 
nurse-led, Post-PCI clinic can 
enhance Self-efficacy (SE) and 
reduce anxiety 
 Secondary aims: 
Attending the nurse-led clinic 
may: 
 Reduce symptoms of depression 
 Facilitate effective self-
management (i.e., medication 
adherence, wound-site care 
management, angina 
management) 
 Education provision (i.e., visual 
and verbal, and scenario 
provision); clinician physical 
assessment; primary assessment 
(i.e., Electrocardiogram, blood 
pressure, waist measurement, 
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psychological distress 
identified utilising 20-
item General Health 
Questionnaire (GHQ) 
measured monthly. 
 GHQ scores >5 each 
month received at least 
two home visits 
 
 
Secondary analysis: n = 431 
 Evidenced an effect on half of participants in 
intervention group after the first two home visits. 
 Participants demonstrating short-term 
improvements evidenced enhancements in 1 year 
health outcomes and prognoses. 
 
weight, temperature). 
 Utilisation of: active listening; 
providing feedback, health 
misconception clarification, 
participant questions. 
 Multi-disciplinary team 
communication: General 
practitioner or cardiology referral 
if required 
 Telephone follow-up: 1 month, 3 
months post-discharge 
Assessment and tools: 
 State-Trait Anxiety Inventory 
(STAI) 
 Cardiac Self-efficacy 
Questionnaire (CSE) 
 Cardiac Depression Scale (CDS) 
 Morisky Medication Adherence 
Scale – 8 Item 
 (MMAS-8) 
 Self-report: diet, activity, weight, 
CR attendance 
Phase Two: Evaluation of Phase One 
 Semi-structured interviews 
 Recorded and transcribed 
interviews 
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Participants: 
 Healthcare professionals and 
 Patients who undertook Phase 
One intervention  
Authors: Lapointe, Lapage, 
Larrivée, & Maheux (2006) 
 
Title: Surveillance and 
treatment of dyslipidaemia in 
the post-infarct patient: Can a 
nurse-led management 
approach make a difference? N 
= 127 study participants 
 
Aim: To investigate the effects 
of nurse-led monitoring and 
treatment in lipid management 
to achieve national 
recommended reference ranges. 
 
Design: Randomised, open-
label clinical trial. 
 
 
Method: 
Intervention group: 
 Follow-up over 18 months 
 Telephone follow-up post-MI and some face-to-
face contact with nurse-manager; 
 Quality of life (QOL) measurement (SF-36) 
 Nurse-led (communication with physician, 
dietician, pharmacist); 
 Measurement of lipid levels 
*First lipid measurement at 3 months post-
discharge 
(*Regular measurement of lipids with close contact and 
monitoring by physician to ensure reference ranges were met). 
 
 When lipid reference ranges were met 
participants discharged from the intensive 
intervention and then reassessed at 12 and 18 
months by a pharmacist to ensure medication 
compliance. 
 Total average time spent with nurse-manager for 
each intervention group participant (+ SD) 52.2+ 
29.8 minutes. 
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Standard care group: 
 Follow-up over 18 months by a primary physician 
only 
 Total average time in contact with nurse-manager 
for each standard care group participant 
19.3+15.5 minutes. 
 
Results: Nil effect demonstrated on lipids, QOL and long-
term medication adherence in intervention group participants. 
 
Authors: Jones, & West (1996) 
 
Title: Psychological 
rehabilitation after myocardial 
infarction. 
N=2328 study participants 
 
Aim: Evaluation of the effect of 
rehabilitation post-MI 
 
Design: Randomised controlled 
clinical trial 
 
*Physicians, clinical 
psychologists, nurses, managers 
assisted in the study’s design. 
 
 
Psychological interventions: counselling, relaxation, stress 
management 
 
Duration: Seven 2 hour clinic sessions for both patients and 
partner’s. Commenced 2–6 weeks post-hospital discharge over 
12 months. 
 
Methods: Cardiovascular education to reduce anxiety and 
fears; generate awareness about stress and stressful 
circumstances; teach skill of relaxation; improve reactions and 
coping with stress; teaching optimism in response to illness; 
confidence building for both patient and partner. 
 
Sessions were undertaken directed by clinical psychologists 
and healthcare professionals. 
 
Patients encouraged to diarise and rehearse techniques in-
between sessions. 
 
Results: Suggest little effect on anxiety, depression, 
morbidity, mortality, medication and disability. Clinical 
anxiety and depression remained unchanged at 6 months. Nil 
major differences between intervention and standard care 
groups as reported by the authors. 
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Author: Mainie, Moore, 
Riddell, Adgey (2005) 
 
Title: To examine the 
effectiveness of a hospital-
based nurse-led secondary 
prevention clinic (N=563) 
 
Aims: To assess and monitor 
cardiac patients with CHD/post-
PCI /Post-MI/ post- CABG risk 
factors 
 
To determine the overall 
effectiveness of the hospital-
based, nurse-led secondary 
prevention service on to risk 
factor modification and to 
enhance medial therapy. 
 
Design: Pilot study 
 
Method: Hospital-based, nurse-led secondary prevention 
clinic visits to reduce risk factors for CHD 
 
 
Baseline visit: 
Full patient medical and family history 
Exercise status 
Physical assessment: blood pressure, height, weight, BMI, 
pathology 
Health behaviours: smoking status, alcohol consumption 
Medications: Prescription of new medications (if required) 
*Referral to GP throughout the course of follow-up if 
required. 
 
Results: The clinic saw positive trends in reaching targets for 
the following areas: 
 Exercise 
 Blood pressure management 
 Smoking cessation 
 Alcohol consumption 
 Weight reduction 
 Cholesterol reduction (i.e., total and low density 
lipoprotein [LDL]) 
 Nurse-led clinics of benefit in secondary 
prevention 
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Recommendations: 
 Application in primary care setting 
 Utilisation in GP practice setting 
 6 monthly or annual visits recommended for low 
risk patients 
 Referral for high-risk patients to clinic whenever 
required 
 
Authors: Campbell, Thain, 
Deams, Ritchie, Rawles, & 
Squair (1998) 
 
Title: Secondary prevention for 
coronary heart disease: 
randomised trial of effect on 
health (N=1173) 
 
Intervention group: n = 593 
Standard care group: n =580 
 
Aim: To determine the effect of 
the nurse-led secondary 
prevention clinic in patients 
with CHD versus GP 
management and standard care 
on: 
 General health and well-
being (SF-36) 
 Anxiety and depression 
(HADS) 
Methods: 
 Patients randomised from 19 general practice 
clinics and then separated into two groups 
 Participants randomised to standard care group or 
intervention group 
 
Intervention and intervention group: 
 Nurse and healthcare professional run secondary 
prevention clinic 
 Duration of 12 months 
 Data entry blinded 
 
Standard care group: 
 GP follow up only 
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 Clinic attendance 
 Hospital readmission 
 
Design: RCT 
 
Results: 
 Statistically significant health improvements 
evidenced in physical function and physical role 
SF-35scores (P=0.001) in intervention group 
participants 
 Improvements in angina in intervention group 
participants 
 Angina in standard care group worsened 
 Nil statistically significant changes in HADS 
scores 
 Statistically significance in hospital readmissions 
between groups at 12 month follow-up. 
Improvements evidenced in intervention group 
 
Authors: Moher, Yudkin, 
Wright, Turner, Fuller, & 
Schofield (2001) 
 
Title: Cluster randomised 
controlled trial to compare three 
methods of promoting 
secondary prevention of 
coronary heart disease in 
primary care 
 
Aim: To investigate three 
methods of secondary 
prevention to prevent CHD in 
primary healthcare in the 
community. 
Method: Randomised to attend nurse-led secondary 
prevention clinic, GP and audit group. Measurement of 3 
risk factors: 1. blood pressure; 2. cholesterol; and 3. 
smoking status. Medication prescription and pathology 
were undertaken. Follow-up over 2 years. 
 
 
Intervention and groups: 
1. Nurse-led recall group – 
 advised of the patients to approach 
 establishment of disease register 
 methodical recall of patients to nurse-led 
clinic 
2. GP recall group – advised of the patients to 
approach 
 establishment of disease register 
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Design: Pragmatic, unblinded 
cluster RCT  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 methodological recall of patients to GP 
clinic 
 
Standard care group: 
Audit group –received audit data 
Received standard care with no additional support 
 
Results: Statistically significant assessment of all groups 
(P= <0.001) 
 effectiveness in nurse-led recall assessment of 
participants (P=<0.004) 
 Statistically significant improvements in blood 
pressure in both intervention groups (P=<0.001) 
 Statistical significance in all groups for 
cholesterol level assessment (P=<0.001) 
 Independent analysis between GP recall and 
nurse-led recall group demonstrated greater  
 Statistical significance in cholesterol levels 
between nurse-led recall group and audit group 
 Statistical significance in cholesterol levels 
between GP recall group and audit group 
(P=<0.001) 
 
 For cholesterol level management, both nurse-
recall and GP recall groups equally as effective 
 Statistical significance evidenced in reduction in 
smoking in participants in both intervention 
groups (P=<0.001) 
 Nurse-led recall group demonstrated statistical 
significance in the increase in the prescription of 
cholesterol lowering medication treatment.  
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Authors: Jolly et al. (1999) 
 
Title: Randomised controlled 
trial of follow up care in general 
practice of patients with 
myocardial infarction and 
angina: final results of the 
Southampton heart integrated 
care project (SHIP) 
 
Aim: To investigate the 
effectiveness of a nurse-led 
follow-up and liaison with 
general practice nurses post-MI 
(n = 422) or angina diagnosis (n 
= 175) 
 
Design: RCT, stratified 
randomisation to groups 
 
Methods 
Intervention: 
Liaison nurses to enhance communication between 
general practice nurses to enhance hospital-general 
practice communication and coordinated patient follow-
up 
 
 Liaison nurse contact with GP clinic or clinic 
nurse (if available) on patient’s discharge from 
hospital to arrange first follow-up appointment 
and patient care 
 GP clinic nurses encouraged to call liaison nurse 
to discuss issues (i.e., clinical, organisational) 
 Participants or family members given a clinical 
pathway for post-discharge care for GP 
 Liaison nurse support to GP practice at 3–6 
months post-discharge (i.e., visits and telephone 
calls) 
 Clinic nurses attendance of courses for behaviour 
change, and support for educative needs 
 Patients given records to direct follow-up 
 
Outcome measures: 
 total cholesterol 
 blood pressure 
 six minute walk test distance 
 smoking and cessation 
 BMI 
 
Follow-up: 
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 Independently undertook questionnaire 
 Questionnaire tools: HADS, EuroQol visual 
analog scale 
 1 month, 4 months, and 12 months 
 12 months – assessment of lifestyle factors, 
cardiac rehabilitation, utilisation of additional 
resources, chest pain, psychological distress and 
independent liaison nurse follow-up and 
assessment (different to intervention liaison 
nurse). 
 
A parallel qualitative study undertaken to explore participants’ 
experiences of MI and their care 
 
Results: 
 Nil significant effects were evidenced on outcome 
measures 
 Demonstrated effectiveness in encouraging 
follow-up in general practice post-discharge 
 
 
 
 
Authors: Lewin et al. (2002) 
 
Title: A randomised controlled 
trial of a self-management plan 
for patients with newly 
diagnosed angina. 
 
Aim: To investigate the 
Methods: 
 Follow-up of 142 participants over 6 months 
 Patients randomised to study groups and given a 
self-help manual or education group, plus 
additional information books 
 
Self-management group: 
Self-help manual plus; 20 minute audio relaxation program for 
patient and partner; 30–40 minute nurse-interview; 
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effectiveness of angina 
management plan by practice 
nurse versus educational 
program 
 
Primary outcome: Anxiety and 
depression 
 
Secondary outcomes: Diarised 
angina – severity, duration, 
episodes, number of GTN 
tablets or sprays consumed. 
 
Quality of life (QOL) – Seattle 
Angina Questionnaire (SAQ) 
 
Design: Blinded RCT 
 
identification of angina misconceptions and nurse correction 
 
Education group: 
Coronary heart disease risk factor identification; and education 
regarding the reduction, and participant education package. 
 
Results: 
 Participation in the self-management group 
demonstrated greater effects on anxiety and 
depression; less episodes of angina; used less 
GTN spray; and saw significant enhancements in 
physical limitation as measured by the SAQ 
(P=<0.001) 
Authors: Koelewijn-van Loon 
et al. (2009) 
 
Aim: To investigate participant 
involvement in nurse-led risk-
management programs on 
adherence to lifestyle changes 
and cardiovascular risk. 
 
Title: Involving patients in 
cardiovascular risk management 
with nurse-led clinics: a cluster 
randomized controlled trial 
Methods: Nurse-led risk assessment, management and risk 
communication; decision support and motivational 
interviewing in risk reduction. 
 
Assessment and follow-up: At baseline and 12 months 
Intervention group: 
Practice nurses: 
 Received 2 days of intense training concerning a. 
risk assessment; b. risk communication; c. 
decision support; d. motivational interviewing 
 
Intervention group participants: 
 Two 15–20 minute, face-to-face sessions at GP 
clinic with practice nurse 
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(N = 615) 
 
Design: Cluster RCT, block 
randomisation. 
 
 
 
Standard care group: 
Nurses: Received 2 hours of risk assessment training 
 
Standard care group participants: risk assessment (10 year) 
and usual care 
 
Results: 
 Nil significant effects of attending the nurse-led 
clinic and techniques utilised 
 Nil effects of nurse-led clinic on cardiovascular 
risk at 10 years 
 
Authors: Lisspers et al. (1999) 
 
Title: Multifactorial Evaluation 
of a Program for Lifestyle 
Behavior Change in 
Rehabilitation and Secondary 
Prevention of Coronary Artery 
Disease 
 
Aim: To investigate the effects 
of a secondary prevention and 
rehabilitation intervention on 
lifestyle behavioural change in 
patients with coronary heart 
disease over 12 months 
 
Participants: N = 292 
 Recent CABG, PCI and 
acute myocardial 
Methods: 
 12 month rehabilitation and secondary prevention 
program 
 
Phase One: 
 4 weeks as inpatient stay in a unit to undertake 
intervention 
 In-depth education concerning: health education, 
behaviour change, lecture attendance, discussion, 
practical component on exercise, stress 
management, smoking 
 Group (5–8 participants) and individual education 
 Each participant assigned an RN to act as a 
personal coach (i.e., structured interviews) and to 
motivate and facilitate behaviour change 
 Stress and lifestyle profile assessment tools 
utilised 
 Goal setting undertaken 
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infarction (AMI) 
 
Design: Evaluation study 
Phase Two: 
 Maintenance phase – 11 months 
 Regular follow-up with RN coach to reflect on 
Phase One goal setting and behaviour change 
 Participant recoded and discussed all aspects of 
their lifestyle and behaviour change (i.e., self-
reporting, self-observation) with their coach 
 Assessment of health related quality of life 
(HRQOL) utilising AP-QLQ questionnaire 
 Type A behaviour assessment – Bortner Type A 
index; HALTAM questionnaire 
 Cynical distrust, anger (Anger Expression Scale; 
State-Trait Anger Scale [STAS]), anxiety (STAI), 
and depression assessment (Beck Depression 
Inventory [BDI]) 
 Assessment for angina and physical exertion: 
electronic braked bicycle ergometer (angina, 
shortness of breath and leg discomfort) 
 
 
Results (p =<0.05) 
Statistically significant results achieved in following areas: 
 Quality of life 
 Symptoms 
 Exercise capacity 
 Triglycerides 
 Cholesterol 
 BMI 
 Items of anger, hostility 
 Depression 
Authors: Vale, Jelinek, & Best Methods:  
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(2005) 
 
Title: Impact on coaching 
patients on coronary risk 
factors: 
Lessons from The COACH 
Program 
Total participants N = 792 
Intervention group: n = 398 
Standard care group: n = 394 
 
Aims: To investigate if a 
coaching program may have an 
effect on total cholesterol and 
cardiac risk factors in patients 
with coronary heart disease 
 
Primary outcome: To achieve 
a reduction in total cholesterol 
from baseline visit to 6 month 
follow-up 
 
Secondary outcomes: 
 Fasting triglycerides 
 Blood pressure 
 Fasting glucose readings 
 Weight (self-report) 
 Smoking status (self-
report) 
 Dietary consumption 
(self- report of fats, 
 Visit 1: Telephone follow-up at two weeks post-
randomisation to group (30 minutes) 
 Visit 2–4: A further 3 telephone follow-up 
coached calls every 6 weeks (20 minutes) 
 Visit 5: At 24 weeks to organise 6 month 
appointment 
 
Standard care group: 
 Usual care with medical practitioner 
 Medical practitioner and patients given 
hospital discharge summary and details on 
risk factor targets as COACH patients given 
 Contacted at 24 weeks only for follow-up 
appointment 
 
Results: 
The COACH program had a statistically significant effect on: 
 Mood, health and increased uptake of walking 
(p = <0.0001) 
 Total cholesterol (p = <0.0001) 
 Fasting lipids: LDL-cholesterol (p = <0.0001) 
 Cholesterol: LDL-C (p = <0.0001) 
 
\ 
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cholesterol and fibre 
consumption) 
 Activity status (i.e., 
walking self-report) 
 Anxiety and depression: 
 measured by the STAI 
and CDS 
 
Design: Multicentre, RCT 
 
Authors: Jiang, Sit, & Wong 
(2007) 
 
Title: The Effect of a Nurse-led 
Cardiac Rehabilitation 
Programme on Coronary Heart 
Disease in Chengdu, China 
 
Aim: To investigate the 
effectiveness of a 12-week 
hospital-initiated home-based 
cardiac rehabilitation program 
for patients with coronary heart 
disease in China 
 
Participants: N = 167 
 
Design: RCT 
 
Methods: 12 Week CR program 
Data collection: 
 Baseline, 12 Week follow-up, and programme 
conclusion 
 
 
 
 
Intervention: 
 Supported cardiac rehabilitation at home 
 Medication management 
 Angina management 
 Physical activity 
 Nutrition 
 Support systems (i.e., families) 
 
Standard care: Usual follow-up and care 
 
Outcomes: 
 Cardiovascular risk 
 Angina 
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 GTN use 
 Health behaviour 
 QOL 
 Unexpected utilisation of healthcare system (i.e., 
cardiovascular consultations) 
 
Results 
Statistical significance achieved in following areas: 
 
 Medication adherence 
 Physical activity 
 Diet 
 Cholesterol levels 
 Lipid levels 
 Blood pressure control 
 Reduced angina episodes 
 
 Reduced consumption of GTN 
 Enhanced QOL: Six SF-36 items (i.e., general 
health, mental health, physical functioning, role 
physical, vitality) 
 Reduction in medical reviews related to 
cardiovascular health  
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Appendix N: Participant Packs for The ‘REALITY CHEC’ Project© 
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Appendix O: Study Protocol 
 
ECG: Electrocardiogram CSE: Cardiac Self-Efficacy CR: Cardiac rehabilitation 
STAI: State-Trait Anxiety Inventory CP: Chest Pain  
CDS: Cardiac Depression Scale 
MMAS-8: Morisky Medication Adherence Scale – 8 Item 
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Appendix P: Data Collection Form (DCF) The ‘REALITY CHEC’ Project© 
PCI Clinic – Data Collection Form (DCF) ©  Date__/__/2012/2013 
Section 1:           
Criteria Tick Yes or No 
Inclusion Criteria 
Age of 18 years and over Yes □ No □ 
Informed consent for primary or elective PCI signed by patient and 
cardiologist 
Yes □ No □ 
Undergone primary or elective PCI  Yes □ No □ 
Understand or speak English language Yes □ No □ 
Post-discharge telephone access (mobile phone and / or landline) Yes □ No □ 
 
Exclusion Criteria 
Child or young person (i.e., <18 years of age) Yes □ No □ 
Unable to understand or speak the English language Yes □ No □ 
Overseas resident returning to home country Yes □ No □ 
Overseas resident on holiday in Australia for less than 12 months Yes □ No □ 
 
Suffering a mental illness and: 
1. Unable to legally consent 
2. Unable to weigh the risks and benefits of participation 
3. Unable to make informed decisions 
 
Yes □ 
Yes □ 
Yes □ 
 
No □ 
No □ 
No □ 
Pregnant Yes □ No □ 
In existing dependent or unequal relationship Yes □ No □ 
Highly dependent on medical care Yes □ No □ 
No telephone communication access Yes □ No □ 
 
Consent signed for participation in: The ‘REALITY CHEC’ Project Yes □ No □ 
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Section 2: Demographics / Patient History  
 Details 
Name  
Date of birth  
Sex Male / Female 
Address  
SEIFA: Socio-Economic 
Indexes for Areas (Post code)  
 
Mobile phone  
Home phone  
e-mail address  
Country of birth (COB)  
Primary language spoken   
Highest level of education Primary/Secondary/Tertiary/Certificate/Diploma/Other 
Document other: 
______________________________________________
______________________________________________
______________________________________________
______________________________________________ 
 
Marital Status Single/Married/De Facto/ Separated/Divorced/Widowed 
  
Local Hospital Name  
Distance to local hospital from 
home (km) (approximate) 
______km  
Study Enrolment Notification  Please tick Yes or No   Communication source 
Cardiologist Yes  No  Writing  e-mail  
GP Yes  No  Writing  e-mail  
Emergency Contact Name:________________________________________ 
H:___________________________________________ 
M:___________________________________________ 
 
 
Cardiologist (s) Name:________________________________________ 
Address:______________________________________ 
Phone: _______________________________________ 
Mobile phone:_________________________________ 
e-mail:_______________________________________ 
 
 
General Practitioner  Name:________________________________________ 
Address:______________________________________ 
Phone:_______________________________________ 
Mobile phone:_________________________________ 
e-mail:_______________________________________ 
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Cardiac Rehabilitation 
Unit 
NOTE: 
If after 3 month follow-up 
standard care group are not 
referred to CR, follow-up with 
hospital site.  
Name:________________________________________ 
Address:______________________________________ 
Phone:_______________________________________ 
Mobile phone:_________________________________ 
e-mail:_______________________________________ 
 
 
Procedure  Percutaneous transluminal coronary angioplasty / Coronary artery stents / 
Directional coronary atherectomy/ Rotational atherectomy 
Emergency / Elective (Researcher to please circle) 
Combination:___________________________________________________ 
Notes:_________________________________________________________ 
______________________________________________________________ 
 
 
Medical History:  
Medical History Details Additional Information 
_________________ 
_________________ 
_________________ 
_________________ 
_________________________ 
_________________________ 
_________________________ 
_________________________ 
 
__________________________ 
__________________________ 
__________________________ 
__________________________ 
 
   
 
Risk factors: 
Risk Factors Details Additional Information 
Non-modifiable, modifiable and cardiac risk factors 
Age Yes / No 
(DOB documented 
above) 
 
Sex Male / Female 
(As above) 
 
Family History Yes /No  
 
 
Hypertension Yes / No See: Australian Institute of Health 
and Welfare (2010). Chapter 3 
Australia’s Health.  
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Conditions 
Chronic kidney disease: Yes / No (Please circle) 
Atrial Fibrillation: Yes / No (Please circle) (New or previous history of) 
Family history: Hypercholesterolaemia Yes / No (Please circle) 
 
Cholesterol a. Yes / No 
b. mmol/L 
See: Australian Institute of Health and Welfare (2010). 
Chapter 3 Australia’s Health. 
Smoking History of 
smoking? 
 
How many 
cigarettes/cigars/ 
pipes did you 
smoke per 
day/wk 
(approximate)? 
 
Do you 
currently 
smoke? 
 
Number of 
cigarettes 
currently 
smoked: 
Yes/No (please circle) 
 
 
 
 
________ per day/wk (please document) N/A (For non-
smoker) 
 
 
 
Yes/No/N/A (please circle) 
 
 
________ per day/wk (please document) (n/a for non-
smoker) 
Alcohol 
consumption 
History of 
alcohol 
consumption 
(have you ever 
consumed 
alcohol)?  
Yes/No (please circle) 
 
 
How many 
standard drinks 
of alcoholic 
beverages would 
you consume 
per day 
(approx)? 
 
 
______ per day/wk/N/A (please document) 
Do you 
currently 
consume 
alcohol?  
 
 
 
Number of 
standard 
alcoholic 
beverages: 
Yes/No/N/A (please circle) 
 
________ per day/wk /N/A(please document)  
      
The REALITY CHEC Project© 
DATA COLLECTION FORM VERSION no. 9.1, 2012 
363 
Randomisation no:   
ACTRN:12612000971831  
UTN: U111-1133-1638 
 
 
 
Stress  Yes/No  
Diabetes a. Yes/No 
b. Type 1 
c. Type 2 
Control of blood glucose levels (i.e., what are current 
readings like and description): 
mmol/L:______________ 
Description:___________________________________ 
 
Weight kg  
Height cm  
BMI Yes/No 
     kg/m2   
 
Hip to Waist 
ratio (WHO 
STEPS on 
measurement) 
 
H: ___cm 
W: ___ cm 
Give patient measuring tape to take home for 
consecutive measurements. Recommend taking first 
thing in the morning before breakfast (as cited in World 
Health Organization (2009).  
Activity / 
Exercise 
None / light / 
moderate / 
heavy 
Comments: 
_____________________________________________ 
 
 
Dietary 
intake  
Daily intake Breakfast  
 
 
Morning tea 
 
 
 
 
Lunch  
 
 
Afternoon tea  
 
 
Dinner  
 
 
Dessert  
 
 
Snacks/Other 
(i.e., Meal 
supplements) 
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Section 3: Assessment 
Salivary cortisol assay (Researcher to demonstrate collection to participant before 
collecting sample). 
Note: Patient pack to include 1 salivette, 1 reply paid envelope, 1 plastic zip lock bag 
and written instructions. 
 
Visit Sample taken 
(Please tick if taken and 
date) 
Sample received by 
laboratory 
(Please tick and date) 
Salivary 
cortisol  
Day of discharge  / / 2012/2013   / / 2012/2013 ______ug/dl 
 
Cardiac Self-Efficacy Questionnaire (CSE) – Attach completed tools to this document 
Visit 
Total score 
Score: 
Control 
symptoms 
(CS) 
Score: Maintain 
Functioning (MF) 
Actions 
Day of discharge  
___________ 
 
___________ 
__________________________
__________________________
__________________________
__________________________ 
 
 
State -Trait Anxiety Inventory (STAI) – Attach completed tools to this document 
Visit State Score Trait Score  Actions 
Day of discharge State 
Anxiety:_____
  
Trait 
Anxiety:_____ 
__________________________ 
__________________________ 
 
 
©Spielberger, Gorsuch, Lushene, Vagg & Jacobs (1983). 
Cardiac Depression Scale (CDS) – Attach completed tools to this document 
Visit Score Actions 
Day of 
discharge 
 ____________________________________________
____________________________________________
____________________________________________ 
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Section 4: Access site assessment 
**Please indicate on diagram below with a circle and/or attach photo of site if 
available and patient consent given. Participants to draw / shade in how they view 
their access site. Please give participant 3 diagrams to take home for follow-up 
(present in patient packs.) 
 
 
Access-site assessment tool (O’Grady, 2007, p. 2). 
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Access Site Assessment 
Access site: Femoral artery / Radial artery / Brachial artery / Combination (i.e., radial for 
angiogram and femoral for PCI) (Please Circle) 
Haematoma 
(now on 
assessment) 
a. Yes / No (Please circle) 
b. Haematoma diagnosed pre-enrolment: Yes/No (See medical chart notes 
for documentation if haematoma observed) 
If yes: Size ___:___cm (new diagnosis)  
Size of pre-diagnosed haematoma: ____:____cm 
Description: ___________________________________________________________
___________________________________________________________
___________________________________________________________
___________________________________________________________ 
 
Action(s): New 
haematoma or 
pre-diagnosed 
requiring 
attention 
___________________________________________________________
___________________________________________________________
___________________________________________________________
___________________________________________________________ 
 
Bleeding New: Yes / No 
Pre-enrolment bleeding: Yes/No (Refer to documentation in medical 
notes) 
If yes a. New: Amount of blood present ________ml 
b. Pre-enrolment documented bleed: __________ml or 
c. Pre-enrolment bleed: Volume not documented (please circle) 
Description ___________________________________________________________
___________________________________________________________
___________________________________________________________
___________________________________________________________
___________________________________________________________ 
 
Action(s) ___________________________________________________________
___________________________________________________________
___________________________________________________________
___________________________________________________________
___________________________________________________________ 
 
Bruising Yes / No 
 Pre-enrolment documented bruising: Yes / No 
Size of bruise New bruising: Length: cm Width: cm 
 
a. Pre-enrolment documented: Length _______cm Width: ______cm 
b. Pre-enrolment bruise: Size not documented (please circle) 
Colour(s)  
Action(s) ___________________________________________________________
___________________________________________________________ 
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Bruit Diagnosed pre-enrolment and documented in patient’s medical notes 
(Please circle) Yes / No 
New Bruit: Yes / No 
If new bruit: Action:_____________________________________________________
___________________________________________________________
___________________________________________________________
___________________________________________________________
___________________________________________________________ 
___________________________________________________________ 
 
 
Site Pain New: Yes / No (Please circle yes or no) 
Pain rating: 0 1 2 3 4 5 6 7 8 9 10 (0 = Nil pain, 10 = Most severe) 
Pre-reported pain (To RN/Doctor): Yes/No (Please circle) 
Pain rating: 0 1 2 3 4 5 6 7 8 9 10 (0 = Nil pain, 10 = Most severe)  
If patient 
experiencing 
pain: Describe 
pain and RN 
actions taken.  
Action:_____________________________________________________
___________________________________________________________
___________________________________________________________
___________________________________________________________
___________________________________________________________ 
___________________________________________________________
___________________________________________________________ 
 
 
Arterial sheath 
removal 
Type of pressure: Digital / Femstop / TR Band/ Radistop/ Other 
_________________________________________________________ 
(Please circle)  
Time to 
haemostasis 
 Minutes  
Complication (s) related to sheath removal (i.e., vasovagal episode, bleed, haematoma post 
removal) 
(in hospital) Yes / No (Please circle) 
Complication(s) 
detail 
___________________________________________________________
___________________________________________________________
___________________________________________________________ 
 
Closure device Yes / No (Please circle) 
Type of closure 
device 
_________________________________________________________ 
Closure device complication(s) (in hospital – see medical notes) Yes / No/N/A (Please 
circle)  
Complication 
(s) detail 
___________________________________________________________
___________________________________________________________ 
 
Access Site Inflammation / Signs of Infection 
Heat at site  Yes / No 
Redness Yes / No 
Ooze Yes / No 
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Odour Yes / No 
Signs of inflammation / infection noted pre-enrolment: Yes / No 
Description ___________________________________________________________
___________________________________________________________ 
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Wound Assessment and Management Tool 
 
Source: Wounds UK (2010). Applied wound management: Assessment and continuation chart. 
Retrieved from http://www.wounds-uk.com/pdf/content_8973.pdf 
 370 
Wound Assessment and Management Tool 
 
Source: Wounds UK (2010). Applied wound management: Assessment and 
continuation chart. Retrieved from http://www.wounds-
uk.com/pdf/content_8973.pdf 
    The REALITY CHEC Project  
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Wound Assessment and Management Tool 
 
Source: Wounds UK (2010). Applied wound management: Assessment and continuation chart. 
Retrieved from http://www.wounds-uk.com/pdf/content_8973.pdf 
 
       
The REALITY CHEC Project© 
DATA COLLECTION FORM VERSION no.9.1, 2012 
 
372 
Randomisation no:   
Section 5: Neurovascular check (Bilateral assessment) 
Neurovascular Chart 
Name: Ward: 
 
Consultant: 
 
Area for observation: 
Hospital no: 
 
Procedure/Injury: 
 
Frequency of Observations:  
Date: Right Left Comments 
Time:     
Pain Score (1–10):    
Colour Normal    
Pale*    
Cyanotic*    
Mottled*    
Warmth Hot*    
Warm    
Cold*    
Cool*    
Pulses Name of pulse:    
Strong    
Weak*    
Absent*    
Capillary refill greater than 2 seconds (yes/no) 
Movement  
Dorsi flexion No movement*     
Movement, no pain    
Movement with 
pain* 
   
Plantar Flexion No movement*     
Movement, no pain    
Movement with 
pain* 
   
Toe extension No movement*     
Movement, no pain    
Movement with 
pain* 
   
Toe flexion No movement*     
Movement, no pain    
Movement with 
pain* 
   
Sensation    
Web space 
First and second toe 
No sensation*    
Tingling/numbness*    
Full sensation    
Web space 
third and fourth toe 
No sensation*    
Tingling/numbness*    
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Full sensation    
Sole of foot/toes No sensation*    
Tingling/numbness*    
Full sensation    
Arch of foot (medial) No sensation*    
Tingling/numbness*    
Full sensation    
Initials    
Always compare with the unaffected limb. If both limbs are affected, use a separate 
chart for each limb. 
*These may be signs of abnormalities, take appropriate action, document and inform a 
member of the medical team. Document all actions taken in the space below. 
Changes present now: Yes  No  (Please tick) 
Affected limb(s): Right upper/Right lower/Left upper/Left lower (Please circle) 
 
Actions:___________________________________________________________________
__________________________________________________________________________
__________________________________________________________________________
__________________________________________________________________________
__________________________________________________________________________
__________________________________________________________________________
__________________________________________________________________________ 
 
  
Judge, N. L. (2007). Neurovascular Assessment. Nursing Standard, 21(45), 39–44. 
Neurovascular complications pre-enrolment: Yes/No (Please circle) 
Details:______________________________________________________________
____________________________________________________________________
____________________________________________________________________
____________________________________________________________________ 
 
Section 6: Vital Signs (All participants: Day of discharge from hospital) 
Vital signs Reading 
Blood Pressure (BP)  / mmHg 
Heart Rate (HR)  beats per minute (bpm) 
Temperature  °C (Taken above in access site assessment)  
Respirations  Respirations per minute (rpm) 
Oxygen Saturation  _____ % 
ECG (Please tick) 
Photocopy ECG from 
medical chart 
(Taken <24 hrs) 
Normal Sinus Rhythm  
Sinus bradycardia  Sinus tachycardia  Sinus 
Arrhythmia  
Atrial Fibrillation  Atrial Flutter  
Paced Rhythm  Sinus rhythm 1st Degree Heart Block  
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Sinus rhythm 2
nd
 Degree Heart Block  Complete heart 
block  
Other Rhythm  (*Please document the rhythm in space 
provided) 
________________________________________________ 
 
Section 7: Chest pain assessment, education & management plan 
 Details Action(s) 
Chest Pain / 
Discomfort  
Yes / No ______________________________________________
______________________________________________ 
______________________________________________
______________________________________________ 
 
a. If no, below not applicable: N/A (Please circle) 
b. If yes, follow this pathway in conjunction with specific risk protocol (i.e., XXX or 
XXX):  
 Description 
Pain 
Sensation(s) 
(Please circle) 
a. Pain b. Pressure c. Heaviness d. Tightness 
e. Other (Describe in patients own words) 
____________________________________________________________
____________________________________________________________ 
 
Pain location a. Chest b. Neck c. Jaw d. Arm/s e. Back f. Shoulders 
g. Other 
Other details: _____________________________________________ 
Pain severity 0 1 2 3 4 5 6 7 8 9 10 (please circle) 
*Note: 0 = Nil pain; 10 = Most excruciating 
Pain symptoms  a. Nausea b. Cold sweat c. Dizziness d. Short of breath e. Other 
 
Other details (Patient’s description): 
____________________________________________________________
____________________________________________________________
____________________________________________________________ 
 
Response to 
rest 
Does the pain respond well to rest (i.e., Is it getting better) Yes/No (please 
circle) 
Duration of the 
pain 
a. Greater than 10 minutes Yes/No b. Patient’s description ____ minutes 
Response to 
nitroglycerin 
(GTN) 
Has the patient self-administered GTN? Yes / No 
Has the patient been instructed by the RN to administer GTN? Yes/No 
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Action(s) ____________________________________________________________
____________________________________________________________ 
 
 
National Heart Foundation of Australia. (2010). Chest Pain Action Plan.  
 Supply the participant with a copy of the NHFA’s, ‘My Heart, My Life’. Donated 
kindly by the NHFA. Advise they are to bring this with them to their follow-up if they 
are in face-to-face group Yes/No /N/A(Please circle). 
 
Section 8: 
Morisky Medication Adherence Scale (MMAS – 8) 
Visit Morisky Medication Adherence Scale (MMAS – 8 
Item) 
Day of discharge: Score: 
*Use of the ©MMAS is protected by US copyright laws. Permission for use is required. A 
license agreement is available from: Donald E. Morisky, ScD, ScM, MSPH, Professor, 
Department of Community Health Sciences, UCLA School of Public Health, 650 
Charles E. Young Drive South, Los Angeles, CA 90095–1772. 
Patient’s understanding of medications, behaviour, compliance and education: 
Do you know what medications you are taking? Yes / No (Please circle) 
If yes, can you tell me what medications you are taking without looking at them or a 
list? Yes/No 
Ask participant to name the medication, dose, frequency and what they are for. 
Current medications: 
Recommended discharge medications for ACS patients Aroney. C., Aylward, P., Kelly, 
A., Chew, D., & Clune, E. (2006). Guidelines for the management of acute coronary 
syndromes: on behalf of the Acute Coronary Syndrome Guidelines Working Group. 
Medical Journal of Australia, 184(8): S1-S30. 
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Medication Dose / 
Tablets 
Frequency Medication purpose 
*Please document in patient’s own words 
Statin 
 
Name given by 
patient: 
 
 
   
NSAID 
 
 
Name given by 
patient: 
 
   
ACE inhibitor 
 
 
Name given by 
patient: 
   
Anti-platelet 
agent: 
 
Name given by 
patient: 
 
 
   
-Blocker 
 
Name given by 
patient: 
 
   
Nitrates 
 
Name given by 
patient: 
 
   
Warfarin 
 
Name given by 
patient: 
 
   
Aldosterone 
Antagonists 
 
Name given by 
patient: 
   
       
The REALITY CHEC Project© 
DATA COLLECTION FORM VERSION no.9.1, 2012 
 
377 
Randomisation no:   
Medication Dose / 
Tablets 
Frequency Medication purpose 
*Please document in patient’s own words 
 
 
Insulin/oral 
hypoglycaemics 
 
 
Name given by 
patient: 
 
   
Other medications 
 
 
Name given by 
patient: 
 
   
Other medications 
 
Name given by 
patient: 
 
 
 
 
  
Other medications 
 
 
Name given by 
patient: 
 
   
Other medications 
 
Name given by 
patient: 
 
   
Other medications 
 
Name given by 
patient: 
 
   
Other 
medications: 
 
Name given by 
patient: 
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Section 9: Cardiac Rehabilitation (CR) 
1a. Have you been 
seen by the CR 
team? 
Please tick: Yes  / No  
1b. If yes, have you 
been enrolled in a 
course? 
Please tick: Yes  / No  
1c.If yes, what are 
you expecting of 
this program?  
Document:_______________________________________________
________________________________________________________  
1d.If no, did anyone 
else speak with you 
about this? 
Please tick: Yes  / No  
 
1e.If yes please 
circle:  
Nurse / Doctor / Allied health/ Family / Other ___________________ 
1f. If yes, what are 
you expecting of 
this program?  
Document: 
________________________________________________________
________________________________________________________
________________________________________________________ 
 
1g.If no, what do 
you think CR may 
involve (i.e., what 
do you expect it 
may be about?)  
Document: 
________________________________________________________
________________________________________________________ 
Event notification Please tick Yes or 
No 
Communication source 
Cardiologist Yes  No   Telephone  Writing   
GP Yes  No  Telephone  Writing  
Family/Next of Kin 
____________________ 
Yes  No  Telephone  Writing  
Ethics: XXX HREC/MS HREC/ QUT 
HREC/XXX DON (via Research Director 
of Nursing) 
Yes  No  Telephone  Writing  
Data Entry and Cleaning 
Data Entered Yes  No   
Date Entered  / / 2012/2013 Signature: 
Data Cleaned Yes  No   
Date Cleaned  / / 2012/2013 Signature: 
 
End of Assessment: Day of discharge from hospital.  
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FOLLOW-UP  Date__/__/2012/2013 
DAY 5–7 POST-DISCHARGE 
*Use ‘My Heart, My life as a guide 
 
a.  
Patient deceased Yes/No *Find out pre-telephone follow-up/face-to-face visit 
(circle). Cause of death: 
__________________________________________________________________________
__________________________________________________________________________
__________________________________________________________________________ 
 
b. Firstly, to ask participant if they require urgent medical attention (i.e., CP, 
access site etc) 
Details: 
__________________________________________________________________________
__________________________________________________________________________
__________________________________________________________________________ 
 
Section 1: Assessment 
Cardiac Self-Efficacy Questionnaire (CSE) – Attach completed tools to this document 
Visit Score: 
Control 
symptoms 
(CS) 
Score: 
Maintain 
Functioning 
(MF) 
Actions 
 _________ ________ __________________________________________
__________________________________________
__________________________________________ 
 
 
 
State -Trait Anxiety Inventory (STAI) – Attach completed tools to this document 
Visit State Score Trait Score Actions 
 State 
Anxiety:_____  
Trait Anxiety:_____ ____________________ 
____________________ 
____________________
____________________ 
©Spielberger, Gorsuch, Lushene, Vagg & Jacobs (1983). 
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Cardiac Depression Scale (CDS) – Attach completed tools to this document 
Visit Score Actions 
  ____________________________________________________________
____________________________________________________________ 
 
Section 2: Access site assessment 
Please note: Not all questions applicable due to telephone assessment 
Access site assessment Digital photograph  
Diagram  e-mail  
MMS  
Australia Post 
 
Posted  
Received  
**Please indicate on figure below with a circle and/or attach photo of site if available and 
patient consent given. Patients may also post or e-mail these figures via mail (Please 
remind participants to complete and forward in reply-paid envelope and figures supplied 
in packs). 
 
 
Access site assessment tool (O’Grady, 2007, p. 2). 
       
The REALITY CHEC Project© 
DATA COLLECTION FORM VERSION no.9.1, 2012 
 
381 
Randomisation no:   
 
Access Site Assessment 
Haematoma 
(new) 
Yes / No 
If yes Size ___:___cm 
Researcher’s 
description 
_____________________________________________________________
_____________________________________________________________
_____________________________________________________________
_____________________________________________________________
_____________________________________________________________ 
 
Action _____________________________________________________________
_____________________________________________________________
_____________________________________________________________ 
 
Haematoma 
present on 
day of 
discharge? 
1. Yes/No 
2. If yes or no, document changes compared to now (Patient’s 
description if telephone follow-up): 
_______________________________________________________
_______________________________________________________
_______________________________________________________
_______________________________________________________
_______________________________________________________
_______________________________________________________
_______________________________________________________
_______________________________________________________
______________________________________________________ 
Haematoma 
between day 
of discharge 
and follow-
up now? 
Yes/No 
If yes, how was this managed (i.e., patient and medical management) If no: 
Circle N/A 
_____________________________________________________________
_____________________________________________________________
_____________________________________________________________
_____________________________________________________________ 
 
  
Bleeding now Yes/No (Please circle) 
If yes Amount of blood present ______ml; b. Participant unsure of volume 
(telephone follow-up) c. N/A 
Description _____________________________________________________________
_____________________________________________________________
_____________________________________________________________
_____________________________________________________________
_____________________________________________________________ 
 
Action _____________________________________________________________
_____________________________________________________________
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_____________________________________________________________
_____________________________________________________________
_____________________________________________________________ 
 
Day of 
discharge 
bleed? 
(review / 
compare 
DCF notes 
from visit 1 
bleed) 
Yes/No 
If yes, compare to now: 
_____________________________________________________________
_____________________________________________________________
_____________________________________________________________ 
 
 
1. Bruising 
present on 
day of 
discharge  
a. Yes / b. No (please circle) 
 
a. Yes If bruising present on day of discharge, document changes/site as observed 
now: 
_____________________________________________________________
_____________________________________________________________
_____________________________________________________________
_____________________________________________________________
_____________________________________________________________
_____________________________________________________________ 
 
b. No If nil bruising on day of discharge, is there bruising present now? a. Yes / b. 
No (please circle) 
a. New 
bruising 
(document 
observations) 
_____________________________________________________________
_____________________________________________________________
_____________________________________________________________
_____________________________________________________________ 
Size of bruise Length: ______cm Width _____cm or b. N/A (if nil bruise) 
Action _____________________________________________________________
_____________________________________________________________
_____________________________________________________________
_____________________________________________________________
_____________________________________________________________ 
  
 
New Bruit 
(heard with 
stethoscope 
face-to-face 
group only) 
Yes / No 
If yes: Action:_______________________________________________________
_____________________________________________________________
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_____________________________________________________________
_____________________________________________________________
_____________________________________________________________ 
 
If previous 
bruit, listen 
and 
document 
status 
Present / No longer present / N/A(please circle) 
If present Action:_______________________________________________________
_____________________________________________________________
_____________________________________________________________ 
 
 
Site Pain 
(now) 
Yes / No (please circle yes or no) 
Site pain 
description  
Pain rating: 0 1 2 3 4 5 6 7 8 9 10 (0 = Nil pain, 10 = Most severe)  
If yes Participants description and researcher’s actions: 
_____________________________________________________________
_____________________________________________________________
_____________________________________________________________
_____________________________________________________________
_____________________________________________________________ 
 
 
 
Access Site Inflammation / Signs of Infection 
Heat at site  Yes / No 
Redness Yes / No 
Ooze Yes / No 
Odour Yes / No 
Description (if signs of 
infection/inflammation 
now) 
___________________________________________________
___________________________________________________
___________________________________________________ 
 
Actions ___________________________________________________
___________________________________________________
___________________________________________________
___________________________________________________ 
 
Access site inflammation/infection changes between day of discharge to now, day 5–7 
(Yes/No) 
a. Access site inflammation/infection changes, description and patient/medical management; 
or b. N/A (please circle) 
__________________________________________________________________________
__________________________________________________________________________
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__________________________________________________________________________
__________________________________________________________________________
__________________________________________________________________________ 
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Intervention patients: Circle N/A for Standard care group participants: 
Haematoma education and management given (What to look for/to do)  
a. Understood: Patient able to verbalise and demonstrate actions Yes/No/N/A (please 
circle) 
Notes:_____________________________________________________________________
__________________________________________________________________________
__________________________________________________________________________ 
Bleeding education and management given (What to do if bleed occurs)  
a. Understood: Patient able to verbalise and demonstrate actions Yes/No/N/A (please 
circle) 
Notes:_____________________________________________________________________
__________________________________________________________________________
__________________________________________________________________________ 
Bruising education and management given (What to look for/Colour/Extent)  
b. Understood: Patient able to verbalise and describe Yes/No/N/A (please 
circle) 
Notes:_____________________________________________________________________
__________________________________________________________________________
__________________________________________________________________________ 
Access site inflammatory changes (Heat/redness/swelling/odour/ooze and type of ooze) 
a. Understood. Patient able to verbalise and explain actions. Yes/No/N/A (please 
circle) 
Notes:_____________________________________________________________________
__________________________________________________________________________
__________________________________________________________________________ 
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Wound Assessment and Management Tool 
 
Applied Wound Management – Assessment and Continuation Chart (Wounds UK, 2010).
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Section 3: Neurovascular check (Bilateral assessment) 
Neurovascular Chart 
Name: Ward: 
 
Consultant: 
 
Area for observation: 
Hospital no: 
 
Procedure/Injury: 
 
Frequency of Observations:  
Date: Right  Left Comments 
Time:     
Pain Score (1–10):    
Colour Normal    
Pale*    
Cyanotic*    
Mottled*    
Warmth Hot*    
Warm    
Cold*    
Cool*    
Pulses Name of pulse:    
Strong    
Weak*    
Absent*    
Capillary refill greater than 2 seconds (yes/no) 
Movement  
Dorsi flexion No movement*     
Movement, no pain    
Movement with pain*    
Plantar Flexion No movement*     
Movement, no pain    
Movement with pain*    
Toe extension No movement*     
Movement, no pain    
Movement with pain*    
Toe flexion No movement*     
Movement, no pain    
Movement with pain*    
Sensation    
Web space 
First and second toe 
No sensation*    
Tingling/numbness*    
Full sensation    
Web space 
third and fourth toe 
No sensation*    
Tingling/numbness*    
Full sensation    
Sole of foot/toes No sensation*    
Tingling/numbness*    
Full sensation    
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Arch of foot (medial) No sensation*    
Tingling/numbness*    
Full sensation    
Initials    
Always compare with the unaffected limb. If both limbs are affected, use a separate 
chart for each limb. 
*These may be signs of abnormalities, take appropriate action, document and inform a 
member of the medical team. Document all actions taken in the space below. 
Changes present between day of discharge to now, day 5–7 post-discharge: Yes/No 
(please circle) 
 
Changes present now: Yes  No  (Please tick) 
Affected limb(s): Right upper/Right lower/Left upper/Left lower/N/A (Please circle) 
 
Actions:___________________________________________________________________
__________________________________________________________________________
__________________________________________________________________________
__________________________________________________________________________
__________________________________________________________________________
__________________________________________________________________________
__________________________________________________________________________
__________________________________________________________________________
__________________________________________________________________________
__________________________________________________________________________
__________________________________________________________________________  
Neurovascular Assessment Tool (Judge, 2007, p. 43). 
 
Neurovascular assessment education (Intervention group only): Yes/No/N/A (please 
circle) 
c. Patient able to verbalise understanding Yes/No/N/A (please circle) 
d. Patient able to demonstrate assessment: Tingling/numbness/capillary refill/ pulse/heat 
Yes/No/N/A 
Notes:_____________________________________________________________________
__________________________________________________________________________
__________________________________________________________________________ 
 
Section 4: Vital Signs 
*Take vital signs on all participants at day 5–7 post discharge in face-to-face clinic. Standard 
care group to be asked if they have taken or had recent measurements and to document 
below. 
Vital signs Reading 
Blood Pressure 
(BP) 
      /      mmHg 
Heart Rate (HR)  beats per minute (bpm) 
Temperature  °C (taken on access site assessment) 
Respirations  Respirations per minute (rpm) 
Oxygen Saturation  _____ % 
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ECG (Please tick) Normal Sinus Rhythm  
(Use Omron ECG)  Sinus bradycardia  Sinus tachycardia  Sinus Arrhythmia  
 Sinus tachycardia  
 Atrial Fibrillation  Atrial Flutter  
 Paced Rhythm  Sinus rhythm 1st Degree Heart Block  Sinus 
rhythm 2
nd
 Degree Heart Block  Complete heart block  
 Other Rhythm  
(*Please document the rhythm in space 
provided)_______________________________________________  
 
Patient’s rhythm 
on discharge from 
hospital  
Document: 
________________________________________________________
________________________________________________________
________________________________________________________ 
 
Rhythm Change Yes / No (Please circle) 
Action(s) ________________________________________________________
________________________________________________________
________________________________________________________
________________________________________________________
________________________________________________________
________________________________________________________ 
 
 
Have you visited or 
spoken to your GP; 
cardiology 
clinic/cardiologist; 
or hospital ward 
prior to this visit for 
any concerns? 
Prompt for 
researcher: 
Did they call any 
health info lines 
such as: 
 NHF, QLD 
Health  
Yes / No 
If yes, what were 
the concerns? 
 
 
________________________________________________________
________________________________________________________
________________________________________________________
________________________________________________________
________________________________________________________ 
________________________________________________________
________________________________________________________ 
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Section 5: Chest pain assessment, education & management plan 
 Details Additional notes 
Chest Pain / 
Discomfort 
leading up to 
clinic 
Yes / No Day 1: 
____________________________________________________
____________________________________________________ 
Day 2: 
____________________________________________________
____________________________________________________ 
Day 3: 
____________________________________________________
____________________________________________________ 
Day 4: 
____________________________________________________
____________________________________________________ 
Day 5: (CP prior to clinic if face-to-face group) 
____________________________________________________
____________________________________________________ 
Day 6: (CP prior to clinic if face-to-face group) 
____________________________________________________
____________________________________________________ 
Day 7: (CP prior to clinic if face-to-face group) 
____________________________________________________
____________________________________________________ 
 
CP at 
clinic/time of 
follow-up? 
If yes, follow 
pathway 
below 
Yes / No  Action/Comments:_____________________________________
____________________________________________________
____________________________________________________
____________________________________________________
____________________________________________________ 
 
 
If no CP, circle: N/A 
If yes, follow the pathway alongside specific hospital risk protocol 
 Description 
Pain 
Sensation(s) 
(Please circle) 
a. Pain b. Pressure c. Heaviness d. Tightness 
e. Other (Describe in patients own words) 
____________________________________________________________
____________________________________________________________ 
 
Pain location a. Chest b. Neck c. Jaw d. Arm/s e. Back f. Shoulders g. Other 
Other details: ________________________________________________ 
 
Pain severity 0 1 2 3 4 5 6 7 8 9 10 (please circle) 
 
*Note: 0 = Nil pain; 10 = Most excruciating 
Pain symptoms  c. Nausea b. Cold sweat c. Dizziness d. Short of breath e. Other 
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Other details (Patient’s description): 
____________________________________________________________
____________________________________________________________
____________________________________________________________ 
 
Response to 
rest 
Does the pain respond well to rest (i.e., Is it getting better) Yes/No (please 
circle) 
Duration of the 
pain 
a. Greater than 10 minutes Yes/No 
b. Patient’s description _______ minutes 
Response to 
nitroglycerin 
(GTN) 
Has the patient self-administered GTN? Yes / No 
Has the patient been instructed by the RN to administer GTN? Yes/No 
If telephone 
follow-up: Call 
Ambulance  
Has the ambulance (000) been called by patient/family/RN/other? Yes/No 
(please circle) 
 
Other: 
___________________________________________________________ 
 
Why did RN/Other call ambulance? (Document) 
____________________________________________________________
____________________________________________________________
____________________________________________________________
____________________________________________________________
____________________________________________________________ 
 
Action(s) ____________________________________________________________
____________________________________________________________
____________________________________________________________
____________________________________________________________ 
 
  NHFA (2010). 
 
 
Intervention group participants only 
 Discuss with the participant their chest pain management plan. Go through chest pain 
management plan with the patient in ‘My heart, my life’. Supplied on day of discharge 
in patient’s study pack. 
 
 Chest pain action plan shown (in face-to-face clinic) to patient with recommendations 
to follow: 
Yes  / No  / N/A  
If no, explain: 
_____________________________________________________________________
_____________________________________________________________________ 
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Section 6: Medication adherence 
MMAS – 8  
Visit Morisky Adherence Scale (MMAS – 8 Item) 
Day 5–7: Score: 
*Use of the ©MMAS is protected by US copyright laws. Permission for use is required. A 
license agreement is available from: Donald E. Morisky, ScD, ScM, MSPH, Professor, 
Department of Community Health Sciences, UCLA School of Public Health, 650 
Charles E. Young Drive South, Los Angeles, CA 90095–1772. 
 
Patient’s understanding of medications, behaviour, compliance and education: 
 Do you know what medications you are taking? Yes / No (Please circle) 
 Can the participant identify cardiac (predominantly) and other medications, what 
they are for, when to take, dose without seeing the medication/a list or 
prompting? Yes/No 
 Have there been any changes to your medications since we last spoke? Yes / No 
 If yes, ask the patient to tell you what the changes are in their own words and 
document in chart below? Yes / No 
 If changes were made, who made them? GP/Cardiologist/Emergency centre 
doctor/ Nurse practitioner/ Patient (please circle) 
 
Current medications Add changes only – Do not ask patient to go through all 
medications at day 5–7): 
 
Recommended discharge medications for ACS patients (Aroney, Alyward, Kelly, 
Chew, & Clune, 2006, p. S23) 
Medication Dose / 
Tablets 
Frequency Medication purpose 
*Please document in patient’s own words 
Statin 
 
Name given by 
patient: 
 
 
   
NSAID 
 
 
Name given by 
patient: 
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Medication Dose / 
Tablets 
Frequency Medication purpose 
*Please document in patient’s own words 
ACE inhibitor 
 
 
 
Name given by 
patient: 
 
   
Anti-platelet 
agent: 
 
Name given by 
patient: 
 
 
   
-Blocker 
 
Name given by 
patient: 
 
   
Nitrates 
 
Name given by 
patient: 
 
   
Warfarin 
 
Name given by 
patient: 
 
   
Aldosterone 
Antagonists 
 
Name given by 
patient: 
 
 
   
Insulin/oral 
hypoglycaemics 
 
 
Name given by 
patient: 
 
   
Other medications 
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Medication Dose / 
Tablets 
Frequency Medication purpose 
*Please document in patient’s own words 
Name given by 
patient: 
 
Other medications 
 
Name given by 
patient: 
 
 
 
 
  
Other medications 
 
 
Name given by 
patient: 
 
   
Other medications 
 
Name given by 
patient: 
 
   
Other medications 
 
Name given by 
patient: 
 
   
Other 
medications: 
 
Name given by 
patient: 
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Intervention group participants 
 Medications discussed with intervention group participant (Use ‘My heart, my life’ 
as a guide): 
 Yes  / No  / N/A  
If no, explain: 
____________________________________________________________________
____________________________________________________________________ 
 Verbal and/or written information given to face-to-face participant: Yes  / No / 
N/A  
If no, explain: 
____________________________________________________________________
____________________________________________________________________ 
 
Section 7: Cardiac Rehabilitation (CR) 
Have you been approached by 
the CR team prior to this visit? 
(i.e., In hospital / via telephone) 
Please tick: Yes  / No  
Comments: 
______________________________________________
______________________________________________
______________________________________________ 
 
If yes, what regarding the 
programme was discussed? 
Comments:____________________________________
______________________________________________
______________________________________________
______________________________________________
______________________________________________ 
 
Both groups of patients (even 
if SCG not aware) 
Will you attend CR? 
Yes  / No  
Why / why not? 
Details (Please make comments 
for both yes and no responses) 
______________________________________________
______________________________________________
______________________________________________
______________________________________________ 
 
If not approached by CR, or 
approached, but no appointment 
arranged, make appointment 
below: 
If in SCG, make appointment at end of follow-up at 3 
months if still not enrolled or contact not made with 
participant. 
 
a. Appointment date for CR: / / 2012/2013 
b. Appointment time for CR:_______ am / pm (Please circle am or pm) 
c. Team member spoke with:_____________________ 
d. Supply CR business card with details for participant  (Please tick box when completed) 
e. Cardiac rehabilitation notified in writing of study enrolment  
 
i. Patient’s expectations of CR (Both groups): 
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__________________________________________________________________________
__________________________________________________________________________
__________________________________________________________________________ 
 
j. Do you think it is important to attend a cardiac rehabilitation (CR) course: Yes  / No  
 
Reason (Why/why not): 
__________________________________________________________________________
__________________________________________________________________________
__________________________________________________________________________ 
 
Intervention group only: CR and Activity 
k. CR education on importance given (Hospital brochure and My heart, my life as a guide): 
Yes  / No  
 
If no, document why not given: 
__________________________________________________________________________
__________________________________________________________________________ 
 
m. Activity education given post-PCI specific (i.e., Hospital brochure and/or My Heart, my 
life as a guide): Yes  / No  
 
n. Current status on modifiable risk factors  
Modifiable 
and Cardiac 
Risk Factors 
Details Additional Information 
 
Hypertension 
Review BP at 
beginning of 
clinic. 
Standard care 
asked via 
telephone if 
they have 
taken or had 
a recent 
reading taken. 
Yes / No/N/A For guidelines on hypertension see Chapter 3 
Australia’s Health (Australian Institute of Health 
and Welfare [AIHW], 2010). 
Is / has blood pressure becoming / become more 
under control with/without medications? 
Comments:______________________________
________________________________________
________________________________________
________________________________________ 
 
Cholesterol 
(if a 
measurement 
requested by 
doctor) 
 mmol/L See Chapter 3 Australia’s Health (AIHW, 2010). 
 
Smoking Number per day/wk: N/A (non-smoker) 
Alcohol 
consumption 
____Standard drinks 
per 
day/wk/month/year 
Or N/A (non-drinker) (please circle) 
Or Social Drinker (please circle) 
 
Stress Yes / No  
Diabetes Type 1 / Type 2/ N/A Control of blood glucose levels (i.e., what are 
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current readings like and description): 
mmol/L:________________________________ 
 
Description:______________________________
________________________________________ 
 
 
Activity (ies)/ 
Exercise 
(post-
discharge) 
None / light / 
moderate / heavy 
Comments (why /why not recommenced or 
commenced) 
________________________________________
________________________________________ 
________________________________________
________________________________________ 
 
Dietary intake  Daily intake  
Breakfast 
 
 
 
 
 
Morning tea 
 
 
 
 
Lunch 
 
 
 
 
Afternoon tea 
 
 
 
 
Dinner 
 
 
 
Dessert  
 
 
Snacks/Other 
(i.e., Meal 
supplements) 
 
 
 
 
o. Tell me, how do you feel about having a blockage/blockages and stents (i.e., 
cardiovascular disease)? (Prompts: Are they concerned? Do they feel they are cured?) 
__________________________________________________________________________
__________________________________________________________________________ 
 
p. Do you have anything you would like to change with respect to your current lifestyle (i.e., 
dietary choices) and behaviours (i.e., highly stressful occupation) (Please circle): Yes / No  
 
 
Why/why not and what they are? (Comment below) 
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Reason:____________________________________________________________________
__________________________________________________________________________
__________________________________________________________________________ 
 
 
q. Would you know a. What to do if you had a complication such as a bleed Yes/No?; b. 
How to manage it; and c. Who to contact if you needed to (post-PCI)? (Stagger questions. 
Please document participant’s responses) 
__________________________________________________________________________
__________________________________________________________________________
__________________________________________________________________________ 
 
r. Who do you turn to for support? 
__________________________________________________________________________ 
 
s. Are there any personal issues that we have not covered that you would like to share with 
me? Yes/No (and document response) 
__________________________________________________________________________
__________________________________________________________________________
__________________________________________________________________________ 
 
Section 8: Participant Questions (Questions asked of the researcher by participants) 
Visit Question(s) asked and Response(s)  
Day 5–7 
post-
discharge 
______________________________________________________________
______________________________________________________________
______________________________________________________________
______________________________________________________________
______________________________________________________________
______________________________________________________________
______________________________________________________________ 
______________________________________________________________
______________________________________________________________ 
 
 
 
Event notification (add to excel 
spreadsheet) 
Please tick Yes or 
No 
Communication source 
Cardiologist Yes  No   Telephone  Writing   
GP Yes  No  Telephone  Writing  
Family/Next of Kin 
____________________ 
Yes  No  Telephone  Writing  
Ethics: XXX HREC/MS HREC/ QUT 
HREC/ XXX DON (via Research Director 
of Nursing) 
Yes  No  Telephone  Writing  
Data Entry and Cleaning   
Data Entered Yes  No   
Date Entered  / / 2012/2013 Signature: 
Data Cleaned Yes  No   
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Date Cleaned  / / 2012/2013 Signature: 
 
 
*NOTE – Arrange time and date for next follow-up call at 1 month post-discharge from 
hospital: 
a. Date: / / 2012/2013 b. Time: am/pm 
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Follow-up visit: 1 Month post-discharge Date__/__/2012/2013 
 
a. Patient deceased Yes/No (*To find out pre-telephone follow-up/face-to-face 
visit) 
(please circle) 
  
b. Cause of 
death:____________________________________________________________ 
 
Section 1b: Tests 
Salivary cortisol assay 
Visit Reminder to 
take sample 
(SMS / 
Telephone 
call) 
(Add to excel) 
Sample taken 
(Please tick Yes 
or No if taken) 
Sample received by 
laboratory 
(Please tick) 
(Add to excel) 
Salivary cortisol  
1 Month 
post-
discharge 
Yes   No  Yes  No  Yes   No  ____ug/dl 
Notes: 
__________________________________________________________________________
__________________________________________________________________________ 
 
Cardiac Self-Efficacy Questionnaire  
Visit: 
1 
Month 
Score: 
Control 
symptoms 
(CS) 
Score: 
Maintain 
Functioni
ng (MF) 
Actions 
 _______ ________ __________________________________________ 
 
 
State -Trait Anxiety Inventory (STAI)  
Visit: 1 
Month 
State Score Trait 
Score  
Actions 
 State 
Anxiety: 
________ 
Trait 
Anxiety: 
________ 
__________________________________________
__________________________________________ 
 
©Spielberger, Gorsuch, Lushene, Vagg & Jacobs (1983) 
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Cardiac Depression Scale (CDS)  
Visit: 1 Month Score Actions 
  ______________________________________
______________________________________ 
 
 
 
 
Section 2: Chest discomfort and Hospitalisation  
Question Participant’s response(s)  
1. How are you feeling 
after 1 month of 
having your 
procedure? (ask 
patient to describe) 
 
___________________________________________________ 
___________________________________________________ 
___________________________________________________ 
___________________________________________________ 
___________________________________________________
___________________________________________________ 
 
2a. Have you had any 
chest heaviness/pain 
since we last spoke? 
Yes/No (Circle) 
 
2b. If yes, what did you 
do? (i.e., actions taken) 
 
___________________________________________________ 
___________________________________________________ 
___________________________________________________ 
___________________________________________________
___________________________________________________ 
___________________________________________________ 
___________________________________________________ 
___________________________________________________ 
 
 
3a. Do you have any CP / Discomfort now? Yes/No (Circle) 
 
3b. If YES: 
1. 3c. Cease participant questions  (Please tick) 
2.  
3. 3d. Follow: Assess CP (Follow NHFA CP Action Plan)  
4. 3e. Circle N/A for participants without CP 
5.  
 Description 
Pain 
Sensation(s) 
(Please 
circle) 
a. Pain b. Pressure c. Heaviness d. Tightness 
e. Other (Describe in patients own words) 
_____________________________________________________________
_____________________________________________________________
_____________________________________________________________
_____________________________________________________________ 
 
Pain location a. Chest b. Neck c. Jaw d. Arm/s e. Back f. Shoulders 
g. Other 
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Other details: ______________________________________________ 
Pain severity 0 1 2 3 4 5 6 7 8 9 10 (please circle) 
*Note: 0 = Nil pain; 10 = Most excruciating 
 
Pain 
symptoms  
 
a. Nausea b. Cold sweat c. Dizziness d. Short of breath 
e. Other 
 
Other details (Patient’s description): 
_____________________________________________________________
_____________________________________________________________
_____________________________________________________________
_____________________________________________________________ 
 
Response to 
rest 
Does the pain respond well to rest (i.e., Is it getting better) Yes/No 
(please circle) 
Duration of 
the pain 
a. Greater than 10 minutes Yes/No 
b. Patient’s description _______ minutes 
Response to 
nitroglycerin 
(GTN) 
Has the patient self-administered GTN? Yes / No 
Has the patient been instructed by the RN to administer GTN? Yes/No 
Did the GTN reduce/eliminate the patient’s CP? Yes/No  
Telephone 
follow-up 
Ambulance 
called 
Has the ambulance (000) been called by patient/family/RN/other? 
Yes/No (please circle) 
 
Other: 
_____________________________________________________________ 
 
Why did RN/Other call ambulance? (Document) 
_____________________________________________________________
_____________________________________________________________
_____________________________________________________________
_____________________________________________________________
_____________________________________________________________
_____________________________________________________________ 
 
Action(s) _____________________________________________________________
_____________________________________________________________
_____________________________________________________________
_____________________________________________________________
_____________________________________________________________ 
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6. 3. Notify cardiologist, and GP of actions taken. Document event and actions taken in 
DCF “Actions”  (Tick) (document in excel) 
  4a. Have you been         
 readmitted to hospital for  
 your heart since we last 
 spoke? Yes / No 
(Circle) 
 
 4b. If yes, what was 
Your diagnosis? (Please 
document in 
participant 
response area) 
___________________________________________________
___________________________________________________
___________________________________________________
___________________________________________________
___________________________________________________ 
___________________________________________________
___________________________________________________
___________________________________________________
___________________________________________________
___________________________________________________ 
 
 
5a. Have you been 
readmitted to hospital 
for any other reason 
since we last spoke? Yes 
/ No (Circle) 
 
 
5b. If yes, please 
document in participant 
response area. 
___________________________________________________
___________________________________________________
___________________________________________________
___________________________________________________
___________________________________________________ 
___________________________________________________
___________________________________________________
___________________________________________________
___________________________________________________
___________________________________________________ 
 
 
Access site assessment: Please note not all assessment items applicable due to telephone 
follow-up. 
Access site assessment Digital photograph  
Diagram   e-mail   Australia Post 
 
Posted  
Received  
 Access site assessment 
**Please indicate on diagram below with a circle and/or attach photo of site if available 
and patient consent given. Patients may also post or e-mail these diagrams. Please remind 
participants to complete diagram and forward in reply-paid envelope supplied in packs). 
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Access site assessment tool (O’Grady, 2007, p.2). 
 
Access Site Assessment  
Haematoma Yes / No  
If yes Size ___:___cm 
Description __________________________________________________________
__________________________________________________________
__________________________________________________________
__________________________________________________________
__________________________________________________________ 
 
Action __________________________________________________________
__________________________________________________________
__________________________________________________________
__________________________________________________________
__________________________________________________________
__________________________________________________________
__________________________________________________________ 
 
Haematoma 3 – Present day of discharge (Yes/No) 
Haematoma 3 – Changes (i.e., complications) present from day of discharge to day 5–7 post 
discharge? (Yes/No) 
Haematoma 3 – Changes (i.e., complications) present from day 5–7 to now at 1 month? (Yes / 
No) 
Haematoma 3 – Management of changes (document details) (i.e., did they see a 
GP/Cardiologist/self etc?) or N/A (Circle) 
_____________________________________________________________________________
_____________________________________________________________________________
_____________________________________________________________________________ 
 
Haematoma 3 – Changes present now? Yes/No  
 
Haematoma 3 – Description of new changes (Patient description as telephone follow-up for all 
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participants. Document below and actions) 
_____________________________________________________________________________
_____________________________________________________________________________
_____________________________________________________________________________
_____________________________________________________________________________
_____________________________________________________________________________
_____________________________________________________________________________
_____________________________________________________________________________
_____________________________________________________________________________
_____________________________________________________________________________ 
 
 
1. Bruising 
day of 
discharge 
Yes/No (see notes DCF at day of discharge for details) 
2. New 
bruising 
present 
day 5–7 
post-
discharge  
Yes / No (please circle) 
 
a. Yes If bruising present day 5–7 post discharge, document changes/site as 
observed now (in photograph, diagram and patient’s description): 
____________________________________________________________
____________________________________________________________
____________________________________________________________
____________________________________________________________
____________________________________________________________
____________________________________________________________ 
 
b. No If nil bruising day 5–7 post-discharge, is there bruising present now (in 
photograph, diagram and patient’s description)? A. Yes / B. No (circle) 
A. New bruising 
(document 
observations 
i.e., colours) 
____________________________________________________________
____________________________________________________________
____________________________________________________________
____________________________________________________________
____________________________________________________________ 
 
Size of bruise Length: cm Width: cm  
Action ____________________________________________________________
____________________________________________________________
____________________________________________________________
____________________________________________________________
____________________________________________________________
____________________________________________________________ 
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Site pain Yes / No (please circle yes or no) 
Site pain score 
 
Pain rating: 0 1 2 3 4 5 6 7 8 9 10 (0 = Nil pain, 10 = Most severe)  
If yes, patient’s 
description of pain 
and researchers 
actions  
Participants description and researcher’s actions: 
____________________________________________________________
____________________________________________________________
____________________________________________________________
____________________________________________________________ 
 
 
Bleeding between 
follow-up and 1 
month post-
discharge follow-
up 
Yes / No (Please circle) 
 
If yes, how was this managed (i.e., how did the patient manage this? Did 
they see a doctor?; Did a family member hold pressure?; Call an 
ambulance?) 
____________________________________________________________
____________________________________________________________
____________________________________________________________
____________________________________________________________
____________________________________________________________ 
 
Bleeding now Yes/No (Please circle) 
If yes Amount of blood present ________mls (ask patient)  
Description ____________________________________________________________
____________________________________________________________
____________________________________________________________
____________________________________________________________ 
 
Action ____________________________________________________________
____________________________________________________________
____________________________________________________________
____________________________________________________________
____________________________________________________________ 
 
 
Access Site Inflammation / Signs of Infection 
Heat at site (new) Yes / No 
Redness (new) Yes / No 
Ooze (new) Yes / No 
Odour (new) Yes / No 
New changes: 
Description 
____________________________________________________________
____________________________________________________________
____________________________________________________________
____________________________________________________________
____________________________________________________________ 
 
New changes: 
Management 
____________________________________________________________
____________________________________________________________
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____________________________________________________________
____________________________________________________________
____________________________________________________________
____________________________________________________________
____________________________________________________________
____________________________________________________________ 
 
Access site 
inflammation/infe
ction changes 
from day of 
discharge to 5–7 
days post-
discharge? 
 
 
Yes/No (please circle) 
 
If yes, what are the changes, description and management? 
____________________________________________________________
____________________________________________________________
____________________________________________________________
____________________________________________________________
____________________________________________________________
____________________________________________________________
____________________________________________________________
____________________________________________________________ 
 
Access site 
inflammation/infe
ction from day 5–
7 to now at 1 
month post-
discharge? 
 
Yes/No (please circle) 
 
If yes, what are the changes, description, and management? 
____________________________________________________________
____________________________________________________________
____________________________________________________________
____________________________________________________________ 
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Wound Assessment and Management Tool 
 
Source: Wounds UK (2010). Applied wound management: Assessment and continuation chart. 
Retrieved from http://www.wounds-uk.com/pdf/content_8973.pdf 
  
409 
Section 3: Neurovascular check (Bilateral assessment) 
Neurovascular assessment 3 – Changes from assessment day of discharge to follow up day 
5–7 (Yes/No) 
 
Neurovascular assessment 3 – Changes from assessment day 5–7 to now (diagnosed 
between this time (Yes/No) 
 
Neurovascular Chart 
Name: Ward: 
 
Consultant: 
 
Area for observation: 
Hospital no: 
 
Procedure/Injury: 
 
Frequency of Observations:  
Date: Right Left Comments 
Time:     
Pain Score (1–10):    
Colour Normal    
Pale*    
Cyanotic*    
Mottled*    
Warmth Hot*    
Warm    
Cold*    
Cool*    
Pulses Name of pulse:    
Strong    
Weak*    
Absent*    
Capillary refill greater than 2 seconds (yes/no) 
Movement  
Dorsi flexion No movement*     
Movement, no pain    
Movement with pain*    
Plantar Flexion No movement*     
Movement, no pain    
Movement with pain*    
Toe extension No movement*     
Movement, no pain    
Movement with pain*    
Toe flexion No movement*     
Movement, no pain    
Movement with pain*    
Sensation    
Web space 
First and second toe 
No sensation*    
Tingling/numbness*    
Full sensation    
Web space 
third and fourth toe 
No sensation*    
Tingling/numbness*    
Full sensation    
Sole of foot/toes No sensation*    
Tingling/numbness*    
Full sensation    
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Arch of foot (medial) No sensation* 
Tingling/numbness*    
Full sensation    
Initials    
Always compare with the unaffected limb. If both limbs are affected, use a separate 
chart for each limb. 
*These may be signs of abnormalities, take appropriate action, document and inform a 
member of the medical team. Document all actions taken in the space below. 
Actions:___________________________________________________________________
__________________________________________________________________________
__________________________________________________________________________
__________________________________________________________________________
__________________________________________________________________________
__________________________________________________________________________ 
 
Neurovascular Assessment Tool (Judge, 2007, p. 43). 
 
Neurovascular assessment 3 – New changes present at 1 month post discharge (i.e., now) – 
Limb(s) (upper or lower): Right upper / Right lower / Left upper / Left lower / N/A (Please 
circle) 
 
Section 4: Patient’s understanding of medications, behaviour, compliance and 
education: 
 Do you know what medications you are taking? Yes / No (Please circle) 
 Have there been any changes to their medications? Yes / No 
 If yes, who made the changes? GP/Cardiologist/Emergency centre 
doctor/Nurse practitioner/ Patient (Please circle) 
 Can the participant identify cardiac (predominantly) and other medications, what 
they are for, when to take, dose without seeing the medication/a list or 
prompting? Yes/No 
 Ask participant to name the medication, dose, frequency and what they are for. 
 
Current medications:  
Visit Morisky Medication Adherence Scale (MMAS – 8 
Item) 
1 Month post-discharge: Score: 
*Use of the ©MMAS is protected by US copyright laws. Permission for use is required. A 
license agreement is available from: Donald E. Morisky, ScD, ScM, MSPH, Professor, 
Department of Community Health Sciences, UCLA School of Public Health, 650 
Charles E. Young Drive South, Los Angeles, CA 90095–1772. 
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Recommended discharge medications for ACS patients (Aroney et al., 2006, p. S23) 
Medication Dose 
 
Frequency Medication purpose 
*Please document in patient’s own words 
Statin 
 
Name given by 
patient: 
 
 
   
NSAID 
 
 
Name given by 
patient: 
 
   
ACE inhibitor 
 
 
 
Name given by 
patient: 
   
Anti-platelet 
agent: 
 
Name given by 
patient: 
 
   
-Blocker 
 
Name given by 
patient: 
 
   
Nitrates 
 
Name given by 
patient: 
 
   
Warfarin 
 
Name given by 
patient: 
 
   
Aldosterone 
Antagonists 
 
Name given by 
patient: 
 
   
Insulin/oral 
hypoglycaemics 
 
 
Name given by 
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Medication Dose 
 
Frequency Medication purpose 
*Please document in patient’s own words 
patient: 
Other medications 
 
 
Name given by 
patient: 
   
Other medications 
 
Name given by 
patient: 
 
 
 
 
  
Other medications 
 
 
Name given by 
patient: 
   
Other medications 
 
Name given by 
patient: 
 
   
Other medications 
 
Name given by 
patient: 
 
   
Other 
medications: 
 
Name given by 
patient: 
 
   
 
Section 4: Nurse-researcher led questions 
At 1 month Post-PCI Cardiac Rehabilitation; Cardiology and Lifestyle 
(*Check participant has taken/will take saliva sample and post today). 
Questions and Responses 
1a. Are you currently attending CR? Yes/No (**If no, go to question 1c) 
 
1b. Attendance confirmed with CR team member Yes / No / N/A 
 
1c. If no, ask participant reasons for not attending and if an appointment has been made and 
rescheduled to attend? (Document comments below) 
__________________________________________________________________________
______________________________________________________________________ 
 
 
1d. Rescheduled appointment confirmed with CR team member Yes (rescheduled) / No (not 
rescheduled) / N/A (please circle) 
1e. If not attending CR, please no proceed to question 3. 
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2a. How are you finding this program? (Document comments below) 
__________________________________________________________________________
__________________________________________________________________________
__________________________________________________________________________
_____________________________________________________________________ 
 
2b. Is it fulfilling your expectations? (i.e., is it what you thought it would be, or different)? 
Yes/No  
If no, ask participant to explain. (Document comments below) 
__________________________________________________________________________
__________________________________________________________________________
__________________________________________________________________________
____________________________________________________________________ 
 
3a. Have you been for follow-up with your cardiologist since your procedure? Yes/No 
(Please circle) 
 
3b. If yes, what did you discuss about your cardiovascular health since your procedure? 
__________________________________________________________________________
__________________________________________________________________________
__________________________________________________________________________
_____________________________________________________________________ 
 
3c. If no, ask reason why: 
__________________________________________________________________________
__________________________________________________________________________
_____________________________________________________________________ 
 
 
4. Are you making lifestyle/behavioural adjustments? (Do they still feel they need to/do not 
need to?) (e.g. Making dietary changes, going to a gym, stopped/stopping smoking, diabetes 
under control, controlling your stress/stressors) Yes/No. Why/why not and what are they? 
__________________________________________________________________________
__________________________________________________________________________
__________________________________________________________________________
__________________________________________________________________________
____________________________________________________________________ 
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5. Modifiable risk factors/Cardiac risk factors 
 
Modifiable, 
and Cardiac 
Risk Factors 
Details Additional Information 
Hypertension 
Review BP at 
beginning of 
clinic. Standard 
care asked via 
telephone if 
they have taken 
or had a recent 
reading taken. 
Yes / No For guidelines on hypertension see 
Chapter 3 Australia’s Health 
(Australian Institute of Health and 
Welfare [AIHW], 2010). 
 
Is / has blood pressure becoming 
/ become more under control with/without medications? 
Comments:____________________________________
______________________________________________
______________________________________________ 
 
Cholesterol 
(if a 
measurement 
requested by 
doctor) 
mmol/L 
 
Reading not 
available  
See Chapter 3 Australia’s Health 
(AIHW, 2010). 
 
Smoking Number per 
day: 
N/A (non-smoker) 
Alcohol 
consumption 
Standard 
drinks per 
day/wk/mont
h/year: 
__________ 
N/A (non-drinker) (please circle) 
Social drinker (please circle) 
Stress Yes / No  
Diabetes Type 1 / 
Type 2 / 
N/A 
Control of blood glucose levels 
(i.e., what are current readings like and description): 
mmol/L:_______________________________________ 
Description:____________________________________
______________________________________________
______________________________________________ 
 
Weight  kg  
BMI  kg/m
2
    Note: Require height and 
weight for calculation 
Hip to Waist 
ratio (WHO 
STEPS on 
measurement) 
W:____ cm 
 
H: ______cm 
Instruct patient over telephone how to take measurement 
if in Standard Care Group. 
Activity (ies)/ 
Exercise (post-
discharge) 
None / light / 
moderate / 
heavy 
Comments (why /why not recommenced or commenced) 
______________________________________________
______________________________________________ 
 
Dietary intake  Daily intake 
 
Nil changes 
made since 
last follow-
up  
Breakfast  
 
 
 
Morning tea 
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(please tick)  
Lunch 
 
 
 
 
Afternoon tea 
 
 
 
 
Dinner 
 
 
 
Dessert  
 
 
Snacks/Other 
(i.e., Meal supplements) 
 
 
 
6a. Who do you turn to for support? 
__________________________________________________________________________ 
 
6b. Are there any personal issues that we have not covered that you would like to share with 
me? 
__________________________________________________________________________
__________________________________________________________________________
__________________________________________________________________________
__________________________________________________________________________ 
 
NOTE – Arrange time and date for 3 month follow-up call: 
 
a. Date: / /2012/2013 b. Time: am/pm 
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Section 5: Participant Questions (Questions asked of the researcher by participants) 
Visit Question(s) asked and Response(s)  
1 month post-discharge _____________________________________________
_____________________________________________
_____________________________________________
_____________________________________________
_____________________________________________
_____________________________________________
_____________________________________________
_____________________________________________
_____________________________________________
_____________________________________________ 
 
Event notification (document in excel 
spreadsheet) 
Please tick 
Yes or No 
Communication 
source 
Cardiologist Yes  
No   
Telephone 
Writing   
GP Yes  
No  
Telephone 
Writing  
Family/Next of Kin _________________________ Yes  
No  
Telephone 
Writing  
Ethics: XXX HREC / MSEC / QUT ETHICS / 
XXX DON (via Research Director of Nursing) 
Yes  
No  
Telephone 
Writing  
 
Data Entry and Cleaning   
Data Entered Yes  No   
Date Entered  / / 2012/2013 Signature: 
Data Cleaned Yes  No   
Date Cleaned  / / 2012/2013 Signature: 
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Follow-up: At 3 Months post-discharge Date__/__/2012/2013 
 
a.Patient deceased Yes/No (*find out pre-telephone follow-up) (please circle)  
Cause of death: 
__________________________________________________________________________ 
Section 1b: Tests 
Cardiac Self-Efficacy Questionnaire (CSE) 
Visit Score: 
Contr
ol 
sympt
oms 
(CS) 
Score: 
Maintain 
Functioning 
(MF) 
Actions 
3 
month
s post-
discha
rge 
_____
_____ 
_________ _____________________________________________
_____________________________________________
_____________________________________________ 
 
 
State -Trait Anxiety Inventory (STAI)  
Visit State Score Trait Score  Actions 
3 months 
post-
discharge 
State 
Anxiety:_____ 
Trait 
Anxiety:______ 
____________________________ 
____________________________ 
____________________________ 
____________________________ 
 
© Spielberger, Gorsuch, Lushene, Vagg & Jacobs (1983). 
 
 
Cardiac Depression Scale (CDS)  
Visit Score Actions 
3 months 
post-
discharge 
  
 
 
 
Section 2: Chest Pain identification & Hospitalisation 
Question Participant’s response(s) 
1. How are you 
feeling after 3 months 
of having your 
procedure? (ask 
patient to describe) 
 
_____________________________________________________ 
_____________________________________________________ 
_____________________________________________________ 
_____________________________________________________ 
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2a. Have you had any 
chest heaviness/pain 
since we last 
spoke? Yes/No 
(Circle) 
 
2b. If yes, what did 
you do? 
(Please document 
response) 
 
______________________________________________________ 
______________________________________________________ 
______________________________________________________ 
______________________________________________________ 
3a. Do you have any CP / Discomfort now? 
 
3b. If YES: 
1. Cease participant questions  (Please tick) 
7.  
2. Assess CP, and Follow NHFA CP Action Plan  
 
 
If no CP: N/A (please circle) 
 
Description 
Pain Sensation(s) 
(Please circle) 
a. Pain b. Pressure c. Heaviness d. Tightness 
e. Other (Describe in patients own words) 
______________________________________________________
______________________________________________________
______________________________________________________ 
 
Pain location a. Chest b. Neck c. Jaw d. Arm/s e. Back f. Shoulders g. Other 
Other details: 
____________________________________________________ 
Pain severity 0 1 2 3 4 5 6 7 8 9 10 (please circle) 
*Note: 0 = Nil pain; 10 = Most excruciating 
Pain symptoms  a. Nausea b. Cold sweat c. Dizziness d. Short of breath e. Other 
 
Other details (Patient’s description): 
______________________________________________________
______________________________________________________
______________________________________________________
______________________________________________________ 
 
Response to rest Does the pain respond well to rest (i.e., Is it getting better) 
Yes/No (please circle) 
Duration of the pain b. Greater than 10 minutes Yes/No 
c. Patient’s description _______ minutes 
Response to 
nitroglycerin (GTN) 
Has the patient self-administered GTN? Yes / No 
Has the patient been instructed by the RN to administer GTN? 
Yes/No 
Telephone follow-up 
Ambulance called 
Has the ambulance (000) been called by patient/family/RN/other? 
Yes/No (please circle) 
 
Other: _______________________________________________ 
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Why did RN/Other call ambulance? (Document) 
______________________________________________________
______________________________________________________
______________________________________________________
______________________________________________________
______________________________________________________ 
 
Action(s) ______________________________________________________
______________________________________________________
______________________________________________________
______________________________________________________
______________________________________________________
______________________________________________________ 
 
 
** Notify cardiologist, and GP of actions taken. Document event and actions taken in 
DCF “Actions”  (Tick) (document in excel) 
 
1a. Have you been 
back to hospital for 
your heart since 
we last spoke? Yes / 
No (Circle) 
 
1b. If yes, what was 
your diagnosis? 
(Please document in 
participant response 
area) 
 
______________________________________________________
______________________________________________________
______________________________________________________
______________________________________________________
______________________________________________________
______________________________________________________
______________________________________________________
______________________________________________________
______________________________________________________
______________________________________________________
___________________________________________________ 
2a. Have you been 
readmitted to hospital 
for any other reason 
since we last spoke? 
Yes / No (Circle) 
 
2b. If yes, please 
document in 
participant response 
area. 
______________________________________________________
______________________________________________________
______________________________________________________
______________________________________________________
______________________________________________________
____________________________________________________ 
 
 
Section 2: Access site assessment 
Please note: Not all questions applicable due to telephone assessment 
Access site assessment Digital photograph  
Diagram   e-mail   Australia Post 
 
Posted  
Received  
**Please indicate on figure below with a circle and/or attach photo of site if available and 
patient consent given. Patients may also post or e-mail these figures via mail (Please 
remind participants to complete and forward in reply-paid envelope and figures supplied 
in packs). 
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Access Site Assessment 
Haematoma Yes / No 
If yes Size ___:___cm 
Description _____________________________________________________________
_____________________________________________________________
_____________________________________________________________
_____________________________________________________________
_____________________________________________________________
_____________________________________________________________ 
 
Action _____________________________________________________________
_____________________________________________________________
_____________________________________________________________
_____________________________________________________________
_____________________________________________________________ 
_____________________________________________________________
_____________________________________________________________ 
 
Haematoma 4 – Present day of discharge (Yes/No) 
Haematoma 4 – Changes (i.e., complications) present from day of discharge to day 5–7 post 
discharge? (Yes/No) 
Haematoma 4 – Changes (i.e., complications) present from day 5–7 post-discharge to 1 
month post discharge? (Yes/No) 
Haematoma 4 – Changes (i.e., complications) present from review at 1 month to now at 3 
months? (Yes / No) 
Haematoma 4 – Description of complications/changes or improvements (Patient words as 
telephone follow-up only) N/A (please circle for those unaffected) 
__________________________________________________________________________
__________________________________________________________________________
__________________________________________________________________________
__________________________________________________________________________
__________________________________________________________________________
__________________________________________________________________________
__________________________________________________________________________
__________________________________________________________________________ 
 
Bleeding 
(new) 
Yes / No 
If yes Amount of blood present ________ml; b. N/A 
Description _____________________________________________________________
_____________________________________________________________
_____________________________________________________________
_____________________________________________________________
_____________________________________________________________
_____________________________________________________________
_____________________________________________________________ 
 
Action _____________________________________________________________
_____________________________________________________________
_____________________________________________________________
_____________________________________________________________
_____________________________________________________________
_____________________________________________________________ 
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Bleeding between 5–7 days and 1 month follow-up? Yes/No (Please circle) 
Bleeding between 1 month and 3months at home? Yes/No (Please circle and document 
below) 
If yes, how was this managed (i.e., how did the patient manage this? Did they see a doctor? 
Have a family member hold pressure? Call an ambulance?) 
__________________________________________________________________________
__________________________________________________________________________
__________________________________________________________________________
__________________________________________________________________________ 
 
1.New 
bruising 
present 
1month post-
discharge  
a. Yes / b. No (Please circle) 
 
c. Yes If bruising present 1 month post discharge, document changes/site as 
observed now (in photograph, diagram and patient’s description): 
_____________________________________________________________
_____________________________________________________________
_____________________________________________________________
_____________________________________________________________
_____________________________________________________________
_____________________________________________________________ 
 
d. No If nil bruising 1 month post-discharge, is there bruising present now (in 
photograph, diagram and patient’s description)? A. Yes/ B. No (Please 
circle) 
 
e. Have there been any changes prior to this follow up and how do they compare to the 
site now? 
B. New 
bruising 
(document 
observations) 
_____________________________________________________________
_____________________________________________________________
_____________________________________________________________
_____________________________________________________________
_____________________________________________________________ 
 
Size of bruise Length: cm Width: cm 
Action _____________________________________________________________
_____________________________________________________________
_____________________________________________________________
_____________________________________________________________
_____________________________________________________________
_____________________________________________________________ 
  
Site Pain Yes / No (please circle yes or no) 
Site pain 
description  
Pain rating: 0 1 2 3 4 5 6 7 8 9 10 (0 = Nil pain, 10 = Most severe)  
If yes Participant’s description and researcher’s actions: 
_____________________________________________________________
_____________________________________________________________
_____________________________________________________________ 
 
_____________________________________________________________
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_____________________________________________________________ 
 
 
Bleeding Yes / No 
If yes Amount of blood present ________ml (ask patient) 
Description _____________________________________________________________
_____________________________________________________________
_____________________________________________________________
_____________________________________________________________
_____________________________________________________________ 
 
Action _____________________________________________________________
_____________________________________________________________
_____________________________________________________________
_____________________________________________________________
_____________________________________________________________ 
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Access site assessment tool (O’Grady, 2007, p.2). 
 
 
Access Site Inflammation / Signs of Infection 
Heat at site 
(new) 
Yes / No 
Redness (new) Yes / No 
Ooze (new) Yes / No 
Odour (new) Yes / No 
Description ___________________________________________________________
___________________________________________________________ 
 
Actions ___________________________________________________________
___________________________________________________________ 
 
Access site inflammatory / infection changes from day of discharge to day 5–7 (Yes/No) 
Access site inflammatory / infection changes from day 5–7 to 1 month (Yes/No) 
Access site inflammatory / infection changes from 1 month to now 3 months (Yes/No) 
Access site description: 
___________________________________________________________________________
___________________________________________________________________________
___________________________________________________________________________
___________________________________________________________________________
___________________________________________________________________________ 
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Wound Assessment and Management Tool 
 
Applied Wound Management – Assessment and Continuation Chart (Wounds UK, 2010).
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Section 3: Neurovascular check (Bilateral assessment) 
Neurovascular assessment 
Neurovascular assessment 4: Changes between 
assessment day of discharge to follow up day 5–7 
Yes/No (please circle) 
Neurovascular assessment 4: Changes between 
assessment day 5–7 to 1 month (Yes/No) 
Yes/No (please circle) 
Neurovascular assessment 4: Changes between 
assessment day 1 month to 3 month (Yes/No) 
Yes/No (please circle) 
 
 
Neurovascular Chart 
Name: Ward: 
 
Consultant: 
 
Area for observation: 
Hospital no: 
 
Procedure/Injury: 
 
Frequency of Observations:  
Date: Right Left Comments 
Time:     
Pain Score (1–10):    
Colour Normal    
Pale*    
Cyanotic*    
Mottled*    
Warmth Hot*    
Warm    
Cold*    
Cool*    
Pulses Name of pulse:    
Strong    
Weak*    
Absent*    
Capillary refill greater than 2 seconds (yes/no) 
Movement  
Dorsi flexion No movement*     
Movement, no pain    
Movement with pain*    
Plantar Flexion No movement*     
Movement, no pain    
Movement with pain*    
Toe extension No movement*     
Movement, no pain    
Movement with pain*    
Toe flexion No movement*     
Movement, no pain    
Movement with pain*    
Sensation    
Web space 
First and second toe 
No sensation*    
Tingling/numbness*    
Full sensation    
Web space 
third and fourth toe 
No sensation*    
Tingling/numbness*    
Full sensation    
Sole of foot/toes No sensation*    
Tingling/numbness*    
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Full sensation    
Arch of foot (medial) No sensation*    
Tingling/numbness*    
Full sensation    
Initials    
Always compare with the unaffected limb. If both limbs are affected, use a separate 
chart for each limb. 
*These may be signs of abnormalities, take appropriate action, document and inform a 
member of the medical team. Document all actions taken in the space below. 
Actions:___________________________________________________________________
__________________________________________________________________________
__________________________________________________________________________
__________________________________________________________________________
__________________________________________________________________________
__________________________________________________________________________
__________________________________________________________________________
__________________________________________________________________________
__________________________________________________________________________
__________________________________________________________________________ 
 
Neurovascular Assessment Tool (Judge, 2007, p. 43). 
 
Section 4 – Patient’s understanding of medications, behaviour, compliance and 
education: 
 
Medication Adherence  
Visit Morisky Medication Adherence Scale (MMAS – 8 
Item) 
3 months post-discharge: Score: 
 
*Use of the ©MMAS is protected by US copyright laws. Permission for use is required. A 
license agreement is available from: Donald E. Morisky, ScD, ScM, MSPH, Professor, 
Department of Community Health Sciences, UCLA School of Public Health, 650 
Charles E. Young Drive South, Los Angeles, CA 90095–1772. 
 
 Do you know what medications you are taking? Yes / No (Please circle) 
 Have there been any changes to your medications since we last spoke? Yes / No 
 If yes, ask the patient to tell you what the changes are in their own words and 
document in chart below? Yes / No 
 If changes were made, who made them? GP/Cardiologist/Emergency centre 
doctor/ Nurse practitioner/ Patient (please circle) 
 Ask participant to name the medication, dose, frequency and what they are for. 
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Current medications: 
Recommended discharge medications for ACS patients (Aroney, Alyward, Kelly, 
Chew, & Clune, 2006, p. S23) 
Medication Dose  Frequency Medication purpose 
*Please document in patient’s own words 
Statin 
 
Name given by 
patient: 
 
 
   
NSAID 
 
 
Name given by 
patient: 
 
   
ACE inhibitor 
 
 
 
Name given by 
patient: 
   
Anti-platelet 
agent: 
 
Name given by 
patient: 
 
   
-Blocker 
 
Name given by 
patient: 
 
   
Nitrates 
 
Name given by 
patient: 
 
   
Warfarin 
 
Name given by 
patient: 
 
   
Aldosterone 
Antagonists 
 
Name given by 
patient: 
 
   
      
428 
Medication Dose  Frequency Medication purpose 
*Please document in patient’s own words 
Insulin/oral 
hypoglycaemics 
 
 
Name given by 
patient: 
   
Other medications 
 
 
Name given by 
patient: 
   
Other medications 
 
Name given by 
patient: 
 
 
 
 
  
Other medications 
 
 
Name given by 
patient: 
   
Other medications 
 
Name given by 
patient: 
 
   
Other medications 
 
Name given by 
patient: 
 
   
Other 
medications: 
 
Name given by 
patient: 
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Section 5: Nurse-researcher led questions 
At 3 months Post-PCI Cardiac Rehabilitation; Cardiology and Lifestyle 
Questions and Responses 
1a. Did you attend your/most of your entire CR course? Yes/No/N/A (Circle)(N/A = Did not 
attend from start) 
 
1b. Attendance confirmed with CR team member Yes / No (Circle) 
 
1c. If no, ask participant reason(s) for not attending (Document comments below) 
__________________________________________________________________________ 
 
1d. If yes, please go to question 2. 
2. How did you find this program after attending? Did it meet your expectations? Yes/No 
(i.e., More knowledgeable; motivated to make changes etc..) 
__________________________________________________________________________
__________________________________________________________________________ 
 
2a. If no, why not? 
__________________________________________________________________________
__________________________________________________________________________ 
 
3. Have you been for follow-up with your cardiologist since your procedure? Yes/No (Please 
circle) 
 
3a. If yes, what did you discuss about your cardiovascular health since your procedure? 
__________________________________________________________________________
__________________________________________________________________________
__________________________________________________________________________ 
 
3b. If no, ask reason why: 
__________________________________________________________________________
______________________________________________________________________ 
4. Are you making lifestyle/behavioural adjustments (e.g. Dietary changes, exercising, 
ceased smoking, diabetes under control) Yes/No (Please circle) Why/Why not?(Document 
below) 
__________________________________________________________________________
__________________________________________________________________________
__________________________________________________________________________ 
__________________________________________________________________________
__________________________________________________________________________
__________________________________________________________________________ 
 
5. Risk factors 
 
Modifiable, 
and Cardiac 
Risk Factors 
Details Additional Information 
Hypertension 
 
Reviewed BP at 
beginning of 
clinic. Standard 
Yes / No For guidelines on hypertension see 
Chapter 3 Australia’s Health 
(Australian Institute of Health & 
Welfare [AIHW], 2010). 
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care asked via 
telephone if 
they have taken 
or had a recent 
reading taken. 
Is / has blood pressure becoming 
/ become more under control with/without medications? 
Comments:_____________________________________
_______________________________________________
_______________________________________________
_______________________________________________
_______________________________________________ 
 
Cholesterol 
(if a 
measurement 
requested by 
doctor) 
mmol/L 
 
Not 
available  
See Chapter 3 Australia’s Health 
(AIHW, 2010). 
 
Smoking Number per 
day: 
Non-smoker (please circle) 
Alcohol 
consumption 
Standard 
drinks per 
day/week/m
onth/year: 
Non-drinker (please circle) 
Social drinker (please circle) 
Stress Yes / No  
Diabetes Type 1 / 
Type 2 
Control of blood glucose levels 
(i.e., what are current readings like and 
description): 
mmol/L:________________________________________ 
 
Description:_____________________________________
_______________________________________________
_______________________________________________
_______________________________________________ 
  
Weight  kg  
BMI  kg/m
2
   Note: Require height and weight for calculation. 
 
Hip to Waist 
ratio (WHO 
STEPS on 
measurement) 
W: ____cm 
H:____cm 
 
Instruct patient over telephone how to take measurement.  
Activity (ies)/ 
Exercise (post-
discharge) 
None / light 
/ moderate / 
heavy 
Comments (why /why not recommenced or commenced) 
_______________________________________________
_______________________________________________ 
_______________________________________________
_______________________________________________
_______________________________________________ 
 
Dietary intake  Daily intake Breakfast 
 
 
 
 
 
Morning tea 
 
 
 
 
Lunch 
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Afternoon tea  
 
 
Dinner 
 
 
 
Dessert  
 
 
Snacks/Other 
(i.e., Meal supplements) 
 
 
 
6. Who do you turn to for 
support?___________________________________________________________________ 
 
6b. Are there any personal issues that we have not covered that you would like to share with 
me? 
__________________________________________________________________________
__________________________________________________________________________
__________________________________________________________________________
__________________________________________________________________________ 
 
7. How did you find this follow-up clinic? (Ask of intervention group participants) 
(Document responses) (Prompts: was it helpful?; Not at all?; A little) (Ask for an example 
of where they applied what they learnt at clinic in their post-discharge period and up to 3 
months). 
__________________________________________________________________________
__________________________________________________________________________
__________________________________________________________________________
__________________________________________________________________________
__________________________________________________________________________ 
 
 
Alerts: 
 Issue(s)  Notes and Action(s) 
 ____________________________________________________________
____________________________________________________________
____________________________________________________________
____________________________________________________________
____________________________________________________________
____________________________________________________________
____________________________________________________________ 
 
 
  
      
432 
Section 6: Participant Questions (Questions asked of the researcher by participants) 
Visit Question(s) asked and Response(s)  
3 months post-
discharge 
__________________________________________________________
__________________________________________________________
__________________________________________________________
__________________________________________________________
__________________________________________________________
__________________________________________________________
__________________________________________________________ 
 
 
Event notification (add to excel 
spreadsheet) 
Please tick Yes or No Communication source 
Cardiologist Yes  No   Telephone  Writing   
GP Yes  No  Telephone  Writing  
Family/Next of Kin 
____________________ 
Yes  No  Telephone  Writing  
Ethics: XXX HREC/ MS 
HREC/QUT HREC/ XXX DON 
(via Research Director of Nursing)  
Yes  No  Telephone  Writing  
   
Data Entry and Cleaning 
Data Entered Yes  No   
Date Entered  / / 2012/2103 Signature: 
Data Cleaned Yes  No   
Date Cleaned  / / 2012/2013 Signature: 
 
Letter of study completion and summary of 
results (Add to excel spreadsheet) 
 
Please tick Yes or No 
Patient Yes  No  
GP Yes  No  
Cardiologist Yes  No  
NOTE: If patient a standard care group 
participant and not been contacted throughout 
3 months by CR centre, contact the hospital at 
which they underwent their procedure to 
arrange for referral.  
Yes  No  
 
*Thank participant for their time and volunteering in this study. Advise participant 
they will receive certificate of appreciation in the mail with a summary of key findings 
on completion of the study. 
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Chest Pain Action Plan 
  
 
Chest Pain Action Plan – National Heart Foundation of Australia (NHFA) (2009). 
*Reproduced with permission from www.heartattackfacts.com.au © 2011 National Heart 
Foundation of Australia. 
 
 
 
 
      
434 
  
Appendix Q: Wound Healing Continuum – Access Site Assessment Tool 
 
Source: Wounds UK (2010). Applied wound management: Assessment and continuation chart. 
Retrieved from http://www.wounds-uk.com/pdf/content_8973.pdf 
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Applied Wound Management – Assessment and Continuation Chart (Wounds UK, 2010).
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Applied Wound Management – Assessment and Continuation Chart (Wounds UK, 
2010). 
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Appendix R: Neurovascular Assessment Tool 
Neurovascular Assessment Tool (Judge, 2007, p. 43). 
Neurovascular Chart 
Name: Ward: 
Consultant: 
Area for observation: 
Hospital no: 
 
Procedure/Injury: 
 
Frequency of Observations:  
Date: Right Left Comments 
Time:     
Pain Score (1–10):    
Colour Normal    
Pale*    
Cyanotic*    
Mottled*    
Warmth Hot*    
Warm    
Cold*    
Cool*    
Pulses Name of pulse:    
Strong    
Weak*    
Absent*    
Capillary refill greater than 2 seconds (yes/no) 
Movement  
Dorsi flexion No movement*     
Movement, no pain    
Movement with 
pain* 
   
Plantar Flexion No movement*     
Movement, no pain    
Movement with 
pain* 
   
Toe extension No movement*     
Movement, no pain    
Movement with 
pain* 
   
Toe flexion No movement*     
Movement, no pain    
Movement with 
pain* 
   
Sensation    
Web space 
First and second toe 
No sensation*    
Tingling/numbness*    
Full sensation    
Web space 
third and fourth toe 
No sensation*    
Tingling/numbness*    
Full sensation    
Sole of foot/toes No sensation*    
Tingling/numbness*    
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Full sensation    
Arch of foot (medial) No sensation*    
Tingling/numbness*    
Full sensation    
Initials    
Always compare with the unaffected limb. If both limbs are affected, use a separate 
chart for each limb. 
*These may be signs of abnormalities, take appropriate action, document and inform a 
member of the medical team. Document all actions taken in the space below. 
Changes present now: Yes  No  (Please tick) 
Affected limb(s): Right upper/Right lower/Left upper/Left lower (Please circle) 
 
Actions:__________________________________________________________________
_________________________________________________________________________
_________________________________________________________________________
_________________________________________________________________________
_________________________________________________________________________
_________________________________________________________________________
_________________________________________________________________________
_________________________________________________________________________
_________________________________________________________________________ 
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Appendix S: Permissions For Assessment Tools 
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Greetings Katina, and thank you for your interest in using the copyrighted Morisky 
Medication Adherence Scale, 8-Items (MMAS-8). Since you are a student, I will 
waive the license fee for use of the instrument, provided that your reference our 
research and send me a summary of your findings upon completion of your research. 
I have attached for you the documents regarding the copyright agreement, waiver of 
licensure fee and coding instructions for the MMAS-8.  I hope this information is 
helpful and look forward to receiving your signed agreement and results of your 
investigation.  Please send me (fax or email) at your earliest convenience the signed 
agreement form and your project results when completed. I have attached relevant 
manuscripts for your background reading. 
 
Sincerely, 
 
Dmorisky 
 
Donald E. Morisky, Sc.D., M.S.P.H., Sc.M. 
Professor and Program Director, Doctoral Training in the Social and Behavioral 
Determinants of HIV/AIDS Prevention 
Department of Community Health Sciences 
UCLA School of Public Health 
 
email: dmorisky@ucla.edu 
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Date: Thu, 16 Jun 2011 14:21:41 +1000 
Subject: Permission 
 
Dear Professor Hare, 
 
I am writing to you seeking permission to use the 'Cardiac Depression Scale' to assess 
cardiac patients in my study for depression. With your written permission (the form of an e-
mail will suffice), may I please use this scale for the purpose of participant assessment in my 
study? Please feel free to contact me at any time via e-mail or alternately via telephone 
if you have any questions. 
 
Kind regards, 
Katina 
 
Katina Corones – PhD Candidate 
School of Nursing & Midwifery | Victoria Park Rd, Kelvin Grove Campus| Queensland 
University of Technology | Kelvin Grove, QLD, 4059, Australia 
 
 
Sent: Thursday, 16 June 2011 6:00 
Subject: Re: Permission 
 
Ok Katina. 
We should send you some extra info when I get back from Europe. 
 
Prof DL Hare 
 
 
Hello Katina 
 
Please find attached some documentation for your use. 
 
Best wishes 
Carol-Lynn 
 
PA to Prof. David L Hare 
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Subject: Re: Permission request Cardiac Self-efficacy 
Questionnaire 
 
 
Katina, 
 
You are welcome to use our scale as long as you cite our 
original paper in Psychosomatic Medicine. 
 
 
Mark Sullivan, MD, PhD                         
Psychiatry and Behavioral Sciences             
University of Washington 
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Good Morning Katina, 
Further to your below e-mail, please accept this as our permission for you to utilise the 
Applied Wound Management Assessment and Continuation Chart for your participants. 
Kind regards 
Lorraine Knowles 
Vi Guyan 
Operations Director 
HealthComm UK T/A Wounds UK 
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Dear Ms Judge, 
 
I am a PhD Candidate seeking permission to use two figures from the following journal 
article in my PhD studies to assess patients and in my Thesis: 
 
Neurovascular assessment' (2007), Nursing Standard, 21(45), pp. 39–44. 
 
The figures consist of the following: 
1. Location of peripheral pulses – p.41; & 
2. Neurovascular Assessment Tool – p.43. 
 
Please feel free to contact me at any time during business hours via telephone or alternately, 
you may e-mail at any time. My contact details are as listed below. 
 
Kind regards, 
Katiana 
 
Katina Corones – PhD Candidate 
School of Nursing & Midwifery | N Block, Victoria Park Rd, Kelvin Grove Campus| 
Queensland University of Technology | Kelvin Grove, QLD, 4059, Australia 
 
 
Dear Katina 
Many thanks for your e-mail. I am more than happy for you to reproduce and use these two 
diagrams. 
 
Kind regards 
Nicola 
 
Nicola Whiteing 
MSc, PG Dip HE, BSc (hons), RN, RNT, ANP 
Senior Lecturer in Advanced Practice 
Department of Applied Biological Sciences 
School of Community & Health Sciences 
City University, London 
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Katina 
 
Approval has been granted. 
 
Please use the action plan located at: http://heartattackfacts.com.au/Action-plan.aspx 
 
The following acknowledgement must be included directly below the action plan within the 
document. 
 
Reproduced with permission from www.heartattackfacts.com.au © 2011 National 
Heart Foundation of Australia. 
 
Regards 
 
Roberto Pietrobon | National Health Content Unit Manager 
Heart Foundation, Level 12, 500 Collins Street, Melbourne VIC 3000 
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Hi Katina, 
 
My apologies for the late reply. 
 
Yes, you can use our printed material for your education purposes.  Please just acknowledge 
the source of those pictures by stating SOURCE: SARSTEDT AUSTRALIA PTY. LTD. 
underneath the pictures. 
 
 
Thanks. 
Shirley 
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Appendix T: Saliva Sample Instruction Sheet 
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Adapted from “Salivette®: Hygenic saliva collection for diagnostics and 
monitoring,” by SARSTEDT Australia, 2008, p.2. Copyright 2008, by SARSTEDT 
AG & Co. Reprinted with permission. 
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Appendix U: The REALITY CHEC Project© – Risk Protocols 
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Appendix V: Nurse-led Clinic – Sample of slide presentation 
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Appendix W: Phase One – Participant Information and Consent Form (PICF) 
and Ethical Approval 
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Phase One PICF and Ethical Approval 
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Ethics Application Approval -- 1200000332 
https://outlook.qut.edu.au/ . . . 
JQJ9lQBUL5N8GBwBA9uc81xqQS7COUnH18FazAAg9myv0AABA9uc81xqQS7COUnH18FazABaX%2fHatAAAJ[
9/10/2012 2:47:20 PM] 
Reply Reply to All Forward 
Sent: Monday, 16 July 2012 9:58 AM 
To: Katina Corones; Karen Theobald; Robyn Clark 
Cc: XXXX 
 
Dear Ms Katina Corones 
Project title: A RandomisEd controlled clinical triAL of a post-
dIscharge 
educational IntervenTion to reduce anxiety and enhance self-efficacY in 
percutaneous Coronar intervention patients witHin five to sEven days 
post-disCharge – The 'REALITY CHEC' Project 
Ethics category: Human – Administrative Review 
QUT approval number: 1200000332 
(HREC approval 
number: HREC/11/QXXX/526; 
HREC approval number: 1125) 
 
QUT clearance until: 31/12/2014 
This email is to advise that your administrative review application has 
been reviewed by the Chair, University Human Research Ethics Committee 
and confirmed as meeting the requirements of the National Statement on 
Ethical Conduct in Human Research. 
Your application has received QUT administrative review approval based 
on the approval gained from the XXXXX Human Research Ethics 
Committee(HREC), approval number XXXXX. We note this HREC has awarded 
the project ethical clearance until 31/12/2014. 
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VARIATIONS 
The XXXX HREC should be considered the lead HREC in terms of the 
ethical review of this project. As such, all variations must first be 
approved by the XXXX HREC before submission to QUT for ratification 
(please submit to QUT using our online variation form: 
http://www.research.qut.edu.au/ethics/humans/applications.jsp#amend) 
 
MONITORING 
Please ensure you also provide QUT with a copy of each adverse event 
report 
and progress report submitted to XXXX HREC. 
When your project has been completed please advise us by email at your 
earliest convenience. 
For information regarding the use of social media in research, please go 
to: 
http://www.research.qut.edu.au/ethics/humans/faqs/index.jsp 
Please do not hesitate to contact the unit if you have any queries. 
 
Regards 
XXXX on behalf of the Chair UHREC 
Research Ethics Unit | Office of Research 
Level 4 | 88 Musk Avenue | Kelvin Grove 
p: +61 7 3138 5123 
e: ethicscontact@qut.edu.au 
w: http://www.research.qut.edu.au/ethics/ 
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Appendix X: Phase Two – Intervention Group and Healthcare Professional 
Interview Questions 
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Phase Two – Healthcare Professionals Semi-Structured Interview Questions 
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Appendix Y: Phase Two Ethical Approval and Consent 
 
Dear Ms Katina Corones 
  
Project title:  A randomised controlled clinical trial of a post-discharge Educational 
intervention to reduce anxiety and enhance self-efficacy in Percutaneous Coronary 
intervention patients within five to seven days Post-discharge - The 'REALITY CHEC' Project 
  
Ethics category:                  Human - Administrative Review  
QUT approval number:     1200000332  
                                               (Metro XXX HREC approval number: HREC/11/QXXX/526; 
                                                XXX approval number: 1125;  
                                               Institute XXX) 
QUT clearance until:         31/12/2014 (as per Metro XXX HREC approval) 
  
This email is to advise that your administrative review application has been reviewed by the 
Chair, University Human Research Ethics Committee and confirmed as meeting the 
requirements of the National Statement on Ethical Conduct in Human Research.   
  
Your application has received QUT administrative review approval based on the approval 
gained from the Metro XXX Human Research Ethics Committee (HREC), approval number 
HREC/11/QXXX/526. We note this HREC has awarded the project ethical clearance until 
31/12/2014. 
  
VARIATIONS 
The Metro XXX HREC should be considered the lead HREC in terms of the ethical review of 
this project. As such, all variations must first be approved by the Metro XXX HREC before 
submission to QUT for ratification (please submit to QUT using our online variation form: 
http://www.research.qut.edu.au/ethics/humans/applications.jsp#amend) 
  
  
478 
MONITORING 
Please ensure you also provide QUT with a copy of each adverse event report and progress 
report submitted to Metro XXX HREC. 
  
When your project has been completed please advise us by email at your earliest 
convenience. 
  
For information regarding the use of social media in research, please go to: 
http://www.research.qut.edu.au/ethics/humans/faqs/index.jsp 
  
Please do not hesitate to contact the unit if you have any queries. 
  
Regards 
  
Janette Lamb on behalf of the Chair UHREC 
Research Ethics Unit   |   Office of Research 
Level 4   |   88 Musk Avenue   |   Kelvin Grove 
p: +61 7 3138 5123   
 
e: ethicscontact@qut.edu.au 
w: http://www.research.qut.edu.au/ethics/ 
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   Phase Two - Participant Consent  
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Phase Two Consent – Healthcare Professionals 
 
 
  
486 
 
 
 
 
  
487 
 
 
 
  
488 
 
Appendix Z: Summary of Post-discharge Angina  
 
Table Z.1. Summary of Post-discharge Angina as a Percentage of the Sample 
Time 
Study Participants  
% (n) 
Time 1–2 36.4% (12) 
Time  - (0) 
Time 2–3 39.4% (13) 
Time 3 -  (0) 
Time 3–4  30.3% (10) 
Time 4  - (0) 
Note. Time 1-2 = Between day of discharge and day 5-7 follow-up; Time 2 = Day 5-7 follow-up;  
Time 2-3= Between day 5-7 and 1 month follow-up; Time 3 = 1 month; Time 4 = 3 months.  
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Appendix A1: Participant demographics 
Table A1.1 General demographics – Intervention versus Standard Care Group 
Condition 
(Intervention or standard care 
group) Frequency Percent 
Valid 
Percent 
Cumulative 
Percent 
Gender     
Standard 
care group 
Valid Female 3 15.0 15.0 15.0 
Male 17 85.0 85.0 100.0 
Total 20 100.0 100.0 
 
Intervention Valid Female 3 23.1 23.1 23.1 
Male 10 76.9 76.9 100.0 
Total 13 100.0 100.0 
 
Country of birth 
Standard 
care group 
Valid Australia 17 85.0 85.0 85.0 
Other 3 15.0 15.0 100.0 
Total 20 100.0 100.0 
 
Intervention Valid Australia 11 84.6 84.6 84.6 
Other 2 15.4 15.4 100.0 
Total 13 100.0 100.0 
 
Primary Language Spoken 
Standard 
care group 
Valid English 18 90.0 90.0 90.0 
Other 2 10.0 10.0 100.0 
Total 20 100.0 100.0 
 
Intervention Valid English 13 100.0 100.0 100.0 
Marital Status  
Standard 
care group 
Valid Not married 4 20.0 20.0 20.0 
Married 16 80.0 80.0 100.0 
Total 20 100.0 100.0 
 
Intervention Valid Not married 3 23.1 23.1 23.1 
Married 10 76.9 76.9 100.0 
Total 13 100.0 100.0 
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Table A1.2 Participant Education 
 
Condition (Intervention or standard care 
group) Frequency Percent Valid Percent 
Standard 
care group 
Valid Secondary or less 11 55.0 55.0 
Post-secondary 
education 
9 45.0 45.0 
Total 20 100.0 100.0 
Intervention Valid Secondary or less 7 53.8 53.8 
Post-secondary 
education 
6 46.2 46.2 
Total 13 100.0 100.0 
 
 
Table A1.3 Education 
Condition (Intervention or standard care group) 
Cumulative 
Percent 
Standard care 
group 
Valid Secondary or less 55.0 
Post-secondary education 100.0 
Total  
Intervention Valid Secondary or less 53.8 
Post-secondary education 100.0 
Total  
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Appendix A2: Participant Risk Factors – Intervention versus Standard Care 
Group 
 
Condition (Intervention or 
standard care group) Risk factor Frequency Percent 
Valid 
Percent 
Cumulative 
Percent 
Age 
Standard 
care group 
Valid Yes 
20 100.0 100.0 100.0 
Intervention Valid Yes 13 100.0 100.0 100.0 
Gender 
Standard 
care group 
Valid No 4 20.0 20.0 20.0 
Yes 16 80.0 80.0 100.0 
Total 20 100.0 100.0 
 
Intervention Valid No 3 23.1 23.1 23.1 
Yes 10 76.9 76.9 100.0 
Total 13 100.0 100.0 
 
Family history 
Standard 
care group 
Valid No 7 35.0 35.0 35.0 
Yes 13 65.0 65.0 100.0 
Total 20 100.0 100.0 
 
Intervention Valid No 3 23.1 23.1 23.1 
Yes 10 76.9 76.9 100.0 
Total 13 100.0 100.0 
 
Hypertension  
Standard 
care group 
Valid No 8 40.0 40.0 40.0 
Yes 12 60.0 60.0 100.0 
Total 20 100.0 100.0 
 
Intervention Valid No 6 46.2 46.2 46.2 
Yes 7 53.8 53.8 100.0 
Total 13 100.0 100.0 
 
Chronic kidney disease (CKD) 
Standard 
care group 
Valid No 
20 100.0 100.0 100.0 
Intervention 
 
Valid No 13 100.0 100.0 100.0 
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Condition (Intervention or 
standard care group) Risk factor Frequency Percent 
Valid 
Percent 
Cumulative 
Percent 
 
Atrial fibrillation (new or previous history) 
Standard 
care group 
Valid No 16 80.0 80.0 80.0 
Yes 4 20.0 20.0 100.0 
Total 20 100.0 100.0 
 
Intervention Valid No 10 76.9 76.9 76.9 
Yes 3 23.1 23.1 100.0 
Total 13 100.0 100.0 
 
Family history hypercholesterolaemia  
Standard 
care group 
Valid No 7 35.0 35.0 35.0 
Yes 13 65.0 65.0 100.0 
Total 20 100.0 100.0 
 
Intervention Valid No 6 46.2 46.2 46.2 
Yes 7 53.8 53.8 100.0 
Total 13 100.0 100.0 
 
Hypercholesterolaemia 
Standard 
care group 
Valid No 6 30.0 30.0 30.0 
Yes 14 70.0 70.0 100.0 
Total 20 100.0 100.0 
 
Intervention Valid No 1 7.7 7.7 7.7 
Yes 12 92.3 92.3 100.0 
Total 13 100.0 100.0 
 
Smoking Status smoke  
Standard 
care group 
Valid No 16 80.0 100.0 100.0 
Missing 666 (N/A) 4 20.0 
  
Total 20 100.0 
  
Intervention Valid No 12 92.3 100.0 100.0 
Missing 666 1 7.7 
  
Total 13 100.0 
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Condition (Intervention or 
standard care group) Risk factor Frequency Percent 
Valid 
Percent 
Cumulative 
Percent 
 
Alcohol consumption  
Standard 
care group 
Valid No 8 40.0 40.0 40.0 
Yes 12 60.0 60.0 100.0 
Total 20 100.0 100.0 
 
Intervention Valid No 4 30.8 30.8 30.8 
Yes 9 69.2 69.2 100.0 
Total 13 100.0 100.0  
Risk factor Stress  
Standard 
care group 
Valid No 10 50.0 50.0 50.0 
Yes 10 50.0 50.0 100.0 
Total 20 100.0 100.0 
 
Intervention Valid No 6 46.2 46.2 46.2 
Yes 7 53.8 53.8 100.0 
Total 13 100.0 100.0 
 
Diabetes Mellitus 
Standard 
care group 
Valid No 18 90.0 90.0 90.0 
Yes 2 10.0 10.0 100.0 
Total 20 100.0 100.0 
 
Intervention Valid No 11 84.6 84.6 84.6 
Yes 2 15.4 15.4 100.0 
Total 13 100.0 100.0 
 
Body Mass Index (BMI) 
Standard 
care group 
Valid No 5 25.0 25.0 25.0 
Yes 15 75.0 75.0 100.0 
Total 20 100.0 100.0 
 
Intervention Valid No 5 38.5 38.5 38.5 
Yes 8 61.5 61.5 100.0 
Total 13 100.0 100.0 
 
Activity  
Standard 
care group 
Valid Not active 1 5.0 5.0 5.0 
Active 19 95.0 95.0 100.0 
Total 20 100.0 100.0 
 
Intervention Valid Active 13 100.0 100.0 100.0 
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Appendix B1: Cohen’s d – Effect Size Calculations Cardiac Self-Efficacy (CSE) 
 
Effect Size (d): Cardiac Self-Efficacy (CSE) Intervention Group Participants 
 
Intervention Group Participants: Cohen’s d 
d = 𝑚𝐴– 𝑚𝐵 
           σ 
 
𝑚𝐴 = Mean of intervention group at Time 2 (2.48) 
𝑚𝐵 = Mean of intervention group at Time 3 (2.11) 
σ = Standard deviation of intervention group at Time 2 (0.62) 
 
d = 2.48 – 2.11  
            0.62 
 
d = 0.37 
      0.62 
 
d = 0.60 
 
Overall, a moderately reducing effect was demonstrated on CSE in intervention 
group participants, d = 0.60.  
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Effect size (d): Cardiac Self-Efficacy (CSE) Standard Care Group Participants 
 
d= 𝑚𝐴– 𝑚𝐵 
           σ 
 
𝑚𝐴 = Mean of standard care group at Time 2 (2.35) 
𝑚𝐵 = Mean of standard care group at Time 3 (2.45) 
σ = Standard deviation of standard care group at Time 2 (0.53) 
 
d = 2.35 – 2.45 
           0.53 
 
 
d = - 0.10 
         0.53 
 
d = -0.19 
 
Overall, receiving standard care alone did not demonstrate any effect on CSE in 
standard care group participants.  
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Appendix C1: Reliable Change Index (RCI) Calculations: Cardiac Self-Efficacy 
(CSE) 
Step 1. Calculation of the Standard Error (SE) 
SE = S1 √1 − 𝑟𝑥𝑥 
S1 = Standard deviation of the sample pre-intervention (0.56) 
rxx = Reliability of the CSE questionnaire (0.697) 
 
SE = 0.56 √1 − 0.697 
SE = 0.56 x 0.56 
SE = 0.31 
 
Step 2. Calculation of the Standard Error of Difference (Sdiff) between the two test 
scores 
Sdiff = √2 (𝑆𝐸)2  
Sdiff = √2 (0.31)2 
Sdiff = √2 (0.09) 
Sdiff = √0.19 
Sdiff = 0.44 
 
Step 3. Calculation of Reliable Change Index (RCI) 
Intervention group participant 082  
X1: Individual pre-treatment score (3.13) 
X2: Individual post-treatment score (1.88)  
Sdiff: 0.44 
 
RCI = (X2 – X1)  
              Sdiff  
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RCI = 3.13 - 1.88 
               0.44  
 
RCI = 2.84 
 
A reliable change of 2.84 (> +1.96) in CSE has occurred for intervention group 
participant 082 after attending the nurse-led clinic. 
 
Standard care group participant 005 
X1: Individual pre-treatment score (2.44) 
X2: Individual post-treatment score (3.38) 
Sdiff: 0.44 
 
RCI = (X2 – X1)  
              Sdiff  
RCI = 2.44 - 3.38 
               0.44  
 
RCI = 2.14 
A positive reliable change of 2.14 (> +1.96) occurred for CSE in intervention group 
participant 005 post nurse-led clinic attendance. 
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Step 4. Cut-off point ‘c’ 
S1: Standard deviation for participants’ pre-treatment (0.56)  
S2: Standard deviation for a well-functioning sample (0.72) 
M1: Pre-treatment mean for the sample (2.40)  
M2: Mean of the well-functioning sample on CSE (3.04) 
 
c = S1M2 + S2M1 
S1 + S2 
  
c = 0.56 (3.04) + 0.72 (2.40) 
                 0.56 + 0.72  
 
c = 1.70 + 1.73 
1.28 
 
c = 2.68 
 
A cut-off point of 2.68 suggests that participants’ score of > 2.68 will fall within the 
normal distribution, thus, indicating clinically significant change.  
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Appendix D1: Mean Cardiac Self-Efficacy (CSE) Ratings  
Table D.1.  Summary of Means for Scores for the Cardiac Self-efficacy Scale (CSE) Items 
Group/CSE Measure Time 1 Time 2 Time 3 Time 4 4 
  M(SD) M(SD) M(SD) M(SD) 
Intervention     
Weight 2.43 (1.13) 2.00 (1.15) 2.57 (1.27) 3.14 (0.90) 
Diet 3.11 (1.17) 2.67 (1.32) 2.89 (0.60) 2.67 (1.12) 
Physical activity 3.00 (1.13) 2.58 (0.79) 2.75 (1.14) 3.00 (1.13) 
Work activities 2.67 (1.15) 3.00 (1.00) 3.33 (0.58) 3.33 (1.16) 
Breathlessness 2.00 (1.41) 1.00 (0.00) 2.00 (0.00) 3.00 (0.00) 
Calling doctor 3.08 (1.24) 3.50 (0.80) 2.92 (1.24) 3.17 (1.20) 
Doctor understanding 2.92 (0.97) 3.00 (1.21) 3.00 (1.04) 3.00 (1.04) 
Fatigue/medications 2.57 (1.27) 3.14 (0.90) 2.50 (0.71) 2.67 (0.58) 
Fatigue and activity 2.71 (1.25) 3.14 (0.69) 2.57 (0.98) 3.00 (0.00) 
Activity/ breathlessness 3.00 (0.71) 2.80 (0.84) 2.20 (0.84) 3.20 (0.45) 
Social activities 2.80 (1.14) 3.10 (0.99) 2.60 (1.51) 2.80 (1.32) 
Heart medications  3.75 (0.45) 3.75 (0.78) 3.25 (0.45) 3.58 (0.67) 
CP and medications  2.75 (0.89) 3.25 (0.87) 2.50 (0.76) 2.75 (1.28) 
CP and activity 2.75 (0.89) 3.00 (0.76) 2.25 (0.71) 3.13 (0.84) 
Family activity  3.25 (0.75) 3.17 (1.03) 2.33 (1.37) 2.92(1.38) 
Sexual activity 2.86 (1.46) 2.86 (1.46) 2.14 (1.57) 2.43 (1.51) 
Standard care      
Weight 2.60 (0.91) 2.67 (0.62) 2.53 (1.13) 2.80 (1.15) 
Dietary 3.07 (1.10) 3.13 (0.64) 3.27 (0.60) 3.27 (0.96) 
Physical activity 2.94 (0.73) 2.67 (0.77) 3.00 (1.40) 3.33 (0.69) 
Work activities 3.75 (0.50) 3.75 (0.50) 4.00 (0.00) 3.75 (0.50) 
Breathlessness 4.00 (0.00) 4.00 (0.00) 3.00 (0.00) 3.00 (0.00) 
Calling doctor 2.94 (1.44) 3.47 (0.62) 3.53 (0.87) 3.47 (1.01) 
Doctor understanding 3.35 (0.49) 3.29 (0.72) 3.53 (0.62) 3.41 (1.07) 
Fatigue/medications  2.67 (0.78) 2.00 (1.32) 3.67 (0.58) 4.00  ( - ) 
Fatigue and activity 2.70 (0.95) 3.00 (0.82) 3.10 (1.29) 3.50 (0.85) 
Activity /breathless  3.25 (0.96) 3.75 (0.50) 3.50 (0.58) 3.75 (0.50) 
Activities at home 3.33 (0.97) 2.83 (1.10) 3.22 (0.81) 3.50 (0.86) 
Heart medications  3.44 (0.98) 3.39 (0.78) 3.78 (0.43) 3.61 (0.78) 
CP and medications 2.92 (0.90) 2.50 (1.10) 3.17 (0.84) 3.33 (1.23) 
CP and activity 3.18 (0.75) 2.55 (1.13) 2.91 (0.94) 3.45 (0.82) 
Family activity 3.44 (0.86) 2.94 (1.00) 3.39 (0.70) 3.61 (0.70) 
Sexual activity 3.29 (0.73) 3.29 (0.99) 3.07 (1.07) 2.86 (1.35) 
Note. CSE = Cardiac Self-Efficacy Scale. Time 1 = Baseline; Time 2 = Pre-intervention (day 5-–7); Time 3 = 1 
month. Time 4 = 3 months. CP = Chest pain.  
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Appendix E1: State Trait Anxiety Inventory - Trait Anxiety Effect Size (d): 
Intervention Group Participants 
 
d = 𝑚𝐴– 𝑚𝐵 
           σ 
 
d = 36.75 – 29.92  
              14.10 
 
d = 6.83 
     14.10 
 
d = 0.48  
 
d = 0.50 
 
Participation in the nurse-led clinic demonstrated a moderate effect on trait anxiety in 
intervention group participants over time (d = 0.50). 
 
Trait Anxiety Effect Size (d): Standard Care Group Participants 
 
d = 𝑚𝐴– 𝑚𝐵 
           σ 
d = 30.95 – 29.47 
             9.43 
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d = 1.48  
      9.43 
  
d = 0.156 
 
d = 0.16 
 
Randomisation to the standard care group alone demonstrated no effect on trait 
anxiety (d = 0.16). 
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Appendix F1: Reliable Change Index Intervention Group Participants For 
Trait Anxiety 
 
 
S1: Standard deviation of the sample pre-intervention (9.45) 
S2: Standard deviation of the well-functioning sample (9.19) 
rxx: Reliability of the STAI-Y2 Form (0.91) 
SE: Standard error of measurement for the STAI-Y2 Form (2.835) 
Sdiff: Standard error of difference between the two test scores (4.01)  
 
Reliable Change Index (RCI): Intervention Group Participants 
X1: Individual pre-treatment score (46) 
X2: Individual post-treatment score (30) 
Sdiff: 4.01 
 
Calculation 1: Participant 010 
RCI = (X2 – X1)  
              Sdiff  
 
RCI = 30 - 46 
             4.01  
 
RCI = -3.99 
 
A negative reliable change of -3.99 occurred in participant 010 over time after 
participation in the intervention. 
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Calculation 2: Participant 006  
X1: Individual pre-treatment score (31) 
X2: Individual post-treatment score (20) 
Sdiff: 4.01 
RCI = (X2 – X1)  
              Sdiff  
 
RCI = 20 - 31 
             4.01  
 
RCI = -2.74 
 
A negative reliable change of -2.74 occurred for intervention group participant 006. 
 
Calculation 3: Participant 066  
X1: Individual pre-treatment score (31) 
X2: Individual post-treatment score (20) 
Sdiff: 4.01 
 
RCI = (X2 – X1)  
              Sdiff  
 
RCI = 24 - 41 
             4.01  
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RCI = -4.24  
A negative reliable change of -4.24 occurred for intervention group participant 066. 
 
Calculation 4: Participant 020 
X1: Individual pre-treatment score (32) 
X2: Individual post-treatment score (24) 
Sdiff: 4.01 
 
RCI = (X2 – X1)  
              Sdiff  
 
RCI = 24 - 32  
             4.01  
 
RCI = - 1.99 
A negative reliable change of -1.99 was evidenced for participant 020.  
 
Calculation 5: Participant STA006 
X1: Individual pre-treatment score (53) 
X2: Individual post-treatment score (27) 
Sdiff: 4.01 
RCI = (X2 – X1)  
              Sdiff  
 
RCI = 27 - 53 
             4.01  
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RCI = - 6.48 
 
A negative reliable change of -6.48 occurred for trait anxiety for participant 106 
post-intervention.  
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Appendix G1: Standard Care Group Participants: Reliable Change Index 
(RCI) Calculations For Trait Anxiety 
 
Calculation 1: Participant 039 
X1: Individual pre-treatment score (45) 
X2: Individual post-treatment score (35) 
Sdiff: 4.01 
 
RCI = (X2 – X1)  
              Sdiff  
 
RCI = 35 - 45 
             4.01  
  
RCI = -2.50 
 
A negative reliable change of -2.50 was evidenced for participant 039 after 
randomisation to the standard care group.  
 
Calculation 2: Participant 021 
X1: Individual pre-treatment score (49) 
X2: Individual post-treatment score (37) 
Sdiff: 4.01 
 
RCI = (X2 – X1)  
              Sdiff  
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RCI = 37 - 49 
             4.01  
 
RCI = -2.99 
 
A negative reliable change of -2.99 was demonstrated for participant 021 after 
randomisation to the standard care group.  
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Appendix H1: Summary of Means for Scores for the STAI Questionnaire: Trait 
Anxiety (Y2 Form) 
 
 
Table H.1. Summary of Means for Scores for the STAI Questionnaire: Trait Anxiety (Y2 
Form) 
 Intervention Group Standard Care Group 
Time  M(SD) M(SD) 
Time 1 38.33 (13.28) 34.37 (8.84) 
Time 2 36.75 (14.10) 30.95 (9.43) 
Time 3 29.92 (12.66) 29.47 (8.13) 
Time 4 31.25 (15.55) 25.37 (5.16) 
Note. STAI = State-Trait Anxiety Inventory. Time 1 = Baseline; Time 2 = Pre-intervention (day 5-7); 
Time 3 = 1 month; Time 4 = 3 months. 
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Appendix I1: Cardiac Depression Scale (CDS) Intervention Group Participants: 
Population Effect Size (ES) 
 
d = 𝑚𝐴– 𝑚𝐵 
           σ 
 
d = 73.83 – 65.83 
            30.32 
 
d =    8 
      30.32 
 
d = 0.263 
 
d = 0.26 
 
Participation in the intervention demonstrated a small effect on depressive symptoms 
in intervention group participants over time (d = 0.26). 
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Cardiac Depression Scale (CDS) Standard Care Group Participants: Population 
Effect Size (ES) 
 
d = 𝑚𝐴– 𝑚𝐵 
           σ 
 
d = 68.58 - 58.26 
           28.10 
 
d = 10.32 
      28.10  
 
d = 0.367 
 
d = 0.37 
 
Receiving standard care alone demonstrated a small effect on depressive symptoms 
in standard care group participants (d = 0.37). 
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Appendix J1: Reliable Change Index (RCI) – Cardiac Depression Scale  
 
Step 1. Calculation of the Standard Error  
S1 = Standard deviation of the sample pre-intervention (28.13) 
rxx = Reliability of the CDS questionnaire (0.79) 
  
SE = S1 √1 − 𝑟𝑥𝑥 
SE = 28.13 √1 − 0.79 
SE = 28.13 √0.21  
SE = 28.13 x 0.458 
SE = 12.9 
 
Step 2. Calculation of the Standard error of difference between the two test scores 
(Sdiff) 
Sdiff = √2 (𝑆𝐸)2 
 
Sdiff =  √2 (12.9)2    
 
Sdiff = √2 (166.41)  
 
 Sdiff = √332.82 
 
 Sdiff = 18.24 
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Step 3. Calculation of Reliable Change Index (RCI) 
Calculation 1: Intervention group participant 010 
X1: Individual pre-treatment score (96) 
X2: Individual post-treatment score (60) 
 
RCI = (X2 – X1)  
              Sdiff  
 
RCI = 60 - 96 
            18.24 
 
RCI = -1.97 
 
 
A negative reliable change of -1.97 occurred for participant 010. 
 
Calculation 2: Standard care group participant 013 
X1: Individual pre-treatment score (157) 
X2: Individual post-treatment score (59) 
 
RCI = (X2 – X1)  
               Sdiff  
 
RCI = 59 - 157 
            18.24 
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RCI = -5.4 
 
A reliable change of -5.4 was evidenced in participant 013. 
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Appendix K1: Mean Ratings for the Cardiac Depression Scale 
 
Table K.1 Summary of Means for Scores for the Cardiac Depression Scale (CDS) 
 
 Intervention Group Standard Care Group 
Time M(SD) M(SD) 
Time 1 79.95 (19.60) 72.32 (22.42) 
Time 2 73.83 (30.32) 68.58 (28.10) 
Time 3  65.83 (27.96) 58.26 (17.78) 
Time 4 73.17 (31.81) 53.37 (14.87) 
Note. CDS = Cardiac Depression Scale. Time 1 = Baseline; Time 2 = Pre-intervention (day 5-7); Time 
3 = 1 month; Time 4 = 3months. 
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Appendix L1: Effect Size Calculations for Medication Adherence (MMAS-8) 
 
Intervention Group Participants: Cohen’s d – Population Effect Size (ES) 
 
d = 𝑚𝐴– 𝑚𝐵 
           σ 
 
d = 7.71 – 7.71 
          0.71 
 
d = 0 
    0.71 
 
d = 0 
 
Overall, the intervention had no effect on participant’s medication adherence. 
 
Standard Care Group Participants: Cohen’s d – Population Effect Size (ES) 
 
d= 𝑚𝐴– 𝑚𝐵 
           σ 
 
d = 7.76 – 7.89 
0.60 
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d = -0.13 
       0.60 
 
d = - 0.2166 
 
d = - 0.22 
 
A small effect was evidenced on standard care group participants. 
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Appendix M1: Summary of Mean Ratings for the MMAS-8 
 
Table M.1. Summary of Means for Scores for the Morisky Medication Adherence Scale 
(MMAS-8) 
 Intervention Group Standard Care Group 
 Time M(SD) M(SD) 
Time 1  7.31 (1.12) 7.24 (1.20) 
Time 2 7.71 (0.71) 7.76 (0.60) 
Time 3 7.71 (0.71) 7.89 (0.47) 
Time 4  7.88 (0.36) 7.97 (0.81) 
Note. MMAS-8 = Morisky Medication Adherence Scale (8-Item). Time 1 = Baseline; Time 2 = Pre-
intervention (day 5-7); Time 3 = 1 month; Time 4 = 3months. 
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Appendix N1: Femoral Arterial Access Site Images and Diagrams  
 
Time 1: Baseline Digital Image_Participant_019 
 
 
 
Time 2 (Day 5-7): Digital Image_Participant_019 
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Time 1: Baseline Digital Image_Participant_105 
                            
 
Time 3 (1 Month): Diagram_Participant_105 
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Time 1: Baseline_ Digital Image_Participant_010 
 
 
Time 2 (Day 5-7): Digital Image_Participant_010 
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Time 3 (1 Month): Diagram_Participant_010 
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Time 1: Baseline Digital Image_Participant_019 
 
 
Time 2 (Day 5-7): Diagram _Participant_019 
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Time 3 (1 Month): Diagram_Participant_019 
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Appendix O1: Phase Three Study Protocol 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
525 
Appendix P1: Morisky Medication Adherence Scale (MMAS-8 item) 
 
 
1. How often do you have difficulty remembering to take all your medications? (Please 
circle the correct number) 
Never/Rarely . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . ..4 
Once in a while . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3 
Sometimes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . ..2 
Usually . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  1 
All the time . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .0 
From “Predictive Validity of a Medication Adherence Measure for Hypertension 
Control,” by D.E. Morisky, A. Ang, and M. Krousel-Wood, 2008, Journal of 
Clinical Hypertension, 10, pp.348–354. Copyright by D.E. Morisky. Reprinted with 
permission. 
 
 
©Morisky Medication Adherence Scale (MMAS-8-Item). This is a generic 
adherence scale and the name of the health concern can be substituted in each 
question item. 
 
You indicated that you are taking medication for your (identify health concern, 
such as “high blood pressure”). Individuals have identified several issues 
regarding their medication-taking behavior and we are interested in your 
experiences. There is no right or wrong answer. Please answer each question 
based on your personal experience with your [health concern] medication. 
 (Please circle the correct number) 
  No=1 Yes=0 
1. Do you sometimes forget to take your [health concern] pills? 
. . . .. 
  
2. People sometimes miss taking their medications for reasons 
other than forgetting. Thinking over the past two weeks, were 
there any days when you did not take your [health concern] 
medicine? . . . .. 
 
 
 
 
 
 
3.Have you ever cut back or stopped taking your medication 
without telling your doctor, because you felt worse when you 
took it? . . . . . . .. 
 
 
 
 
4.When you travel or leave home, do you sometimes forget to 
bring along your [health concern] medication? . . . . . . . . . . . . 
. . . . . . . . . . . . . . . .. 
 
 
 
 
5.Did you take your [health concern] medicine yesterday? . . . 
. . . . . . . 
  
6.When you feel like your [health concern] is under control, do 
you sometimes stop taking your medicine? . . . . . . . . . . . . . . . 
. . . . . . . . . . . . . . . . . .  
 
 
 
 
7.Taking medication everyday is a real inconvenience for some 
people. Do you ever feel hassled about sticking to your [health 
concern] treatment plan? . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
. . . . . . . . . . . . . . . . . . . . .  
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